|
England and Wales
(State or other jurisdiction of incorporation or organization) |
| |
7374
(Primary Standard Industrial Classification Code Number) |
| |
Not applicable
(I.R.S. Employer Identification Number) |
|
|
Nigel D.J. Wilson
Martin A. Wellington Sidley Austin LLP 1001 Page Mill Road, Building 1 Palo Alto, California 94304 (650) 565 7000 |
| |
Stelios G. Saffos
Adam J. Gelardi Scott W. Westhoff Latham & Watkins LLP 1271 Avenue of the Americas New York, New York 10020 (212) 906-1200 |
|
| | | |
PER ADS
|
| |
TOTAL
|
| ||||||
|
Initial public offering price
|
| | | $ | | | | | | $ | | | |
|
Underwriting discounts and commissions(1)
|
| | | $ | | | | | | $ | | | |
|
Proceeds, before expenses, to Argo Blockchain plc
|
| | | $ | | | | | | $ | | | |
| Jefferies | | |
Barclays
|
|
| Canaccord Genuity | | |
Stifel GMP
|
|
| Compass Point | | |
D.A. Davidson & Co.
|
| |
Ladenburg Thalmann
|
|
| Roth Capital Partners | | |
finnCap Ltd
|
| |
Tennyson Securities
|
|
| TABLE OF CONTENTS | | | |||||
| | | | | ii | | | |
| | | | | iii | | | |
| | | | | 1 | | | |
| | | | | 7 | | | |
| | | | | 9 | | | |
| | | | | 13 | | | |
| | | | | 64 | | | |
| | | | | 65 | | | |
| | | | | 66 | | | |
| | | | | 68 | | | |
| | | | | 69 | | | |
| | | | | 70 | | | |
| | | | | 72 | | | |
| | | | | 74 | | | |
| | | | | 87 | | | |
| | | | | 102 | | | |
| | | | | 111 | | | |
| | | | | 113 | | | |
| | | | | 114 | | | |
| | | | | 136 | | | |
| | | | | 149 | | | |
| | | | | 151 | | | |
| | | | | 158 | | | |
| | | | | 166 | | | |
| | | | | 167 | | | |
| | | | | 167 | | | |
| | | | | 168 | | | |
| | | | | 170 | | | |
| | | | | F-1 | | |
| | |
Month Ended July 31, 2021
|
| |
Month Ended August 31, 2021
|
| ||||||||||||||||||
| | |
£
|
| |
$
|
| |
£
|
| |
$
|
| ||||||||||||
Gross profit
|
| | | | 9,168,743 | | | | | | 12,658,366 | | | | | | 10,427,531 | | | | | | 14,396,250 | | |
Gross margin(1)
|
| | | | 155% | | | | | | 155% | | | | | | 145% | | | | | | 145% | | |
Depreciation of mining equipment
|
| | | | 846,573 | | | | | | 1,168,779 | | | | | | 846,382 | | | | | | 1,168,515 | | |
Change in fair value movement of digital currencies
|
| | | | (5,051,548) | | | | | | (6,974,167) | | | | | | (4,736,507) | | | | | | (6,539,222) | | |
Profit on sale of digital currencies
|
| | | | — | | | | | | — | | | | | | (305,366) | | | | | | (421,588) | | |
Mining profit | | | | | 4,963,768 | | | | | | 6,852,978 | | | | | | 6,232,040 | | | | | | 8,603,955 | | |
Bitcoin and Bitcoin Equivalent Mining Margin
|
| | | | 83% | | | | | | 83% | | | | | | 86% | | | | | | 86% | | |
| | |
Year ended December 31,
|
| |
SIX MONTHS ENDED JUNE 30,
|
| ||||||||||||||||||||||||||||||
| | |
2020
|
| |
2019
|
| |
2021
|
| |
2020
|
| ||||||||||||||||||||||||
| | |
£
|
| |
$
|
| |
£
|
| |
£
|
| |
$
|
| |
£
|
| ||||||||||||||||||
Revenues
|
| | | | 18,957,417 | | | | | | 25,899,623 | | | | | | 8,616,879 | | | | | | 31,085,716 | | | | | | 42,916,940 | | | | | | 11,124,455 | | |
Direct costs
|
| | | | (11,210,889) | | | | | | (15,477,753) | | | | | | (3,476,159) | | | | | | (5,606,856) | | | | | | (7,740,825) | | | | | | (6,787,636) | | |
Depreciation of mining equipment
|
| | | | (5,895,573) | | | | | | (8,139,428) | | | | | | (2,083,636) | | | | | | (4,757,986) | | | | | | (6,568,875) | | | | | | (2,909,480) | | |
Change in fair value of digital
currencies |
| | | | 2,342,538 | | | | | | 3,234,108 | | | | | | (201,747) | | | | | | (6,407,446) | | | | | | (8,846,120) | | | | | | (154,295) | | |
Realized loss on sale of digital
currencies |
| | | | (272,142) | | | | | | (375,719) | | | | | | (132,107) | | | | | | 219,008 | | | | | | 302,362 | | | | | | (90,532) | | |
Gross profit
|
| | | | 3,921,351 | | | | | | 5,413,818 | | | | | | 2,723,230 | | | | | | 14,532,436 | | | | | | 20,063,482 | | | | | | 1,182,512 | | |
Gross margin
|
| | | | 21% | | | | | | 21% | | | | | | 32% | | | | | | 47% | | | | | | 47% | | | | | | 11% | | |
Operating costs and expenses | | | | | | | | | | | | | | | | | | | | | | | |||||||||||||||
Consulting fees
|
| | | | 690,430 | | | | | | 953,208 | | | | | | 1,186,450 | | | | | | 304,379 | | | | | | 420,226 | | | | | | 177,328 | | |
Professional fees
|
| | | | 249,440 | | | | | | 344,377 | | | | | | 607,190 | | | | | | 415,066 | | | | | | 573,040 | | | | | | 171,514 | | |
General and administrative
|
| | | | 1,498,460 | | | | | | 2,526,764 | | | | | | 1,763,405 | | | | | | 1,136,755 | | | | | | 1,569,404 | | | | | | 183,708 | | |
Share based payment charge
|
| | | | 331,733 | | | | | | — | | | | | | — | | | | | | 1,567,608 | | | | | | 2,164,240 | | | | | | — | | |
Gain from reversal of credit loss
|
| | | | (447,242) | | | | | | (617,462) | | | | |
|
—
|
| | | | | — | | | | | | — | | | | | | — | | |
Total operating expenses
|
| | | | 2,322,821 | | | | | | 3,206,887 | | | | | | 3,557,045 | | | | | | 3,423,808 | | | | | | 4,726,910 | | | | | | 532,550 | | |
Operating income/(loss)
|
| | | | 1,598,530 | | | | | | 2,206,931 | | | | | | (833,815) | | | | | | 11,108,628 | | | | | | 15,336,572 | | | | | | 649,962 | | |
Other income (expenses) | | | | | | | | | | | | | | | | | | | | | | | |||||||||||||||
Interest income
|
| | | | 1,389 | | | | | | — | | | | | | 5,617 | | | | | | — | | | | | | — | | | | | | 26 | | |
Interest expense
|
| | | | (157,501) | | | | | | (217,446) | | | | | | (40,853) | | | | | | (410,804) | | | | | | (567,156) | | | | | | (126,914) | | |
|
| | |
Year ended December 31,
|
| |
SIX MONTHS ENDED JUNE 30,
|
| ||||||||||||||||||||||||||||||
| | |
2020
|
| |
2019
|
| |
2021
|
| |
2020
|
| ||||||||||||||||||||||||
| | |
£
|
| |
$
|
| |
£
|
| |
£
|
| |
$
|
| |
£
|
| ||||||||||||||||||
Total other loss
|
| | | | (156,112) | | | | | | (217,446) | | | | | | (35,236) | | | | | | (410,804) | | | | | | (567,156) | | | | | | (126,888) | | |
Income tax expense
|
| | | | — | | | | | | — | | | | | | — | | | | | | (3,483,827) | | | | | | (4,809,772) | | | | | | — | | |
Net income/(loss)
|
| | | | 1,442,418 | | | | | | 1,989,485 | | | | | | (869,051) | | | | | | 7,213,997 | | | | | | 9,959,644 | | | | | | 523,074 | | |
Other comprehensive
income – Foreign exchange gain/(loss) |
| | | | 264,612 | | | | | | 365,323 | | | | | | 178,240 | | | | | | (361,029) | | | | | | (498,437) | | | | | | (431,746) | | |
Total comprehensive income
|
| | | | 1,707,030 | | | | | | 2,354,808 | | | | | | 690,811 | | | | | | 6,852,968 | | | | | | 9,461,207 | | | | | | 91,328 | | |
Basic earnings per share (pence)
|
| | | | 0.6 | | | | | | | | | | | | (0.2) | | | | | | 1.9 | | | | | | | | | | | | 0.2 | | |
Diluted earnings per share (pence)
|
| | | | 0.5 | | | | | | | | | | | | (0.2) | | | | | | 1.8 | | | | | | | | | | | | 0.2 | | |
Weighted average ordinary shares for the purposes of basic earnings per share (millions)
|
| | | | 303.4 | | | | | | | | | | | | 293.8 | | | | | | 381.8 | | | | | | | | | | | | 293.8 | | |
Weighted average ordinary shares for the purposes of diluted earnings per share (millions)
|
| | | | 334.6 | | | | | | | | | | | | 293.8 | | | | | | 393.1 | | | | | | | | | | | | 350.1 | | |
| | |
Year ended December 31,
|
| |
SIX MONTHS ENDED JUNE 30,
|
| ||||||||||||||||||
| | |
2020
|
| |
2019
|
| |
2021(5)
|
| |
2020
|
| ||||||||||||
| | |
(unaudited)
|
| |||||||||||||||||||||
Bitcoin and Bitcoin Equivalents Mined
|
| | | | 2,465 | | | | | | 1,330 | | | | | | 883 | | | | | | 1,669 | | |
Bitcoin and Bitcoin Equivalent Mining Margin(2)
|
| | | | 41% | | | | | | 60% | | | | | | 81% | | | | | | 39% | | |
Average Total Cost Per Bitcoin or Bitcoin Equivalent Mined
|
| |
£6,100
|
| |
£4,431
|
| |
£18,747
|
| |
£5,957
|
| ||||||||||||
Average Direct Cost Per Bitcoin or Bitcoin Equivalent Mined(3)
|
| |
£4,548
|
| |
£2,614
|
| |
£6,350
|
| |
£4,067
|
| ||||||||||||
Bitcoin and Bitcoin Equivalents Held (end of period)
|
| | | | 216 | | | | | | 193 | | | | | | 1,268 | | | | | | 127 | | |
EBITDA(4) | | | | £ | 7,625,309 | | | | | £ | 1,387,386 | | | | | £ | 15,970,278 | | | | | £ | 3,662,424 | | |
| | |
AS OF JUNE 30, 2021
|
| |||||||||||||||||||||||||||||||||
| | |
Actual
|
| |
PRO FORMA(6)
|
| |
Pro Forma, As Adjusted(7)
|
| |||||||||||||||||||||||||||
| | |
£
|
| |
$
|
| |
£
|
| |
$
|
| |
£
|
| |
$
|
| ||||||||||||||||||
Cash and cash equivalents
|
| | | | 16,047,609 | | | | | | 22,155,329 | | | | | | 34,155,677 | | | | | | 47,155,328 | | | | | | 138,619,693 | | | | | | 191,378,348 | | |
Total assets
|
| | | | 139,707,663 | | | | | | 19,28,80,400 | | | | | | 139,707,663 | | | | | | 192,880,400 | | | | | | 244,171,679 | | | | | | 337,103,420 | | |
Total liabilities
|
| | | | 53,755,370 | | | | | | 74,214,664 | | | | | | 71,863,438 | | | | | | 99,214,663 | | | | | | 71,863,438 | | | | | | 99,214,663 | | |
Accumulated surplus
|
| | | | 29,178,867 | | | | | | 40,284,344 | | | | | | 29,178,867 | | | | | | 40,284,344 | | | | | | 29,178,867 | | | | | | 40,284,344 | | |
Total equity
|
| | | | 56,773,426 | | | | | | 78,381,392 | | | | | | 56,773,426 | | | | | | 78,381,392 | | | | | | 161,237,442 | | | | | | 222,604,412 | | |
| | |
Year ended
December 31, |
| |
SIX MONTHS ENDED
June 30, |
| ||||||||||||||||||
| | |
2020
|
| |
2019
|
| |
2021
|
| |
2020
|
| ||||||||||||
| | |
£
|
| |
£
|
| |
£
|
| |||||||||||||||
Gross profit
|
| | | | 3,921,351 | | | | | | 2,723,230 | | | | | | 14,532,436 | | | | | | 1,202,512 | | |
Gross margin
|
| | | | 21% | | | | | | 32% | | | | | | 47% | | | | | | 11% | | |
Depreciation of mining equipment
|
| | | | 5,895,573 | | | | | | 2,083,636 | | | | | | 4,757,986 | | | | | | 2,909,480 | | |
Change in fair value of digital currencies
|
| | | | (2,342,538) | | | | | | 201,747 | | | | | | 6,407,446 | | | | | | 134,295 | | |
Realized loss on sale of digital currencies
|
| | | | 272,142 | | | | | | 132,107 | | | | | | (219,008) | | | | | | 90,532 | | |
Mining profit
|
| | | | 7,746,528 | | | | | | 5,140,720 | | | | | | 25,478,860 | | | | | | 4,336,819 | | |
Bitcoin and Bitcoin Equivalent Mining Margin
|
| | | | 41% | | | | | | 60% | | | | | | 81% | | | | | | 39% | | |
| | |
Year Ended
December31, |
| |
Six Months
Ended June 30, |
| ||||||||||||||||||
| | |
2020
|
| |
2019
|
| |
2021
|
| |
2020
|
| ||||||||||||
| | |
£
|
| |
£
|
| ||||||||||||||||||
Total Cost of Bitcoin and Bitcoin Equivalent Mined .
|
| | | | 15,036,066 | | | | | | 5,893,649 | | | | | | 16,553,280 | | | | | | 9,941,943 | | |
Average Total Cost of Bitcoin and Bitcoin Equivalent Mined
|
| |
£6,100
|
| |
£4,431
|
| |
£18,747
|
| |
£5,957
|
| ||||||||||||
Less: Depreciation.
|
| | | | (5,895,573) | | | | | | (2,083,636) | | | | | | (4,757,986) | | | | | | (2,909,480) | | |
Change in fair value of digital currencies.
|
| | | | 2,342,538 | | | | | | (201,747) | | | | | | (6,407,446) | | | | | | (154,295) | | |
Realized Loss on Sale of Digital Currencies
|
| | | | (272,142) | | | | | | (132,107) | | | | | | (219,008) | | | | | | (90,532) | | |
Direct Cost of Bitcoin and Bitcoin Equivalent Mined.
|
| | | | 11,210,889 | | | | | | 3,476,159 | | | | | | 5,606,856 | | | | | | 6,787,636 | | |
Average Direct Cost of Bitcoin and Bitcoin
|
| | | | 4,548 | | | | | | 2,614 | | | | | | 6,350 | | | | | | 4,067 | | |
|
| | |
YEAR ENDED
DECEMBER 31, |
| |
SIX MONTHS ENDED JUNE 30,
|
| ||||||||||||||||||
| | |
2020
|
| |
2019
|
| |
2021
|
| |
2020
|
| ||||||||||||
| | |
£
|
| |
£
|
| ||||||||||||||||||
Net income/(loss)
|
| | | | 1,442,418 | | | | | | (869,051) | | | | | | 7,213,997 | | | | | | 523,074 | | |
Interest
|
| | | | | | | | | | | | | | | | | | | | | | | | |
Interest expense
|
| | | | 157,501 | | | | | | 40,853 | | | | | | 410,804 | | | | | | 126,914 | | |
Interest income
|
| | | | (1,389) | | | | | | (5,617) | | | | | | — | | | | | | (26) | | |
Depreciation of mining equipment
|
| | | | 5,895,573 | | | | | | 2,066,248 | | | | | | 4,757,986 | | | | | | 2,909,480 | | |
Depreciation of mining facilities
|
| | | | — | | | | | | — | | | | | | 35,155 | | | | | | — | | |
Depreciation of improvements to mining facilities
|
| | | | 17,039 | | | | | | 17,388 | | | | | | 9,544 | | | | | | 6,680 | | |
Amortization
|
| | | | 114,167 | | | | | | 137,565 | | | | | | 68,509 | | | | | | 96,302 | | |
Taxation
|
| | | | — | | | | | | — | | | | | | 3,483,827 | | | | | | — | | |
EBITDA
|
| | | | 7,625,309 | | | | | | 1,387,386 | | | | | | 15,979,822 | | | | | | 3,662,424 | | |
| | |
AS OF JUNE 30, 2021
|
| | | |||||||||||||||||||||||||||||||
| | |
Actual
|
| |
PRO
FORMA |
| |
Pro Forma, As Adjusted(1)
|
| |||||||||||||||||||||||||||
| | |
£
|
| |
$
|
| |
£
|
| |
$
|
| |
£
|
| |
$
|
| ||||||||||||||||||
Cash and cash equivalents
|
| | | | 16,047,609 | | | | | | 22,155,329 | | | | | | 34,155,677 | | | | | | 47,155,328 | | | | | | 120,511,625 | | | | | | 166,378,349 | | |
Total Debt
|
| | | | 25,060,763 | | | | | | 34,598,889 | | | | | | 43,168,831 | | | | | | 59,598,888 | | | | | | 25,060,763 | | | | | | 34,598,889 | | |
Stockholders’ equity
|
| | | | 381,832 | | | | | | 527,157 | | | | | | 381,832 | | | | | | 527,157 | | | | | | 456,832 | | | | | | 630,702 | | |
Common stock, £0.001 par value;
381,832,335 shares authorized, issued and outstanding at June 30, 2021 |
| | | | 381,832 | | | | | | 527,157 | | | | | | 381,832 | | | | | | 527,157 | | | | | | 381,832 | | | | | | 527,157 | | |
Additional paid-in capital
|
| | | | 29,178,867 | | | | | | 40,284,344 | | | | | | 29,178,867 | | | | | | 40,284,344 | | | | | | 133,567,883 | | | | | | 184,403,819 | | |
Accumulated other comprehensive income
|
| | | | 81,823 | | | | | | 112,965 | | | | | | 81,823 | | | | | | 112,965 | | | | | | 81,823 | | | | | | 112,965 | | |
Share based payment reserve
|
| | | | 992,324 | | | | | | 1,370,002 | | | | | | 992,324 | | | | | | 1,370,002 | | | | | | 992,324 | | | | | | 1,370,002 | | |
Accumulated Surplus
|
| | | | 29,178,867 | | | | | | 40,284,344 | | | | | | 29,178,867 | | | | | | 40,284,344 | | | | | | 29,178,867 | | | | | | 40,284,344 | | |
Total Capitalization
|
| | | | 101,303,917 | | | | | | 139,860,188 | | | | | | 137,520,053 | | | | | | 189,860,185 | | | | | | 310,231,948 | | | | | | 428,306,227 | | |
|
Assumed initial public offering price per ADS
|
| | | | | | | | | $ | 18.40 | | |
|
Historical net tangible book value per ADS as of June 30, 2021
|
| | | $ | 3.11 | | | | | | | | |
|
Increase in net tangible book value per ADS attributable to this offering
|
| | | | 2.22 | | | | | | | | |
|
As adjusted net tangible book value per ADS after this offering
|
| | | | 5.33 | | | | | | | | |
|
Dilution per ADS to new investors participating in this offering
|
| | | | | | | | | $ | 13.07 | | |
|
| | |
Ordinary Shares
Purchased (including those represented by ADSs) |
| |
Total
Consideration |
| |
Average Price Per
Ordinary Share (including those represented by ADSs) |
| |||||||||||||||||||||
| | |
Number
|
| |
Percent
|
| |
Amount
|
| |
Percent
|
| | | | | | | ||||||||||||
Existing shareholders
|
| | | | 381,832,335 | | | | | | 84.00% | | | | | $ | 111,761,733 | | | | | | 43.7% | | | | | $ | 0.29 | | |
New investors
|
| | | | 75,000,000 | | | | | | 16.00% | | | | | $ | 144,223,020 | | | | | | 56.3% | | | | | $ | 1.92 | | |
Totals
|
| | | | 456,832,335 | | | | | | 100.0% | | | | | $ | 255,984,985 | | | | | | 100.0% | | | | | $ | 0.56 | | |
| | |
Year ended December 31,
|
| |
SIX MONTHS ENDED JUNE 30,
|
| ||||||||||||||||||
| | |
2020
|
| |
2019
|
| |
2021
|
| |
2020
|
| ||||||||||||
| | |
Unaudited
|
| |||||||||||||||||||||
Bitcoin and Bitcoin Equivalents Mined
|
| | | | 2,465 | | | | | | 1,330 | | | | | | 883 | | | | | | 1,669 | | |
Gross Margin
|
| | | | 21% | | | | | | 32% | | | | | | 47% | | | | | | 11% | | |
Bitcoin and Bitcoin Equivalent Mining Margin
|
| | | | 41% | | | | | | 60% | | | | | | 81% | | | | | | 39% | | |
Average Total Cost Per Bitcoin or Bitcoin Equivalent Mined
|
| | | £ | 6,100 | | | | | £ | 4,431 | | | | | £ | 18,747 | | | | | £ | 5,957 | | |
Average Direct Cost Per Bitcoin or Bitcoin Equivalent Mined
|
| | | £ | 4,548 | | | | | £ | 2,614 | | | | | £ | 6,350 | | | | | £ | 4,067 | | |
Bitcoin and Bitcoin Equivalents Held (end of period)
|
| | | | 216 | | | | | | 193 | | | | | | 1,268 | | | | | | 127 | | |
Net Income/(Loss)
|
| | | £ | 1,442,418 | | | | | £ | (869,051) | | | | | £ | 7,213,997 | | | | | £ | 523,074 | | |
EBITDA
|
| | | £ | 7,625,309 | | | | | £ | 1,387,386 | | | | | £ | 15,978,266 | | | | | £ | 3,662,424 | | |
| | |
Year ended December 31,
|
| |
SIX MONTHS ENDED JUNE 30,
|
| ||||||||||||||||||||||||||||||
| | |
2020
|
| |
2020
|
| |
2019
|
| |
2021
|
| |
2021
|
| |
2020
|
| ||||||||||||||||||
| | |
£
|
| |
$
|
| |
£
|
| |
£
|
| |
$
|
| |
£
|
| ||||||||||||||||||
Revenues | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Total revenue
|
| | | | 18,957,417 | | | | | | 25,899,623 | | | | | | 8,616,879 | | | | | | 31,085,716 | | | | | | 42,916,940 | | | | | | 11,124,455 | | |
Direct costs
|
| | | | (11,210,889) | | | | | | (15,316,317) | | | | | | (3,476,159) | | | | | | (5,606,856) | | | | | | (7,740,825) | | | | | | (6,787,636) | | |
Depreciation of mining equipment
|
| | | | (5,895,573) | | | | | | (8,054,532) | | | | | | (2,083,636) | | | | | | (4,757,986) | | | | | | (6,568,875) | | | | | | (2,909,480) | | |
Change in fair value of digital currencies
|
| | | | 2,342,538 | | | | | | 3,200,376 | | | | | | (201,747) | | | | | | (6,407,446) | | | | | | (8,846,120) | | | | | | (134,295) | | |
Realized loss on sale of digital currencies
|
| | | | (272,142) | | | | | | (371,800) | | | | | | (132,107) | | | | | | 219,008 | | | | | | 302,362 | | | | | | (90,532) | | |
Gross profit
|
| | | | 3,921,351 | | | | | | 5,357,350 | | | | | | 2,723,230 | | | | | | 14,532,436 | | | | | | 20,063,481 | | | | | | 1,182,512 | | |
Gross margin
|
| | | | 21% | | | | | | 21% | | | | | | 32% | | | | | | 47% | | | | | | 47% | | | | | | 11% | | |
Operating costs and expenses
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Consulting fees
|
| | | | 690,430 | | | | | | 943,265 | | | | | | 1,186,450 | | | | | | 304,379 | | | | | | 420,226 | | | | | | 177,328 | | |
Professional fees
|
| | | | 249,440 | | | | | | 340,785 | | | | | | 607,190 | | | | | | 415,066 | | | | | | 573,040 | | | | | | 171,514 | | |
General administrative
|
| | | | 1,830,193 | | | | | | 2,500,410 | | | | | | 1,763,405 | | | | | | 1,136,755 | | | | | | 1,569,404 | | | | | | 183,708 | | |
Gain from reversal of credit loss
|
| | | | (447,242) | | | | | | (611,022) | | | | |
|
—
|
| | | | | — | | | | | | — | | | | | | — | | |
Share based payment
|
| | | | — | | | | | | — | | | | | | — | | | | | | 1,567,608 | | | | | | 2,164,240 | | | | | | — | | |
Total operating expenses
|
| | | | 2,322,821 | | | | | | 3,173,438 | | | | | | 3,557,045 | | | | | | 3,423,808 | | | | | | 4,726,909 | | | | | | 532,550 | | |
Operating income/(loss)
|
| | | | 1,598,530 | | | | | | 2,183,912 | | | | | | (833,815) | | | | | | 11,108,628 | | | | | | 15,336,572 | | | | | | 649,962 | | |
Interest income
|
| | | | 1,389 | | | | | | 1,898 | | | | | | 5,617 | | | | | | — | | | | | | — | | | | | | 26 | | |
Interest expense
|
| | | | (157,501) | | | | | | (215,178) | | | | | | (40,853) | | | | | | (410,804) | | | | | | (567,156) | | | | | | (126,914) | | |
Total other income
|
| | | | (156,112) | | | | | | (213,280) | | | | | | (35,236) | | | | | | (410,804) | | | | | | (567,156) | | | | | | (126,888) | | |
Income/(loss) before income taxes
|
| | | | 1,442,418 | | | | | | 1,970,632 | | | | | | (869,051) | | | | | | 10,697,824 | | | | | | 14,769,415 | | | | | | 523,074 | | |
Income tax expense
|
| | | | — | | | | | | — | | | | | | — | | | | | | (3,483,827) | | | | | | (4,809,771) | | | | | | — | | |
Net income/(loss)
|
| | | | 1,442,418 | | | | | | 1,970,632 | | | | | | (869,051) | | | | | | 7,213,997 | | | | | | 9,959,644 | | | | | | 523,074 | | |
Other comprehensive income – Foreign exchange gain/(loss)
|
| | | | 264,612 | | | | | | 361,513 | | | | | | 178,240 | | | | | | (361,029) | | | | | | (498,437) | | | | | | (431,746) | | |
Total comprehensive income
|
| | | | 1,707,030 | | | | | | 2,332,145 | | | | | | (690,811) | | | | | | 6,852,968 | | | | | | 9,461,208 | | | | | | 91,328 | | |
|
| | |
Year ended December 31,
|
| |
SIX MONTHS ENDED JUNE 30,
|
| ||||||||||||||||||||||||||||||
| | |
2020
|
| |
2020
|
| |
2019
|
| |
2021
|
| |
2021
|
| |
2020
|
| ||||||||||||||||||
| | |
£
|
| |
$
|
| |
£
|
| |
£
|
| |
$
|
| |
£
|
| ||||||||||||||||||
Net cash flow from / (used in) operating activities.
|
| | | | 2,409,830 | | | | | | 3,292,310 | | | | | | (887,852) | | | | | | 2,372,843 | | | | | | 3,275,947 | | | | | | 3,696,386 | | |
Net cash (used in) investing activities
|
| | | | (1,102,300) | | | | | | (1,505,962) | | | | | | (16,424,467) | | | | | | (50,198,757) | | | | | | (69,304,404) | | | | | | (1,619,997) | | |
Net cash generated from / (used in) financing activities
|
| | | | 581,889 | | | | | | 794,976 | | | | | | 1,084,218 | | | | | | 61,822,761 | | | | | | 85,352,504 | | | | | | (924,369) | | |
Net increase /
(decrease) in cash and cash equivalents |
| | | | 1,889,419 | | | | | | 2,581,324 | | | | | | (16,228,101) | | | | | | 13,996,847 | | | | | | 19,324,047 | | | | | | 1,155,020 | | |
Location
|
| |
Owned or Hosted
|
| |
Facility Size (ft)
|
| |
Power Capacity (MW)(2)
|
|
Quebec, Canada | | | Owned | | | 40,000 | | | 15 | |
Quebec, Canada | | | Owned | | | 100,000 | | | 5 | |
Quebec, Canada | | | Hosted | | | N/A | | | 1.1 | |
Kentucky, United States | | | Hosted | | | 260,000 | | | 17.4 | |
Georgia, United States | | | Hosted | | | 54,000 | | | 3.2 | |
North Carolina, United States | | | Hosted | | | 250,000 | | | 2.9 | |
Texas, United States | | | Owned | | |
Under construction
|
| | Up to 200(1) | |
Name
|
| |
Age
|
| |
Position(s)
|
| |||
Executive Officers | | | | | | | | | | |
Peter Wall(1)
|
| | | | 45 | | | | Chief Executive Officer and Interim Chairman | |
Alex Appleton(2)
|
| | | | 41 | | | | Principal Financial Officer and Director | |
Non-Executive Directors | | | | | | | | | | |
Sarah Gow(3)
|
| | | | 50 | | | | Director | |
Maria Perrella(4)
|
| | | | 55 | | | | Director | |
Matthew Shaw
|
| | | | 61 | | | | Director | |
Colleen Sullivan(5)
|
| | | | 47 | | | | Director | |
Name and Principal Position
|
| |
Year
|
| |
Salary
(£) |
| |
Bonus(1)
(£) |
| |
Total(2)
(£) |
| ||||||||||||
Peter Wall(3)
|
| | | | 2020 | | | | | | 213,873 | | | | | | 27,049 | | | | | | 240,922 | | |
Chief Executive Officer and Interim Chairman
|
| | | | | | | | | | | | | | | | | | | | | | | | |
Ian MacLeod
|
| | | | 2020 | | | | | | 128,539 | | | | | | 36,444 | | | | | | 164,983 | | |
Former Executive Chairman
|
| | | | | | | | | | | | | | | | | | | | | | | | |
Alex Appleton(4)
|
| | | | 2020 | | | | | | 35,500 | | | | | | 4,950 | | | | | | 40,450 | | |
Principal Financial Officer
|
| | | | | | | | | | | | | | | | | | | | | | | | |
James Savage(5)
|
| | | | 2020 | | | | | | 47,035 | | | | | | — | | | | | | 47,035 | | |
Former Principal Financial Officer
|
| | | | | | | | | | | | | | | | | | | | | | | | |
Timothy Le Druillenec(6)
|
| | | | 2020 | | | | | | 30,000 | | | | | | — | | | | | | 30,000 | | |
Former Principal Financial Officer
|
| | | | | | | | | | | | | | | | | | | | | | | | |
Name
|
| |
Ordinary
Shares Underlying Options |
| |
Exercise
Price Per Ordinary Share (£) |
| |
Grant Date
|
| |
Expiration Date
(if applicable) |
| ||||||||||||
Executive officers | | | | | | | | | | | | | | | | | | | | | | | | | |
Peter Wall
|
| | | | 1,000,000 | | | | | | 0.16 | | | | | | 07/25/2018 | | | | | | 07/25/2024 | | |
| | | | | 5,700,000 | | | | | | 0.07 | | | | | | 02/05/2020 | | | | | | 02/04/2030 | | |
Ian MacLeod
|
| | | | 1,900,000 | | | | | | 0.07 | | | | | | 02/05/2020 | | | | | | 07/25/2024 | | |
Alex Appleton
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Timothy Le Druillenec
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Non-executive directors(1) | | | | | | | | | | | | | | | | | | | | | | | | | |
Matthew Shaw
|
| | | | 1,000,000 | | | | | | 0.16 | | | | | | 07/17/2019 | | | | | | 07/17/2025 | | |
| | | | | 475,000 | | | | | | 0.07 | | | | | | 02/05/2020 | | | | | | 07/25/2024 | | |
James Savage
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Marco D’Attanasio
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Name
|
| |
Fees Delivered
in Cash (£) |
| |
Fees Delivered
in Shares (£) |
| |
Total
Fees (£) |
| |||||||||
Non-executive directors(1) | | | | | | | | | | | | | | | | | | | |
Matthew Shaw
|
| | | | 36,532 | | | | | | — | | | | | | 40,862 | | |
James Savage
|
| | | | 8,750 | | | | | | — | | | | | | 8,750 | | |
Marco D’Attanasio
|
| | | | 12,500 | | | | | | — | | | | | | 12,500 | | |
Timothy Le Druillenec
|
| | | | 6,000 | | | | | | — | | | | | | 6,000 | | |
Name of Beneficial Owner
|
| |
Number of
Ordinary Shares Beneficially Owned |
| |
Percentage of Ordinary Shares
Beneficially Owned |
| ||||||||||||
|
Before Offering
|
| |
After Offering
|
| ||||||||||||||
3% or Greater Shareholders: | | | | | | | | | | | | | | | | | | | |
Amplify Transformational Data Sharing ETF(1)
|
| | | | 20,446,985 | | | | | | 5.35% | | | | | | 4.48% | | |
Executive Officers and Directors: | | | | | | | | | | | | | | | | | | | |
Peter Wall
|
| | | | * | | | | | | * | | | | | | * | | |
Alex Appleton
|
| | | | * | | | | | | * | | | | | | * | | |
Matthew Shaw
|
| | | | * | | | | | | * | | | | | | * | | |
Sarah Gow
|
| | | | * | | | | | | * | | | | | | * | | |
Colleen Sullivan
|
| | | | * | | | | | | * | | | | | | * | | |
Maria Perrella
|
| | | | * | | | | | | * | | | | | | * | | |
All current directors and executive officers as a group (6 persons)
|
| | | | | | | | | | | | | | | | | | |
| | |
Number of
Options and Warrants |
| |
Weighted Average
Exercise Price (£) |
| ||||||
Outstanding, as of January 1, 2021
|
| | | | 41,776,456 | | | | | | 0.12 | | |
Granted
|
| | | | 2,841,886 | | | | | | 1.00 | | |
Exercised
|
| | | | (33,498,922) | | | | | | 0.12 | | |
Lapsed
|
| | | | (360,523) | | | | | | 0.08 | | |
Outstanding, as of June 30, 2021
|
| | | | 10,758,897 | | | | | | 0.33 | | |
Exercisable, as of June 30, 2021
|
| | | | 3,869,793 | | | | | | 0.10 | | |
| | |
England and Wales
|
| |
Delaware
|
|
Number of Directors
|
| | Under the Companies Act, a public limited company must have at least two directors and the number of directors may be fixed by or in the manner provided in a company’s articles of association. | | | Under Delaware law, a corporation must have at least one director and the number of directors shall be fixed by or in the manner provided in the bylaws. | |
Removal of Directors
|
| | Under the Companies Act, shareholders may remove a director without cause by an ordinary resolution (which is passed by a simple majority of those voting in person or by proxy at a general meeting) irrespective of any provisions of any service contract the director has with the company, provided 28 clear days’ notice of the resolution has been given to the company and its shareholders. On receipt of notice of an intended resolution to remove a director, the company must forthwith send a copy of the notice to the director concerned. Certain other procedural requirements under the Companies Act must also be followed such as allowing the director to make representations against his or her removal either at the meeting or in writing. | | | Under Delaware law, any director or the entire board of directors may be removed, with or without cause, by the holders of a majority of the shares then entitled to vote at an election of directors, except (a) unless the certificate of incorporation provides otherwise, in the case of a corporation whose board of directors is classified, shareholders may effect such removal only for cause, or (b) in the case of a corporation having cumulative voting, if less than the entire board of directors is to be removed, no director may be removed without cause if the votes cast against his removal would be sufficient to elect him if then cumulatively voted at an election of the entire board of directors, or, if there are classes of directors, at an election of the class of directors of which he is a part. | |
Vacancies on the Board of Directors
|
| | Under the laws of England and Wales, the procedure by which directors, other than a company’s initial directors, are appointed is generally set out in a company’s articles of association, provided that where two or more persons are appointed as directors of a public limited company by resolution of the shareholders, resolutions appointing each director must be voted on individually. | | | Under Delaware law, vacancies and newly created directorships may be filled by a majority of the directors then in office (even though less than a quorum) or by a sole remaining director unless (a) otherwise provided in the certificate of incorporation or by-laws of the corporation or (b) the certificate of incorporation directs that a particular class of stock is to elect such director, in which case a majority of the other directors elected by such class, or a sole remaining director elected by such class, will fill such vacancy. | |
| | |
England and Wales
|
| |
Delaware
|
|
Annual General Meeting
|
| | Under the Companies Act, a public limited company must hold an annual general meeting in each six-month period following its annual accounting reference date. | | | Under Delaware law, the annual meeting of stockholders shall be held at such place, on such date and at such time as may be designated from time to time by the board of directors or as provided in the certificate of incorporation or by the bylaws. | |
General Meeting
|
| |
Under the Companies Act, a general meeting of the shareholders of a public limited company may be called by the directors.
Shareholders holding at least 5% of the paid-up capital of the company carrying voting rights at general meetings (excluding any paid up capital held as treasury shares) can require the directors to call a general meeting and, if the directors fail to do so within a certain period, may themselves (or any of them representing more than one half of the total voting rights of all of them) convene a general meeting.
|
| | Under Delaware law, special meetings of the stockholders may be called by the board of directors or by such person or persons as may be authorized by the certificate of incorporation or by the bylaws. | |
Notice of General Meetings
|
| | Subject to a company’s articles of association providing for a longer period, under the Companies Act, 21 clear days’ notice must be given for an annual general meeting and any resolutions to be proposed at the meeting. Under the Companies Act, as a traded company, the minimum notice period for any other general meeting of the Company is also 21 clear days, unless certain conditions relating to the general meeting are met and at the preceding Annual General Meeting shareholders have approved by special resolution the holding of general meetings on 14 clear days’ notice. In addition, certain matters, such as the removal of directors or auditors, require special notice, which is 28 clear | | | Under Delaware law, unless otherwise provided in the certificate of incorporation or bylaws, written notice of any meeting of the stockholders must be given to each stockholder entitled to vote at the meeting not less than 10 nor more than 60 days before the date of the meeting and shall specify the place, date, hour, and purpose or purposes of the meeting. | |
| | |
England and Wales
|
| |
Delaware
|
|
| | | company other than shares that, with respect to dividends and capital, carry a right to participate only up to a specified amount in a distribution, referred to as “ordinary shares,” or (2) rights to subscribe for, or to convert securities into, ordinary shares, proposed to be allotted for cash must be offered first to the existing equity shareholders in the Company in proportion to the respective nominal value of their holdings, unless an exception applies or a special resolution to the contrary has been passed by shareholders in a general meeting or the articles of association provide otherwise in each case in accordance with the provisions of the Companies Act. | | | subscribe to additional issues of stock or to any security convertible into such stock unless, and except to the extent that, such rights are expressly provided for in the certificate of incorporation. | |
Authority to Allot
|
| | Under the Companies Act, the directors of a company must not allot shares or grant of rights to subscribe for or to convert any security into shares unless an exception applies or an ordinary resolution to the contrary has been passed by shareholders in a general meeting or the articles of association provide otherwise in each case in accordance with the provisions of the Companies Act. | | | Under Delaware law, if the corporation’s charter or certificate of incorporation so provides, the board of directors has the power to authorize the issuance of stock. It may authorize capital stock to be issued for consideration consisting of cash, any tangible or intangible property or any benefit to the corporation or any combination thereof. It may determine the amount of such consideration by approving a formula. In the absence of actual fraud in the transaction, the judgment of the directors as to the value of such consideration is conclusive. | |
Liability of Directors and Officers
|
| | Under the Companies Act, any provision, whether contained in a company’s articles of association or any contract or otherwise, that purports to exempt a director of a company, to any extent, from any liability that would otherwise attach to him in connection with any negligence, default, breach of duty or breach of trust in relation to the Company is void. | | | Under Delaware law, a corporation’s certificate of incorporation may include a provision eliminating or limiting the personal liability of a director to the corporation and its stockholders for damages arising from a breach of fiduciary duty as a director. However, no provision can limit the liability of a director for: | |
| | |
England and Wales
|
| |
Delaware
|
|
| | | Any provision by which a company directly or indirectly provides an indemnity, to any extent, for a director of the Company or of an associated company against any liability attaching to him in connection with any negligence, default, breach of duty or breach of trust in relation to the company of which he is a director is also void except as permitted by the Companies Act, which provides exceptions for the company to (a) purchase and maintain insurance against such liability; (b) provide a “qualifying third party indemnity” (being an indemnity against liability incurred by the director to a person other than the company or an associated company or criminal proceedings in which he is convicted); and (c) provide a “qualifying pension scheme indemnity” (being an indemnity against liability incurred in connection with our activities as trustee of an occupational pension plan). | | |
▪
any breach of the director’s duty of loyalty to the corporation or its stockholders;
▪
acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law;
▪
intentional or negligent payment of unlawful dividends or stock purchases or redemptions; or
▪
any transaction from which the director derives an improper personal benefit.
|
|
Voting Rights
|
| | For a company incorporated under the laws of England and Wales, it is usual for the articles of association to provide that, unless a poll is demanded by the shareholders of a company or is required by the chairman of the meeting or our articles of association, shareholders shall vote on all resolutions on a show of hands. Under the Companies Act, a company’s articles may determine the procedure for demanding a poll, provided any provision in the articles is void if it has the effect of making ineffective a demand for a poll by (a) not fewer than five shareholders having the right to vote on the resolution; (b) any shareholder(s) representing not | | | Delaware law provides that, unless otherwise provided in the certificate of incorporation, each stockholder is entitled to one vote for each share of capital stock held by such stockholder. | |
| | |
England and Wales
|
| |
Delaware
|
|
| | |
less than 10% of the total voting rights of all the shareholders having the right to vote on the resolution (excluding any voting rights attaching to treasury shares); or (c) any shareholder(s) holding shares in the company conferring a right to vote on the resolution (excluding any voting rights attaching to treasury shares) being shares on which an aggregate sum has been paid up equal to not less than 10% of the total sum paid up on all the shares conferring that right. A company’s articles of association may provide more extensive rights for shareholders to call a poll.
Under the laws of England and Wales, an ordinary resolution is passed on a show of hands if it is approved by a simple majority (more than 50%) of the votes cast by shareholders present (in person or by proxy) and entitled to vote. If a poll is demanded, an ordinary resolution is passed if it is approved by holders representing a simple majority of the total voting rights of shareholders present, in person or by proxy, who, being entitled to vote, vote on the resolution. Special resolutions require the affirmative vote of not less than 75% of the votes cast by shareholders present, in person or by proxy, at the meeting. If a poll is demanded, a special resolution is passed if it is approved by holders representing not less than 75% of the total voting rights of shareholders in person or by proxy who, being entitled to vote, vote on the resolution.
|
| | | |
Shareholder Vote on Certain Transactions
|
| | The Companies Act provides for schemes of arrangement, which are arrangements or compromises between a company and any class | | | Generally, under Delaware law, unless the certificate of incorporation provides for the vote of a larger portion of the stock, | |
| | |
England and Wales
|
| |
Delaware
|
|
| | |
of shareholders or creditors and used in certain types of reconstructions, amalgamations, capital reorganizations, or takeovers. These arrangements require:
▪
the approval at a shareholders’ or creditors’ meeting convened by order of the court, of a majority in number of shareholders or creditors or a class thereof representing 75% in value of the capital held by, or debt owed to, the class of shareholders or creditors, or class thereof present and voting, either in person or by proxy; and
▪
the approval of the court.
|
| |
completion of a merger, consolidation, sale, lease or exchange of all or substantially all of a corporation’s assets or dissolution requires:
▪
the approval of the board of directors; and
▪
approval by the vote of the holders of a majority of the outstanding stock or, if the certificate of incorporation provides for more or less than one vote per share, a majority of the votes of the outstanding stock of a corporation entitled to vote on the matter.
|
|
Standard of Conduct for Directors
|
| |
Under the laws of England and Wales, a director owes various statutory and fiduciary duties to the company, including:
▪
to act in the way he considers, in good faith, would be most likely to promote the success of the company for the benefit of its members as a whole, and in doing so have regard (amongst other matters) to: (i) the likely consequences of any decision in the long-term, (ii) the interests of the company’s employees, (iii) the need to foster the company’s business relationships with suppliers, customers and others, (iv) the impact of the company’s operations on the community and the environment, (v) the desirability to maintain a reputation for high standards of business conduct, and (vi) the need to act fairly as between members of the company;
▪
to avoid a situation in which he has, or can have, a direct or indirect interest that conflicts, or possibly conflicts, with the
|
| |
Delaware law does not contain specific provisions setting forth the standard of conduct of a director. The scope of the fiduciary duties of directors is generally determined by the courts of the State of Delaware. In general, directors have a duty to act without self-interest, on a well-informed basis and in a manner they reasonably believe to be in the best interest of the stockholders.
Directors of a Delaware corporation owe fiduciary duties of care and loyalty to the corporation and to its shareholders. The duty of care generally requires that a director act in good faith, with the care that an ordinarily prudent person would exercise under similar circumstances. Under this duty, a director must inform himself of all material information reasonably available regarding a significant transaction. The duty of loyalty requires that a director act in a manner he reasonably believes to be in the best interests of the corporation. He must not
|
|
| | |
England and Wales
|
| |
Delaware
|
|
| | |
interests of the company;
▪
to act in accordance with our constitution and only exercise his powers for the purposes for which they are conferred;
▪
to exercise independent judgment;
▪
to exercise reasonable care, skill, and diligence;
▪
not to accept benefits from a third party conferred by reason of his being a director or doing, or not doing, anything as a director; and
▪
a duty to declare any interest that he has, whether directly or indirectly, in a proposed or existing transaction or arrangement with the company.
|
| |
use his corporate position for personal gain or advantage. In general, but subject to certain exceptions, actions of a director are presumed to have been made on an informed basis, in good faith and in the honest belief that the action taken was in the best interests of the corporation. However, this presumption may be rebutted by evidence of a breach of one of the fiduciary duties. Delaware courts have also imposed a heightened standard of conduct upon directors of a Delaware corporation who take any action designed to defeat a threatened change in control of the corporation.
In addition, under Delaware law, when the board of directors of a Delaware corporation approves the sale or break-up of a corporation, the board of directors may, in certain circumstances, have a duty to obtain the highest value reasonably available to the shareholders.
|
|
Shareholder Litigation
|
| | Under the laws of England and Wales, generally, the company, rather than its shareholders, is the proper claimant in an action in respect of a wrong done to the company or where there is an irregularity in the company’s internal management. Notwithstanding this general position, the Companies Act provides that (1) a court may allow a shareholder to bring a derivative claim (that is, an action in respect of and on behalf of the company) in respect of a cause of action arising from a director’s negligence, default, breach of duty or breach of trust and (2) a shareholder may bring a claim for a court order where our affairs have been or are being conducted | | |
Under Delaware law, a stockholder may initiate a derivative action to enforce a right of a corporation if the corporation fails to enforce the right itself. The complaint must:
▪
state that the plaintiff was a stockholder at the time of the transaction of which the plaintiff complains or that the plaintiff’s shares thereafter devolved on the plaintiff by operation of law; and
▪
allege with particularity the efforts made by the plaintiff to obtain the action the plaintiff desires from the directors and the reasons for the plaintiff’s failure to obtain the action; or
▪
state the reasons for not making the effort.
|
|
| | |
England and Wales
|
| |
Delaware
|
|
| | | in a manner that is unfairly prejudicial to some of its shareholders. | | | Additionally, the plaintiff must remain a stockholder through the duration of the derivative suit. The action will not be dismissed or compromised without the approval of the Delaware Court of Chancery. | |
Underwriter
|
| |
Number of ADSs
|
| |||
Jefferies LLC
|
| | | | | | |
Barclays Capital Inc.
|
| | | | | | |
Canaccord Genuity LLC
|
| | | | | | |
Stifel Nicolaus Canada Inc
|
| | | | | | |
Compass Point Research & Trading, LLC
|
| | | | | | |
D.A. Davidson & Co
|
| | | | | | |
Ladenburg Thalmann & Co. Inc
|
| | | | | | |
Roth Capital Partners, LLC
|
| | | | | | |
finnCap Ltd
|
| | | | | | |
Tennyson Securities, a trading name of Shard Capital LLP
|
| | | | | | |
Total
|
| | | | | | |
|
| | |
Per ADS
|
| |
Total
|
| ||||||||||||||||||
| | |
Without
Option to Purchase Additional ADSs |
| |
With
Option to Purchase Additional ADSs |
| |
Without
Option to Purchase Additional ADSs |
| |
With
Option to Purchase Additional ADSs |
| ||||||||||||
Public offering price
|
| | | $ | | | | | | $ | | | | | | $ | | | | | | $ | | | |
Underwriting discounts and commissions paid by us
|
| | | $ | | | | | | $ | | | | | | $ | | | | | | $ | | | |
Proceeds to us, before expenses
|
| | | $ | | | | | | $ | | | | | | $ | | | | | | $ | | | |
Expense
|
| |
Amount
|
| |||
SEC registration fee
|
| | | $ | 17,859.67 | | |
Nasdaq initial listing fee
|
| | | $ | 295,000.00 | | |
FINRA filing fee
|
| | | $ | 24,305.00 | | |
Printing expenses
|
| | | $ | 122,500.00 | | |
Legal fees and expenses
|
| | | $ | 3,200,000.00 | | |
Accounting fees and expenses
|
| | | $ | 50,000.00 | | |
Miscellaneous fees and expenses
|
| | | $ | 300,000.00 | | |
Total | | | | $ | 3,985,359.67 | | |
| | |
Page
|
| |||
| | | | F-2 | | | |
Consolidated Financial Statements: | | | |||||
| | | | F-5 | | | |
| | | | F-6 | | | |
| | | | F-7 | | | |
| | | | F-8 | | | |
| | | | F-9 | | |
Critical audit matter
|
| |
How we addressed the matter in our audit
|
|
Revenue recognition (Note 19)
There is an inherent risk around the accuracy and completeness of revenue. |
| | In responding to the identified critical audit matter we completed the following audit procedures: | |
Revenues are received from participation in the mining pools, which incorporate both block rewards and transaction fees, and gives rise to a completeness risk. The fair value of crypto assets received are in addition subject to high levels of volatility, therefore generating a significant risk of misstatement in respect of the accuracy of revenue recognised. | | |
▪
Updating our understanding of the internal control environment in operation for the significant income streams and obtaining an understanding of whether the key controls within these systems have been operating in the period under audit;
▪
Performing substantive transactional testing of income recognised in the financial statements, by vouching a sample of transactions within the group’s wallets to the respective blockchain, and testing the fair value on initial recognition;
▪
Vouching a sample of transactions directly from the blockchain back to the group’s wallets to confirm completeness of revenue;
▪
Undertaking an analytical review of total revenue expected to be recognised within these financial statements by assessing the total hashpower contributed onto the network by the group against total block rewards and transaction fees issued over the year;
▪
Vouching a sample of cryptocurrencies sold for fiat currency or separate cryptocurrencies and recalculating the gain or loss on disposal;
▪
Performing a recalculation of the gain or loss on the revaluation on digital assets throughout the year and at the year-end;
▪
Performing a review of post year end cryptocurrency receipts to ensure completeness of income recorded in the accounting period;
▪
Testing the crypto-mining process to ensure delivery is in line with contractual terms, and subsequent revenue is recognised correctly and in accordance with the applicable framework; and
▪
Ensuring disclosures in the financial statements are complete and adequate.
|
|
Recognition and valuation of digital currencies (Note 3)
|
| | In responding to the identified critical audit matter we completed the following audit procedures: | |
The group during the year entered into material transactions involving the purchase, mining and disposal of Crypto assets.
The group has other current assets of £4,637,438 at the period end comprising of Crypto currencies. The type and form of these assets can differ significantly
|
| |
▪
Confirming good title to and quantities of the Crypto assets within the group’s wallets;
▪
Reviewing and testing underlying agreements giving rise to the receipt of Crypto assets;
▪
Agreeing the fair values of the Crypto assets at the transaction date and year end date to an
|
|
Critical audit matter
|
| |
How we addressed the matter in our audit
|
|
with regard to the ability to make payments, trade or exchange. In addition, not all Crypto assets have an active market whereby transactions in the digital currencies take place with sufficient frequency and volume in order to provide pricing information on an ongoing basis. Crypto assets can be subject to high levels of volatility. Therefore, there is a significant risk of material misstatement due to both the significant management estimates involved and the volatility attributed to crypto assets. | | |
independent third party source;
▪
Confirming that only the Crypto currencies traded on an active market have been measured at fair value; and
▪
Performing a post year-end review to identify transactions which support the realisation of the year-end carrying value.
|
|
| | |
Note
|
| |
As at
31 December 2020 £ |
| |
As at
31 December 2019 £ |
| ||||||
ASSETS | | | | | | | | | | | | | | | | |
Current assets | | | | | | | | | | | | | | | | |
Trade and other receivables
|
| |
12
|
| | | | 2,175,319 | | | | | | 2,085,699 | | |
Digital currencies
|
| |
3
|
| | | | 4,637,438 | | | | | | 1,040,964 | | |
Cash and cash equivalents
|
| | | | | | | 2,050,761 | | | | | | 161,342 | | |
Total current assets
|
| | | | | | | 8,863,518 | | | | | | 3,288,005 | | |
Non-current assets | | | | | | | | | | | | | | | | |
Investments at fair value through income or loss
|
| |
7
|
| | | | 1,393,303 | | | | | | 58,140 | | |
Financial assets fair valued through income or loss
|
| |
8
|
| | | | — | | | | | | 1,346,236 | | |
Intangible assets, net of accumulated amortization of £304,153 and £189,986 for December 31, 2020 and 2019, respectively
|
| |
9
|
| | | | 367,768 | | | | | | 481,935 | | |
Property and equipment, net of accumulated depreciation of £7,425,042 and £2,518,912 for December 31, 2020 and 2019, respectively
|
| |
10
|
| | | | 10,524,232 | | | | | | 15,399,312 | | |
Right-of-use assets, net of accumulated depreciation of £nil
|
| |
10
|
| | | | 7,379,387 | | | | | | — | | |
Other receivables
|
| |
11
|
| | | | 4,114,726 | | | | | | 4,151,400 | | |
Total non-current assets
|
| | | | | | | 23,779,416 | | | | | | 21,437,023 | | |
Total assets
|
| | | | | | | 32,642,934 | | | | | | 24,725,028 | | |
LIABILITIES AND STOCKHOLDERS’ EQUITY | | | | | | | | | | | | | | | | |
Current liabilities | | | | | | | | | | | | | | | | |
Trade and other payables
|
| |
13
|
| | | | 936,659 | | | | | | 3,987,086 | | |
Lease liability
|
| |
14
|
| | | | 3,469,672 | | | | | | — | | |
Total current liabilities
|
| | | | | | | 4,406,331 | | | | | | 3,987,086 | | |
Non-current liabilities | | | | | | | | | | | | | | | | |
Lease liability
|
| |
14
|
| | | | 3,909,715 | | | | | | — | | |
Total liabilities
|
| | | | | | | 8,316,046 | | | | | | 3,987,086 | | |
Stockholders’ Equity | | | | | | | | | | | | | | | | |
Common stock, £0.001 par value; 303,435,997 shares authorized, issued and outstanding at December 31, 2020 and 293,750,000 shares authorized, issued and outstanding at December 31, 2019
|
| |
16
|
| | | | 303,436 | | | | | | 293,750 | | |
Additional paid-in capital
|
| |
17
|
| | | | 1,615,730 | | | | | | 25,252,288 | | |
Accumulated other comprehensive income
|
| |
17
|
| | | | 442,852 | | | | | | 178,240 | | |
Accumulated surplus/(deficit)
|
| |
17
|
| | | | 21,964,870 | | | | | | (4,986,336) | | |
Total equity
|
| | | | | | | 24,326,888 | | | | | | 20,737,942 | | |
Total equity and liabilities
|
| | | | | | | 32,642,934 | | | | | | 24,725,028 | | |
|
| | |
Note
|
| |
Year ended
31 December 2020 £ |
| |
Year ended
31 December 2019 £ |
| ||||||
Revenues | | | | | | | | | | | | | | | | |
Cryptocurrency mining revenue
|
| |
19
|
| | | | 18,957,417 | | | | | | 8,616,879 | | |
Direct costs
|
| | | | | | | (11,210,889) | | | | | | (3,476,159) | | |
Depreciation of mining equipment
|
| | | | | | | (5,895,573) | | | | | | (2,083,636) | | |
Change in fair value of digital currencies
|
| |
3
|
| | | | 2,342,538 | | | | | | (201,747) | | |
Realized loss on sale of digital currencies
|
| |
3
|
| | | | (272,142) | | | | | | (132,107) | | |
Gross profit
|
| | | | | | | 3,921,351 | | | | | | 2,723,230 | | |
Operating costs and expenses | | | | | | | | | | | | | | | | |
Consulting fees
|
| | | | | | | 690,430 | | | | | | 1,186,450 | | |
Professional fees
|
| | | | | | | 249,440 | | | | | | 607,190 | | |
General and administrative
|
| |
24
|
| | | | 1,830,193 | | | | | | 1,763,405 | | |
Gain from reversal of credit loss
|
| |
24
|
| | | | (447,242) | | | | | | — | | |
Total operating expenses
|
| | | | | | | 2,322,821 | | | | | | 3,557,045 | | |
Operating income/(loss)
|
| | | | | | | 1,598,530 | | | | | | (833,815) | | |
Other income (expenses) | | | | | | | | | | | | | | | | |
Interest income
|
| | | | | | | 1,389 | | | | | | 5,617 | | |
Interest expense
|
| | | | | | | (157,501) | | | | | | (40,853) | | |
Total other income
|
| | | | | | | (156,112) | | | | | | (35,236) | | |
Income/loss before income taxes
|
| | | | | | | 1,442,418 | | | | | | (869,051) | | |
Income tax expense
|
| |
23
|
| | | | — | | | | | | — | | |
Net income/(loss)
|
| | | | | | | 1,442,418 | | | | | | (869,051) | | |
Other comprehensive income | | | | | | | | | | | | | | | | |
Items which may be subsequently reclassified to profit or loss: | | | | | | | | | | | | | | | | |
– Foreign exchange gain
|
| | | | | | | 264,612 | | | | | | 178,240 | | |
Total comprehensive income
|
| | | | | | | 1,707,030 | | | | | | (690,811) | | |
Earnings per share attributable to equity owners (pence) | | | | | | | | | | | | | | | | |
Basic earnings per share
|
| |
3
|
| | | | 0.6p | | | | | | (0.2p) | | |
Diluted earnings per share
|
| |
3
|
| | | | 0.5p | | | | | | (0.2p) | | |
Weighted average shares outstanding | | | | | | | | | | | | | | | | |
Basic
|
| | | | | | | 303,435,997 | | | | | | 293,750,000 | | |
Diluted
|
| | | | | | | 334,638,379 | | | | | | 293,750,000 | | |
|
| | |
Common stock
|
| |
Additional
paid in capital £ |
| |
Accumulated
(deficit)/ surplus £ |
| |
Accumulated
other comprehensive income £ |
| |
Total
£ |
| |||||||||||||||||||||
| | |
Number
|
| |
£
|
| ||||||||||||||||||||||||||||||
Balance at 1 January 2019
|
| | | | 293,750,000 | | | | | | 293,750 | | | | | | 25,252,288 | | | | | | (4,117,285) | | | | | | — | | | | | | 21,428,753 | | |
Other comprehensive income
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 178,240 | | | | | | 178,240 | | |
Net loss
|
| | | | — | | | | | | — | | | | | | — | | | | | | (869,051) | | | | | | — | | | | | | (869,051) | | |
Total comprehensive income for the period
|
| | | | — | | | | | | — | | | | | | — | | | | | | (869,051) | | | | | | 178,240 | | | | | | (690,811) | | |
Balance at 31 December 2019
|
| | | | 293,750,000 | | | | | | 293,750 | | | | | | 25,252,288 | | | | | | (4,986,336) | | | | | | 178,240 | | | | | | 20,737,942 | | |
Stock based compensation charge
|
| | | | | | | | | | — | | | | | | 331,733 | | | | | | — | | | | | | — | | | | | | 331,733 | | |
Common stock warrants lapsed/expired
|
| | | | | | | | | | — | | | | | | (256,500) | | | | | | 256,500 | | | | | | — | | | | | | — | | |
Common stock warrants exercised*
|
| | | | 8,550,000 | | | | | | 8,550 | | | | | | 1,359,450 | | | | | | — | | | | | | — | | | | | | 1,368,000 | | |
Common stock options exercised*
|
| | | | 1,135,997 | | | | | | 1,136 | | | | | | 181,047 | | | | | | — | | | | | | — | | | | | | 182,183 | | |
Cancellation of share premium account
|
| | | | | | | | | | — | | | | | | (25,252,288) | | | | | | 25,252,288 | | | | | | — | | | | | | — | | |
Total transactions with equity owners
|
| | | | 9,685,997 | | | | | | 9,686 | | | | | | (23,636,558) | | | | | | 25,508,788 | | | | | | — | | | | | | 1,881,916 | | |
Other comprehensive income
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 264,612 | | | | | | 264,612 | | |
Net loss
|
| | | | — | | | | | | — | | | | | | — | | | | | | 1,442,418 | | | | | | — | | | | | | 1,442,418 | | |
Total comprehensive income for the period
|
| | | | — | | | | | | — | | | | | | — | | | | | | 1,442,418 | | | | | | 264,612 | | | | | | 1,707,030 | | |
Balance at 31 December 2020
|
| | | | 303,435,997 | | | | | | 303,436 | | | | | | 1,615,730 | | | | | | 21,964,870 | | | | | | 442,852 | | | | | | 24,326,888 | | |
|
| | |
Note
|
| |
Year ended
31 December 2020 £ |
| |
Year ended
31 December 2019 £ |
| ||||||
Cash flows from operating activities | | | | | | | | | | | | | | | | |
Operating income/(loss)
|
| | | | | | | 1,598,530 | | | | | | (833,815) | | |
Adjustments for: | | | | | | | | | | | | | | | | |
Depreciation/Amortisation
|
| |
9, 10
|
| | | | 6,026,779 | | | | | | 2,221,201 | | |
Foreign exchange movements
|
| | | | | | | 318,921 | | | | | | 178,240 | | |
Loss on disposal of tangible assets
|
| | | | | | | 66,157 | | | | | | — | | |
Stock based compensation
|
| | | | | | | 331,733 | | | | | | — | | |
Interest expense
|
| | | | | | | (157,501) | | | | | | (40,853) | | |
Changes in assets and liabilities: | | | | | | | | | | | | | | | | |
(Increase) in trade and other receivables
|
| |
12
|
| | | | (89,620) | | | | | | (4,058,043) | | |
(Decrease)/increase in trade and other payables
|
| |
13
|
| | | | (2,106,788) | | | | | | 2,684,300 | | |
(Increase) in digital assets
|
| |
3
|
| | | | (3,578,381) | | | | | | (1,038,882) | | |
Net cash flow from/(used in) operating activities
|
| | | | | | | 2,409,830 | | | | | | (887,852) | | |
Investing activities | | | | | | | | | | | | | | | | |
Investment in GPUone
|
| |
7
|
| | | | — | | | | | | (58,140) | | |
Convertible loan note with GPUone
|
| |
8
|
| | | | — | | | | | | (1,346,236) | | |
Purchase of tangible fixed assets
|
| |
10
|
| | | | (1,807,971) | | | | | | (15,025,708) | | |
Proceeds from disposal of tangible fixed assets
|
| |
10
|
| | | | 704,282 | | | | | | — | | |
Interest received
|
| | | | | | | 1,389 | | | | | | 5,617 | | |
Net cash used in investing activities
|
| | | | | | | (1,102,300) | | | | | | (16,424,467) | | |
Financing activities | | | | | | | | | | | | | | | | |
(Decrease)/Increase in loans
|
| |
13
|
| | | | (968,294) | | | | | | 1,084,218 | | |
Proceeds from shares to be issued from the exercise of stock options
|
| | | | | | | 1,550,183 | | | | | | — | | |
Net cash generated from financing activities
|
| | | | | | | 581,889 | | | | | | 1,084,218 | | |
Net increase/(decrease) in cash and cash equivalents
|
| | | | | | | 1,889,419 | | | | | | (16,228,101) | | |
Cash and cash equivalents at beginning of period
|
| | | | | | | 161,342 | | | | | | 16,389,443 | | |
Cash and cash equivalents at end of period
|
| | | | | | | 2,050,761 | | | | | | 161,342 | | |
|
Group
|
| |
2020
£ |
| |
2019
£ |
| ||||||
Brought forward
|
| | | | 1,040,964 | | | | | | 2,082 | | |
Additions | | | | | | | | | | | | | |
Crypto assets purchased and received
|
| | | | 9,896,641 | | | | | | 237,018 | | |
Crypto assets mined
|
| | | | 18,947,908 | | | | | | 8,348,184 | | |
Total additions
|
| | | | 28,844,549 | | | | | | 8,585,202 | | |
Disposals | | | | | | | | | | | | | |
Crypto assets sold
|
| | | | (27,318,471) | | | | | | (7,212,466) | | |
Total disposals
|
| | | | (27,318,471) | | | | | | (7,212,466) | | |
Fair value movements | | | | | | | | | | | | | |
Movements on crypto asset sales
|
| | | | (13,816) | | | | | | (132,107) | | |
Loss on futures
|
| | | | (258,326) | | | | | | — | | |
Movements on crypto assets held at the year end
|
| | | | 2,342,538 | | | | | | (201,747) | | |
Total fair value movements
|
| | | | 2,070,396 | | | | | | (333,854) | | |
Carried forward
|
| | | | 4,637,438 | | | | | | 1,040,964 | | |
|
Group 2020
Crypto asset name |
| |
Coins/tokens
|
| |
Fair value
£ |
| ||||||
Bitcoin – Bitcoin
|
| | | | 183 | | | | | | 3,929,696 | | |
Polkadot – DOT
|
| | | | 75,000 | | | | | | 515,176 | | |
Ethereum – ETH
|
| | | | 254 | | | | | | 138,257 | | |
Binance Coin – BNB
|
| | | | 1,243 | | | | | | 34,260 | | |
USDT,USDC (stable coin – fixed to USD)
|
| | | | 26,509 | | | | | | 19,553 | | |
Alternative coins
|
| | | | — | | | | | | 496 | | |
At 31 December 2020
|
| | | | | | | | | | 4,637,438 | | |
|
Group 2019
Crypto asset name |
| |
Coins/tokens
|
| |
Fair value
£ |
| ||||||
Bitcoin
|
| | | | 63 | | | | | | 339,839 | | |
PAX and USDT (stable coin – fixed to USD)
|
| | | | 404,108 | | | | | | 321,615 | | |
XTZ
|
| | | | 153,198 | | | | | | 158,688 | | |
ETH
|
| | | | 548 | | | | | | 54,149 | | |
BEAM
|
| | | | 66,967 | | | | | | 27,600 | | |
XRP
|
| | | | 130,143 | | | | | | 19,001 | | |
ZEC
|
| | | | 795 | | | | | | 17,155 | | |
LTC
|
| | | | 536 | | | | | | 16,859 | | |
BCH
|
| | | | 107 | | | | | | 16,551 | | |
EOS
|
| | | | 5,240 | | | | | | 10,320 | | |
Alternative coins
|
| | | | Various | | | | | | 59,187 | | |
At 31 December 2019
|
| | | | | | | | | | 1,040,964 | | |
|
| | |
Group
2020 £ |
| |
Group
2019 £ |
| ||||||
Carrying amount of financial assets | | | | ||||||||||
Measured at amortised cost | | | | ||||||||||
– Trade and other receivables
|
| | | | 144,607 | | | | | | 74,929 | | |
– Cash and cash equivalents
|
| | | | 2,050,761 | | | | | | 161,342 | | |
Measured at fair value through income or loss
|
| | | | — | | | | | | — | | |
Total carrying amount of financial assets
|
| | | | 2,195,368 | | | | | | 236,271 | | |
Carrying amount of financial liabilities | | | | ||||||||||
Measured at amortised cost | | | | ||||||||||
– Trade and other payables
|
| | | | 548,293 | | | | | | 2,463,501 | | |
– Short term loans
|
| | | | 115,924 | | | | | | 1,084,218 | | |
– Lease liabilities
|
| | | | 7,409,387 | | | | | | — | | |
Total carrying amount of financial liabilities
|
| | | | 8,073,604 | | | | | | 3,547,719 | | |
|
| | |
2020
|
| |
2019
|
| ||||||
Net gain/(loss) for the period attributable to ordinary equity holders from continuing operations (£)
|
| | | | 1,707,030 | | | | | | (690,811) | | |
Weighted average number of ordinary shares in issue
|
| | | | 303,435,997 | | | | | | 293,750,000 | | |
Basic earnings per share for continuing operations (pence)
|
| | | | 0.6 | | | | | | (0.2) | | |
|
| | |
2020
|
| |
2019
|
| ||||||
Net gain/(loss) for the period attributable to ordinary equity holders for continuing operations (£)
|
| | | | 1,707,030 | | | | | | (690,811) | | |
Diluted number of ordinary shares in issue
|
| | | | 334,638,379 | | | | | | 338,604,769 | | |
Diluted earnings per share for continuing operations (pence)
|
| | | | 0.5 | | | | | | (0.2) | | |
|
Standard or
Interpretation |
| |
Description
|
| |
Effective date for
annual accounting period beginning on or after |
|
IAS 1 | | |
Amendments – Classification of Liabilities as Current or
Non-current |
| |
1 January 2023
|
|
IAS 16 | | | Amendments – Property, Plant and Equipment | | |
1 January 2022
|
|
IAS 8 | | | Amendments – Definition of Accounting Estimates | | |
1 January 2023
|
|
IAS 1 | | | Amendments – Disclosure of Accounting Policies | | |
1 January 2023
|
|
IFRS | | | Annual Improvements to IFRS Standards 2018-2020 | | |
1 January 2022
|
|
Group
|
| |
£
|
| |||
At 1 January 2020
|
| | | | 58,140 | | |
Additions:
|
| | | | 1,335,676 | | |
Foreign exchange movement
|
| | | | (513) | | |
At 31 December 2020
|
| | | | 1,393,303 | | |
|
| | |
£
|
| |||
At 1 January 2020
|
| | | | 1,346,236 | | |
Converted loan note
|
| | | | (1,335,676) | | |
Foreign exchange loss
|
| | | | (10,560) | | |
At 31 December 2020
|
| | | | — | | |
|
| | |
Website
£ |
| |||
Cost | | | | | | | |
As at 31 December 2018 and 2019
|
| | | | 671,921 | | |
Additions
|
| | | | — | | |
At 31 December 2020
|
| | | | 671,921 | | |
Amortisation and impairment | | | | | | | |
At 31 December 2018
|
| | | | 52,421 | | |
Amortisation charged during the period
|
| | | | 137,565 | | |
At 31 December 2019
|
| | | | 189,986 | | |
Amortisation charged during the period
|
| | | | 114,167 | | |
Impairment losses
|
| | | | — | | |
At 31 December 2020
|
| | | | 304,153 | | |
Carrying amount | | | | | | | |
At 31 December 2019
|
| | | | 481,935 | | |
At 31 December 2020
|
| | | | 367,768 | | |
|
| | |
Right of
use Assets £ |
| |
Mining and
Computer Equipment £ |
| |
Improvements
to DATA CENTRE £ |
| |
Total
£ |
| ||||||||||||
Cost | | | | | | | | | | | | | | | | | | | | | | | | | |
At 31 December 2018
|
| | | | — | | | | | | 2,807,589 | | | | | | 84,927 | | | | | | 2,892,516 | | |
Additions
|
| | | | — | | | | | | 15,025,708 | | | | | | — | | | | | | 15,025,708 | | |
At 31 December 2019
|
| | | | — | | | | | | 17,833,297 | | | | | | 84,927 | | | | | | 17,918,224 | | |
Foreign exchange movement
|
| | | | — | | | | | | (136,479) | | | | | | — | | | | | | (136,479) | | |
Additions
|
| | | | 7,379,387 | | | | | | 1,807,971 | | | | | | — | | | | | | 9,187,358 | | |
Disposals
|
| | | | — | | | | | | (1,640,442) | | | | | | — | | | | | | (1,640,442) | | |
At 31 December 2020
|
| | | | 7,379,387 | | | | | | 17,864,347 | | | | | | 84,927 | | | | | | 25,328,661 | | |
Depreciation and impairment | | | | | | | | | | | | | | | | | | | | | | | | | |
At 31 December 2018
|
| | | | — | | | | | | 421,711 | | | | | | 13,565 | | | | | | 435,276 | | |
Depreciation charged during the period
|
| | | | — | | | | | | 2,066,248 | | | | | | 17,388 | | | | | | 2,083,636 | | |
At 31 December 2019
|
| | | | — | | | | | | 2,487,959 | | | | | | 30,953 | | | | | | 2,518,912 | | |
Foreign charge movement
|
| | | | | | | | | | 14,658 | | | | | | — | | | | | | 14,658 | | |
Depreciation charged during the period
|
| | | | — | | | | | | 5,895,573 | | | | | | 17,039 | | | | | | 5,912,612 | | |
Depreciation on disposals
|
| | | | — | | | | | | (1,021,140) | | | | | | — | | | | | | (1,021,140) | | |
At 31 December 2020
|
| | | | — | | | | | | 7,377,050 | | | | | | 47,992 | | | | | | 7,425,042 | | |
Carrying amount | | | | | | | | | | | | | | | | | | | | | | | | | |
At 31 December 2019
|
| | | | — | | | | | | 15,345,338 | | | | | | 53,974 | | | | | | 15,399,312 | | |
At 31 December 2020
|
| | | | 7,379,387 | | | | | | 10,487,297 | | | | | | 36,935 | | | | | | 17,903,619 | | |
|
| | |
2020
£ |
| |
2019
£ |
| ||||||
Deposits
|
| | | | 4,114,726 | | | | | | 4,151,400 | | |
Total carrying amount of other receivables
|
| | |
|
4,114,726
|
| | | | | 4,151,400 | | |
|
| | |
2020
£ |
| |
2019
£ |
| ||||||
Amounts due from group companies
|
| | | | — | | | | | | — | | |
Prepayments and other receivables
|
| | | | 811,684 | | | | | | 268,842 | | |
Other taxation and social security
|
| | | | 1,363,635 | | | | | | 1,816,857 | | |
Total trade and other receivables
|
| | | | 2,175,319 | | | | | | 2,085,699 | | |
|
| | |
2020
£ |
| |
2019
£ |
| ||||||
Trade payables
|
| | | | 548,292 | | | | | | 2,463,501 | | |
Accruals and other payables
|
| | | | 271,471 | | | | | | 439,367 | | |
Short term loans
|
| | | | 115,924 | | | | | | 1,084,218 | | |
Other taxation and social security
|
| | | | 972 | | | | | | — | | |
Total trade and other creditors
|
| | | | 936,659 | | | | | | 3,987,086 | | |
|
| | |
2020
£ |
| |
2019
£ |
| ||||||
Lease liability – current
|
| | | | 3,469,672 | | | | | | — | | |
Lease liability – non current
|
| | | | 3,909,715 | | | | |
|
—
|
| |
|
Options /
warrants |
| |
Grant date
|
| |
Expiry date
|
| |
Exercise
price |
| |
Number of
options and warrants outstanding at 31 December 2020 |
| |
Number of
options and warrants exercisable at 31 December 2020 |
| |||||||||
Warrants
|
| | 2 February 2018 | | | 2 February 2023 | | | | £ | 0.08 | | | | | | 2,250,000 | | | | | | 2,250,000 | | |
Warrants
|
| |
23-26 February 2018
|
| |
23-26 February 2021
|
| | | £ | 0.08 | | | | | | 6,580,000 | | | | | | 6,580,000 | | |
Warrants
|
| | 23 February 2018 | | | 23 February 2021 | | | | £ | 0.08 | | | | | | 1,400,000 | | | | | | 1,400,000 | | |
Warrants
|
| | 14-17 June 2018 | | | 14-17 June 2021 | | | | £ | 0.16 | | | | | | 650,000 | | | | | | 650,000 | | |
Warrants
|
| | 15 June 2018 | | | 15 June 2021 | | | | £ | 0.16 | | | | | | 210,453 | | | | | | 210,453 | | |
Warrants
|
| | 3 August 2018 | | | 3 August 2023 | | | | £ | 0.16 | | | | | | 3,231,600 | | | | | | 3,231,600 | | |
Options
|
| | 25 July 2018 | | | 25 July 2024 | | | | £ | 0.16 | | | | | | 10,506,784 | | | | | | 10,506,784 | | |
Options
|
| | 25 July 2018 | | | 30 August 2022 | | | | £ | 0.16 | | | | | | 5,000,000 | | | | | | 5,000,000 | | |
Options
|
| | 17 July 2019 | | | 17 July 2025 | | | | £ | 0.16 | | | | | | 1,000,000 | | | | | | 425,926 | | |
Options
|
| | 5 February 2020 | | | 4 February 2030 | | | | £ | 0.07 | | | | | | 4,750,000 | | | | | | 1,809,524 | | |
Options
|
| | 5 February 2020 | | | 4 February 2030 | | | | £ | 0.07 | | | | | | 475,000 | | | | | | 180,952 | | |
Options
|
| | 5 February 2020 | | | 4 February 2030 | | | | £ | 0.07 | | | | | | 5,700,000 | | | | | | 2,171,429 | | |
Options
|
| | 5 February 2020 | | | 25 July 2024 | | | | £ | 0.07 | | | | | | 22,619 | | | | | | 22,619 | | |
| | | | | | | | | | | | | | | | | 41,776,456 | | | | | | 34,439,287 | | |
|
| | |
Number of
options and warrants |
| |
Weighted
average exercise price £ |
| ||||||
At 1 January 2020
|
| | | | 45,037,075 | | | | | | 0.14 | | |
Granted
|
| | | | 11,400,000 | | | | | | 0.07 | | |
Exercised
|
| | | | (9,685,997) | | | | | | 0.16 | | |
Lapsed
|
| | | | (4,974,622) | | | | | | 0.16 | | |
Outstanding at 31 December 2020
|
| | | | 41,776,456 | | | | | | 0.12 | | |
Exercisable at 31 December 2020
|
| | | | 34,439,287 | | | | | | 0.13 | | |
|
| | |
Number of
options and warrants |
| |
Weighted
average exercise price £ |
| ||||||
At 1 January 2019
|
| | | | 48,230,103 | | | | | | 0.14 | | |
Granted
|
| | | | 1,000,000 | | | | | | 0.16 | | |
Exercised
|
| | | | — | | | | | | — | | |
Lapsed
|
| | | | (4,375,334) | | | | | | 0.16 | | |
Outstanding at 31 December 2019
|
| | | | 44,854,769 | | | | | | 0.14 | | |
Exercisable at 31 December 2019
|
| | | | 37,910,408 | | | | | | 0.14 | | |
|
Grant date
|
| |
Grant date
share price |
| |
Exercise
price |
| |
Volatility
|
| |
Life
|
| |
Risk free
interest rate |
| |
Marketability
discount |
| ||||||||||||||||||
2 February 2018
|
| | | | 0.08 | | | | | | 0.08 | | | | | | 40% | | | | | | 5 years | | | | | | 1% | | | | | | 75% | | |
23-26 February 2018
|
| | | | 0.08 | | | | | | 0.08 | | | | | | 40% | | | | | | 3 years | | | | | | 1% | | | | | | 75% | | |
23 February 2018
|
| | | | 0.08 | | | | | | 0.08 | | | | | | 40% | | | | | | 3 years | | | | | | 1% | | | | | | 75% | | |
14-17 June 2018
|
| | | | 0.08 | | | | | | 0.16 | | | | | | 40% | | | | | | 3 years | | | | | | 1% | | | | | | 75% | | |
15 June 2018
|
| | | | 0.08 | | | | | | 0.16 | | | | | | 40% | | | | | | 3 years | | | | | | 1% | | | | | | 75% | | |
3 August 2018
|
| | | | 0.11 | | | | | | 0.16 | | | | | | 40% | | | | | | 5 years | | | | | | 1% | | | | | | 0% | | |
25 July 2018
|
| | | | 0.08 | | | | | | 0.16 | | | | | | 40% | | | | | | 6 years | | | | | | 1% | | | | | | 75% | | |
25 July 2018
|
| | | | 0.08 | | | | | | 0.16 | | | | | | 40% | | | | | | 6 years | | | | | | 1% | | | | | | 75% | | |
17 July 2019
|
| | | | 0.09 | | | | | | 0.16 | | | | | | 40% | | | | | | 6 years | | | | | | 1% | | | | | | 90% | | |
5 February 2020
|
| | | | 0.07 | | | | | | 0.07 | | | | | | 40% | | | | | | 10 years | | | | | | 1% | | | | | | 0% | | |
5 February 2020
|
| | | | 0.07 | | | | | | 0.07 | | | | | | 40% | | | | | | 10 years | | | | | | 1% | | | | | | 0% | | |
5 February 2020
|
| | | | 0.07 | | | | | | 0.07 | | | | | | 40% | | | | | | 10 years | | | | | | 1% | | | | | | 0% | | |
5 February 2020
|
| | | | 0.07 | | | | | | 0.07 | | | | | | 40% | | | | | | 10 years | | | | | | 1% | | | | | | 0% | | |
| | |
2020
£ |
| |
2019
£ |
| ||||||
Ordinary share capital | | | | | | | | | | | | | |
Issued and fully paid | | | | | | | | | | | | | |
293,750,000 Ordinary Shares of £0.001 each
|
| | | | 293,750 | | | | | | 293,750 | | |
Fully paid not yet issued | | | | | | | | | | | | | |
9,685,997 Ordinary Shares of £0.001 each
|
| | | | 9,686 | | | | | | — | | |
303,435,997 Ordinary Shares of £0.001 each
|
| | | | 303,436 | | | | | | 293,750 | | |
Additional paid in capital | | | | | | | | | | | | | |
At beginning of the period
|
| | | | 25,252,288 | | | | | | 25,252,288 | | |
Cancelled during the year
|
| | | | (25,252,288) | | | | | | — | | |
Fully paid not yet issued
|
| | | | 1,540,497 | | | | | | — | | |
At the end of period
|
| | | | 1,540,597 | | | | | | 25,252,288 | | |
|
Reserve
|
| |
Description
|
|
Common stock | | | Represents the nominal value of equity shares | |
Additional paid in capital | | | Amount subscribed for share capital in excess of nominal value and the fair value of shares granted during the year and as a result of a change in estimation those granted in prior periods | |
Foreign currency translation
|
| | Cumulative effects of translation of opening balances on non-monetary assets between subsidiary functional currency (Canadian dollars) and Group functional and presentational currency (Sterling). | |
Retained earnings | | | Cumulative net gains and losses and other transactions with equity holders not recognised elsewhere. | |
| | |
2020
£ |
| |
2019
£ |
| ||||||
Canada (corporate reseller)
|
| | | | — | | | | | | 239,453 | | |
Subscriber revenue – worldwide
|
| | | | 9,509 | | | | | | 29,242 | | |
Cryptocurrency mining – worldwide
|
| | | | 18,947,908 | | | | | | 8,348,184 | | |
Total cryptocurrency revenue
|
| | | | 18,957,417 | | | | | | 8,616,879 | | |
|
| | |
2020
£ |
| |
2019
£ |
| ||||||
In relation to statutory audit services
|
| | | | 100,000 | | | | | | 50,000 | | |
Other audit assurance services
|
| | | | 35,000 | | | | | | — | | |
Total auditor’s remuneration
|
| | | | 135,000 | | | | | | 50,000 | | |
|
| | |
2020
Number |
| |
2019
Number |
| ||||||
Directors and employees
|
| | | | 6 | | | | | | 7 | | |
| | |
2020
£ |
| |
2019
£ |
| ||||||
Wages and salaries
|
| | | | 191,057 | | | | | | 268,620 | | |
Social security costs
|
| | | | 12,939 | | | | | | 16,592 | | |
Pension costs
|
| | | | — | | | | | | 4,060 | | |
Share based payment charge
|
| | | | 23,664 | | | | | | — | | |
| | | | | 227,660 | | | | | | 289,272 | | |
|
| | |
2020
£ |
| |
2019
£ |
| ||||||
Director’s remuneration for qualifying services
|
| | | | 532,221 | | | | | | 688,767 | | |
Senior management loss of office
|
| | | | — | | | | | | 236,194 | | |
Key management personnel
|
| | | | — | | | | | | 578,103 | | |
Share based payment expense
|
| | | | 20,271 | | | | | | — | | |
Total remuneration for directors and key management
|
| | | | 552,492 | | | | | | 1,503,064 | | |
|
| | |
2020
£ |
| |
2019
£ |
| ||||||
Gain/(loss) before taxation
|
| | | | 1,442,418 | | | | | | (869,051) | | |
Expected tax charge/(credit) based on a weighted average of 24% (UK and Canada)
|
| | | | 346,180 | | | | | | (208,572) | | |
Effect of expenses not deductible in determining taxable gain
|
| | | | 3,260 | | | | | | 31,871 | | |
Capital allowances in excess of depreciation
|
| | | | (100,861) | | | | | | (1,141,206) | | |
Unrealised (gains)/loss on crypto assets
|
| | | | (562,209) | | | | | | 48,419 | | |
Other tax adjustments
|
| | | | (141,428) | | | | | | 45,710 | | |
Unutilised tax losses carried forward
|
| | | | 455,058 | | | | | | 1,223,778 | | |
Taxation charge in the financial statements
|
| | | | — | | | | | | — | | |
|
Administrative expenses
|
| |
2020
£ |
| |
2019
£ |
| ||||||
Salary and other employee costs
|
| | | | 460,881 | | | | | | 289,272 | | |
Depreciation and amortisation
|
| | | | 131,206 | | | | | | 137,565 | | |
Foreign exchange losses
|
| | | | 271,175 | | | | | | 401,038 | | |
Advertising fees
|
| | | | 113,027 | | | | | | 104,806 | | |
Travel and subsistence
|
| | | | 45,624 | | | | | | 168,567 | | |
Research costs
|
| | | | 20,000 | | | | | | 103,973 | | |
Share based payment
|
| | | | 331,733 | | | | | | — | | |
Senior management loss of office
|
| | | | — | | | | | | 236,194 | | |
Other expenses
|
| | | | 456,547 | | | | | | 321,990 | | |
Total administrative expenses
|
| | | | 1,830,193 | | | | | | 1,763,405 | | |
|
| | |
Page
|
| |||
| | | | F-32 | | | |
| | | | F-33 | | | |
| | | | F-34 | | | |
| | | | F-35 | | | |
| | | | F-36 | | |
| | |
NOTE
|
| |
AS AT
30 JUNE 2021 (UNAUDITED) £ |
| |
AS AT
31 DECEMBER 2020 (AUDITED) £ |
| ||||||
ASSETS | | | | | | | | | | | | | | | | |
Current assets | | | | | | | | | | | | | | | | |
Investments at fair value through income and loss
|
| |
8
|
| | | | 1,411,376 | | | | | | — | | |
Trade and other receivables
|
| |
13
|
| | | | 39,246,333 | | | | | | 2,175,319 | | |
Digital currencies
|
| |
14
|
| | | | 31,896,437 | | | | | | 4,637,438 | | |
Cash and cash equivalents
|
| | | | | | | 16,047,609 | | | | | | 2,050,761 | | |
Total current assets
|
| | | | | | | 88,601,755 | | | | | | 8,863,518 | | |
Non-current assets | | | | | | | | | | | | | | | | |
Investments at fair value through income or loss
|
| |
8
|
| | | | 219,360 | | | | | | 1,393,303 | | |
Investments accounted for using the equity method
|
| |
9
|
| | | | 8,444,820 | | | | | | — | | |
Intangible assets, net of accumulated amortization of £395,043 and £259,192 for December 31, 2020 and 2019, respectively
|
| | | | | | | 291,270 | | | | | | 367,768 | | |
Property and equipment, net of accumulated depreciation of £11,193,988 and £5,438,016 for December 31, 2020 and 2019, respectively
|
| |
11
|
| | | | 35,795,266 | | | | | | 10,524,232 | | |
Right-of-use assets, net of accumulated depreciation of £1,024,195 for 30 June 2021 and nil respectively
|
| |
11
|
| | | | 6,355,192 | | | | | | 7,379,387 | | |
Other receivables
|
| |
12
|
| | | | — | | | | | | 4,114,726 | | |
Total non-current assets
|
| | | | | | | 51,105,908 | | | | | | 23,779,416 | | |
Total assets
|
| | | | | | | 139,707,663 | | | | | | 32,642,934 | | |
LIABILITIES AND STOCKHOLDERS’ EQUITY | | | | | | | | | | | | | | | | |
Current liabilities | | | | | | | | | | | | | | | | |
Trade and other payables
|
| |
17
|
| | | | 25,210,780 | | | | | | 936,659 | | |
Loans and borrowings
|
| |
18
|
| | | | 15,383,111 | | | | | | — | | |
Income tax
|
| | | | | | | 3,483,827 | | | | | | — | | |
Lease liability
|
| | | | | | | 3,990,370 | | | | | | 3,469,672 | | |
Total current liabilities
|
| | | | | | | 48,068,088 | | | | | | 4,406,331 | | |
Non-current liabilities | | | | | | | | | | | | | | | | |
Lease liability
|
| | | | | | | 1,654,918 | | | | | | 3,909,715 | | |
Loans and borrowings
|
| |
18
|
| | | | 4,032,364 | | | | | | — | | |
Total liabilities
|
| | | | | | | 53,755,370 | | | | | | 8,316,046 | | |
Stockholders’ equity | | | | | | | | | | | | | | | | |
Common stock, £0.001 par value; 381,832,335 shares authorized,
issued and outstanding at June 30, 2021 and 303,435,997 shares authorized, issued and outstanding at December 31, 2020 |
| |
15
|
| | | | 381,832 | | | | | | 303,436 | | |
Additional paid-in capital
|
| |
15
|
| | | | 55,317,447 | | | | | | 1,540,497 | | |
Share based payment reserve
|
| |
16
|
| | | | 992,324 | | | | | | 75,233 | | |
Accumulated other comprehensive income
|
| |
16
|
| | | | 81,823 | | | | | | 442,852 | | |
Accumulated surplus/(deficit)
|
| |
16
|
| | | | 29,178,867 | | | | | | 21,964,870 | | |
Total equity
|
| | | | | | | 85,952,293 | | | | | | 24,326,888 | | |
Total equity and liabilities
|
| | | | | | | 139,707,663 | | | | | | 32,642,934 | | |
|
| | |
NOTE
|
| |
SIX MONTHS
ENDED 30 JUNE 2021 £ |
| |
SIX MONTHS
ENDED 30 JUNE 2020 £ |
| ||||||
Revenues | | | | | | | | | | | | | | | | |
Revenues
|
| |
5
|
| | | | 31,085,716 | | | | | | 11,124,455 | | |
Direct costs
|
| | | | | | | (5,606,856) | | | | | | (6,787,636) | | |
Depreciation of mining equipment
|
| |
11
|
| | | | (4,757,986) | | | | | | (2,909,480) | | |
Change in fair value of digital currencies
|
| |
14
|
| | | | (6,407,446) | | | | | | (154,295) | | |
Realized loss on sale of digital currencies
|
| |
11
|
| | | | 219,008 | | | | | | (90,532) | | |
Gross profit
|
| | | | | | | 14,532,436 | | | | | | 1,182,512 | | |
Operating costs and expenses | | | | | | | | | | | | | | | | |
Consulting fees
|
| | | | | | | (304,379) | | | | | | (177,328) | | |
Professional fees
|
| | | | | | | (415,066) | | | | | | (171,514) | | |
General and administrative
|
| | | | | | | (1,136,755) | | | | | | (183,708) | | |
Share based payment
|
| | | | | | | (1,567,608) | | | | | | — | | |
Total operating expenses
|
| | | | | | | 3,423,808 | | | | | | 532,550 | | |
Operating income
|
| | | | | | | 11,108,628 | | | | | | 649,962 | | |
Other income (expenses) | | | | | | | | | | | | | | | | |
Interest income
|
| | | | | | | — | | | | | | 26 | | |
Interest expense
|
| | | | | | | (410,804) | | | | | | (126,914) | | |
Total other income
|
| | | | | | | (410,804) | | | | | | (126,888) | | |
Income/loss before income taxes
|
| | | | | | | 10,697,824 | | | | | | 523,074 | | |
Income tax expense
|
| |
7
|
| | | | (3,483,827) | | | | | | — | | |
Net income/(loss)
|
| | | | | | | 7,213,997 | | | | | | 523,074 | | |
Other comprehensive income | | | | | | | | | | | | | | | | |
Items which may be subsequently reclassified to profit or loss:
|
| | | | | | | | | | | | | | | |
–Foreign exchange gain/(loss)
|
| | | | | | | (361,029) | | | | | | (431,746) | | |
Total comprehensive income
|
| | | | | | | 6,852,968 | | | | | | 91,328 | | |
Earnings per share attributable to equity owners (pence) | | | | | | | | | | | | | | | | |
Basic earnings per share
|
| |
6
|
| | | | 1.9p | | | | | | 0.2p | | |
Diluted earnings per share
|
| |
6
|
| | | | 1.8p | | | | | | 0.2p | | |
Weighted average shares outstanding | | | | | | | | | | | | | | | | |
Basic
|
| | | | | | | 381,832,335 | | | | | | 293,750,000 | | |
Diluted
|
| | | | | | | 393,091,232 | | | | | | 350,098,603 | | |
|
| | |
COMMON
STOCK £ |
| |
ADDITIONAL
PAID IN CAPITAL £ |
| |
ACCUMULATED
OTHER COMPREHENSIVE INCOME £ |
| |
SHARE
BASED PAYMENT RESERVE £ |
| |
ACCUMULATED
(DEFICIT)/ SURPLUS £ |
| |
TOTAL
|
| ||||||||||||||||||
Balance at 1 January 2021
|
| | | | 303,436 | | | | | | 1,540,497 | | | | | | 442,852 | | | | | | 75,233 | | | | | | 21,964,870 | | | | | | 24,326,888 | | |
Other comprehensive income
|
| | | | — | | | | | | — | | | | | | (361,029) | | | | | | — | | | | | | — | | | | | | (361,029) | | |
Net profit
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 7,213,997 | | | | | | 7,213,997 | | |
Total comprehensive income for the period
|
| | | | — | | | | | | — | | | | | | (361,029) | | | | | | — | | | | | | 7,213,997 | | | | | | 6,852,968 | | |
Transactions with equity owners: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Common stock to be issued*
|
| | | | 71 | | | | | | 11,296 | | | | | | — | | | | | | — | | | | | | — | | | | | | 11,367 | | |
Issue of common stock net of issue costs
|
| | | | 78,235 | | | | | | 53,765,654 | | | | | | — | | | | | | — | | | | | | — | | | | | | 53,843,889 | | |
Stock based compensation charge
|
| | | | — | | | | | | — | | | | | | — | | | | | | 1,567,608 | | | | | | — | | | | | | 1,567,608 | | |
Common stock options/warrants exercised
|
| | | | — | | | | | | — | | | | | | — | | | | | | (567,523) | | | | | | 567,523 | | | | | | — | | |
Common stock options/warrants lapsed/expired
|
| | | | — | | | | | | — | | | | | | — | | | | | | (82,994) | | | | | | 82,994 | | | | | | — | | |
Total transactions with equity owners
|
| | | | 78,306 | | | | | | 53,776,950 | | | | | | — | | | | | | 917,091 | | | | | | 650,517 | | | | | | 55,422,864 | | |
Balance at 30 June 2021
|
| | | | 381,832 | | | | | | 55,317,447 | | | | | | 81,823 | | | | | | 992,324 | | | | | | 29,178,867 | | | | | | 85,952,293 | | |
|
| | |
COMMON
STOCK £ |
| |
ADDITIONAL
PAID IN CAPITAL £ |
| |
ACCUMULATED
OTHER COMPREHENSIVE INCOME £ |
| |
ACCUMULATED
(DEFICIT)/ SURPLUS £ |
| |
TOTAL
£ |
| |||||||||||||||
Balance at 1 January 2020
|
| | | | 293,750 | | | | | | 25,252,288 | | | | | | | | | | | | | | | | | | | | |
Other comprehensive income
|
| | | | — | | | | | | — | | | | | | (431,746) | | | | | | — | | | | | | (431,746) | | |
Net profit
|
| | | | — | | | | | | — | | | | | | — | | | | | | 523,074 | | | | | | 523,074 | | |
Total comprehensive income for the period
|
| | | | — | | | | | | — | | | | | | (431,746) | | | | | | 523,074 | | | | | | 91,328 | | |
Transactions with equity owners: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Issue of common stock net of issue costs
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Balance at 30 June 2020
|
| | | | 293,750 | | | | | | 25,252,288 | | | | | | (253,506) | | | | | | (4,463,262) | | | | | | 20,829,270 | | |
|
| | |
NOTE
|
| |
SIX MONTHS
ENDED 30 JUNE 2021 £ |
| |
SIX MONTHS
ENDED 30 JUNE 2020 £ |
| ||||||
Cash flows from operating activities | | | | | | | | | | | | | | | | |
Operating income
|
| | | | | | | 11,108,628 | | | | | | 649,962 | | |
Adjustments for: | | | | | | | | | | | | | | | | |
Depreciation/Amortisation
|
| | | | | | | 4,869,638 | | | | | | 3,012,462 | | |
Foreign exchange movements
|
| | | | | | | 25,087 | | | | | | (431,746) | | |
Stock based compensation
|
| | | | | | | 1,567,608 | | | | | | — | | |
Changes in assets and liabilities: | | | | | | | | | | | | | | | | |
(Increase)/decrease in trade and other receivables
|
| |
13
|
| | | | (2,092,532) | | | | | | 534,947 | | |
Increase/(decrease) in trade and other payables
|
| |
17
|
| | | | 15,245,263 | | | | | | (167,503) | | |
(Increase)/decrease in digital assets
|
| |
14
|
| | | | (34,758,295) | | | | | | 203,045 | | |
Fair value change in digital assets
|
| |
14
|
| | | | 6,407,446 | | | | | | (104,781) | | |
Net cash flow from operating activities
|
| | | | | | | 2,372,843 | | | | | | 3,696,386 | | |
Investing activities | | | | | | | | | | | | | | | | |
Acquisition of subsidiaries, net of cash acquired
|
| | | | | | | (271,732) | | | | | | — | | |
Investment in associate
|
| |
9
|
| | | | (7,352,970) | | | | | | — | | |
Other investments
|
| |
8
|
| | | | (219,361) | | | | | | — | | |
Purchase of tangible fixed assets
|
| |
11
|
| | | | (6,883,195) | | | | | | (1,617,024) | | |
Mining equipment prepayments
|
| |
13
|
| | | | (35,471,499) | | | | | | — | | |
Interest received
|
| | | | | | | — | | | | | | 27 | | |
Net cash used in investing activities
|
| | | | | | | (50,198,757) | | | | | | (1,619,997) | | |
Financing activities | | | | | | | | | | | | | | | | |
Increase/(decrease) in loans
|
| |
8
|
| | | | 14,375,021 | | | | | | (797,455) | | |
Lease payments
|
| | | | | | | (1,734,098) | | | | | | — | | |
Interest paid
|
| | | | | | | (410,803) | | | | | | (126,914) | | |
Proceeds from shares issued
|
| | | | | | | 49,592,641 | | | | | | — | | |
Net cash generated from/(used) financing activities
|
| | | | | | | 61,822,761 | | | | | | (924,369) | | |
Net increase/(decrease) in cash and cash equivalents
|
| | | | | | | 13,996,847 | | | | | | 1,155,020 | | |
Cash and cash equivalents at beginning of period
|
| | | | | | | 2,050,761 | | | | | | 161,342 | | |
Cash and cash equivalents at end of period
|
| | | | | | | 16,047,608 | | | | | | 1,316,362 | | |
|
STANDARD OR
INTERPRETATION |
| |
DESCRIPTION
|
| |
EFFECTIVE DATE
FOR ANNUAL ACCOUNTING PERIOD BEGINNING ON OR AFTER |
|
IAS 1 | | |
Amendments – Classification of Liabilities as Current or Non-current
|
| |
1 January 2023
|
|
IAS 16 | | | Amendments – Property, Plant and Equipment | | |
1 January 2022
|
|
IAS 8 | | | Amendments – Definition of Accounting Estimates | | |
1 January 2023
|
|
IAS 1 | | | Amendments – Disclosure of Accounting Policies | | |
1 January 2023
|
|
IFRS | | | Annual Improvements to IFRS Standards 2018-2020 | | |
1 January 2022
|
|
| | |
PERIOD ENDED
30 JUNE 2021 (UNAUDITED) |
| |
PERIOD ENDED
30 JUNE 2020 (UNAUDITED) |
| ||||||
| | |
£
|
| |
£
|
| ||||||
Crypto currency mining – worldwide
|
| | | | 29,937,270 | | | | | | 11,124,455 | | |
Crypto currency management fees – United States
|
| | | | 1,148,446 | | | | | | — | | |
Total revenue
|
| | | | 31,085,716 | | | | | | 11,124,455 | | |
|
| | |
PERIOD ENDED
30 JUNE 2021 (UNAUDITED) £ |
| |
PERIOD ENDED
30 JUNE 2020 (UNAUDITED) £ |
| ||||||
Net profit for the period attributable to ordinary equity holders from continuing operations (£)
|
| | | | 7,213,997 | | | | | | 523,074 | | |
Weighted average number of ordinary shares in issue
|
| | | | 381,832,335 | | | | | | 293,750,000 | | |
Basic earnings per share for continuing operations (pence)
|
| | | | 1.9 | | | | | | 0.2 | | |
|
| | |
£
|
| |
£
|
| ||||||
Net profit for the period attributable to ordinary equity holders for continuing operations (£)
|
| | | | 7,213,997 | | | | | | 523,074 | | |
Diluted number of ordinary shares in issue
|
| | | | 393,091,232 | | | | | | 350,098,603 | | |
Diluted earnings per share for continuing operations (pence)
|
| | | | 1.8 | | | | | | 0.2 | | |
|
| | |
PERIOD ENDED
30 JUNE 2021 (UNAUDITED) £ |
| |
PERIOD ENDED
30 JUNE 200 (UNAUDITED) £ |
| ||||||
Income tax expense – foreign tax
|
| | | | 3,483,827 | | | | | | — | | |
Deferred tax expense
|
| | | | — | | | | | | — | | |
Taxation charge in the financial statements
|
| | | | 3,483,827 | | | | | | — | | |
|
NON CURRENT
|
| |
As at
30 June 2021 (unaudited) £ |
| |
As at
31 December 2020 (audited) £ |
| ||||||
At 1 January 2021 and 1 January 2020
|
| | | | 1,393,303 | | | | | | 58,140 | | |
Additions
|
| | | | 219,360 | | | | | | 1,335,676 | | |
Foreign exchange movement
|
| | | | 18,073 | | | | | | (513) | | |
Transferred to current investments
|
| | | | (1,411,376) | | | | | | — | | |
At 30 June 2021 and 31 December 2020
|
| | | | 219,360 | | | | | | 1,393,303 | | |
|
CURRENT
|
| | | | | | | | | | | | |
At 1 January 2021 and 1 January 2020
|
| | | | — | | | | | | — | | |
Transferred from non-current investments
|
| | | | 1,411,376 | | | | | | — | | |
At 30 June 2021 and 31 December 2020
|
| | | | 1,411,376 | | | | | | — | | |
|
| | |
As at
30 June 2021 (unaudited) £ |
| |
As at
31 December 2020 (audited) £ |
| ||||||
Opening balance
|
| | | | — | | | | | | — | | |
Acquired during the period
|
| | | | 8,444,820 | | | | | | — | | |
Total Associates
|
| | | | 8,444,820 | | | | | | — | | |
|
| Name of entity | | | Pluto Digital PLC | |
| Address of the registered office | | | Hill Dickinson LLP, 8th Floor The Broadgate Tower, 20 Primrose Street, London, United Kingdom, EC2A 2EW | |
| % of ownership interest | | | 24.65% | |
| Nature of relationship | | | Refer below | |
| Measurement method | | | Equity | |
| | |
£
|
| |||
Cash
|
| | | | 291,867 | | |
Payment for deposits
|
| | | | 666,845 | | |
Cancellation of prepayment and deposits
|
| | | | 4,664,113 | | |
Total consideration
|
| | | | 5,622,825 | | |
|
| | |
£
|
| |||
Cash and cash equivalents
|
| | | | 20,135 | | |
Property, plant and equipment (Note 11)
|
| | | | 10,159,851 | | |
Trade and other receivables
|
| | | | 483,294 | | |
Property mortgages
|
| | | | (5,040,455) | | |
Total | | | | | 5,622,825 | | |
|
| | |
RIGHT OF
USE ASSETS £ |
| |
MINING AND
COMPUTER EQUIPMENT £ |
| |
LAND &
BUILDINGS £ |
| |
IMPROVEMENTS
TO DATA CENTRE £ |
| |
TOTAL
£ |
| |||||||||||||||
Cost | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
At 1 January 2021
|
| | | | 7,379,387 | | | | | | 17,864,347 | | | | | | — | | | | | | 84,927 | | | | | | 25,328,661 | | |
Foreign exchange movement
|
| | | | — | | | | | | (132,458) | | | | | | — | | | | | | — | | | | | | (132,457) | | |
Acquisition through business combination
|
| | | | — | | | | | | 163,416 | | | | | | 9,996,435 | | | | | | — | | | | | | 10,159,851 | | |
Additions
|
| | | | — | | | | | | — | | | | | | 19,012,587 | | | | | | — | | | | | | 19,012,587 | | |
At 30 June 2021
|
| | | | 7,379,387 | | | | | | 17,895,305 | | | | | | 29,009,022 | | | | | | 84,927 | | | | | | 54,368,642 | | |
Depreciation and impairment | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
At 1 January 2021
|
| | | | — | | | | | | 7,377,050 | | | | | | — | | | | | | 47,992 | | | | | | 7,425,042 | | |
Depreciation charged during the
period |
| | | | 1,024,915 | | | | | | 3,723,527 | | | | | | 35,155 | | | | | | 9,544 | | | | | | 4,793,141 | | |
At 30 June 2021
|
| | | | 1,024,195 | | | | | | 11,101,297 | | | | | | 35,155 | | | | | | 57,536 | | | | | | 12,218,183 | | |
Carrying amount | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
At 1 January 2021
|
| | | | 7,379,387 | | | | | | 10,487,297 | | | | | | — | | | | | | 36,935 | | | | | | 17,903,619 | | |
At 30 June 2021
|
| | | | 6,355,192 | | | | | | 6,794,008 | | | | | | 28,973,867 | | | | | | 27,391 | | | | | | 42,150,459 | | |
|
| | |
AS AT
30 JUNE 2021 (UNAUDITED) £ |
| |
AS AT
31 DECEMBER 2020 (AUDITED) £ |
| ||||||
Deposits | | | | | | | | | | | | | |
Brought forward
|
| | | | 4,114,726 | | | | | | 4,151,400 | | |
Exchange movement
|
| | | | — | | | | | | (36,674) | | |
Cancelled on acquisition of GPUone subsidiaries
|
| | | | (4,114,726) | | | | | | — | | |
Total carrying amount of other receivables
|
| | | | — | | | | | | 4,114,726 | | |
|
| | |
AS AT
30 JUNE 2021 (UNAUDITED) £ |
| |
AS AT
31 DECEMBER 2020 (AUDITED) £ |
| ||||||
Mining equipment prepayments
|
| | | | 35,471,499 | | | | | | — | | |
Prepayments and other receivables
|
| | | | 1,957,977 | | | | | | 811,684 | | |
Other taxation and social security
|
| | | | 1,816,857 | | | | | | 1,363,635 | | |
Total trade and other receivables
|
| | | | 39,246,333 | | | | | | 23,227,957 | | |
|
GROUP
|
| |
AS AT
30 JUNE 2021 (UNAUDITED) £ |
| |
AS AT
31 DECEMBER 2020 (AUDITED) £ |
| ||||||
Brought forward
|
| | | | 4,637,438 | | | | | | 1,040,964 | | |
Additions | | | | | | | | | | | | | |
Crypto assets purchased and received
|
| | | | 4,383,010 | | | | | | 9,896,641 | | |
Crypto assets mined
|
| | | | 29,937,270 | | | | | | 18,947,908 | | |
Total additions
|
| | | | 34,320,280 | | | | | | 28,844,549 | | |
Disposals | | | | | | | | | | | | | |
Crypto assets sold
|
| | | | (1,091,850) | | | | | | (27,318,471) | | |
Total disposals
|
| | | | (1,091,850) | | | | | | (27,318,471) | | |
Fair value movements | | | | | | | | | | | | | |
Loss on futures
|
| | | | — | | | | | | (258,326) | | |
Movements on crypto asset sales
|
| | | | 219,008 | | | | | | (13,816) | | |
Movements on crypto assets held at the period/year end
|
| | | | (6,407,446) | | | | | | 2,342,538 | | |
Total fair value movements
|
| | | | (6,188,439) | | | | | | 2,070,396 | | |
Carried forward
|
| | | | 31,896,437 | | | | | | 4,637,438 | | |
|
30 JUNE 2021 CRYPTO ASSET NAME
|
| |
COINS/TOKENS
|
| |
FAIR VALUE
£ |
| ||||||
Bitcoin – Bitcoin
|
| | | | 471 | | | | | | 11,700,276 | | |
Bitcoin – held as collateral
|
| | | | 795 | | | | | | 19,748,876 | | |
Ethereum – ETH
|
| | | | 254 | | | | | | 394,963 | | |
Alternative coins
|
| | | | | | | | | | 52,322 | | |
At 30 June 2021
|
| | | | | | | | | | 31,896,437 | | |
|
31 DECEMBER 2020 CRYPTO ASSET NAME
|
| |
COINS/TOKENS
|
| |
FAIR VALUE
£ |
| ||||||
Bitcoin – Bitcoin
|
| | | | 183 | | | | | | 3,929,696 | | |
Polkadot – DOT
|
| | | | 75,000 | | | | | | 515,176 | | |
Ethereum – ETH
|
| | | | 254 | | | | | | 138,257 | | |
Binance Coin – BNB
|
| | | | 1,243 | | | | | | 34,260 | | |
USDT,USDC (stable coin – fixed to USD)
|
| | | | 26,509 | | | | | | 19,553 | | |
Alternative coins
|
| | | | — | | | | | | 496 | | |
At 31 December 2020
|
| | | | | | | | | | 4,637,438 | | |
|
| | |
AS AT
30 JUNE 2021 (UNAUDITED) £ |
| |
AS AT
31 DECEMBER 2020 (AUDITED) £ |
| ||||||
Ordinary share capital | | | | | | | | | | | | | |
Issued and fully paid | | | | | | | | | | | | | |
303,435,997 Ordinary Shares of £0.001 each
|
| | | | 303,436 | | | | | | 293,750 | | |
Issued in the period | | | | | | | | | | | | | |
78,325,292 Ordinary Shares of £0.001 each
|
| | | | 78,325 | | | | | | — | | |
Fully paid not yet issued | | | | | | | | | | | | | |
71,046 Ordinary Shares of £0.001 each
|
| | | | 71 | | | | | | 9,686 | | |
381,832,335 Ordinary Shares of £0.001 each
|
| | | | 381,832 | | | | | | 303,436 | | |
Additional paid in capital | | | | | | | | | | | | | |
At beginning of the period
|
| | | | 1,540,497 | | | | | | 25,252,288 | | |
Cancelled during the year
|
| | | | — | | | | | | (25,252,288) | | |
Issued in the period
|
| | | | 53,765,654 | | | | | | — | | |
Fully paid not yet issued
|
| | | | 11,296 | | | | | | 1,540,497 | | |
At the end of period
|
| | | | 55,317,447 | | | | | | 1,540,597 | | |
|
OPTIONS /
WARRANTS |
| |
GRANT DATE
|
| |
EXPIRY DATE
|
| |
EXERCISE
PRICE |
| |
NUMBER OF
OPTIONS AND WARRANTS OUTSTANDING AT 30 June 2021 |
| |
NUMBER OF
OPTIONS AND WARRANTS EXERCISABLE AT June 30 2021 |
| |||||||||
Warrants
|
| |
5 January 2021
|
| | 2 March 2031 | | | | £ | 1.25 | | | | | | 240,000 | | | | | | 60,000 | | |
Warrants
|
| | 19 April 2021 | | | 1 March 2024 | | | | £ | 1.35 | | | | | | 223,821 | | | | | | 223,821 | | |
Warrants
|
| |
19 January 2021
|
| |
1 January 2026
|
| | | £ | 0.87 | | | | | | 50,000 | | | | | | 50,000 | | |
Warrants
|
| |
17 January 2021
|
| | 1 March 2024 | | | | £ | 1.50 | | | | | | 22,000 | | | | | | 22,000 | | |
Options
|
| | 25 July 2018 | | | 25 July 2024 | | | | £ | 0.16 | | | | | | 1,000,000 | | | | | | 759,259 | | |
Options
|
| | 17 July 2019 | | | 25 July 2024 | | | | £ | 0.16 | | | | | | 537,037 | | | | | | 296,296 | | |
Options
|
| |
5 February 2020
|
| | 25 July 2024 | | | | £ | 0.07 | | | | | | 3,254,048 | | | | | | 1,263,572 | | |
Options
|
| |
5 February 2020
|
| |
4 February 2030
|
| | | £ | 0.07 | | | | | | 3,700,000 | | | | | | 1,528,571 | | |
Options
|
| |
3 February 2021
|
| |
2 February 2031
|
| | | £ | 0.94 | | | | | | 231,991 | | | | | | 22,094 | | |
Options
|
| | 27 June 2021 | | | 26 June 2031 | | | | £ | 1.35 | | | | | | 500,000 | | | | | | 0 | | |
Options
|
| | 24 June 2021 | | | 23 June 2031 | | | | £ | 1.26 | | | | | | 1,000,000 | | | | | | 0 | | |
| | | | | | | | | | | | | | | | | 10,758,897 | | | | | | 4,225,614 | | |
|
RESERVE
|
| |
DESCRIPTION
|
|
Common stock | | | Represents the nominal value of equity shares | |
Additional paid in capital | | | Amount subscribed for share capital in excess of nominal value and the fair value of shares granted during the year and as a result of a change in estimation those granted in prior periods | |
Accumulated other comprehensive income | | | Cumulative effects of translation of opening balances on non-monetary assets between subsidiary functional currency (Canadian dollars) and Group functional and presentational currency (Sterling). | |
Retained earnings | | | Cumulative net gains and losses and other transactions with equity holders not recognised elsewhere. | |
Share based payment reserve | | | Represents the fair value of options and warrants granted less amounts transferred on exercise, lapse or expiry | |
| | |
As at
30 June 2021 (unaudited) £ |
| |
As at
31 December 2020 (audited) £ |
| ||||||
Trade payables
|
| | | | 15,233,372 | | | | | | 548,293 | | |
Accruals and other payables
|
| | | | 949,976 | | | | | | 271,471 | | |
Short term loans
|
| | | | — | | | | | | 115,924 | | |
Deferred contingent consideration
|
| | | | 9,025,857 | | | | | | — | | |
Other taxation and social security
|
| | | | 1,575 | | | | | | 972 | | |
|
| | |
As at
30 June 2021 (unaudited) £ |
| |
As at
31 December 2020 (audited) £ |
| ||||||
Total trade and other payables
|
| | | | 25,210,780 | | | | | | 936,660 | | |
|
NON CURRENT
|
| |
As at
30 June 2021 (unaudited) £ |
| |
As at
31 December 2020 (audited) £ |
| ||||||
Assumed mortgage on acquisition
|
| | | | 4,032,364 | | | | | | — | | |
At 30 June 2021 and 31 December 2020
|
| | | | 4,032,364 | | | | | | — | | |
|
CURRENT
|
| | | | | | | | | | | | |
Short term loan
|
| | | | 14,375,021 | | | | | | — | | |
Assumed mortgage on acquisition
|
| | | | 1,008,090 | | | | | | — | | |
At 30 June 2021 and 31 December 2020
|
| | | | 15,383,111 | | | | | | — | | |
|
| | |
As at
30 June 2021 (unaudited) £ |
| |
As at
31 December 2020 (audited) £ |
| ||||||
Carrying amount of financial assets | | | | | | | | | | | | | |
Measured at amortised cost | | | | | | | | | | | | | |
– Trade and other receivables
|
| | | | 209,498 | | | | | | 144,607 | | |
– Cash and cash equivalents
|
| | | | 16,047,608 | | | | | | 2,050,761 | | |
Measured at fair value through income or loss
|
| | | | 1,630,736 | | | | | | 1,393,303 | | |
Total carrying amount of financial assets
|
| | | | 17,887,842 | | | | | | 3,588,671 | | |
Carrying amount of financial liabilities | | | | | | | | | | | | | |
Measured at amortised cost | | | | | | | | | | | | | |
– Trade and other payables
|
| | | | 16,105,765 | | | | | | 548,293 | | |
– Short term loans
|
| | | | 15,383,111 | | | | | | 115,924 | | |
– Long term loans
|
| | | | 4,032,364 | | | | | | — | | |
– Lease liabilities
|
| | | | 5,645,239 | | | | | | 7,409,387 | | |
Measured at fair value through income or loss
|
| | | | 9,025,857 | | | | | | — | | |
Total carrying amount of financial liabilities
|
| | | | 50,192,336 | | | | | | 8,073,604 | | |
|
| | |
Level 1
|
| |
Level 2
|
| |
Level 3
|
| |
Total
|
| ||||||||||||
Assets
|
| |
£
|
| |
£
|
| |
£
|
| |
£
|
| ||||||||||||
Financial assets at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | | | | | |
– Equity holdings
|
| | | | — | | | | | | — | | | | | | 1,630,736 | | | | | | 1,630,736 | | |
– Digital assets
|
| | | | — | | | | | | 31,896,437 | | | | | | — | | | | | | 31,896,437 | | |
Total at 30 June 2021
|
| | | | — | | | | | | 31,896,437 | | | | | | 1,630,736 | | | | | | 33,527,173 | | |
Liabilities | | | | | | | | | | | | | | | | | | | | | | | | | |
Financial liabilities at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | | | | | |
– Deferred contingent consideration
|
| | | | — | | | | | | — | | | | | | 9,025,857 | | | | | | 9,025,857 | | |
Total at 30 June 2021
|
| | | | — | | | | | | — | | | | | | 9,025,857 | | | | | | 9,025,857 | | |
|
| | |
Level 1
|
| |
Level 2
|
| |
Level 3
|
| |
Total
|
| ||||||||||||
Assets
|
| |
£
|
| |
£
|
| |
£
|
| |
£
|
| ||||||||||||
Financial assets at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | | | | | |
– Equity holdings
|
| | | | — | | | | | | — | | | | | | 1,393,303 | | | | | | 1,393,303 | | |
– Digital assets
|
| | | | — | | | | | | 4,637,438 | | | | | | — | | | | | | 4,637,438 | | |
Total at 31 December 2020
|
| | | | — | | | | | | 4,637,438 | | | | | | 1,393,303 | | | | | | 6,030,741 | | |
Exhibit No.
|
| |
Description
|
|
1.1 | | | | |
3.1* | | | | |
3.2 | | | | |
4.1 | | | | |
4.2 | | | | |
5.1* | | | | |
10.1* | | | | |
10.2* | | | | |
10.3* | | | | |
10.4* | | |
[Reserved]
|
|
10.5* | | | | |
10.6* | | | | |
10.7* | | | | |
10.8*† | | | | |
10.9* | | | | |
10.10* | | | | |
21.1* | | | | |
23.1 | | | | |
23.2* | | | | |
24.1* | | | |
|
Name
|
| |
Title
|
|
|
/s/ Peter Wall
Peter Wall
|
| |
Chief Executive Officer and Interim Chairman of the Board
(Principal Executive Officer) |
|
|
/s/ Alex Appleton
Alex Appleton
|
| |
Chief Financial Officer and Member of the Board
(Principal Financial Officer and Principal Accounting Officer) |
|
|
/s/ Matthew Shaw
Matthew Shaw
|
| |
Member of the Board
|
|
|
/s/ Sarah Gow
Sarah Gow
|
| |
Member of the Board
|
|
|
/s/ Colleen Sullivan
Colleen Sullivan
|
| |
Member of the Board
|
|
|
/s/ Maria Perrella
Maria Perrella
|
| |
Member of the Board
|
|
Exhibit 1.1
Argo Blockchain plc
[ n ] American Depositary Shares
Representing [ n ] Ordinary Shares
(Nominal Value £0.001 Per Share)
UNDERWRITING AGREEMENT
[ n ], 2021
JEFFERIES LLC
BARCLAYS CAPITAL INC.
As Representatives of the several Underwriters
c/o JEFFERIES LLC
520 Madison Avenue
New York, New York 10022
and
c/o BARCLAYS CAPITAL INC.
745 Seventh Avenue
New York, New York 10019
Ladies and Gentlemen:
Introductory. Argo Blockchain plc, a public limited company incorporated under the laws of England and Wales (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) an aggregate of [●] American Depositary Shares (“ADSs”), each representing one ordinary share, nominal value £0.001 per share, of the Company (each an “Ordinary Share”). The [●] ADSs to be sold by the Company are called the “Firm ADSs.” In addition, the Company has granted to the Underwriters an option to purchase up to an additional [●] ADSs as provided in Section 2. The additional [●] ADSs to be sold by the Company pursuant to such option are called the “Optional ADSs.” The Firm ADSs and, if and to the extent such option is exercised, the Optional ADSs are collectively called the “Offered ADSs.” The Ordinary Shares represented by the Firm ADSs are hereinafter called the “Firm Shares,” the Ordinary Shares represented by the Optional ADSs are hereinafter called the “Optional Shares,” and the Firm Shares and Optional Shares are hereinafter collectively called the “Shares.” Unless the context otherwise requires, each reference to the Firm ADSs, the Optional ADSs or the Offered ADSs herein also includes the Shares. Jefferies LLC (“Jefferies”) and Barclays Capital Inc. (“Barclays”) have agreed to act as representatives of the several Underwriters (in such capacity, the “Representatives”) in connection with the offering and sale of the Offered ADSs. To the extent there are no additional underwriters listed on Schedule A, the term “Representatives” as used herein shall mean you, as Underwriters, and the term “Underwriters” shall mean either the singular or the plural, as the context requires.
The ADSs will be evidenced by American Depositary Receipts (the “ADRs”) to be issued pursuant to a deposit agreement dated as of [●], 2021 (the “Deposit Agreement”), among the Company, JPMorgan Chase Bank, N.A., as depositary (the “Depositary”), and the holders from time to time of the ADRs evidencing the ADSs issued thereunder. The Company shall, following subscription by the Underwriters of the Firm ADSs and, if applicable, the Optional ADSs, deposit, on behalf of the Underwriters, the Shares represented by such ADSs with JPMorgan Chase Bank N.A., London, as custodian (the “Depositary Custodian”) for the Depositary, which shall deliver such ADSs to the Representatives for the account of the several Underwriters for subsequent delivery to the other several Underwriters or the investors, as the case may be.
The Company has prepared and filed with the Securities and Exchange Commission (the “Commission”) a registration statement on Form F-1, File No. 333-258926 with respect to the Shares underlying the Offered ADSs, which contains a form of prospectus to be used in connection with the public offering and sale of the Offered ADSs. Such registration statement, as amended, including the financial statements, exhibits and schedules thereto, in the form in which it became effective under the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder (collectively, the “Securities Act”), including any information deemed to be a part thereof at the time of effectiveness pursuant to Rule 430A under the Securities Act, is called the “Registration Statement.” Any registration statement filed by the Company pursuant to Rule 462(b) under the Securities Act in connection with the offer and sale of the Offered ADSs is called the “Rule 462(b) Registration Statement,” and from and after the date and time of filing of any such Rule 462(b) Registration Statement the term “Registration Statement” shall include the Rule 462(b) Registration Statement. The Company and the Depositary have prepared and filed with the Commission a registration statement on Form F-6 (File No. 333-[●]) relating to the Offered ADSs. Such registration statement, as amended, including the financial statements, exhibits and schedules thereto, in the form in which it became effective under the Securities Act is called the “F-6 Registration Statement.” The prospectus, in the form first used by the Underwriters to confirm sales of the Offered ADSs or in the form first made available to the Underwriters by the Company to meet requests of purchasers pursuant to Rule 173 under the Securities Act is called the “Prospectus.” The preliminary prospectus, dated [●], 2021 describing the Offered ADSs and the offering thereof is called the “Preliminary Prospectus,” and the Preliminary Prospectus and any other prospectus in preliminary form that describes the Offered ADSs and the offering thereof and is used prior to the filing of the Prospectus is called a “preliminary prospectus.” As used herein, “Applicable Time” is [●][a.m.][p.m.] (New York City time) on [●], 2021. As used herein, “free writing prospectus” has the meaning set forth in Rule 405 under the Securities Act, and “Time of Sale Prospectus” means the Preliminary Prospectus, together with the free writing prospectuses, if any, identified in Schedule B hereto and the pricing information identified in Schedule C hereto. As used herein, “Road Show” means a “road show” (as defined in Rule 433 under the Securities Act) relating to the offering of the Offered ADSs contemplated hereby that is a “written communication” (as defined in Rule 405 under the Securities Act). As used herein, “Testing-the-Waters Written Communication” means each written communication (within the meaning of Rule 405 under the Securities Act) that is made in reliance on Section 5(d) of or Rule 163B under the Securities Act by the Company or any person authorized to act on behalf of the Company to one or more potential investors that are or are reasonably believed to be qualified institutional buyers (“QIBs”) and/or institutions that are accredited investors (“IAIs”), as such terms are respectively defined in Rule 144A and Rule 501(a) under the Securities Act, to determine whether such investors might have an interest in the offering of the Offered ADSs; “Testing-the-Waters Oral Communication” means each oral communication, if any, made in reliance on Section 5(d) of or Rule 163B under the Securities Act by the Company or any person authorized to act on behalf of the Company made to one or more potential investors that are or are reasonably believed to be QIBs and/or IAIs to determine whether such investors might have an interest in the offering of the Offered ADSs; “Marketing Materials” means any materials or information provided to investors by, or with the approval of, the Company in connection with the marketing of the offering of the Offered ADSs, including any roadshow or investor presentations made to investors by the Company (whether in person or electronically); and “Permitted Testing-the-Waters Communication” means the Testing-the-Waters Written Communication(s) and Marketing Materials listed on Schedule D attached hereto.
All references in this Agreement to (i) the Registration Statement, the F-6 Registration Statement, any preliminary prospectus (including the Preliminary Prospectus) or the Prospectus, or any amendments or supplements to any of the foregoing, or any free writing prospectus, shall include any copy thereof filed with the Commission pursuant to its Electronic Data Gathering, Analysis and Retrieval System (“EDGAR”) and (ii) the Prospectus shall be deemed to include any “electronic Prospectus” provided for use in connection with the offering of the Offered ADSs as contemplated by Section 3(n) of this Agreement.
2 |
In the event that the Company has only one subsidiary, then all references herein to “subsidiaries” of the Company shall be deemed to refer to such single subsidiary, mutatis mutandis.
The Company hereby confirms its agreements with the Underwriters as follows:
Section 1. Representations and Warranties.
The Company hereby represents, warrants and covenants to each Underwriter, as of the date of this Agreement, as of the First Closing Date (as hereinafter defined) and as of each Option Closing Date (as hereinafter defined), if any, as follows:
(a) Compliance with Registration Requirements. The Registration Statement and the F-6 Registration Statement have each become effective under the Securities Act. The Company has complied, to the Commission’s satisfaction, with all requests of the Commission for additional or supplemental information, if any. No stop order suspending the effectiveness of the Registration Statement or the F-6 Registration Statement is in effect and no proceedings for such purpose have been instituted or are pending or, to the best knowledge of the Company, are contemplated or threatened by the Commission. The Company is a “foreign private issuer” within the meaning of Rule 405 under the Securities Act.
(b) Disclosure. Each preliminary prospectus and the Prospectus when filed complied in all material respects with the Securities Act and, if filed by electronic transmission pursuant to EDGAR, was identical (except as may be permitted by Regulation S-T under the Securities Act) to the copy thereof delivered to the Underwriters for use in connection with the offer and sale of the Offered ADSs. Each of the Registration Statement and any post-effective amendment thereto and the F-6 Registration Statement and any post-effective amendment thereto, at the time it became or becomes effective, complied and will comply in all material respects with the Securities Act and did not and will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading. As of the Applicable Time, the Time of Sale Prospectus did not, and at the First Closing Date (as defined in Section 2) and at each applicable Option Closing Date (as defined in Section 2), will not, contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading. The Prospectus, as of its date, did not, and at the First Closing Date and at each applicable Option Closing Date, will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The representations and warranties set forth in the three immediately preceding sentences do not apply to statements in or omissions from the Registration Statement or any post-effective amendment thereto, the F-6 Registration Statement or any post-effective amendment thereto, or the Prospectus or the Time of Sale Prospectus, or any amendments or supplements thereto, made in reliance upon and in conformity with written information relating to any Underwriter furnished to the Company in writing by the Representatives expressly for use therein, it being understood and agreed that the only such information consists of the information described in Section 9(b) below. There are no contracts or other documents required to be described in the Time of Sale Prospectus or the Prospectus or to be filed as an exhibit to the Registration Statement or the F-6 Registration Statement which have not been described or filed as required.
3 |
(c) Free Writing Prospectuses; Road Show. As of the determination date referenced in Rule 164(h) under the Securities Act, the Company was not, is not or will not be (as applicable) an “ineligible issuer” in connection with the offering of the Offered ADSs pursuant to Rules 164, 405 and 433 under the Securities Act. Each free writing prospectus that the Company is required to file pursuant to Rule 433(d) under the Securities Act has been, or will be, filed with the Commission in accordance with the requirements of the Securities Act. Each free writing prospectus that the Company has filed, or is required to file, pursuant to Rule 433(d) under the Securities Act or that was prepared by or on behalf of or used or referred to by the Company complies or will comply in all material respects with the requirements of Rule 433 under the Securities Act, including timely filing with the Commission, retention and legending, as applicable, and each such free writing prospectus, as of its issue date and at all subsequent times through the completion of the public offer and sale of the Offered ADSs did not, does not and will not include any information that conflicted, conflicts or will conflict with the information contained in the Registration Statement, the Prospectus or any preliminary prospectus unless such information has been superseded or modified as of such time. The representations and warranties set forth in the immediately preceding sentence do not apply to statements in or omissions from the Registration Statement or any post-effective amendment thereto, the F-6 Registration Statement or any post-effective amendment thereto, or the Prospectus or the Time of Sale Prospectus, or any amendments or supplements thereto, made in reliance upon and in conformity with written information relating to any Underwriter furnished to the Company in writing by the Representatives expressly for use therein, it being understood and agreed that the only such information consists of the information described in Section 9(b) below. Except for the free writing prospectuses, if any, identified in Schedule B, and electronic road shows, if any, furnished to you before first use, the Company has not prepared, used or referred to, and will not, without your prior written consent, prepare, use or refer to, any free writing prospectus. Each Road Show, when considered together with the Time of Sale Prospectus, did not, as of the Applicable Time, contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading.
(d) [Reserved.]
(e) Distribution of Offering Material By the Company. Prior to the later of (i) the expiration or termination of the option granted to the several Underwriters in Section 2, (ii) the completion of the Underwriters’ distribution of the Offered ADSs and (iii) the expiration of 25 days after the date of the Prospectus, the Company has not distributed and will not distribute any offering material in connection with the offering and sale of the Offered ADSs other than the Registration Statement, the F-6 Registration Statement, the Time of Sale Prospectus, the Prospectus or any free writing prospectus reviewed and consented to by the Representatives, the free writing prospectuses, if any, identified on Schedule B hereto and any Permitted Testing-the-Waters Communications.
(f) The Underwriting Agreement. This Agreement has been duly authorized, executed and delivered by the Company.
(g) Authorization of the Shares and the Offered ADSs. The Shares have been duly authorized and, when issued and delivered against payment therefor pursuant to this Agreement, will be validly issued, fully paid and will not be subject to any call for further payment of capital and free of any preemptive rights, rights of first refusal or other similar rights to subscribe for or purchase the Shares. The Shares may be freely deposited by the Company with the Depositary or its nominee against issuance of ADRs evidencing the Offered ADSs, as contemplated by the Deposit Agreement. The Offered ADSs have been duly authorized for issuance and sale pursuant to this Agreement and, when issued and delivered by the Company against payment therefor pursuant to this Agreement, will be validly issued, fully paid and will not be subject to any call for further payment of capital, and the issuance and sale of the Offered ADSs is not subject to any preemptive rights, rights of first refusal or other similar rights to subscribe for or purchase the Offered ADSs. Upon the sale and delivery to the Underwriters of the Offered ADSs, and payment therefor, the Underwriters will acquire good, marketable and valid title to such Offered ADSs, free and clear of all pledges, liens, security interests, charges, claims or encumbrances.
4 |
(h) No Applicable Registration or Other Similar Rights. There are no persons with registration or other similar rights to have any equity or debt securities registered for sale under the Registration Statement or the F-6 Registration Statement or included in the offering contemplated by this Agreement, except for such rights as have been duly waived.
(i) No Material Adverse Change. Except as otherwise disclosed in the Registration Statement, the Time of Sale Prospectus and the Prospectus, subsequent to the respective dates as of which information is given in the Registration Statement, the Time of Sale Prospectus and the Prospectus: (i) there has been no material adverse change, or any development that would reasonably be expected to result in a material adverse change, in (A) the condition, financial or otherwise, or in the earnings, business, properties, operations, assets, or liabilities or prospects, whether or not arising from transactions in the ordinary course of business, of the Company and its subsidiaries, considered as one entity or (B) the ability of the Company to consummate the transactions contemplated by this Agreement or perform its obligations hereunder (any such change being referred to herein as a “Material Adverse Change”); (ii) the Company and its subsidiaries, considered as one entity, have not incurred any material liability or obligation, indirect, direct or contingent, including without limitation any losses or interference with their business from fire, explosion, flood, earthquakes, accident or other calamity, whether or not covered by insurance, or from any strike, labor dispute or court or governmental action, order or decree, that are material, individually or in the aggregate, to the Company and its subsidiaries, considered as one entity, and have not entered into any transactions not in the ordinary course of business; and (iii) there has not been any material decrease in the share capital or any material increase in any short-term or long-term indebtedness of the Company or its subsidiaries and there has been no dividend or distribution of any kind declared, paid or made by the Company or, except for dividends paid to the Company or other subsidiaries, by any of the Company’s subsidiaries on any class of share capital, or any repurchase or redemption by the Company or any of its subsidiaries of any class of share capital.
(j) The Deposit Agreement; ADRs. The Deposit Agreement has been duly authorized, executed and delivered by the Company and, assuming due authorization, execution and delivery by the Depositary, constitutes a valid and legally binding obligation of the Company, enforceable in accordance with its terms, except as the enforceability thereof may be limited by bankruptcy, insolvency, reorganization or similar laws relating to or affecting creditors’ rights generally or by general equitable principles. Upon due issuance by the Depositary of the ADRs evidencing the Offered ADSs against the deposit of the Shares in respect thereof in accordance with the provisions of the Deposit Agreement, such ADRs will be duly and validly issued and the persons in whose names the ADRs are registered will be entitled to the rights specified therein and in the Deposit Agreement. The issuance and sale of the Offered ADSs by the Company and the deposit of the Shares with the Depositary and the issuance of the ADRs evidencing the Shares as contemplated by this Agreement and the Deposit Agreement will neither (i) cause any holder of any Ordinary Shares or ADSs, securities convertible into or exchangeable or exercisable for Ordinary Shares or ADSs or options, warrants or other rights to purchase Ordinary Shares or ADSs or any other securities of the Company to have any right to acquire any shares of preferred stock of the Company nor (ii) trigger any anti-dilution rights of any such holder with respect to such Shares, ADSs, securities, options, warrants or rights. The Deposit Agreement and the ADRs conform in all material respects to each description thereof in the Time of Sale Prospectus. Each holder of ADRs issued pursuant to the Deposit Agreement shall be entitled, subject to the Deposit Agreement, to seek enforcement of its rights through the Depositary or its nominee registered as a representative of the holders of the ADRs in a direct suit, action or proceeding against the Company.
5 |
(k) Independent Accountants. PKF Littlejohn LLP, which has expressed its opinion with respect to the financial statements (which term as used in this Agreement includes the related notes thereto) filed with the Commission as a part of the Registration Statement, the Time of Sale Prospectus and the Prospectus, is (i) an independent registered public accounting firm as required by the Securities Act , the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder (collectively, the “Exchange Act”), and the rules of the Public Company Accounting Oversight Board (“PCAOB”), (ii) in compliance with the applicable requirements relating to the qualification of accountants under Rule 2-01 of Regulation S-X under the Securities Act and (iii) a registered public accounting firm as defined by the PCAOB whose registration has not been suspended or revoked and who has not requested such registration to be withdrawn.
(l) Financial Statements. The financial statements filed with the Commission as a part of the Registration Statement, the Time of Sale Prospectus and the Prospectus present fairly the consolidated financial position of the Company and its subsidiaries as of the dates indicated and the results of their operations, changes in stockholders’ equity and cash flows for the periods specified. Such financial statements have been prepared in conformity with International Financial Reporting Standards (“IFRS”) as issued by the European Union and the International Accounting Standards Board (the “IASB”) applied on a consistent basis throughout the periods involved, except as may be expressly stated in the related notes thereto. No other financial statements or supporting schedules are required to be included in the Registration Statement, the Time of Sale Prospectus or the Prospectus. The financial data set forth in each of the Registration Statement, the Time of Sale Prospectus and the Prospectus under the captions “Prospectus Summary—Summary Historical Consolidated Financial and Other Data” and “Capitalization” fairly present in all material respects the information set forth therein on a basis consistent with that of the audited financial statements contained in the Registration Statement, the Time of Sale Prospectus and the Prospectus. All disclosures contained in the Registration Statement, any preliminary prospectus or the Prospectus and any free writing prospectus that constitute non-IFRS financial measures (as defined by the rules and regulations under the Securities Act and the Exchange Act) comply with Regulation G under the Exchange Act and Item 10 of Regulation S-K under the Securities Act, as applicable. To the Company’s knowledge, no person who has been suspended or barred from being associated with a registered public accounting firm, or who has failed to comply with any sanction pursuant to Rule 5300 promulgated by the PCAOB, has participated in or otherwise aided the preparation of, or audited, the financial statements, supporting schedules or other financial data filed with the Commission as a part of the Registration Statement, the Time of Sale Prospectus and the Prospectus.
(m) Company’s Accounting System. The Company and each of its subsidiaries make and keep accurate books and records and maintain a system of internal accounting controls designed and which the Company reasonably believes (x) enables it to comply with the Listing Rules of the UK Financial Conduct Authority (“FCA”) (“Listing Rules”) and (y) is sufficient to provide reasonable assurance that: (i) transactions are executed in accordance with management’s general or specific authorization; (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with IFRS as issued by IASB and to maintain accountability for assets; (iii) access to assets is permitted only in accordance with management’s general or specific authorization; and (iv) the recorded accountability for assets is compared with existing assets at reasonable intervals and appropriate action is taken with respect to any differences.
6 |
(n) Disclosure Controls and Procedures; Deficiencies in or Changes to Internal Control Over Financial Reporting. The Company has established and maintains disclosure controls and procedures (as defined in Rules 13a-15 and 15d-15 under the Exchange Act), which (i) are designed to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to the Company’s principal executive officer and its principal financial officer by others within those entities, particularly during the periods in which the periodic reports required under the Exchange Act are being prepared; (ii) have been evaluated by management of the Company for effectiveness as of the end of the Company’s most recent fiscal quarter; and (iii) are effective in all material respects to perform the functions for which they were established. Since the end of the Company’s most recent audited fiscal year, there have been no significant deficiencies or material weakness in the Company’s internal control over financial reporting (whether or not remediated) and no change in the Company’s internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting. The Company is not aware of any change in its internal control over financial reporting that has occurred during its most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
(o) Incorporation and Good Standing of the Company. The Company has been duly incorporated and is validly existing as a public limited company under the laws of England and Wales and has the corporate power and authority to own, lease and operate its properties and to conduct its business as described in the Registration Statement, the Time of Sale Prospectus and the Prospectus and to enter into and perform its obligations under this Agreement. The Company is duly qualified as a foreign corporation to transact business and is in good standing in each other jurisdiction in which such qualification is required, whether by reason of the ownership or leasing of property or the conduct of business, except for such failure to be so qualified or in good standing as would not reasonably be expected to result in a Material Adverse Change.
(p) Subsidiaries. (i) Each of the Company’s “subsidiaries” (for purposes of this Agreement, as defined in Rule 405 under the Securities Act) has been duly incorporated or organized, as the case may be, and is validly existing as a corporation, partnership or limited liability company, as applicable, in good standing under the laws of the jurisdiction of its incorporation or organization and has the power and authority (corporate or other) to own, lease and operate its properties and to conduct its business as described in the Registration Statement, the Time of Sale Prospectus and the Prospectus, (ii) each of the Company’s subsidiaries is duly qualified as a foreign corporation, partnership or limited liability company, as applicable, to transact business and is in good standing in each jurisdiction in which such qualification is required, whether by reason of the ownership or leasing of property or the conduct of business, (iii) all of the issued and outstanding share capital or other equity or ownership interests of each of the Company’s subsidiaries have been duly authorized and validly issued, are fully paid and nonassessable and are owned by the Company, directly or through subsidiaries, free and clear of any security interest, mortgage, pledge, lien, encumbrance or adverse claim, except as would not reasonably be expected to result in a Material Adverse Change, (iv) none of the outstanding share capital or equity interest in any subsidiary was issued in violation of preemptive or similar rights of any security holder of such subsidiary, and (v) the constitutive or organizational documents of each of the subsidiaries comply in all material respects with the requirements of applicable laws of its jurisdiction of incorporation or organization and are in full force and effect. The Company does not own or control, directly or indirectly, any corporation, association or other entity other than the subsidiaries listed in or included as an exhibit to the Registration Statement.
7 |
(q) Capitalization and Other Share Capital Matters. The authorized, issued and outstanding share capital of the Company is as set forth in the Registration Statement, the Time of Sale Prospectus and the Prospectus under the caption “Capitalization” (other than for subsequent issuances, if any, pursuant to employee benefit plans, or upon the exercise of outstanding options or warrants, in each case described in the Registration Statement, the Time of Sale Prospectus and the Prospectus). The share capital of the Company, including the Shares and the Offered ADSs, conforms in all material respects to each description thereof contained in the Time of Sale Prospectus. All of the issued and outstanding Ordinary Shares and all outstanding ADSs have been duly authorized and validly issued, are fully paid and nonassessable, will not be subject to any call for further capital and have been issued in compliance with all federal, state and local securities laws. None of the outstanding Ordinary Shares or ADSs was issued in violation of any preemptive rights, rights of first refusal or other similar rights to subscribe for or purchase securities of the Company that have not been duly waived, disapplied or satisfied. There are no authorized or outstanding options, warrants, preemptive rights, rights of first refusal or other rights to purchase, or equity or debt securities convertible into or exchangeable or exercisable for, any share capital of the Company or any of its subsidiaries other than those described in the Registration Statement, the Time of Sale Prospectus and the Prospectus. The descriptions of the Company’s stock option, stock bonus and other stock plans or arrangements, and the options or other rights granted thereunder, set forth in the Registration Statement, the Time of Sale Prospectus and the Prospectus accurately and fairly presents in all material respects the information required to be shown with respect to such plans, arrangements, options and rights. The ADRs evidencing the Offered ADSs are in due and proper form.
(r) Stock Exchange Listing. The Offered ADSs have been approved for listing on The NASDAQ Global Market (the “NASDAQ”), subject only to official notice of issuance.
(s) Non-Contravention of Existing Instruments; No Further Authorizations or Approvals Required. Neither the Company nor any of its subsidiaries is in violation of its articles of association or by-laws, partnership agreement or operating agreement or similar organizational documents, as applicable, or is in default (or, with the giving of notice or lapse of time, would be in default) (“Default”) under any indenture, loan, credit agreement, note, lease, license agreement, contract, franchise or other instrument (including, without limitation, any pledge agreement, security agreement, mortgage or other instrument or agreement evidencing, guaranteeing, securing or relating to indebtedness) to which the Company or any of its subsidiaries is a party or by which it or any of them may be bound, or to which any of their respective properties or assets are subject (each, an “Existing Instrument”), except for such Defaults as would not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Change. The Company’s execution, delivery and performance of this Agreement, consummation of the transactions contemplated hereby, by the Deposit Agreement and by the Registration Statement, the F-6 Registration Statement, the Time of Sale Prospectus and the Prospectus and the issuance and sale of the Offered ADSs (including the use of proceeds from the sale of the Offered ADSs as described in the Registration Statement, the Time of Sale Prospectus and the Prospectus under the caption “Use of Proceeds”) (i) have been duly authorized by all necessary corporate action and will not result in any violation of the provisions of the articles of association or by-laws, partnership agreement or operating agreement or similar organizational documents, as applicable, of the Company or any subsidiary (ii) will not conflict with or constitute a breach of, or Default or a Debt Repayment Triggering Event (as defined below) under, or result in the creation or imposition of any lien, charge or encumbrance upon any property or assets of the Company or any of its subsidiaries pursuant to, or require the consent of any other party to, any Existing Instrument, except as would not reasonably be expected to result in a Material Adverse Change and (iii) will not result in any violation of any law, administrative regulation or administrative or court decree applicable to the Company or any of its subsidiaries, except as would not reasonably be expected to result in a Material Adverse Change. No consent, approval, authorization or other order of, or registration or filing with, any court or other governmental or regulatory authority or agency, is required for the Company’s execution, delivery and performance of this Agreement and consummation of the transactions contemplated hereby, by the Deposit Agreement and by the Registration Statement, the F-6 Registration Statement, the Time of Sale Prospectus and the Prospectus, except such as have been obtained or made by the Company and are in full force and effect under the Securities Act and such as may be required under applicable state securities or blue sky laws or the Financial Industry Regulatory Authority (“FINRA”). As used herein, a “Debt Repayment Triggering Event” means any event or condition which gives, or with the giving of notice or lapse of time would give, the holder of any note, debenture or other evidence of indebtedness (or any person acting on such holder’s behalf) the right to require the repurchase, redemption or repayment of all or a portion of such indebtedness by the Company or any of its subsidiaries.
8 |
(t) Compliance with Laws. The Company and its subsidiaries have been and are in compliance with all applicable laws, rules and regulations and continuing obligations pursuant to the Listing Rules, the UK and EU Market Abuse Regulation, as applicable at the relevant time, the UK Disclosure Guidance and Transparency Rules made by the FCA and the Prospectus Regulation Rules made by the FCA, except where failure to be so in compliance would not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Change.
(u) No Material Actions or Proceedings. There is no action, suit, proceeding, inquiry or investigation brought by or before any legal or governmental entity now pending or, to the knowledge of the Company, threatened, against or affecting the Company or any of its subsidiaries, which would reasonably be expected, individually or in the aggregate, to result in a Material Adverse Change. No material labor dispute with the employees of the Company or any of its subsidiaries, or with the employees of any principal supplier, manufacturer, customer or contractor of the Company, exists or, to the knowledge of the Company, is threatened or imminent.
(v) Intellectual Property Rights. Except as disclosed in the Registration Statement, the Time of Sale Prospectus and the Prospectus, the Company and its subsidiaries own, or have obtained valid and enforceable licenses for, the inventions, patent applications, patents, trademarks, trade names, service names, domain names, copyrights, trade secrets, know how, data, databases, software and other intellectual property and proprietary rights described in the Registration Statement, the Time of Sale Prospectus and the Prospectus as being owned or licensed by them or which are used in or necessary for the conduct of their respective businesses as currently conducted or as currently proposed to be conducted (collectively, “Intellectual Property”), and the Company, its subsidiaries and the conduct of their respective businesses have no, do not and will not infringe, misappropriate, violate or otherwise conflict in any material respect with any intellectual property or proprietary rights of others. The Intellectual Property owned by the Company and its subsidiaries (collectively, “Owned IP”) is valid, subsisting and enforceable and has not been adjudged by a court of competent jurisdiction to be invalid or unenforceable, in whole or in part, and the Company is unaware of any facts which would form a reasonable basis for any such adjudication. The Owned IP is owned solely by the Company and its subsidiaries free and clear of all liens, encumbrances and other similar restrictions. To the Company’s knowledge: (i) there are no third parties who have rights to any Intellectual Property, except for customary reversionary rights of third-party licensors with respect to Intellectual Property that is disclosed in the Registration Statement, the Time of Sale Prospectus and the Prospectus as licensed to the Company or one or more of its subsidiaries; and (ii) there is no infringement, misappropriation or violation by third parties of any Intellectual Property. There is no pending or, to the Company’s knowledge, threatened action, suit, proceeding or claim by others: (A) challenging the Company’s rights in or to any Intellectual Property, and the Company is unaware of any facts which would form a reasonable basis for any such action, suit, proceeding or claim; (B) challenging the validity, enforceability or scope of any Intellectual Property, and the Company is unaware of any facts which would form a reasonable basis for any such action, suit, proceeding or claim; or (C) asserting that the Company or any of its subsidiaries infringes, misappropriates or otherwise violates, or would, upon the commercialization of any product or service described in the Registration Statement, the Time of Sale Prospectus or the Prospectus as under development, infringe, misappropriate or violate, any patent, trademark, trade name, service name, copyright, trade secret or other intellectual property or proprietary rights of others, and the Company is unaware of any facts which would form a reasonable basis for any such action, suit, proceeding or claim. The Company and its subsidiaries have materially complied with the terms of each agreement pursuant to which Intellectual Property has been licensed to the Company or any subsidiary, and all such agreements are in full force and effect. To the Company’s knowledge, there are no material defects in any of the patents or patent applications included in the Intellectual Property. The Company and its subsidiaries have taken all reasonable steps to protect, maintain and safeguard their Intellectual Property, including the execution of nondisclosure and invention assignment agreements with their employees and independent contractors engaged in the development of Intellectual Property for the Company and execution of nondisclosure agreements with employees and independent contractors that have access to trade secrets and other material confidential information of the Company and its subsidiaries, and, to the Company’s knowledge, there has been no unauthorized use or disclosure of any of the confidential Intellectual Property. None of the Intellectual Property or technology (including information technology and outsourced arrangements) used by the Company or its subsidiaries has been obtained or is being used by the Company or its subsidiary in violation of any contractual obligation binding on the Company or its subsidiaries or any of their respective officers, directors or employees or otherwise in violation of the rights of any persons.
9 |
(w) All Necessary Permits, etc. The Company and its subsidiaries possess such valid and current certificates, authorizations or permits required by state, federal or foreign regulatory agencies or bodies to conduct their respective businesses as currently conducted and as described in the Registration Statement, the Time of Sale Prospectus or the Prospectus (“Permits”), except where failure to possess such Permits would not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Change. Neither the Company nor any of its subsidiaries is in violation of, or in default under, any of the Permits or has received any notice of proceedings relating to the revocation or modification of, or non-compliance with, any such certificate, authorization or permit, except as would not reasonably be expected to result in a Material Adverse Change.
(x) Title to Properties. The Company and its subsidiaries have good and marketable title to all of the real and personal property and other assets reflected as owned in the financial statements referred to in Section 1(l) above (or elsewhere in the Registration Statement, the Time of Sale Prospectus or the Prospectus), in each case free and clear of any security interests, mortgages, liens, encumbrances, equities, adverse claims and other defects, except as would not reasonably be expected to result in a Material Adverse Change. The real property, improvements, equipment and personal property held under lease by the Company or any of its subsidiaries are held under valid and enforceable leases, with such exceptions as are not material and do not materially interfere with the use made or proposed to be made of such real property, improvements, equipment or personal property by the Company or such subsidiary.
(y) Tax Law Compliance. The Company and its subsidiaries have filed all necessary federal, state and foreign income and franchise tax returns or have properly requested extensions thereof and have paid all taxes required to be paid by any of them and, if due and payable, any related or similar assessment, fine or penalty levied against any of them except as may be being contested in good faith and by appropriate proceedings, or as would not reasonably be expected to result in a Material Adverse Change. The Company has made adequate charges, accruals and reserves in the applicable financial statements referred to in Section 1(l) above in respect of all federal, state and foreign income and franchise taxes for all periods as to which the tax liability of the Company or any of its subsidiaries has not been finally determined, except as would not reasonably be expected to result in a Material Adverse Change. No stamp duty, stamp duty reserve, registration, transfer tax or other similar taxes or duties (together, “Transfer Taxes”) imposed by the United Kingdom, the United States, or any political subdivision or any taxing authority thereof are payable by or on behalf of the Underwriters in connection with (i) the creation and issuance of the Shares by the Company in the manner contemplated by this Agreement and the Deposit Agreement; (ii) the delivery of the Shares by the Company to the Depositary Custodian in the manner contemplated by the Deposit Agreement, (iii) the issuance of the Offered ADSs (or the ADRs evidencing the Offered ADSs) by the Depositary, and the delivery of the Offered ADSs (or the ADRs evidencing the Offered ADSs) to or for the account of the Underwriters, in each case in the manner contemplated by this Agreement and the Deposit Agreement; (iv) the initial sale and delivery by the Underwriters of the Offered ADSs (or the ADRs evidencing the Offered ADSs) to purchasers thereof in the manner contemplated by this Agreement; or (v) the execution and delivery of this Agreement or the Deposit Agreement.
10 |
(z) Tax Disclosure. The statements set forth in the Time of Sale Prospectus and the Prospectus under the caption “Material Income Tax Considerations” constitute summaries of United Kingdom tax law and United States federal income tax law and regulations or legal conclusions thereto, and are accurate and fair summaries of the material contained therein.
(aa) Insurance. Each of the Company and its subsidiaries are insured by recognized, financially sound and reputable institutions with policies in such amounts and with such deductibles and covering such risks as the Company reasonably believes are generally adequate and customary for their businesses including, but not limited to, policies covering real and personal property owned or leased by the Company and its subsidiaries against theft, damage, destruction, acts of vandalism and earthquakes. The Company has no reason to believe that it or any of its subsidiaries will not be able (i) to renew its existing insurance coverage as and when such policies expire or (ii) to obtain comparable coverage from similar institutions as may be necessary or appropriate to conduct its business as now conducted and at a cost that would not reasonably be expected to result in a Material Adverse Change. Neither the Company nor any of its subsidiaries has been denied any insurance coverage which it has sought or for which it has applied.
(bb) Compliance with Environmental Laws. Except as would not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Change: (i) neither the Company nor any of its subsidiaries is in violation of any federal, state, local or foreign statute, law, rule, regulation, ordinance, code, legally-binding policy or rule of common law or any judicial or administrative interpretation thereof, including any judicial or administrative order, consent, decree or judgment, relating to pollution, preservation or protection of human health, the environment (including, without limitation, ambient air, surface water, groundwater, natural resources, land surface or subsurface strata) or wildlife, including, without limitation, laws and regulations relating to the release or threatened release of chemicals, pollutants, contaminants, wastes, toxic substances, hazardous substances, petroleum or petroleum products (collectively, “Hazardous Materials”) or to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials (collectively, “Environmental Laws”); (ii) the Company and its subsidiaries have all permits, authorizations and approvals required under any applicable Environmental Laws and are each in compliance with their requirements; (iii) there are no pending or, to the Company’s knowledge, threatened administrative, regulatory or judicial actions, suits, demands, orders, complaints, directives, demand letters, claims, liens, notices of noncompliance or violation, investigation or proceedings relating to any Environmental Law against the Company or any of its subsidiaries; and (iv) there are no events or circumstances that would reasonably be expected to form the basis of an order for clean-up or remediation, or an action, suit or proceeding by any private party or governmental body or agency, against the Company or any of its subsidiaries relating to Hazardous Materials, bodily injury, or any Environmental Laws.
(cc) Periodic Review of Costs of Environmental Compliance. In the ordinary course of its business, the Company conducts a periodic review of the effect of Environmental Laws on the business, operations and properties of the Company and its subsidiaries, in the course of which it identifies and evaluates associated costs and liabilities (including, without limitation, any capital or operating expenditures required for clean-up, closure of properties or compliance with Environmental Laws or any permit, license or approval, any related constraints on operating activities and any potential liabilities to third parties). No facts or circumstances have come to the Company’s attention that would give rise to such costs or liabilities that would reasonably be expected, individually or in the aggregate, to result in a Material Adverse Change.
11 |
(dd) ERISA Compliance. Except as would not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Change, (i) the Company and its subsidiaries and any “employee benefit plan” (as defined under the Employee Retirement Income Security Act of 1974, as amended, and the regulations and published interpretations thereunder (collectively, “ERISA”)) established or maintained by the Company or its subsidiaries that is subject to ERISA (each, a “Company ERISA Plan”) are in compliance in all material respects with ERISA, and (ii) no “reportable event” (as defined under ERISA) has occurred or is reasonably expected to occur in connection with the offering of the Offered ADSs with respect to any Company ERISA Plan. No Company ERISA Plan or “employee benefit plan” established or maintained by any “ERISA Affiliate” (as defined below) of the Company that is subject to ERISA, if such plan were terminated, would reasonably be expected to have any material “amount of unfunded benefit liabilities” (as defined under ERISA). Neither the Company, its subsidiaries nor any of their ERISA Affiliates has incurred or reasonably expects to incur any liability under (i) Title IV of ERISA with respect to termination of, or withdrawal from, any “employee benefit plan” or (ii) Sections 412, 4971, 4975 or 4980B of the Internal Revenue Code of 1986, as amended, and the regulations and published interpretations thereunder (the “Code”), except in the case of (i) and (ii), as would not be expected to result in material liability to the Company or its subsidiaries. No Company ERISA Plan is intended to be qualified under Section 401(a) of the Code. ERISA Affiliate” means, with respect to the Company or any of its subsidiaries, any member of any group of organizations described in Sections 414(b), (c), (m) or (o) of the Code of which the Company or such subsidiary is a member.
(ee) Company Not an “Investment Company”; Not a “Passive Foreign Investment Company” The Company is not, and will not, be, either after receipt of payment for the Offered ADSs or after the application of the proceeds therefrom as described under the “Use of Proceeds” in the Registration Statement, the Time of Sale Prospectus or the Prospectus, required to register as an “investment company” under the Investment Company Act of 1940, as amended (the “Investment Company Act”). Based on the analysis of the Company’s activities and current estimates of the composition of its income and assets (including goodwill), the Company does not expect to be a passive foreign investment company (a “PFIC”), as defined in Section 1297 of the Code, for the current taxable year or in the foreseeable future. Neither the Company nor any Subsidiary is, and, after giving effect to the offering and sale of the Offered ADSs and the application of the proceeds thereof, neither of them will be, a “controlled foreign corporation” as defined by the Code.
(ff) No Price Stabilization or Manipulation; Compliance with Regulation M. Neither the Company nor any of its subsidiaries has taken, directly or indirectly, without giving effect to any activities by the Underwriters, any action designed to or that might reasonably be expected to cause or result in stabilization or manipulation of the price of the Offered ADSs or of any “reference security” (as defined in Rule 100 of Regulation M under the Exchange Act (“Regulation M”)) with respect to the Offered ADSs, whether to facilitate the sale or resale of the Offered ADSs or otherwise, and has taken no action which would directly or indirectly violate Regulation M.
(gg) Related-Party Transactions. There are no business relationships or related-party transactions involving the Company or any of its subsidiaries or any other person required to be described in the Registration Statement, the Time of Sale Prospectus or the Prospectus that have not been described as required.
(hh) FINRA Matters. All of the information provided to the Underwriters or to counsel for the Underwriters by the Company, its counsel, its officers and directors and the holders of any securities (debt or equity) or options to acquire any securities of the Company in connection with the offering of the Offered ADSs is true, complete, correct and compliant with FINRA’s rules and any letters, filings or other supplemental information provided to FINRA pursuant to FINRA Rules or is true, complete and correct.
12 |
(ii) Parties to Lock-Up Agreements. The Company has furnished to the Underwriters a letter agreement in substantially the form attached hereto as Exhibit A (the “Lock-up Agreement”) from each of the persons listed on Exhibit B. Such Exhibit B lists under an appropriate caption the directors and officers of the Company. If any additional persons shall become directors or officers of the Company prior to the end of the Company Lock-up Period (as defined below), the Company shall cause each such person, prior to or contemporaneously with their appointment or election as a director or officer of the Company, to execute and deliver to Jefferies a Lock-up Agreement.
(jj) Statistical and Market-Related Data. All statistical, demographic and market-related data included in the Registration Statement, the Time of Sale Prospectus or the Prospectus are based on or derived from sources that the Company believes, after reasonable inquiry, to be reliable and accurate in all material respects. To the extent required, the Company has obtained the written consent to the use of such data from such sources.
(kk) Sarbanes-Oxley Act. There is, and has been, no failure on the part of the Company or any of the Company’s directors or officers, in their capacities as such, to comply with any applicable provision of the Sarbanes-Oxley Act of 2002, as amended and the rules and regulations promulgated in connection therewith, including Section 402 related to loans and Sections 302 and 906 related to certifications.
(ll) No Unlawful Contributions or Other Payments. Neither the Company nor any of its subsidiaries nor, to the best of the Company’s knowledge, any employee or agent of the Company or any subsidiary, has made any contribution or other payment to any official of, or candidate for, any federal, state or foreign office in violation of any law or of the character required to be disclosed in the Registration Statement, the Time of Sale Prospectus or the Prospectus.
(mm) Anti-Corruption and Anti-Bribery Laws. Neither the Company nor any of its subsidiaries nor any director, officer, or employee of the Company or any of its subsidiaries, nor to the knowledge of the Company, any agent, affiliate or other person acting on behalf of the Company or any of its subsidiaries has, in the course of its actions for, or on behalf of, the Company or any of its subsidiaries (i) used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expenses relating to political activity; (ii) made or taken any act in furtherance of an offer, promise, or authorization of any direct or indirect unlawful payment or benefit to any foreign or domestic government official or employee, including of any government-owned or controlled entity or public international organization, or any political party, party official, or candidate for political office; (iii) violated or is in violation of any provision of the U.S. Foreign Corrupt Practices Act of 1977, as amended (the “FCPA”), the UK Bribery Act 2010, or any other applicable anti-bribery or anti-corruption law; or (iv) made, offered, authorized, requested, or taken an act in furtherance of any unlawful bribe, rebate, payoff, influence payment, kickback or other unlawful payment or benefit. The Company and its subsidiaries and, to the knowledge of the Company, the Company’s affiliates have conducted their respective businesses in compliance with the FCPA, the UK Bribery Act 2010, and other applicable anti-corruption or anti-bribery laws and have instituted and maintain policies and procedures designed to ensure, and which are reasonably expected to continue to ensure, continued compliance therewith.
13 |
(nn) Money Laundering Laws. The operations of the Company and its subsidiaries are, and have been conducted at all times, in compliance with applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the UK Proceeds of Crime Act 2002, the UK Terrorism Act 2000 (as amended), the Money Laundering, Terrorist Financing and Transfer of Funds (Information on the Payer) Regulations 2017, as amended by the Money Laundering and Transfer of Funds (Information) (Amendment) (EU Exit) Regulations 2019 and any laws enacted pursuant to the Sanctions and Anti-Money Laundering Act 2018, the money laundering statutes of all applicable jurisdictions, the rules and regulations thereunder and any related or similar applicable rules, regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the “Money Laundering Laws”), and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any of its subsidiaries with respect to the Money Laundering Laws is pending or, to the best knowledge of the Company, threatened.
(oo) Sanctions. Neither the Company nor any of its subsidiaries, directors, officers, , nor, to the knowledge of the Company, after due inquiry, any agent, employee, affiliate or other person acting on behalf of the Company or any of its subsidiaries is currently the subject or the target of any sanctions administered by the Office of Foreign Assets Control of the U.S. Department of the Treasury (“OFAC”) or the U.S. Department of State, the United Nations Security Council, the European Union, Her Majesty’s Treasury of the United Kingdom, or other relevant sanctions authority (collectively, “Sanctions”); nor is the Company or any of its subsidiaries located, organized or resident in a country or territory that is the subject or the target of a comprehensive embargo under Sanctions (“Sanctioned Countries”), including, without limitation, Crimea, Cuba, Iran, North Korea, and Syria; and the Company will not directly or indirectly use the proceeds of this offering, or lend, contribute or otherwise make available such proceeds to any subsidiary, or any joint venture partner or other person or entity, for the purpose of financing the activities of or business (i) with any person that, at the time of such financing, is the subject or the target of Sanctions, (ii) in or with any Sanctioned Country, or (iii) in any other manner that will result in a violation by any person (including any person participating in the transaction whether as underwriter, advisor, investor or otherwise) of applicable Sanctions. For the past five years, the Company and its subsidiaries have not engaged in, are not now engaged in, and will not engage in any dealings or transactions with any person that at the time of the dealing or transaction is or was the subject or the target of Sanctions or with any Sanctioned Country. The Company has implemented compliance procedures reasonably designed to prevent the Company from engaging in dealings or transactions prohibited by applicable Sanctions.
(pp) Brokers. Except pursuant to this Agreement, there is no broker, finder or other party that is entitled to receive from the Company any brokerage or finder’s fee or other fee or commission as a result of any transactions contemplated by this Agreement.
(qq) Submission to Jurisdiction. The Company has the power to submit, and pursuant to Section 19 of this Agreement, has legally, validly, effectively and irrevocably submitted, to the personal jurisdiction of each United States federal court and New York state court located in the Borough of Manhattan, in the City of New York, New York, U.S.A. (each, a “New York Court”), and the Company has the power to designate, appoint and authorize, and pursuant to Section 19 of this Agreement, has legally, validly, effectively and irrevocably designated, appointed and authorized an agent for service of process in any action arising out of or relating to this Agreement or the Offered ADSs in any New York Court, and service of process effected on such authorized agent will be effective to confer valid personal jurisdiction over the Company as provided in Section 19 hereof.
14 |
(rr) No Rights of Immunity. Except as provided by laws or statutes generally applicable to transactions of the type described in this Agreement, neither the Company nor any of its respective properties, assets or revenues has any right of immunity under English, New York or United States law, from any legal action, suit or proceeding, from the giving of any relief in any such legal action, suit or proceeding, from set-off or counterclaim, from the jurisdiction of any English, New York or United States federal court, from service of process, attachment upon or prior judgment, or attachment in aid of execution of judgment, or from execution of a judgment, or other legal process or proceeding for the giving of any relief or for the enforcement of a judgment, in any such court, with respect to its obligations, liabilities or any other matter under or arising out of or in connection with this Agreement or the Deposit Agreement. To the extent that the Company or any of its respective properties, assets or revenues may have or may hereafter become entitled to any such right of immunity in any such court in which proceedings may at any time be commenced, the Company waives or will waive such right to the extent permitted by law and has consented to such relief and enforcement as provided in Section 19 of this Agreement.
(ss) Enforceability of Judgments. Any final judgment for a fixed or readily calculable sum of money rendered by a New York Court having jurisdiction under its own domestic laws and recognized by the English courts as having jurisdiction (according to English conflicts of laws principles and rules of English private international law at the time when proceedings were initiated) to give such final judgment in respect of any suit, action or proceeding against the Company based upon this Agreement or the Deposit Agreement and any instruments or agreements entered into for the consummation of the transactions contemplated herein and therein would be declared enforceable against the Company, without re-examination or review of the merits of the cause of action in respect of which the original judgment was given or re-litigation of the matters adjudicated upon, by the courts of England.
(tt) Forward-Looking Statements. Each financial or operational projection or other “forward-looking statement” (as defined by Section 27A of the Securities Act or Section 21E of the Exchange Act) contained in the Registration Statement, the Time of Sale Prospectus or the Prospectus (i) was so included by the Company in good faith and with reasonable basis after due consideration by the Company of the underlying assumptions, estimates and other applicable facts and circumstances and (ii) is accompanied by meaningful cautionary statements identifying those factors that could cause actual results to differ materially from those in such forward-looking statement. No such statement was made with the knowledge of an executive officer or director of the Company that it was false or misleading.
(uu) No Outstanding Loans or Other Extensions of Credit. The Company does not have any outstanding extension of credit, in the form of a personal loan, to or for any director or executive officer (or equivalent thereof) of the Company except for such extensions of credit as are expressly permitted by Section 13(k) of the Exchange Act.
(vv) Cybersecurity. The Company and its subsidiaries’ information technology assets and equipment, computers, systems, networks, hardware, software, websites, applications, and databases, including without limitation, those provided, operated and/or managed by third parties for or on behalf of the Company and its subsidiaries (collectively, “IT Systems”) are materially adequate for, and operate and perform in all material respects as required in connection with, the operation of the business of the Company and its subsidiaries as currently conducted, and in relation to the Company’s IT Systems, are free and clear of all material bugs, errors, defects, Trojan horses, time bombs, malware and other corruptants. The Company and its subsidiaries have implemented and maintain, and in relation to IT Systems owned and operated by third parties, caused such third parties to implement and maintain commercially reasonable physical, technical and administrative controls, policies, procedures, and safeguards in accordance with industry best practices to maintain and protect their material confidential information and the integrity, continuous operation, redundancy and security of all IT Systems and data, including “Personal Data,” used in connection with the Company’s and its subsidiaries’ businesses (collectively, “IT Systems and Data”). “Personal Data” means (i) a natural person’s name, street address, telephone number, e-mail address, photograph, social security number or tax identification number, driver’s license number, passport number, credit card number, bank information, or customer or account number; (ii) any information which would qualify as “personally identifying information,” “personal information,” “personal data,” or “protected health information” under Privacy Laws; and (iii) any other piece of information that identifies, relates to, describes, is reasonably capable of being associated with, could reasonably be linked, or allows the identification, directly or indirectly, of a natural person, or his or her family, household, or device, or permits the collection or analysis of any data related to a natural person, household, or device. There have been no breaches, violations, outages or unauthorized uses of or accesses to the Company’s IT Systems or confidential information or Personal Data collected or stored by the Company or any of its subsidiaries, except for those that did not result in material liability for the Company. The Company and its subsidiaries are presently in material compliance with all applicable laws, statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification.
15 |
(ww) Compliance with Data Privacy Laws. The Company and its subsidiaries are, and at all prior times, were, in compliance with all applicable state and federal data privacy and security laws and regulations, including without limitation, the Health Insurance Portability and Accountability Act of 1996, as amended by the Health Information Technology for Economic and Clinical Health Act (“HIPAA”), and all applicable laws regarding the processing of Personal Data, and the Company and its subsidiaries have taken commercially reasonable actions to prepare to comply with, and since May 25, 2018, have been and currently are in compliance with, the European Union General Data Protection Regulation (“GDPR”) (EU 2016/679), GDPR as it forms part of the law of England and Wales, Scotland and Northern Ireland by virtue of section 3 of the United Kingdom European Union (Withdrawal) Act 2018 and as amended by Schedule 1 to the Data Protection, Privacy and Electronic Communications (Amendments etc) (EU Exit) Regulations 2019 (SI 2019/419) (collectively, the “Privacy Laws”). To ensure compliance with the Privacy Laws, the Company and its subsidiaries have in place, comply with, and take reasonable and appropriate steps to ensure compliance in all material respects with their policies and procedures relating to data privacy and security of IT Systems and Data, and the collection, storage, use, disclosure, handling, and analysis of Personal Data (the “Policies”). The Company and its subsidiaries have at all times made all disclosures to individuals, including without limitation, users or customers, required by applicable laws and regulatory rules or requirements, and none of such disclosures made or contained in any Policy have, been inaccurate or in violation of any applicable laws and regulatory rules or requirements in any material respect. The Company further certifies that neither it nor any subsidiary: (i) has received notice of any actual or potential liability under or relating to, or actual or potential violation of, any of the Privacy Laws or the handling of any IT Systems and Data, and has no knowledge of any event or condition that would reasonably be expected to result in any such notice; (ii) is currently conducting or paying for, or has conducted or paid for, in whole or in part, any investigation, remediation, or other corrective action pursuant to any Privacy Law or handling of IT Systems and Data; (iii) is a party to any order or decree that imposes any obligation or liability under any Privacy Law; and is a party to any agreement that imposes any material obligation or liability under any Privacy Law.
(xx) Emerging Growth Company Status. From the time of initial confidential submission of the Registration Statement to the Commission (or, if earlier, the first date on which the Company engaged in any Testing-the-Waters Written Communication or any Testing-the-Waters Oral Communication) through the date hereof, the Company has been and is an “emerging growth company,” as defined in Section 2(a) of the Securities Act (an “Emerging Growth Company”).
16 |
(yy) Communications. The Company (i) has not alone engaged in communications with potential investors in reliance on Section 5(d) of or Rule 163B under the Securities Act other than Permitted Testing-the-Waters Communications with the consent of the Representatives with entities that are or are reasonably believe to be QIBs or IAIs and (ii) has not authorized anyone other than the Representatives to engage in such communications; the Company reconfirms that the Representatives have been authorized to act on its behalf in undertaking Marketing Materials, Testing-the-Waters Oral Communications and Testing-the-Waters Written Communications; as of the Applicable Time, each Permitted Testing-the-Waters Communication, when considered together with the Time of Sale Prospectus, did not, as of the Applicable Time, include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; and each Permitted Testing-the-Waters Communication, if any, does not, as of the date hereof, conflict with the information contained in the Registration Statement, the Preliminary Prospectus and the Prospectus (except where such Permitted Testing-the-Waters Communication has been superseded by the information contained in the Registration Statement, the Preliminary Prospectus and the Prospectus); and the Company has filed publicly on EDGAR at least 15 calendar days prior to any “road show” (as defined in Rule 433 under the Act), any confidentially submitted registration statement and registration statement amendments relating to the offer and sale of the Offered ADSs.
Any certificate signed by any officer of the Company or any of its subsidiaries and delivered to any Underwriter or to counsel for the Underwriters in connection with the offering, or the purchase and sale, of the Offered ADSs shall be deemed a representation and warranty by the Company (and not by any such officer in his or her personal capacity) to each Underwriter as to the matters covered thereby.
The Company has a reasonable basis for making each of the representations set forth in this Section 1. The Company acknowledges that the Underwriters and, for purposes of the opinions to be delivered pursuant to Section 6 hereof, counsel to the Company and counsel to the Underwriters, will rely upon the accuracy and truthfulness of the foregoing representations and hereby consents to such reliance.
Section 2. Purchase, Sale and Delivery of the Offered ADSs.
(a) The Firm ADSs. Upon the terms herein set forth, the Company agrees to issue and sell to the several Underwriters an aggregate of [●] Firm ADSs. On the basis of the representations, warranties and agreements herein contained, and upon the terms but subject to the conditions herein set forth, the Underwriters agree, severally and not jointly, to purchase from the Company the respective number of Firm ADSs set forth opposite their names on Schedule A. The purchase price per Firm ADS to be paid by the several Underwriters to the Company shall be $[●] per ADS.
(b) The First Closing Date. Delivery of certificates for the Firm ADSs to be purchased by the Underwriters and payment therefor shall be made at the offices of Latham & Watkins LLP (or such other place as may be agreed to by the Company and the Representatives) at 9:00 a.m. New York City time, on [●], 2021, or such other time and date not later than 1:30 p.m. New York City time, on [●], 2021 as the Representatives shall designate by notice to the Company (the time and date of such closing are called the “First Closing Date”). The Company hereby acknowledges that circumstances under which the Representatives may provide notice to postpone the First Closing Date as originally scheduled include, but are not limited to, any determination by the Company or the Representatives to recirculate to the public copies of an amended or supplemented Prospectus or a delay as contemplated by the provisions of Section 11.
17 |
(c) The Optional ADSs; Option Closing Date. In addition, on the basis of the representations, warranties and agreements herein contained, and upon the terms but subject to the conditions herein set forth, the Company hereby grants an option to the several Underwriters to purchase, severally and not jointly, up to an aggregate of [●] Optional ADSs from the Company at the purchase price per share to be paid by the Underwriters for the Firm ADSs. The option granted hereunder may be exercised at any time and from time to time in whole or in part upon notice by the Representatives to the Company, which notice may be given at any time within 30 days from the date of this Agreement. Such notice shall set forth (i) the aggregate number of Optional ADSs as to which the Underwriters are exercising the option and (ii) the time, date and place at which certificates for the Optional ADSs will be delivered (which time and date may be simultaneous with, but not earlier than, the First Closing Date; and in the event that such time and date are simultaneous with the First Closing Date, the term “First Closing Date” shall refer to the time and date of delivery of the Firm ADSs and such Optional ADSs). Any such time and date of delivery, if subsequent to the First Closing Date, is called an “Option Closing Date,” and shall be determined by the Representatives and shall not be earlier than two or later than five full business days after delivery of such notice of exercise. If any Optional ADSs are to be purchased, each Underwriter agrees, severally and not jointly, to purchase the number of Optional ADSs (subject to such adjustments to eliminate fractional shares as the Representatives may determine) that bears the same proportion to the total number of Optional ADSs to be purchased as the number of Firm ADSs set forth on Schedule A opposite the name of such Underwriter bears to the total number of Firm ADSs. The Representatives may cancel the option at any time prior to its expiration by giving written notice of such cancellation to the Company.
(d) Public Offering of the Offered ADSs. The Representatives hereby advise the Company that the Underwriters intend to offer for sale to the public, initially on the terms set forth in the Registration Statement, the Time of Sale Prospectus and the Prospectus, their respective portions of the Offered ADSs as soon after this Agreement has been executed and the Registration Statement has been declared effective as the Representatives, in their sole judgment, have determined is advisable and practicable.
(e) Payment for the Offered ADSs. (i) Payment for the Offered ADSs shall be made at the First Closing Date (and, if applicable, at each Option Closing Date) by wire transfer of immediately available funds to the order of the Company.
(ii) It is understood that the Representatives have been authorized, for their own account and the accounts of the several Underwriters, to accept delivery of and receipt for, and make payment of the purchase price for, the Firm ADSs and any Optional ADSs the Underwriters have agreed to purchase. Each of Jefferies and Barclays, individually and not as the Representatives of the Underwriters, may (but shall not be obligated to) make payment for any Offered ADSs to be purchased by any Underwriter whose funds shall not have been received by the Representatives by the First Closing Date or the applicable Option Closing Date, as the case may be, for the account of such Underwriter, but any such payment shall not relieve such Underwriter from any of its obligations under this Agreement.
(f) Delivery of the Offered ADSs. The Company shall deliver, or cause to be delivered to the Representatives for the accounts of the several Underwriters ADRs for the Firm ADSs at the First Closing Date, against release of a wire transfer of immediately available funds for the amount of the purchase price therefor. The Company shall also deliver, or cause to be delivered to the Representatives for the accounts of the several Underwriters, ADRs for the Optional ADSs the Underwriters have agreed to purchase at the First Closing Date or the applicable Option Closing Date, as the case may be, against the release of a wire transfer of immediately available funds for the amount of the purchase price therefor. If Jefferies so elects, delivery of the Offered ADSs may be made by credit to the accounts designated by Jefferies through The Depository Trust Company’s full fast transfer or DWAC programs. If Jefferies so elects, the ADRs for the Offered ADSs shall be in definitive form and registered in such names and denominations as the Representatives shall have requested at least two full business days prior to the First Closing Date (or the applicable Option Closing Date, as the case may be) and shall be made available for inspection on the business day preceding the First Closing Date (or the applicable Option Closing Date, as the case may be) at a location in New York City as the Representatives may designate. Time shall be of the essence, and delivery at the time and place specified in this Agreement is a further condition to the obligations of the Underwriters.
18 |
Section 3. Additional Covenants.
The Company further covenants and agrees with each Underwriter as follows:
(a) Delivery of Registration Statement, F-6 Registration Statement, Time of Sale Prospectus and Prospectus. The Company shall furnish to you in New York City, without charge, prior to 10:00 a.m. New York City time on the business day next succeeding the date of this Agreement and during the period when a prospectus relating to the Offered ADSs is required by the Securities Act to be delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) in connection with sales of the Offered ADSs, as many copies of the Time of Sale Prospectus, the Prospectus and any supplements and amendments thereto or to the Registration Statement or the F-6 Registration Statement as you may reasonably request.
(b) Representatives’ Review of Proposed Amendments and Supplements. During the period when a prospectus relating to the Offered ADSs is required by the Securities Act to be delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule), the Company (i) will furnish to the Representatives for review, a reasonable period of time prior to the proposed time of filing of any proposed amendment or supplement to the Registration Statement or the F-6 Registration Statement, a copy of each such amendment or supplement and (ii) will not amend or supplement the Registration Statement or the F-6 Registration Statement without the Representatives’ prior written consent, which will not be unreasonably withheld, conditioned or delayed. Prior to amending or supplementing any preliminary prospectus, the Time of Sale Prospectus or the Prospectus, the Company shall furnish to the Representatives for review, a reasonable amount of time prior to the time of filing or use of the proposed amendment or supplement, a copy of each such proposed amendment or supplement. The Company shall not file or use any such proposed amendment or supplement without the Representatives’ prior written consent, which will not be unreasonably withheld, conditioned or delayed. The Company shall file with the Commission within the applicable period specified in Rule 424(b) under the Securities Act any prospectus required to be filed pursuant to such Rule.
(c) Free Writing Prospectuses. The Company shall furnish to the Representatives for review, a reasonable amount of time prior to the proposed time of filing or use thereof, a copy of each proposed free writing prospectus or any amendment or supplement thereto prepared by or on behalf of, used by, or referred to by the Company, and the Company shall not file, use or refer to any proposed free writing prospectus or any amendment or supplement thereto without the Representatives’ prior written consent, which will not be unreasonably withheld, conditioned or delayed. The Company shall furnish to each Underwriter, without charge, as many copies of any free writing prospectus prepared by or on behalf of, used by or referred to by the Company as such Underwriter may reasonably request. If at any time when a prospectus is required by the Securities Act to be delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) in connection with sales of the Offered ADSs (but in any event if at any time through and including the First Closing Date) there occurred or occurs an event or development as a result of which any free writing prospectus prepared by or on behalf of, used by, or referred to by the Company conflicted or would conflict with the information contained in the Registration Statement or the F-6 Registration Statement or included or would include an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances prevailing at such time, not misleading, the Company shall promptly amend or supplement such free writing prospectus to eliminate or correct such conflict or so that the statements in such free writing prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances prevailing at such time, not misleading, as the case may be; provided, however, that prior to amending or supplementing any such free writing prospectus, the Company shall furnish to the Representatives for review, a reasonable amount of time prior to the proposed time of filing or use thereof, a copy of such proposed amended or supplemented free writing prospectus, and the Company shall not file, use or refer to any such amended or supplemented free writing prospectus without the Representatives’ prior written consent, which will not be unreasonably withheld, conditioned or delayed.
19 |
(d) Filing of Underwriter Free Writing Prospectuses. The Company shall not take any action that would result in an Underwriter or the Company being required to file with the Commission pursuant to Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of such Underwriter that such Underwriter otherwise would not have been required to file thereunder.
(e) Amendments and Supplements to Time of Sale Prospectus. If the Time of Sale Prospectus is being used to solicit offers to buy the Offered ADSs at a time when the Prospectus is not yet available to prospective purchasers, and any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Time of Sale Prospectus so that the Time of Sale Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when delivered to a prospective purchaser, not misleading, or if any event shall occur or condition exist as a result of which the Time of Sale Prospectus conflicts with the information contained in the Registration Statement, or if, in the reasonable opinion of counsel for the Underwriters, it is necessary to amend or supplement the Time of Sale Prospectus to comply with applicable law, the Company shall (subject to Section 3(b) and Section 3(c) hereof) promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, either amendments or supplements to the Time of Sale Prospectus so that the statements in the Time of Sale Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when delivered to a prospective purchaser, not misleading or so that the Time of Sale Prospectus, as amended or supplemented, will no longer conflict with the information contained in the Registration Statement or the F-6 Registration Statement, or so that the Time of Sale Prospectus, as amended or supplemented, will comply with applicable law.
(f) Certain Notifications and Required Actions. After the date of this Agreement, the Company shall promptly advise the Representatives in writing of: (i) the receipt of any comments of, or requests for additional or supplemental information from, the Commission; (ii) the time and date of any filing of any post-effective amendment to the Registration Statement or the F-6 Registration Statement or any amendment or supplement to any preliminary prospectus, the Time of Sale Prospectus, any free writing prospectus or the Prospectus; (iii) the time and date that any post-effective amendment to the Registration Statement or the F-6 Registration Statement becomes effective; and (iv) the issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement or any post-effective amendment thereto or the F-6 Registration Statement or any post-effective amendment thereto or any amendment or supplement to any preliminary prospectus, the Time of Sale Prospectus or the Prospectus or of any order preventing or suspending the use of any preliminary prospectus, the Time of Sale Prospectus, any free writing prospectus or the Prospectus, or of any proceedings to remove, suspend or terminate from listing or quotation the Offered ADSs from any securities exchange upon which they are listed for trading or included or designated for quotation, or of the threatening or initiation of any proceedings for any of such purposes. If the Commission shall enter any such stop order at any time, the Company will use its best efforts to obtain the lifting of such order as soon as reasonably practicable. Additionally, the Company agrees that it shall comply with all applicable provisions of Rule 424(b), Rule 433 and Rule 430A under the Securities Act and will use its reasonable efforts to confirm that any filings made by the Company under Rule 424(b) or Rule 433 were received in a timely manner by the Commission.
20 |
(g) Amendments and Supplements to the Prospectus and Other Securities Act Matters. If any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the reasonable opinion of the Representatives or counsel for the Underwriters it is otherwise necessary to amend or supplement the Prospectus to comply with applicable law, the Company agrees (subject to Section 3(b) and Section 3(c)) hereof to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with applicable law. Neither the Representatives’ consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(c).
(h) Blue Sky Compliance. The Company shall cooperate with the Representatives and counsel for the Underwriters to qualify or register the Offered ADSs for sale under (or obtain exemptions from the application of) the state securities or blue sky laws (or foreign securities laws) of those jurisdictions reasonably designated by the Representatives, shall comply with such laws and shall continue such qualifications, registrations and exemptions in effect so long as required for the distribution of the Offered ADSs. The Company shall not be required to qualify as a foreign corporation or to take any action that would subject it to general service of process in any such jurisdiction where it is not presently qualified or where it would be subject to taxation as a foreign corporation. The Company will advise the Representatives promptly of the suspension of the qualification or registration of (or any such exemption relating to) the Offered ADSs for offering, sale or trading in any jurisdiction or any initiation or threat of any proceeding for any such purpose, and in the event of the issuance of any order suspending such qualification, registration or exemption, the Company shall use its best efforts to obtain the withdrawal thereof as soon as reasonably practicable.
(i) Use of Proceeds. The Company shall apply the net proceeds from the sale of the Offered ADSs sold by it substantially in the manner described under the caption “Use of Proceeds” in the Registration Statement, the Time of Sale Prospectus and the Prospectus.
(j) Earnings Statement. The Company will make generally available to its security holders and to the Representatives as soon as practicable an earnings statement (which need not be audited) covering a period of at least twelve months beginning with the first fiscal quarter of the Company commencing after the date of this Agreement that will satisfy the provisions of Section 11(a) of the Securities Act and the rules and regulations of the Commission thereunder; provided, however, that the requirements of this Section 3(j) shall be satisfied to the extent such earnings statement is available on EDGAR.
(k) Continued Compliance with Securities Laws. The Company will comply with the Securities Act and the Exchange Act so as to permit the completion of the distribution of the Offered ADSs as contemplated by this Agreement, the Registration Statement, the F-6 Registration Statement, the Time of Sale Prospectus and the Prospectus. Without limiting the generality of the foregoing, the Company will, during the period when a prospectus relating to the Offered ADSs is required by the Securities Act to be delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule), file on a timely basis with the Commission and the NASDAQ all reports and documents required to be filed under the Exchange Act. Additionally, the Company shall report the use of proceeds from the issuance of the Offered ADSs as may be required under Rule 463 under the Securities Act.
21 |
(l) [Reserved.]
(m) Listing. The Company will use its best efforts to list, subject to notice of issuance, the Offered ADSs on the NASDAQ.
(n) Company to Provide Copy of the Prospectus in Form That May be Downloaded from the Internet. If requested by the Representatives, the Company shall cause to be prepared and delivered, at its expense, within one business day from the effective date of this Agreement, to the Representatives an “electronic Prospectus” to be used by the Underwriters in connection with the offering and sale of the Offered ADSs. As used herein, the term “electronic Prospectus” means a form of Prospectus, and any amendment or supplement thereto, that meets each of the following conditions: (i) it shall be encoded in an electronic format, satisfactory to the Representatives, that may be transmitted electronically by the Representatives and the other Underwriters to offerees and purchasers of the Offered ADSs; (ii) it shall disclose the same information as the paper Prospectus, except to the extent that graphic and image material cannot be disseminated electronically, in which case such graphic and image material shall be replaced in the electronic Prospectus with a fair and accurate narrative description or tabular representation of such material, as appropriate; and (iii) it shall be in or convertible into a paper format or an electronic format, satisfactory to Jefferies, that will allow investors to store and have continuously ready access to the Prospectus at any future time, without charge to investors (other than any fee charged for subscription to the Internet as a whole and for on-line time). The Company hereby confirms that it has included or will include in the Prospectus filed pursuant to EDGAR or otherwise with the Commission and in the Registration Statement at the time it was declared effective an undertaking that, upon receipt of a request by an investor or his or her representative, the Company shall transmit or cause to be transmitted promptly, without charge, a paper copy of the Prospectus.
22 |
(o) Agreement Not to Offer or Sell Additional Shares. During the period commencing on and including the date hereof and continuing through and including the 90th day following the date of the Prospectus (such period, as extended as described below, being referred to herein as the “Lock-up Period”), the Company will not, without the prior written consent of Jefferies and Barclays (which consent may be withheld in their sole discretion), directly or indirectly: (i) sell, offer to sell, contract to sell or lend any ADSs, Ordinary Shares or Related Securities (as defined below); (ii) effect any short sale, or establish or increase any “put equivalent position” (as defined in Rule 16a-1(h) under the Exchange Act) or liquidate or decrease any “call equivalent position” (as defined in Rule 16a-1(b) under the Exchange Act) of any ADSs, Ordinary Shares or Related Securities; (iii) pledge, hypothecate or grant any security interest in any ADSs, Ordinary Shares or Related Securities; (iv) in any other way transfer or dispose of any ADSs, Ordinary Shares or Related Securities; (v) enter into any swap, hedge or similar arrangement or agreement that transfers, in whole or in part, the economic risk of ownership of any ADSs, Ordinary Shares or Related Securities, regardless of whether any such transaction is to be settled in securities, in cash or otherwise; (vi) announce the offering of any ADSs, Ordinary Shares or Related Securities; (vii) submit or file any registration statement under the Securities Act in respect of any ADSs, Ordinary Shares or Related Securities (other than as contemplated by this Agreement with respect to the Offered ADSs); (viii) effect a reverse stock split, recapitalization, share consolidation, reclassification or similar transaction affecting the outstanding Ordinary Shares; or (ix) publicly announce the intention to do any of the foregoing; provided, however, that the Company may (A) effect the transactions contemplated hereby; (B) issue ADSs, Ordinary Shares or options to purchase ADSs or Ordinary Shares, or issue ADSs or Ordinary Shares upon exercise of options, pursuant to any stock option, stock bonus or other stock plan or arrangement described in the Registration Statement, the Time of Sale Prospectus and the Prospectus, but only if the holders of such ADSs or Ordinary Shares or options agree in writing with the Underwriters not to sell, offer, dispose of or otherwise transfer any such ADSs or Ordinary Shares or options during such Lock-up Period without the prior written consent of Jefferies and Barclays (which consent may be withheld in their sole discretion); (C) file one or more registration statements on Form S-8 with respect to any ADSs, Ordinary Shares or Related Securities issued or issuable pursuant to any stock option, stock bonus, or other stock plan or arrangement described in the Registration Statement, the Time of Sale Prospectus and the Prospectus; (D) issue ADSs, Ordinary Shares or Related Securities in connection with the acquisition or license by the Company of the securities, business, property, technology or other assets of another person or business entity or pursuant to any employee benefit plan assumed by the Company in connection with any such acquisition; (E) issue ADSs, Ordinary Shares or Related Securities, or enter into an agreement to issue ADSs, Ordinary Shares or Related Securities, in connection with any merger, joint venture, strategic alliance, commercial, consulting, or other collaborative transaction, provided that the aggregate number of ADSs, Ordinary Shares or Related Securities that the Company may issue or agree to issue pursuant to clause (D) and (E) shall not exceed, in the aggregate, 5% of the total outstanding share capital of the Company immediately following the issuance of the Shares; and provided further, that the recipients of any such ADSs, Ordinary Shares or Related Securities issued pursuant to clauses (D) or (E) during the Lock-Up Period shall enter into an agreement substantially in the form attached hereto as Exhibit A on or prior to such issuance; and (F) assist any stockholder of the Company in the establishment of a trading plan by such stockholder pursuant to Rule 10b5-1 under the Exchange Act for the transfer of ADSs, Ordinary Shares or Related Securities, provided that such plan does not provide for the transfer of ADSs, Ordinary Shares or Related Securities during the Lock-Up Period, and the establishment of such plan does not require or otherwise result in any public filings or other public announcement of such plan during such Lock-Up Period and such plan is otherwise permitted to be implemented during the Lock-up Period pursuant to the terms of the Lock-Up Agreement between such stockholder and the Underwriters in connection with the offering of the Offered ADSs. For purposes of the foregoing, “Related Securities” shall mean any options or warrants or other rights to acquire ADSs or Ordinary Shares or any securities exchangeable or exercisable for or convertible into ADSs or Ordinary Shares, or to acquire other securities or rights ultimately exchangeable or exercisable for, or convertible into, ADSs or Ordinary Shares.
(p) Future Reports to the Representatives. During the period of five years hereafter, the Company will furnish to the Representatives, c/o Jefferies, at 520 Madison Avenue, New York, New York 10022, Attention: Global Head of Syndicate: (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each Annual Report on Form 20-F, Report on Form 6-K or other report filed by the Company with the Commission, FINRA or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company furnished or made available generally to holders of its share capital; provided, however, that the requirements of this Section 3(p) shall be satisfied to the extent that such reports, statement, communications, financial statements or other documents are available on EDGAR.
(q) Investment Limitation. The Company shall not invest or otherwise use the proceeds received by the Company from its sale of the Offered ADSs in such a manner as would require the Company or any of its subsidiaries to register as an investment company under the Investment Company Act.
(r) No Stabilization or Manipulation; Compliance with Regulation M. The Company will not take, and will ensure that no affiliate of the Company will take, directly or indirectly, any action designed to or that would reasonably be expected to cause or result in stabilization or manipulation of the price of the Offered ADSs or any reference security with respect to the Offered ADSs, whether to facilitate the sale or resale of the Offered ADSs or otherwise, and the Company will, and shall cause each of its affiliates to, comply with all applicable provisions of Regulation M.
23 |
(s) Enforce Lock-Up Agreements. During the Lock-up Period, the Company will enforce all agreements between the Company and any of its securityholders that restrict or prohibit, expressly or in operation, the offer, sale or transfer of ADSs, Ordinary Shares or Related Securities or any of the other actions restricted or prohibited under the terms of the form of Lock-up Agreement. In addition, the Company will direct the transfer agent to place stop transfer restrictions upon any such securities of the Company that are bound by such “lock-up” agreements for the duration of the periods contemplated in such agreements, including, without limitation, “lock-up” agreements entered into by the Company’s officers, directors and securityholders pursuant to Section 6(j) hereof.
(t) Company to Provide Interim Financial Statements. Prior to the First Closing Date and each applicable Option Closing Date, the Company will furnish the Underwriters, as soon as they have been prepared by or are available to the Company, a copy of any unaudited interim financial statements of the Company for any period subsequent to the period covered by the most recent financial statements appearing in the Registration Statement and the Prospectus.
(u) Deposit Agreement. Prior to the First Closing Date and each applicable Option Closing Date, the Company agrees (i) to deposit Shares with the Depositary in accordance with the provisions of the Deposit Agreement and will otherwise comply with the Deposit Agreement so that ADRs evidencing the Offered ADSs will be executed (and, if applicable, countersigned) and issued by the Depositary against receipt of such Shares and delivered to the Underwriters at such Closing Date and (ii) to otherwise comply with the terms of the Deposit Agreement, including without limitation, the covenants set forth in the Deposit Agreement.
(v) Tax Indemnity. The Company will indemnify and hold harmless the Underwriters against any Transfer Taxes (including any related interest and penalties) payable on (i) the delivery of the Ordinary Shares by the Company to the Depositary Custodian in the manner contemplated by the Deposit Agreement, (ii) the issuance of the Offered ADSs (or the ADRs evidencing the Offered ADSs) by the Depositary, and the delivery of the Offered ADSs (or the ADRs evidencing the Offered ADSs) to or for the account of the Underwriters, in each case in the manner contemplated by this Agreement and the Deposit Agreement; (iii) the initial sale and delivery by the Underwriters of the Offered ADSs (or the ADRs evidencing the Offered ADSs) to purchasers thereof in the manner contemplated by this Agreement; or (iv) the execution and delivery of this Agreement.
(w) Transfer Agent. The Company agrees to maintain a transfer agent and, if necessary under the jurisdiction of incorporation of the Company, a registrar for the Shares.
(x) Amendments and Supplements to Permitted Testing-the-Waters Communications. If at any time following the distribution of any Permitted Testing-the-Waters Communication, there occurred or occurs an event or development as a result of which such Permitted Testing-the-Waters Communication included or would include an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances existing at that subsequent time, not misleading, the Company will promptly notify the Representatives and will promptly amend or supplement, at its own expense, such Permitted Testing-the-Waters Communication to eliminate or correct such untrue statement or omission.
24 |
(y) Emerging Growth Company Status. The Company will promptly notify the Representatives if the Company ceases to be an Emerging Growth Company at any time prior to the later of (i) the time when a prospectus relating to the Offered ADSs is not required by the Securities Act to be delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) and (ii) the expiration of the Lock-Up Period (as defined herein).
(z) Announcement Regarding Lock-ups. The Company agrees to announce the Underwriters’ intention to release any director or “officer” (within the meaning of Rule 16a-1(f) under the Exchange Act) of the Company from any of the restrictions imposed by any Lock-Up Agreement, by issuing, through a major news service, a press release in form and substance satisfactory to the Representatives or, if consented to by the Representatives, in a registration statement that is publicly filed in connection with a secondary offering of the Company’s shares promptly following the Company’s receipt of any notification from the Representatives in which such intention is indicated, but in any case not later than the close of the third business day prior to the date on which such release or waiver is to become effective; provided, however, that nothing shall prevent the Representatives, on behalf of the Underwriters, from announcing the same through a major news service, irrespective of whether the Company has made the required announcement; and provided, further, that no such announcement shall be made of any release or waiver granted solely to permit a transfer of securities that is not for consideration and where the transferee has agreed in writing to be bound by the terms of a Lock-Up Agreement in the form set forth as Exhibit A hereto.
(aa) Sales Taxes. If the performance by the Underwriters of any of their obligations under this Agreement shall represent for VAT purposes under any applicable law the making by the Underwriters of any supply of goods or services to the Company (to the extent applicable), the Company shall pay to the Underwriters, in addition to the amounts otherwise payable by the Company pursuant to this Agreement, an amount equal to the VAT chargeable on any such supply of goods and services provided that the Underwriters shall have first issued the Company with a valid VAT invoice in respect of the supply to which the payment relates. Where a sum (a “Relevant Sum”) is paid or reimbursed to the Underwriters pursuant to this Agreement in respect of any cost, expense or other amount and that cost, expense or other amount includes an amount in respect of irrecoverable VAT (the “VAT Element”) which has been certified as such by the Underwriters (acting reasonably and in good faith), then the Company, to the extent applicable, shall, in addition, pay an amount equal to the VAT Element to the Underwriters. For the purposes of this Agreement, “VAT” means value added tax as provided for in the United Kingdom Value Added Tax Act 1994 (and legislation and regulations supplemental thereto) and any other tax of a similar nature, including sales tax, or tax instead of or in addition to value added tax, wherever imposed, together with any interest, surcharge or penalty payable in respect thereof.
The Representatives, on behalf of the several Underwriters, may, in their sole discretion, waive in writing the performance by the Company of any one or more of the foregoing covenants or extend the time for their performance.
25 |
Section 4. Payment of Expenses. The Company agrees to pay all costs, fees and expenses incurred in connection with the performance of its obligations hereunder and in connection with the transactions contemplated hereby, including without limitation (i) all expenses incident to the issuance, sale and delivery of the Offered ADSs (including all printing and engraving costs), (ii) all fees and expenses of the registrar and transfer agent of the Ordinary Shares, (iii) all fees and expenses of the Depositary related to the Offered ADSs, (iv) all necessary Transfer Taxes arising in respect of the issuance and sale of the Offered ADSs to the Underwriters and the initial sale and delivery by the Underwriters to the purchasers thereof in the manner contemplated by this Agreement (to the extent payment for the same has not already been made pursuant to Section 3(v)), (v) all fees and expenses of the Company’s counsel, independent public or certified public accountants and other advisors, (vi) all costs and expenses incurred in connection with the preparation, printing, filing, shipping and distribution of the Registration Statement (including financial statements, exhibits, schedules, consents and certificates of experts), the F-6 Registration Statement, the Time of Sale Prospectus, the Prospectus, each free writing prospectus prepared by or on behalf of, used by, or referred to by the Company, and each preliminary prospectus, each Permitted Testing-the-Waters Communication, and all amendments and supplements thereto, and this Agreement, (vii) all filing fees, reasonable and documented attorneys’ fees and expenses incurred by the Company or the Underwriters in connection with qualifying or registering (or obtaining exemptions from the qualification or registration of) all or any part of the Offered ADSs for offer and sale under the state securities or blue sky laws, and, if requested by the Representatives, preparing and printing a “Blue Sky Survey” or memorandum and a “Canadian wrapper”, and any supplements thereto, advising the Underwriters of such qualifications, registrations and exemptions, (viii) the costs, fees and expenses incurred by the Underwriters in connection with determining their compliance with the rules and regulations of FINRA related to the Underwriters’ participation in the offering and distribution of the Offered ADSs, including any related filing fees and the legal fees of, and disbursements by, counsel to the Underwriters, (ix) the costs and expenses of the Company relating to investor presentations on any “road show”, any Permitted Testing-the-Waters Communication or any Testing-the-Waters Oral Communication undertaken in connection with the offering of the Offered ADSs, including, without limitation, expenses associated with the preparation or dissemination of any electronic road show, expenses associated with the production of road show slides and graphics, fees and expenses of any consultants engaged in connection with the road show presentations with the prior approval of the Company, travel and lodging expenses of the representatives, employees and officers of the Company and any such consultants, and 50% of the cost of any aircraft chartered in connection with the road show (the remaining 50% of the cost of such aircraft to be paid by the Underwriters), and (ix) the fees and expenses associated with listing the Offered ADSs on the NASDAQ and Ordinary Shares underlying the ADSs on the London Stock Exchange; provided, however, that the costs, fees and expenses of counsel in clauses (vii) and (viii) shall in no event exceed $50,000 in the aggregate. Except as provided in this Section 4 or in Section 7, Section 9 or Section 10 hereof, the Underwriters shall pay their own expenses, including the fees and disbursements of their counsel.
Section 5. Covenant of the Underwriters. Each Underwriter severally and not jointly covenants with the Company not to take any action that would result in the Company being required to file with the Commission pursuant to Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of such Underwriter that otherwise would not, but for such actions, be required to be filed by the Company under Rule 433(d).
Section 6. Conditions of the Obligations of the Underwriters. The respective obligations of the several Underwriters hereunder to purchase and pay for the Offered ADSs as provided herein on the First Closing Date and, with respect to the Optional ADSs, each Option Closing Date, shall be subject to the accuracy of the representations and warranties on the part of the set forth in Section 1 hereof as of the date hereof and as of the First Closing Date as though then made and, with respect to the Optional ADSs, as of each Option Closing Date as though then made, to the timely performance by the Company of its covenants and other obligations hereunder, and to each of the following additional conditions:
(a) Comfort Letter. On the date hereof, the Representatives shall have received from PKF Littlejohn LLP, independent registered public accountants for the Company, a letter dated the date hereof addressed to the Underwriters, in form and substance satisfactory to the Representatives, containing statements and information of the type ordinarily included in accountant’s “comfort letters” to underwriters, delivered according to Statement of Auditing Standards No. 72 (or any successor bulletin), with respect to the audited and unaudited financial statements and certain financial information contained in the Registration Statement, the Time of Sale Prospectus, and each free writing prospectus, if any.
26 |
(b) Compliance with Registration Requirements; No Stop Order; No Objection from FINRA. For the period from and after the date of this Agreement and through and including the First Closing Date and, with respect to any Optional Shares purchased after the First Closing Date, each Option Closing Date:
(i) The Company shall have filed the Prospectus with the Commission (including the information required by Rule 430A under the Securities Act) in the manner and within the time period required by Rule 424(b) under the Securities Act.
(ii) No stop order suspending the effectiveness of the Registration Statement or any post-effective amendment to the Registration Statement or the F-6 Registration Statement or any post-effective amendment to the F-6 Registration Statement shall be in effect, and no proceedings for such purpose shall have been instituted or, to the knowledge of the Company, threatened by the Commission.
(iii) FINRA shall have raised no objection to the fairness and reasonableness of the underwriting terms and arrangements.
(c) No Material Adverse Change or Ratings Agency Change. For the period from and after the date of this Agreement and through and including the First Closing Date and, with respect to any Optional ADSs purchased after the First Closing Date, each Option Closing Date:
(i) in the reasonable judgment of the Representatives there shall not have occurred any Material Adverse Change; and
(ii) there shall not have occurred any downgrading, nor shall any notice have been given of any intended or potential downgrading or of any review for a possible change that does not indicate the direction of the possible change, in the rating accorded any securities of the Company or any of its subsidiaries by any “nationally recognized statistical rating organization” as that term is used in Rule 15c3-1(c)(2)(vi)(F) under the Exchange Act.
(d) Opinion of U.S. Counsel for the Company. On each of the First Closing Date and each Option Closing Date the Representatives shall have received the opinion and negative assurance letter of Sidley Austin LLP, counsel for the Company, dated as of such date, in form and substance reasonably satisfactory to the Underwriters.
(e) Opinion of Fladgate LLP. On each of the First Closing Date and each Option Closing Date, the Representatives shall have received the opinion of Fladgate LLP, counsel for the Company with respect to English law, dated as of such date, in form and substance reasonably satisfactory to the Underwriters.
(f) Opinion of Counsel for the Depositary. On each of the First Closing Date and each Option Closing Date, the Representatives shall have received the opinion of Norton Rose Fulbright, counsel for the Depositary, dated as of such date, in form and substance reasonably satisfactory to the Underwriters.
(g) Opinion of Counsel for the Underwriters. On each of the First Closing Date and each Option Closing Date the Representatives shall have received the opinion of Latham & Watkins LLP, counsel for the Underwriters in connection with the offer and sale of the Offered ADSs, in form and substance reasonably satisfactory to the Underwriters, dated as of such date.
27 |
(h) Officers’ Certificate. On each of the First Closing Date and each Option Closing Date, the Representatives shall have received a certificate executed by the Chief Executive Officer or President of the Company and the Chief Financial Officer of the Company, on behalf of the Company and not in their individual capacities, dated as of such date, to the effect set forth in Section 6(b)(ii) and further to the effect that:
(i) for the period from and including the date of this Agreement through and including such date, there has not occurred any Material Adverse Change;
(ii) the representations, warranties and covenants of the Company set forth in Section 1 of this Agreement are true and correct with the same force and effect as though expressly made on and as of such date; and
(iii) the Company has complied with all the agreements hereunder and satisfied all the conditions on its part to be performed or satisfied hereunder at or prior to such date.
(i) Bring-down Comfort Letter. On each of the First Closing Date and each Option Closing Date the Representatives shall have received from PKF Littlejohn LLP, independent registered public accountants for the Company, a letter dated such date, in form and substance satisfactory to the Representatives, which letter shall: (i) reaffirm the statements made in the letter furnished by them pursuant to Section 6(a), except that the specified date referred to therein for the carrying out of procedures shall be no more than three business days prior to the First Closing Date or the applicable Option Closing Date, as the case may be; and (ii) cover certain financial information contained in the Prospectus.
(j) Lock-Up Agreements. On or prior to the date hereof, the Company shall have furnished to the Representatives an agreement in the form of Exhibit A hereto from each of the persons listed on Exhibit B hereto, and each such agreement shall be in full force and effect on each of the First Closing Date and each Option Closing Date.
(k) Rule 462(b) Registration Statement. In the event that a Rule 462(b) Registration Statement is filed in connection with the offering contemplated by this Agreement, such Rule 462(b) Registration Statement shall have been filed with the Commission on the date of this Agreement and shall have become effective automatically upon such filing.
(l) Approval of Listing. At the First Closing Date, the Offered ADSs shall have been approved for listing on the NASDAQ, subject only to official notice of issuance.
(m) Deposit Agreement. The Company and the Depositary shall have executed and delivered the Deposit Agreement and the Deposit Agreement shall be in full force and effect. The Depositary shall have delivered to the Company certificates satisfactory to the Underwriters evidencing the deposit with the Depositary or its nominee of the Shares being so deposited against issuance of ADRs evidencing the Offered ADSs to be delivered by the Company at such Closing Date, and the execution, countersignature (if applicable), issuance and delivery of ADRs evidencing such Offered ADSs pursuant to the Deposit Agreement.
(n) [Reserved.]
28 |
(o) Additional Documents. On or before each of the First Closing Date and each Option Closing Date, the Representatives and counsel for the Underwriters shall have received such information, documents and opinions as they may reasonably request for the purposes of enabling them to pass upon the issuance and sale of the Offered ADSs as contemplated herein, or in order to evidence the accuracy of any of the representations and warranties, or the satisfaction of any of the conditions or agreements, herein contained; and all proceedings taken by the Company in connection with the issuance and sale of the Offered ADSs as contemplated herein and in connection with the other transactions contemplated by this Agreement shall be satisfactory in form and substance to the Representatives and counsel for the Underwriters.
If any condition specified in this Section 6 is not satisfied when and as required to be satisfied, this Agreement may be terminated by the Representatives by notice from Jefferies to the Company at any time on or prior to the First Closing Date and, with respect to the Optional ADSs, at any time on or prior to the applicable Option Closing Date, which termination shall be without liability on the part of any party to any other party, except that Section 4, Section 7, Section 9 and Section 10 shall at all times be effective and shall survive such termination.
Section 7. Reimbursement of Underwriters’ Expenses. If this Agreement is terminated by the Representatives pursuant to Section 6, Section 11 or, Section 12, or if the sale to the Underwriters of the Offered ADSs on the First Closing Date is not consummated because of any refusal, inability or failure on the part of the Company to perform any agreement herein or to comply with any provision hereof, the Company agrees to reimburse the Representatives and the other Underwriters (or such Underwriters as have terminated this Agreement with respect to themselves), severally, upon demand for all documented out-of-pocket expenses that shall have been reasonably incurred by the Representatives and the Underwriters in connection with the proposed purchase and the offering and sale of the Offered ADSs, including, but not limited to, reasonably incurred and documented fees and disbursements of counsel, printing expenses, travel expenses, postage, facsimile and telephone charges.
Section 8. Effectiveness of this Agreement. This Agreement shall become effective upon the execution and delivery hereof by the parties hereto.
Section 9. Indemnification.
(a) Indemnification of the Underwriters. The Company agrees to indemnify and hold harmless each Underwriter, its affiliates, directors, officers, employees and agents, and each person, if any, who controls any Underwriter within the meaning of the Securities Act or the Exchange Act against any loss, claim, damage, liability or expense, as incurred, to which such Underwriter or such affiliate, director, officer, employee, agent or controlling person may become subject, under the Securities Act, the Exchange Act, other federal or state statutory law or regulation, or the laws or regulations of foreign jurisdictions where Offered ADSs have been offered or sold or at common law or otherwise (including in settlement of any litigation, if such settlement is effected with the written consent of the Company), insofar as such loss, claim, damage, liability or expense (or actions in respect thereof as contemplated below) arises out of or is based upon (i) any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement or the F-6 Registration Statement, or any amendment to the Registration Statement or F-6 Registration Statement, or the omission or alleged omission to state therein a material fact required to be stated in the Registration Statement or F-6 Registration Statement or necessary to make the statements in the Registration Statement or F-6 Registration Statement not misleading; or (ii) any untrue statement or alleged untrue statement of a material fact included in any preliminary prospectus, the Time of Sale Prospectus, any free writing prospectus that the Company has used, referred to or filed, or is required to file, pursuant to Rule 433(d) of the Securities Act, any Marketing Material, any Testing-the-Waters Written Communication, any announcements released by the Company via a regulatory information service in the United Kingdom, or the Prospectus (or any amendment or supplement to the foregoing), or the omission or alleged omission to state therein a material fact necessary in order to make the statements, in the light of the circumstances under which they were made, not misleading; and to reimburse each Underwriter and each such affiliate, director, officer, employee, agent and controlling person for any and all expenses (including the reasonable and documented fees and disbursements of counsel) as such expenses are incurred by such Underwriter or such affiliate, director, officer, employee, agent or controlling person in connection with investigating, defending, settling, compromising or paying any such loss, claim, damage, liability, expense or action; provided, however, that the foregoing indemnity agreement shall not apply to any loss, claim, damage, liability or expense to the extent, but only to the extent, arising out of or based upon any untrue statement or alleged untrue statement or omission or alleged omission made in reliance upon and in conformity with information relating to any Underwriter furnished to the Company by the Representatives in writing expressly for use in the Registration Statement, the F-6 Registration Statement, any preliminary prospectus, the Time of Sale Prospectus, any such free writing prospectus, any Marketing Material, any Testing-the-Waters Written Communication or the Prospectus (or any amendment or supplement thereto), it being understood and agreed that the only such information consists of the information described in Section 9(b) below. The indemnity agreement set forth in this Section 9(a) shall be in addition to any liabilities that the Company may otherwise have.
29 |
(b) Indemnification of the Company, its Directors and Officers. Each Underwriter agrees, severally and not jointly, to indemnify and hold harmless the Company, each of its directors, each of its officers who signed the Registration Statement and the F-6 Registration Statement, and each person, if any, who controls the Company within the meaning of the Securities Act or the Exchange Act, against any loss, claim, damage, liability or expense, as incurred, to which the Company, or any such director, officer or controlling person may become subject, under the Securities Act, the Exchange Act, or other federal or state statutory law or regulation, or at common law or otherwise (including in settlement of any litigation, if such settlement is effected with the written consent of such Underwriter), insofar as such loss, claim, damage, liability or expense (or actions in respect thereof as contemplated below) arises out of or is based upon (i) any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement or the F-6 Registration Statement, or any amendment to the Registration Statement or F-6 Registration Statement, or the omission or alleged omission to state therein a material fact required to be stated in the Registration Statement or F-6 Registration Statement or necessary to make the statements in the Registration Statement or F-6 Registration Statement not misleading or (ii) any untrue statement or alleged untrue statement of a material fact included in any preliminary prospectus, the Time of Sale Prospectus, any free writing prospectus that the Company has used, referred to or filed, or is required to file, pursuant to Rule 433 of the Securities Act, any Testing-the-Waters Written Communication or the Prospectus (or any such amendment or supplement) or the omission or alleged omission to state therein a material fact necessary in order to make the statements, in the light of the circumstances under which they were made, not misleading, in each case to the extent, but only to the extent, that such untrue statement or alleged untrue statement or omission or alleged omission was made in the Registration Statement, the F-6 Registration Statement, such preliminary prospectus, the Time of Sale Prospectus, such free writing prospectus, such Testing-the-Waters Written Communication or the Prospectus (or any such amendment or supplement), in reliance upon and in conformity with information relating to such Underwriter furnished to the Company by the Representatives in writing expressly for use therein; and to reimburse the Company, or any such director, officer or controlling person for any and all expenses (including the fees and disbursements of counsel) as such expenses are incurred by the Company, or any such director, officer or controlling person in connection with investigating, defending, settling, compromising or paying any such loss, claim, damage, liability, expense or action. The Company hereby acknowledges that the only information that the Representatives have furnished to the Company expressly for use in the Registration Statement, the F-6 Registration Statement, any preliminary prospectus, the Time of Sale Prospectus, any free writing prospectus that the Company has filed, or is required to file, pursuant to Rule 433(d) of the Securities Act, any Testing-the-Waters Written Communication or the Prospectus (or any amendment or supplement to the foregoing) are the statements set forth in the first sentence of the third paragraph, the first three sentences under the caption “— Commission and Expenses” and the first sentence under the caption “—Stabilization,” in each case under the caption “Underwriting” in the Preliminary Prospectus and the Prospectus. The indemnity agreement set forth in this Section 9(b) shall be in addition to any liabilities that each Underwriter may otherwise have.
30 |
(c) Notifications and Other Indemnification Procedures. Promptly after receipt by an indemnified party under this Section 9 of notice of the commencement of any action, such indemnified party will, if a claim in respect thereof is to be made against an indemnifying party under this Section 9, notify the indemnifying party in writing of the commencement thereof, but the omission to so notify the indemnifying party will not relieve the indemnifying party from any liability which it may have to any indemnified party to the extent the indemnifying party is not materially prejudiced as a proximate result of such failure and shall not in any event relieve the indemnifying party from any liability that it may have otherwise than on account of this indemnity agreement. In case any such action is brought against any indemnified party and such indemnified party seeks or intends to seek indemnity from an indemnifying party, the indemnifying party will be entitled to participate in, and, to the extent that it shall elect, jointly with all other indemnifying parties similarly notified, by written notice delivered to the indemnified party promptly after receiving the aforesaid notice from such indemnified party, to assume the defense thereof with counsel reasonably satisfactory to such indemnified party; provided, however, that if the defendants in any such action include both the indemnified party and the indemnifying party and the indemnified party shall have reasonably concluded that a conflict may arise between the positions of the indemnifying party and the indemnified party in conducting the defense of any such action or that there may be legal defenses available to it and/or other indemnified parties which are different from or additional to those available to the indemnifying party, the indemnified party or parties shall have the right to select separate counsel to assume such legal defenses and to otherwise participate in the defense of such action on behalf of such indemnified party or parties. Upon receipt of notice from the indemnifying party to such indemnified party of such indemnifying party’s election to so assume the defense of such action and approval by the indemnified party of counsel, the indemnifying party will not be liable to such indemnified party under this Section 9 for any reasonable and documented legal or other expenses subsequently incurred by such indemnified party in connection with the defense thereof unless (i) the indemnified party shall have employed separate counsel in accordance with the proviso to the preceding sentence (it being understood, however, that the indemnifying party shall not be liable for the fees and expenses of more than one separate counsel (together with local counsel), representing the indemnified parties who are parties to such action), which counsel (together with any local counsel) for the indemnified parties shall be selected by Jefferies (in the case of counsel for the indemnified parties referred to in Section 9(a) above) or by the Company (in the case of counsel for the indemnified parties referred to in Section 9(b) above)) or (ii) the indemnifying party shall not have employed counsel reasonably satisfactory to the indemnified party to represent the indemnified party within a reasonable time after notice of commencement of the action or (iii) the indemnifying party has authorized in writing the employment of counsel for the indemnified party at the expense of the indemnifying party, in each of which cases the fees and expenses of counsel shall be at the expense of the indemnifying party and shall be paid as they are incurred.
(d) Settlements. The indemnifying party under this Section 9 shall not be liable for any settlement of any proceeding effected without its written consent, but if settled with such consent or if there be a final judgment for the plaintiff, the indemnifying party agrees to indemnify the indemnified party against any loss, claim, damage, liability or expense by reason of such settlement or judgment. Notwithstanding the foregoing sentence, if at any time an indemnified party shall have requested an indemnifying party to reimburse the indemnified party for fees and expenses of counsel as contemplated by Section 9(c) hereof, the indemnifying party shall be liable for any settlement of any proceeding effected without its written consent if (i) such settlement is entered into more than 30 days after receipt by such indemnifying party of the aforesaid request and (ii) such indemnifying party shall not have reimbursed the indemnified party in accordance with such request prior to the date of such settlement. No indemnifying party shall, without the prior written consent of the indemnified party, effect any settlement, compromise or consent to the entry of judgment in any pending or threatened action, suit or proceeding in respect of which any indemnified party is or could have been a party and indemnity was or could have been sought hereunder by such indemnified party, unless such settlement, compromise or consent includes an unconditional release of such indemnified party from all liability on claims that are the subject matter of such action, suit or proceeding and does not include an admission of fault or culpability or a failure to act by or on behalf of such indemnified party.
31 |
Section 10. Contribution. If the indemnification provided for in Section 9 is for any reason held to be unavailable to or otherwise insufficient to hold harmless an indemnified party in respect of any losses, claims, damages, liabilities or expenses referred to therein, then each indemnifying party shall contribute to the aggregate amount paid or payable by such indemnified party, as incurred, as a result of any losses, claims, damages, liabilities or expenses referred to therein (i) in such proportion as is appropriate to reflect the relative benefits received by the Company, on the one hand, and the Underwriters, on the other hand, from the offering of the Offered ADSs pursuant to this Agreement or (ii) if the allocation provided by clause (i) above is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) above but also the relative fault of the Company, on the one hand, and the Underwriters, on the other hand, in connection with the statements or omissions which resulted in such losses, claims, damages, liabilities or expenses, as well as any other relevant equitable considerations. The relative benefits received by the Company, on the one hand, and the Underwriters, on the other hand, in connection with the offering of the Offered ADSs pursuant to this Agreement shall be deemed to be in the same respective proportions as the total proceeds from the offering of the Offered ADSs pursuant to this Agreement (before deducting expenses) received by the Company, and the total underwriting discounts and commissions received by the Underwriters, in each case as set forth on the front cover page of the Prospectus, bear to the aggregate initial public offering price of the Offered ADSs as set forth on such cover. The relative fault of the Company, on the one hand, and the Underwriters, on the other hand, shall be determined by reference to, among other things, whether any such untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to information supplied by the Company, on the one hand, or the Underwriters, on the other hand, and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission.
The amount paid or payable by a party as a result of the losses, claims, damages, liabilities and expenses referred to above shall be deemed to include, subject to the limitations set forth in Section 9(c), any reasonable and documented legal or other fees or expenses reasonably incurred by such party in connection with investigating or defending any action or claim. The provisions set forth in Section 9(c) with respect to notice of commencement of any action shall apply if a claim for contribution is to be made under this Section 10; provided, however, that no additional notice shall be required with respect to any action for which notice has been given under Section 9(c) for purposes of indemnification.
The Company and the Underwriters agree that it would not be just and equitable if contribution pursuant to this Section 10 were determined by pro rata allocation (even if the Underwriters were treated as one entity for such purpose) or by any other method of allocation which does not take account of the equitable considerations referred to in this Section 10.
32 |
Notwithstanding the provisions of this Section 10, no Underwriter shall be required to contribute any amount in excess of the underwriting discounts and commissions received by such Underwriter in connection with the Offered ADSs underwritten by it and distributed to the public. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. The Underwriters’ obligations to contribute pursuant to this Section 10 are several, and not joint, in proportion to their respective underwriting commitments as set forth opposite their respective names on Schedule A. For purposes of this Section 10, each affiliate, director, officer, employee and agent of an Underwriter and each person, if any, who controls an Underwriter within the meaning of the Securities Act or the Exchange Act shall have the same rights to contribution as such Underwriter, and each director of the Company, each officer of the Company who signed the Registration Statement or the F-6 Registration Statement, and each person, if any, who controls the Company within the meaning of the Securities Act and the Exchange Act shall have the same rights to contribution as the Company.
Section 11. Default of One or More of the Several Underwriters. If, on the First Closing Date or any Option Closing Date any one or more of the several Underwriters shall fail or refuse to purchase Offered ADSs that it or they have agreed to purchase hereunder on such date, and the aggregate number of Offered ADSs which such defaulting Underwriter or Underwriters agreed but failed or refused to purchase does not exceed 10% of the aggregate number of the Offered ADSs to be purchased on such date, the Representatives may make arrangements satisfactory to the Company for the purchase of such Offered ADSs by other persons, including any of the Underwriters, but if no such arrangements are made by such date, the other Underwriters shall be obligated, severally and not jointly, in the proportions that the number of Firm ADSs set forth opposite their respective names on Schedule A bears to the aggregate number of Firm ADSs set forth opposite the names of all such non-defaulting Underwriters, or in such other proportions as may be specified by the Representatives with the consent of the non-defaulting Underwriters, to purchase the Offered ADSs which such defaulting Underwriter or Underwriters agreed but failed or refused to purchase on such date. If, on the First Closing Date or any Option Closing Date any one or more of the Underwriters shall fail or refuse to purchase Offered ADSs and the aggregate number of Offered ADSs with respect to which such default occurs exceeds 10% of the aggregate number of Offered ADSs to be purchased on such date, and arrangements satisfactory to the Representatives and the Company for the purchase of such Offered ADSs are not made within 48 hours after such default, this Agreement shall, subject to the last sentence of this Section 11, terminate without liability of any party to any other party except that the provisions of Section 4, Section 7, Section 9 and Section 10 shall at all times be effective and shall survive such termination. In any such case either the Representatives or the Company shall have the right to postpone the First Closing Date or the applicable Option Closing Date, as the case may be, but in no event for longer than seven days in order that the required changes, if any, to the Registration Statement and the Prospectus or any other documents or arrangements may be effected.
As used in this Agreement, the term “Underwriter” shall be deemed to include any person substituted for a defaulting Underwriter under this Section 11. Any action taken under this Section 11 shall not relieve any defaulting Underwriter from liability in respect of any default of such Underwriter under this Agreement.
Section 12. Termination of this Agreement. Prior to the purchase of the Firm ADSs by the Underwriters on the First Closing Date, this Agreement may be terminated by Jefferies and Barclays by notice given to the Company if at any time: (i) trading or quotation in any of the Company’s securities shall have been suspended or limited by the Commission or by the NASDAQ, or trading in securities generally on or by, as the case may be, any of the London Stock Exchange, the NASDAQ or the NYSE shall have been suspended or limited, or minimum or maximum prices shall have been generally established on any of such stock exchanges; (ii) a general banking moratorium shall have been declared by any of federal, New York or United Kingdom authorities; (iii) there shall have occurred any outbreak or escalation of national or international hostilities or any crisis or calamity, or any change in the United States or international financial markets, or any substantial change or development involving a prospective substantial change in United States’ or international political, financial or economic conditions, as in the judgment of Jefferies and Barclays is material and adverse and makes it impracticable to market the Offered ADSs in the manner and on the terms described in the Time of Sale Prospectus or the Prospectus or to enforce contracts for the sale of securities; (iv) in the judgment of Jefferies and Barclays there shall have occurred any Material Adverse Change; or (v) the Company shall have sustained a loss by strike, fire, flood, earthquake, accident or other calamity of such character as in the judgment of Jefferies and Barclays may interfere materially with the conduct of the business and operations of the Company regardless of whether or not such loss shall have been insured. Any termination pursuant to this Section 12 shall be without liability on the part of (a) the Company to any Underwriter, except that the Company shall be obligated to reimburse the expenses of the Representatives and the Underwriters pursuant to Section 4 or Section 7 hereof or (b) any Underwriter to the Company; provided, however, that the provisions of Section 9 and Section 10 shall at all times be effective and shall survive such termination.
33 |
Section 13. No Advisory or Fiduciary Relationship. The Company acknowledges and agrees that (a) the purchase and sale of the Offered ADSs pursuant to this Agreement, including the determination of the public offering price of the Offered ADSs and any related discounts and commissions, is an arm’s-length commercial transaction between the Company, on the one hand, and the several Underwriters, on the other hand, (b) in connection with the offering contemplated hereby and the process leading to such transaction, each Underwriter is and has been acting solely as a principal and is not the agent or fiduciary of the Company, or its stockholders, creditors, employees or any other party, (c) no Underwriter has assumed or will assume an advisory or fiduciary responsibility in favor of the Company with respect to the offering contemplated hereby or the process leading thereto (irrespective of whether such Underwriter has advised or is currently advising the Company on other matters) and no Underwriter has any obligation to the Company with respect to the offering contemplated hereby except the obligations expressly set forth in this Agreement, (d) the Underwriters and their respective affiliates may be engaged in a broad range of transactions that involve interests that differ from those of the Company, and (e) the Underwriters have not provided any legal, accounting, regulatory or tax advice with respect to the offering contemplated hereby and the Company has consulted its own legal, accounting, regulatory and tax advisors to the extent it deemed appropriate.
Section 14. Representations and Indemnities to Survive Delivery. The respective indemnities, agreements, representations, warranties and other statements of the Company, of its officers and of the several Underwriters set forth in or made pursuant to this Agreement will remain in full force and effect, regardless of any investigation made by or on behalf of any Underwriter or the Company or any of its or their partners, officers or directors or any controlling person, as the case may be, and, anything herein to the contrary notwithstanding, will survive delivery of and payment for the Offered ADSs sold hereunder and any termination of this Agreement.
Section 15. Notices. All communications hereunder shall be in writing and shall be mailed, hand delivered or telecopied and confirmed to the parties hereto as follows:
If to the Representatives: Jefferies
LLC
520 Madison Avenue
New York, New York 10022
Facsimile: (646) 619-4437
Attention: General Counsel
Barclays Capital Inc.
745 Seventh Avenue
New York, New York 10019
Facsimile: (646) 834-8133
Attention: Syndicate Registration
34 |
with a copy to: Latham & Watkins LLP
1271 Avenue of the Americas
New York, New York 10020
Facsimile: (212) 751-4864
Attention: Stelios G. Saffos
If to the Company: Argo Blockchain
plc
9th Floor
16 Great Queen Street
London, England WC2B 5DG
Attention: Peter Wall
with a copy to: Sidley Austin LLP
1001 Page Mill Road, Building 1
Palo Alto, California 94304
Attention: Martin A. Wellington
and
Fladgate LLP
16 Great Queen Street
London, WC2B 5DG, United Kingdom
Facsimile: +44 (0)20 3036 7600
Attention: David Robinson
Any party hereto may change the address for receipt of communications by giving written notice to the others.
Section 16. Successors. This Agreement will inure to the benefit of and be binding upon the parties hereto, including any substitute Underwriters pursuant to Section 11 hereof, and to the benefit of the affiliates, directors, officers, employees, agents and controlling persons referred to in Section 9 and Section 10, and in each case their respective successors, and no other person will have any right or obligation hereunder. The term “successors” shall not include any purchaser of the Offered ADSs as such from any of the Underwriters merely by reason of such purchase.
Section 17. Partial Unenforceability. The invalidity or unenforceability of any section, paragraph or provision of this Agreement shall not affect the validity or enforceability of any other section, paragraph or provision hereof. If any section, paragraph or provision of this Agreement is for any reason determined to be invalid or unenforceable, there shall be deemed to be made such minor changes (and only such minor changes) as are necessary to make it valid and enforceable.
Section 18. Recognition of the U.S. Special Resolution Regimes.
(a) In the event that any Underwriter that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States.
(b) In the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States.
35 |
For purposes of this Agreement, (A) “BHC Act Affiliate” has the meaning assigned to the term “affiliate” in, and shall be interpreted in accordance with, 12 U.S.C. § 1841(k); (B) “Covered Entity” means any of the following: (i) a “covered entity” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 252.82(b); (ii) a “covered bank” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 47.3(b); or (iii) a “covered FSI” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 382.2(b); (C) “Default Right” has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. §§ 252.81, 47.2 or 382.1, as applicable; and (D) “U.S. Special Resolution Regime” means each of (i) the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii) Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.
Section 19. Governing Law Provisions; Currency Provisions. This Agreement shall be governed by and construed in accordance with the internal laws of the State of New York applicable to agreements made and to be performed in such state. Any legal suit, action or proceeding arising out of or based upon this Agreement or the transactions contemplated hereby (“Related Proceedings”) may be instituted in the federal courts of the United States of America located in the Borough of Manhattan in the City of New York or the courts of the State of New York in each case located in the Borough of Manhattan in the City of New York (collectively, the “Specified Courts”), and each party irrevocably submits to the exclusive jurisdiction (except for proceedings instituted in regard to the enforcement of a judgment of any such court (a “Related Judgment”), as to which such jurisdiction is non-exclusive) of such courts in any such suit, action or proceeding. Service of any process, summons, notice or document by mail to such party’s address set forth above shall be effective service of process for any suit, action or other proceeding brought in any such court. The parties irrevocably and unconditionally waive any objection to the laying of venue of any suit, action or other proceeding in the Specified Courts and irrevocably and unconditionally waive and agree not to plead or claim in any such court that any such suit, action or other proceeding brought in any such court has been brought in an inconvenient forum. The Company and each other party not located in the United States has irrevocably appointed Puglisi & Associates which currently maintains an office at 850 Library Avenue, Suite 204, Newark, DE 19711, United States of America, as its agent to receive service of process or other legal summons for purposes of any such suit, action or proceeding that may be instituted in any state or federal court in the Borough of Manhattan in the City of New York, United States of America.
With respect to any Related Proceeding, each party irrevocably waives, to the fullest extent permitted by applicable law, all immunity (whether on the basis of sovereignty or otherwise) from jurisdiction, service of process, attachment (both before and after judgment) and execution to which it might otherwise be entitled in the Specified Courts, and with respect to any Related Judgment, each party waives any such immunity in the Specified Courts or any other court of competent jurisdiction, and will not raise or claim or cause to be pleaded any such immunity at or in respect of any such Related Proceeding or Related Judgment, including, without limitation, any immunity pursuant to the United States Foreign Sovereign Immunities Act of 1976, as amended.
The obligations of the Company pursuant to this Agreement in respect of any sum due to any Underwriter shall, notwithstanding any judgment in a currency other than United States dollars, not be discharged until the first business day, following receipt by any Underwriter of any sum adjudged to be so due in such other currency, on which such Underwriter may in accordance with normal banking procedures purchase United States dollars with such other currency. If the United States dollars so purchased are less than the sum originally due to such Underwriter in United States dollars hereunder, the Company agrees as a separate obligation and notwithstanding any such judgment, to indemnify such Underwriter against such loss. If the United States dollars so purchased are greater than the sum originally due to such Underwriter hereunder, such Underwriter agrees to pay to the Company an amount equal to the excess of the dollars so purchased over the sum originally due to such Underwriter hereunder.
36 |
All payments made by the Company under this Agreement, if any, will be made without withholding or deduction for or on account of any taxes, duties, assessments or governmental charges of whatever nature imposed or levied by or on behalf of the United Kingdom, the United States, Canada or any political subdivision or any taxing authority thereof or therein unless the Company is or becomes required by law to withhold or deduct such taxes, duties, assessments or other governmental charges. In such event, the Company will pay such additional amounts as will result, after such withholding or deduction, in the receipt by each Underwriter and each person controlling any Underwriter, as the case may be, of the amounts that would otherwise have been receivable in respect thereof.
Section 20. General Provisions. This Agreement constitutes the entire agreement of the parties to this Agreement and supersedes all prior written or oral and all contemporaneous oral agreements, understandings and negotiations with respect to the subject matter hereof. This Agreement may be executed in two or more counterparts, each one of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument. Electronic signatures complying with the New York Electronic Signatures and Records Act (N.Y. State Tech. §§ 301-309), as amended from time to time, or other applicable law will be deemed original signatures for purposes of this Agreement. Transmission by telecopy, electronic mail or other transmission method of an executed counterpart of this Agreement will constitute due and sufficient delivery of such counterpart. This Agreement may not be amended or modified unless in writing by all of the parties hereto, and no condition herein (express or implied) may be waived unless waived in writing by each party whom the condition is meant to benefit. The section headings herein are for the convenience of the parties only and shall not affect the construction or interpretation of this Agreement.
Each of the parties hereto acknowledges that it is a sophisticated business person who was adequately represented by counsel during negotiations regarding the provisions hereof, including, without limitation, the indemnification provisions of Section 9 and the contribution provisions of Section 10, and is fully informed regarding said provisions. Each of the parties hereto further acknowledges that the provisions of Section 9 and Section 10 hereof fairly allocate the risks in light of the ability of the parties to investigate the Company, its affairs and its business in order to assure that adequate disclosure has been made in the Registration Statement, any preliminary prospectus, the Time of Sale Prospectus, each free writing prospectus and the Prospectus (and any amendments and supplements to the foregoing), as contemplated by the Securities Act and the Exchange Act.
Section 21. EU MiFID II Product Governance Rules. Solely for the purposes of the requirements of Article 9(8) of the MIFID Product Governance rules under EU Delegated Directive 2017/593 (the “Delegated Directive”) regarding the mutual responsibilities of manufacturers under the Product Governance requirements contained within: (a) Directive 2014/65/EU on markets in financial instruments, as amended (“MiFID II”); (b) Articles 9 and 10 of the Delegated Directive; and (c) local implementing measures (the “EU MiFID II Product Governance Rules”, each manufacturer acknowledges to each other manufacturer that it understands the responsibilities conferred upon it under the EU MiFID II Product Governance Rules relating to each of (i) the target market and the eligible distribution channels for dissemination of the ADSs each as set out in the Prospectus in connection with the ADSs; and (ii) the requirement to carry out a product approval process.
37 |
If the foregoing is in accordance with your understanding of our agreement, kindly sign and return to the Company the enclosed copies hereof, whereupon this instrument, along with all counterparts hereof, shall become a binding agreement in accordance with its terms.
Very truly yours, |
ARGO BLOCKCHAIN PLC |
By: |
Name: |
Title: |
The foregoing Underwriting Agreement is hereby confirmed and accepted by the Representatives in New York, New York as of the date first above written.
JEFFERIES LLC
BARCLAYS CAPITAL INC.
Acting individually and as Representatives
of the several Underwriters named in
the attached Schedule A.
JEFFERIES LLC
By: |
Name: |
Title: |
BARCLAYS CAPITAL INC.
By: |
Name: |
Title: |
38 |
Schedule A
Underwriters |
Number of
Firm ADSs to be Purchased |
|
Jefferies LLC | [●] | |
Barclays Capital Inc. | [●] | |
[ n ] | [●] | |
[ n ] | [●] | |
[ n ] | [●] | |
[ n ] | [●] | |
[ n ] | [●] | |
[ n ] | [●] | |
Total | [●] |
Schedule B
Free Writing Prospectuses Included in the Time of Sale Prospectus
[None.]
Schedule C
Pricing Information
Price to public: | $[ n ] per ADS |
Firm ADSs: | [ n ] ADSs, representing [ n ] Ordinary Shares |
Optional ADSs: | [ n ] ADSs, representing [ n ] Ordinary Shares |
Schedule D
Permitted Testing-the-Waters Communications
[See attached.]
Exhibit A
Form of Lock-up Agreement
[ n ], 2021
Jefferies LLC
Barclays Capital Inc.
As Representatives of the Several Underwriters
c/o Jefferies LLC
520 Madison Avenue
New York, New York 10022
and
c/o Barclays Capital Inc.
745 Seventh Avenue
New York, New York 10019
RE: | Argo Blockchain plc (the “Company”) |
Ladies & Gentlemen:
The undersigned is a record or beneficial owner of the Company’s ordinary shares, nominal value £0.001 per share (“Ordinary Shares”). The Company proposes to conduct a public offering of American Depositary Shares (“ADSs”), each representing one Ordinary Share, of Ordinary Shares or of securities convertible into or exchangeable or exercisable for ADSs or Ordinary Shares (the “Offering”) for which Jefferies LLC (“Jefferies”) and Barclays Capital Inc. (“Barclays”) will act as the representatives of the several underwriters (together, the “Representatives”). The undersigned recognizes that the Offering will benefit each of the Company and the undersigned. The undersigned acknowledges, as applicable, that the underwriters are relying on the representations and agreements of the undersigned contained in this letter agreement in conducting the Offering and, at a subsequent date, in entering into an underwriting agreement (the “Underwriting Agreement”) and other underwriting arrangements with the Company with respect to the Offering.
Annex A sets forth definitions for capitalized terms used in this letter agreement (the “Lock-up Agreement”) that are not defined in the body of this agreement. Those definitions are a part of this agreement.
In consideration of the foregoing, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the undersigned hereby agrees that, during the Lock-up Period, the undersigned will not (and, if the undersigned is a natural person, will cause any Family Member not to), without the prior written consent of the Representatives, who may withhold their consent in their sole discretion:
l | Sell or Offer to Sell any ADSs, Ordinary Shares or Related Securities (together, the “Lock-Up Securities”) currently or hereafter owned either of record or beneficially (as defined in Rule 13d-3 under the Exchange Act) by the undersigned or such Family Member, |
A-1
l | enter into any Swap, |
l | make any demand for, or exercise any right with respect to, the registration under the Securities Act of the offer and sale of any Lock-up Securities, or cause to be filed a registration statement, prospectus or prospectus supplement (or an amendment or supplement thereto) with respect to any such registration, or |
l | publicly announce any intention to do any of the foregoing. |
The foregoing will not apply to the registration of the offer and sale of the Offered ADSs, and the sale of the Offered ADSs to the underwriters, in each case as contemplated by the Underwriting Agreement.
Additionally, the foregoing restrictions in this Lock-Up Agreement shall not apply to the below exceptions, provided that in any such case, it shall be a condition to such transfer that each transferee executes and delivers to the Representatives an agreement in form and substance satisfactory to the Representatives stating that such transferee is receiving and holding such ADSs, Ordinary Shares and/or Related Securities subject to the provisions of this letter agreement and agrees not to Sell or Offer to Sell such ADSs, Ordinary Shares and/or Related Securities, engage in any Swap or engage in any other activities restricted under this letter agreement except in accordance with this letter agreement (as if such transferee had been an original signatory hereto):
(a) any exercise of options or vesting or exercise of any other equity-based award and the settlement thereof, in each case, outstanding on the public offering date, and in each case under the Company’s equity incentive plan or any other plan or agreement described in the prospectus included in the registration statement filed pursuant to the Offering, provided that any Lock-up Securities received upon such exercise or vesting will also be subject to this Lock-Up Agreement, provided further, that if required, any public report or filing shall clearly indicate in the footnotes thereto that the filing relates to the exercise of a stock option or other equity-based award and that no ADSs or Ordinary Shares were sold by the reporting person;
(b) the disposition of Lock-up Securities, or withholding of Lock-up Securities by the Company, in a transaction exempt from Section 16(b) of the Exchange Act, solely to the extent required for the payment of taxes due with respect to the settlement of Lock-up Securities described in clause (a), provided that any underlying equity securities of the Company shall continue to be subject to this Lock-Up Agreement, provided further, that if required, any public report or filing shall clearly indicate in the footnotes thereto that such transfer is being made pursuant to the circumstances described in this clause (b);
(c) transfers of Lock-Up Securities acquired in the open market after completion of the Offering, provided that no public disclosure or filing under the Exchange Act (other than filings under Section 13 of the Exchange Act) by any party to the transfer shall be required, or made voluntarily, during the Lock-up Period;
(d) pursuant to a bona fide third-party tender offer, merger, consolidation or other similar transaction approved or recommended by the Company’s board of directors, made to all holders of Lock-Up Securities involving a Change of Control of the Company, provided that in the event that such tender offer, merger, consolidation or other such transaction is not completed, the Lock-Up Securities owned by the undersigned shall remain subject to the provisions of this Lockup Agreement;
A-2
(e) pursuant to an order of a court of competent jurisdiction in connection with a divorce settlement, provided that the undersigned shall use its commercially reasonable efforts to cause the transferee to agree in writing to be bound by the terms of this Lock-up Agreement prior to such transfer, provided further that any filings required to be made pursuant to Section 16 of the Exchange Act will indicate by footnote disclosure or otherwise the nature of the transaction;(f) if the undersigned is an individual, the transfer of Lock-up Securities by gift, or by will or intestate succession to a Family Member or to a trust whose beneficiaries consist exclusively of one or more of the undersigned and/or a Family Member;
(g) if the undersigned is a partnership, limited liability company or a corporation, transfers to its limited partners, members or stockholders as part of a distribution or to any corporation, partnership or other entity that is an affiliate;
(h) transfers for bona fide tax planning purposes;
(i) transfers to the undersigned’s affiliates or to any investment fund or other entity controlled or managed by the undersigned;
(j) if the undersigned is an individual, transfers to the undersigned’s employer, if required by the terms of such individual’s employment or termination thereof, to the extent applicable; or
(k) any transfer of Lock-up Securities to a Family Member trust, Family Member limited partnership or Family Member limited liability company for the direct or indirect benefit of the undersigned or his or her Family Members; provided that (1) the transferee agrees to be bound in writing by the terms of this Lock-Up Agreement prior to such transfer, (2) such transfer shall not involve a disposition for value and (3) no filing by any party (donor, donee, transferor or transferee) under the Exchange Act shall be required or shall be voluntarily made in connection with such transfer (other than a filing on a Form 5 made after the expiration of the Lock-Up Period).The undersigned acknowledges and agrees that written notice by the Representatives delivered to the Company, if by postage mail, to: 2028 E Ben White Blvd, suite 240 #6167, Austin, Texas 78741and if by electronic mail, to: alex@argoblockchain.com, with a copy to steven@argoblockchain.com,of any extension to the 90-day Lock-up Period will be deemed to have been given to, and received by, the undersigned.
If the undersigned is an officer or director of the Company, the undersigned further agrees that the foregoing provisions shall be equally applicable to any Company-directed ADSs the undersigned may purchase or otherwise receive in the Offering, including any ADSs received pursuant to a directed share program.
In addition, if the undersigned is an officer or director of the Company, (i) the Representatives agree that, at least three business days before the effective date of any release or waiver of the foregoing restrictions in connection with a transfer of ADSs, the Representatives will notify the Company of the impending release or waiver, and (ii) the Company (in accordance with the provisions of the Underwriting Agreement) will announce the impending release or waiver (A) by press release through a major news service at least two business days before the effective date of the release or waiver or (B) any other method reasonably acceptable to the Representatives that satisfies the obligations described in Financial Industry Regulatory Authority, Inc. Rule 5131(d)(2). Any release or waiver granted by the Representatives hereunder to any such officer or director shall only be effective two business days after the publication date of such press release. The provisions of this paragraph will not apply if both (a) the release or waiver is effected solely to permit a transfer not for consideration and (b) the transferee has agreed in writing to be bound by the same terms described in this Lock-Up Agreement that are applicable to the transferor to the extent and for the duration that such terms remain in effect at the time of the transfer.
A-3
Nothing herein shall prevent the undersigned from establishing a 10b5-1 trading plan that complies with Rule 10b5-1 under the Exchange Act (“10b5-1 trading plan”) so long as there are no sales of Lock-up Securities under such plans during the Lock-Up Period; and provided that the establishment of a 10b5-1 trading plan or the amendment of a 10b5-1 trading plan shall only be permitted if (i) the establishment of such plan is not required to be reported in any public report or filing with the SEC, or otherwise and (ii) the undersigned does not otherwise voluntarily effect any public filing or report regarding the establishment of such plan during the Lock-Up Period.
The undersigned also agrees and consents to the entry of stop transfer instructions with the Company’s transfer agent and registrar against the transfer of the Lock-up Securities held by the undersigned and the undersigned’s Family Members, if any, except in compliance with the foregoing restrictions.
With respect to the Offering only, the undersigned waives any registration rights relating to registration under the Securities Act of the offer and sale of any ADSs, Ordinary Shares and/or any Related Securities owned either of record or beneficially by the undersigned, including any rights to receive notice of the Offering.The undersigned confirms that the undersigned has not, and has no knowledge that any Family Member has, directly or indirectly, taken any action designed to or that might reasonably be expected to cause or result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale of the ADSs. The undersigned will not, and will cause any Family Member not to take, directly or indirectly, any such action.
The occurrence of the Offering as currently contemplated or at all depends on market conditions as well as other factors. The Offering will only be made pursuant to the Underwriting Agreement, the terms of which are subject to negotiation between the Company and the underwriters.
This Lock-Up Agreement and related restrictions shall automatically terminate and become null and void upon the earliest to occur, if any, of (i) the Representatives, on behalf of the Underwriters, on the one hand, or the Company on the other hand, advising the other in writing that they have or it has determined not to proceed with the Offering, (ii) the registration statement filed pursuant to the Offering is withdrawn, (iii) the termination of the Underwriting Agreement (other than the provisions thereof which survive termination) prior to the initial closing date of the sale of the Lock-up Securities to be sold thereunder or (iv) November 1, 2021, in the event that the Underwriting Agreement has not been executed by such date (provided, that the Company may by written notice to the undersigned prior to such date extend such date for a period of up to an additional six months). The undersigned hereby represents and warrants that the undersigned has full power, capacity and authority to enter into this Lock-Up Agreement. This Lock-Up Agreement is irrevocable and will be binding on the undersigned and the successors, heirs, personal representatives and assigns of the undersigned.
This Lock-Up Agreement shall be governed by, and construed in accordance with, the laws of the State of New York.
A-4
Name of Entity (as applicable)
Signature
Printed Name of Person Signing
(Indicate capacity of person signing if
signing as custodian or trustee, or on behalf
of an entity)
A-5
Certain Defined Terms
Used in Lock-up Agreement
For purposes of the Lock-Up Agreement to which this Annex A is attached and of which it is made a part:
l | “Call Equivalent Position” shall have the meaning set forth in Rule 16a-1(b) under the Exchange Act. |
l | “Change of Control” shall mean the consummation of any bona fide third party tender offer, merger, consolidation or other similar transaction the result of which is that any “person” (as defined in Section 13(d)(3) of the Exchange Act), or group of persons, becomes the beneficial owner (as defined in Rules 13d-3 and 13d-5 of the Exchange Act) of more than 90% of total voting power of the voting stock of the Company. |
l | “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended. |
l | “Family Member” shall mean the spouse of the undersigned, an immediate family member of the undersigned, whether through marriage, domestic partnership or adoption, or an immediate family member of the undersigned’s spouse, whether through marriage, domestic partnership or adoption.,. |
l | “Immediate family member” as used above shall have the meaning set forth in Rule 16a-1(e) under the Exchange Act. |
l | “Lock-up Period” shall mean the period beginning on the date hereof and continuing through the close of trading on the date that is 90 days after the date of the Final Prospectus used to sell the ADSs (as defined in the Underwriting Agreement). |
l | “Put Equivalent Position” shall have the meaning set forth in Rule 16a-1(h) under the Exchange Act. |
l | “Related Securities” shall mean any options or warrants or other rights to acquire ADSs or Ordinary Shares or any securities exchangeable or exercisable for or convertible into ADSs or Ordinary Shares, or to acquire other securities or rights ultimately exchangeable or exercisable for or convertible into ADSs or Ordinary Shares. |
l | “Securities Act” shall mean the Securities Act of 1933, as amended. |
l | “Sell or Offer to Sell” shall mean to: |
o | sell, offer to sell, contract to sell or lend, |
o | effect any short sale or establish or increase a Put Equivalent Position or liquidate or decrease any Call Equivalent Position |
o | pledge, hypothecate or grant any security interest in, or |
o | in any other way transfer or dispose of, |
in each case whether effected directly or indirectly.
A-6
l | “Swap” shall mean any swap, hedge or similar arrangement or agreement that transfers, in whole or in part, the economic risk of ownership of ADSs, Ordinary Shares or Related Securities, regardless of whether any such transaction is to be settled in securities, in cash or otherwise. |
Capitalized terms not defined in this Annex A shall have the meanings given to them in the body of this Lock-up Agreement.
A-7
Exhibit B
Directors, Officers and Others
Signing Lock-up Agreement
Alex Appleton
Sebastien Chalus
Jean Esquier
Sarah Gow
Inderpreet Hothi
Justin Nolan
Maria Perrella
Matthew Shaw
Colleen Sullivan
Peter Wall
Davis Zaffpe
B-1
Exhibit 3.2
ARTICLES OF ASSOCIATION
of Argo Blockchain plc
Public company limited by shares
Incorporated in England and Wales on 5 December 2017
(Adopted under the Companies Act 2006 by special resolution passed on 6 September 2021
Fladgate LLP | 16 Great Queen Street | London WC2B 5DG
T +44 (0)20 3036 7000 | F +44 (0)20 3036 7600 | DX 37971 Kingsway | www.fladgate.com
Contents
1. | Exclusion of Model Articles and other prescribed regulations | 1 |
2. | Interpretation | 1 |
3. | Limited liability | 4 |
4. | Change of name | 4 |
5. | Share capital and variation of rights | 4 |
6. | Certificates and Uncertificated Shares | 5 |
7. | Lien | 8 |
8. | Calls on shares | 8 |
9. | Forfeiture of shares | 9 |
10. | Transfer of shares | 10 |
11. | Transmission of shares | 11 |
12. | Disclosure of interests in shares | 12 |
13. | Approved depositaries | 14 |
14. | New shares | 16 |
15. | Alteration of capital | 16 |
16. | Convening and format of general meetings | 17 |
17. | Procedure where meetings held at more than one place | 18 |
18. | Notice of general meetings | 19 |
19. | Proceedings at general meetings | 20 |
20. | Votes of Members | 21 |
21. | Corporations acting by representatives | 24 |
22. | Directors | 24 |
23. | Alternate Directors | 24 |
24. | Powers and duties of Directors | 25 |
25. | Delegation of Directors’ powers and duties | 26 |
26 | Borrowing powers | 26 |
27. | Appointment and retirement of Directors | 27 |
28. | Disqualification and removal of Directors | 28 |
29. | Executive and other Directors | 29 |
30. | Remuneration of Directors | 29 |
31. | Directors’ expenses | 30 |
32. | Directors’ interests | 30 |
33. | Conflicts of interest requiring Board authorisation | 32 |
34. | Proceedings of Directors | 33 |
35. | Secretary | 35 |
36. | Minutes | 35 |
37. | Seal and authentication of documents | 35 |
38. | Dividends | 36 |
39. | Reserves | 39 |
40. | Capitalisation of profits | 40 |
41. | Accounts | 41 |
42. | Record dates | 41 |
43. | Audit | 41 |
44. | Notices | 42 |
45. | Untraced Members | 44 |
46. | Destruction of documents | 45 |
47. | Winding-up | 46 |
48. | Indemnity | 46 |
49. | Indemnity against claims in respect of shares | 46 |
50. | Exclusive jurisdiction | 47 |
Company no. 11097258
The Companies Act 2006
Public company limited by shares
New Articles of association
of
Argo Blockchain plc (Company)
(Adopted by special resolution
passed on ____6 September____ 2021
1. | Exclusion of Model Articles and other prescribed regulations |
No regulations or articles set out in any statute, or in any statutory instrument or other subordinate legislation made under any statute, concerning companies (including the regulations in the Companies (Model Articles) Regulations 2008 (SI 2008/3229) will apply as the articles of the Company. The following will be the articles of association of the Company.
2. | Interpretation |
2.1 | In these articles of association, the following words and expressions have the following meanings if not inconsistent with the subject or context: |
Approved Depositary | a custodian or some other person appointed in writing by the Directors whereby such person holds or is interested in ordinary shares and issues securities or other documents of title, including depositary receipts, evidencing the entitlement of the holder thereof to receive such shares, provided and to the extent that the terms and conditions of the custodian or other person acting as such have been approved by the Directors for the purpose of these Articles | |
Articles | these articles of association as amended from time to time | |
Auditors | the auditors of the Company from time to time. | |
Board | the board of Directors present at a duly convened and quorate meeting or Directors at a duly authorised committee of Directors as the context requires. | |
CA 2006 | the Companies Act 2006 as amended or re-enacted from time to time. | |
Certificated Share | a share in the capital of the Company that is not an Uncertificated Share and references in these Articles to a share being held in certificated form will be construed accordingly. |
1 |
Clear Days | in relation to a period of notice, means that period excluding the day when the notice is served or deemed to be served and the day for which it is given or on which it is to take effect. | |
Default Shares | as defined in article 12.1. | |
Depository Shares | ordinary shares which are registered from time to time in the name of the Approved Depositary or its nominee | |
Director | a director from time to time of the Company. | |
Dividend | a dividend or bonus. | |
Electronic Address | any address or number used for the purposes of Electronic Communication. | |
Electronic Communication | as defined in section 15(1) of the Electronic Communications Act 2000. | |
Electronic Form | has the meaning given in section 1168 CA 2006. | |
Exchange Act | the Securities Exchange Act of 1934. | |
Executed | any mode of execution including signed, sealed or authenticated in some other way. | |
Holder | in relation to shares, a Member whose name is entered in the Register as the Holder of those shares. | |
Listing Rules | the Listing Rules of the UK Listing Authority. | |
London Stock Exchange | the London Stock Exchange plc or any successor body carrying on its functions. | |
Member | any Holder for the time being of shares in the capital of the Company of whatever class. | |
Nasdaq | the Nasdaq Stock Market. | |
Office | the registered office for the time being and from time to time of the Company. | |
Operator | as defined in Regulation 3 of the Regulations. | |
Paid Up | includes credited as paid up. | |
Principal Place | the place specified in the notice of any general meeting of the Company at which the chairman of the meeting will preside. |
2 |
Register | the register of Members to be kept pursuant to section 113 CA 2006 and includes, if relevant, and so long as the Regulations require, a related Operator register of Members maintained under Regulation 20(1)(b) of the Regulations. | |
Regulations | the Uncertificated Securities Regulations 2001 (SI 2001 no. 3755) including any modification of them or any regulations in substitution for them for the time being in force. | |
Relevant Class | a class of share which is, for the time being, a participating security for the purposes of, and subject to, the Regulations. | |
Secretary | the secretary of the Company and, subject to the provisions of the Statutes, includes an assistant or deputy secretary and any person appointed by the Directors to perform any of the duties of the secretary. | |
Section 793 Notice | a notice served by the Company under section 793 CA 2006. | |
Securities Act | the Securities Act of 1933. | |
Statutes | CA 2006, the Regulations, the Electronic Communications Act 2000 and all other statutes and secondary legislation for the time being in force relating to companies to the extent that they apply to the Company. | |
Uncertificated Share | (subject to Regulation 42(11)(a) of the Regulations), a share in the capital of the Company title to which is recorded on the Operator register of Members of the Company and which may, by virtue of the Regulations, be transferred by means of a relevant system and references in these Articles to a share being held in uncertificated form will be construed accordingly. | |
United Kingdom | Great Britain and Northern Ireland. | |
UK Listing Authority | means the Financial Conduct Authority in its capacity as competent authority for the purposes of part VI Financial Services and Markets Act 2000. |
2.2 | Where the context so requires, words denoting the singular include the plural and vice versa, words denoting the masculine gender include the feminine, and persons include corporations, partnerships, other incorporated bodies and all other legal entities, with the necessary adaptation. |
3 |
2.3 | Words and expressions defined in CA 2006 and in the Regulations have the same meanings in these Articles, unless the context otherwise requires. |
2.4 | Where these Articles refer to a relevant system in relation to any share, the reference is to the system in which that share is a participating security at the relevant time. |
2.5 | Any reference to a provision of any statute, statutory instrument, note, order or regulation is construed as a reference to such provision as amended, modified, consolidated or re-enacted from time to time. |
2.6 | References in these Articles to a share being in uncertificated form are references to that share being an uncertificated unit of a security. |
2.7 | References to writing and written include references to a method of representing words in a legible and non transitory form, whether sent or supplied in electronic form or otherwise. |
2.8 | The headings are inserted for convenience and do not affect the construction of these Articles. |
3. | Limited liability |
The liability of the Members is limited to the amount, if any, unpaid on the shares in the Company held by them.
4. | Change of name |
The Company may change its name by resolution of the Board.
5. | Share capital and variation of rights |
5.1 | Subject to the Statutes and without prejudice to any rights for the time being conferred on the Holders of any shares or class of shares, any share in the Company may be allotted with such preferred, deferred or other rights, or such restrictions, whether in regard to Dividend, return of capital, voting or otherwise, as the Company may from time to time by ordinary resolution determine or, if no such determination be made, as the Board determines. |
5.2 | Subject to the provisions of CA 2006 and to the authority of the Company in general meeting, the Board has unconditional authority to allot, grant options over, issue warrants in respect of, offer or otherwise deal with or dispose of any shares of the Company to such persons, at such times and generally on such terms and conditions as they may determine. |
5.3 | The Company may issue shares which are to be redeemed or are liable to be redeemed at the option of the Company or the Holders of those shares. |
5.4 | Subject to the provisions of the Statutes and to the authority of the Company in general meeting, the Company has power to purchase its own shares, including any redeemable shares. |
5.5 | When any shares are to be issued, the Board may vary the amount of calls to be paid and the time of payment of such calls as between the allottees of such shares. |
5.6 | If by the conditions of allotment of any share the whole or part of its issue price is payable by instalments, every such instalment will, when due, be paid to the Company by the person who for the time being is the registered Holder of the share. |
4 |
5.7 | In addition to all other powers of paying commissions, the Company may exercise the powers conferred by the Statutes of paying commissions to persons subscribing or procuring subscriptions for shares of the Company, or agreeing so to do, whether absolutely or conditionally. Subject to the provisions of the Statutes and to the rules of the UK Listing Authority, any such commissions may be satisfied by the payment of cash or, with the sanction of an ordinary resolution, by the allotment of fully or partly Paid Up shares of the Company or by any such combination. The Company may also, on any issue of shares, pay such brokerage as may be lawful. |
5.8 | Except as required by law, no person will be recognised by the Company as holding any share upon any trust, and except only as otherwise provided by these Articles or as required by law or under an order of a court of competent jurisdiction, the Company will not be bound by or recognise any equitable, contingent, future or partial interest in any share, or any interest in any fraction or part of a share, or any other right in respect of any share, except an absolute right to the entirety of it in the registered Holder. |
5.9 | Subject to the Statutes, if at any time the capital of the Company is divided into different classes of shares, all or any of the rights or privileges attached to any class may be varied or abrogated either in such manner, if any, as may be provided by such rights, or in the absence of any such provision, with the consent in writing of the Holders of at least three fourths of the nominal value of the issued shares of that class (excluding any shares of that class held as treasury shares), or with the sanction of a special resolution passed at a separate meeting of the Holders of the shares of that class, but not otherwise. |
5.10 | All the provisions of these Articles relating to general meetings of the Company, or to the proceedings at them, and the provisions of sections 284, 307 and 310 CA 2006 apply to every such separate meeting referred to in article 5.9, with any necessary modifications, except that the necessary quorum at any such meeting other than an adjourned meeting will be two or more persons present holding or representing by proxy at least one third in nominal value of the issued shares of the class in question (excluding any shares of that class held as treasury shares). The quorum at an adjourned meeting will be one person holding shares of the class in question or his proxy. Any Holder of shares of the class in question present in person or by proxy may demand a poll. |
5.11 | The creation or issue of shares ranking equally with or subsequent to the shares of any class will not, unless otherwise expressly provided by these Articles or the rights attached to such shares as a class, be deemed to be a variation of the rights of such shares. |
6. | Certificates and Uncertificated Shares |
6.1 | Subject to articles 6.7 to 6.9, every person, other than a person in respect of whom the Company is not required by law to complete and have ready for delivery a certificate by virtue of section 778 CA 2006 whose name is entered as a Member in the Register is entitled, without payment, to one certificate for all the shares of each class for the time being held by him or, upon payment of such reasonable out-of-pocket expenses as the Board may from time to time determine for every certificate after the first, to several certificates, each for one or more of his shares. |
6.2 | Every certificate will: |
6.2.1 | be issued within two months after allotment or the lodgement with the Company of the transfer of the shares, not being a transfer which the Company is for any reason entitled to refuse to register and does not register, unless the conditions of issue of such shares otherwise provide or except as exempted by virtue of section 778 CA 2006; |
5 |
6.2.2 | be issued by affixing the official seal kept by the Company by virtue of section 50 CA 2006 to, or printing the seal or a representation of it on the certificate or signed by at least two Directors or by at least one Director and the Secretary. The Directors may by resolution decide, either generally or in any particular case or cases, that the signatures on any share certificates need not be autographic but may be applied to the certificates by some mechanical or other means, or may be printed on them, or that the certificates need not be signed by any person; and |
6.2.3 | specify the number and class and distinguishing numbers, if any, of the shares to which it relates, and the amount Paid Up on them. |
6.3 | The Company is not bound to register more than four persons as the joint Holders of any share or shares, except in the case of executors or trustees of a deceased Member. In the case of a share held jointly by several persons, the Company is not bound to issue more than one certificate for it. Delivery of a certificate for a share to one of several joint Holders will be sufficient delivery to all. |
6.4 | Subject to articles 6.7 to 6.10, where a Member transfers part of his holding of shares, he will be entitled to a certificate for the balance of his holding without charge. |
6.5 | Subject to articles 6.7 to 6.10, if a share certificate is lost, destroyed, defaced or worn out, it will be renewed and, in case of loss or destruction, on such terms, if any, as to evidence and indemnity as the Board thinks fit, and, in case of defacement or wearing out, on delivery to the Company of the old certificate. |
6.6 | The Company will not make any charge for any certificate issued under article 6.5 but will be entitled to charge for any exceptional out of pocket expenses it incurred relating to the issue of any new certificate. |
6.7 | The Board has power to implement whatever arrangements it, in its absolute discretion, sees fit in order for any class of shares to be a participating security for the purposes of, and subject always to, the Regulations and the facilities and requirements of the relevant system concerned. Where the Board does so, articles 6.8 and 6.9 will take effect immediately prior to the time at which the Operator of the relevant system concerned permits the class of shares concerned to be a participating security. |
6.8 | In relation to any class of shares which is a participating security, and as long as that class remains a participating security, no provision of these Articles will apply or have effect to the extent that it is in any respect inconsistent with: |
6.8.1 | the holding of that class in uncertificated form; |
6.8.2 | the transfer of title to shares of that class by means of a relevant system; or |
6.8.3 | the Regulations. |
6.9 | Without prejudice to the generality of article 6.8 and notwithstanding anything contained in these Articles, where any class of share is, for the time being, a participating security: |
6.9.1 | the Register relating to the Relevant Class will be maintained at all times in the United Kingdom; |
6 |
6.9.2 | shares of the Relevant Class may be issued in uncertificated form in accordance with, and subject to, the Regulations; |
6.9.3 | unless the Board decides otherwise, shares of the Relevant Class held by the same Holder or joint Holder in certificated and uncertificated form will be treated as separate holdings; |
6.9.4 | shares of the Relevant Class may be changed from uncertificated to certificated form and vice versa, in accordance with and subject to the Regulations; |
6.9.5 | title to shares of the Relevant Class which are recorded on the Register as being held in uncertificated form may be transferred by means of the relevant system concerned and accordingly, and in particular, articles 6.1 to 6.8 and article 10 will not apply to those shares to the extent that those articles require or contemplate transfer by an instrument in writing and the production of a certificate for the shares to be transferred; |
6.9.6 | the Company will comply with the provisions of Regulations 20 and 22 in relation to the Relevant Class and article 6.7, in particular, will be read as subject to Regulation 22; |
6.9.7 | the provisions of these Articles relating to meetings of or including Holders of the Relevant Class, including notices of such meetings, will be subject to Regulation 34; and |
6.9.8 | articles 6.1 to 6.8 will not apply so as to require the Company to issue a certificate to any person holding shares of the Relevant Class in uncertificated form. |
6.10 | Where any class of shares is a participating security and the Company is entitled under the Statutes or these Articles to sell, transfer, dispose of, forfeit, re-allot, accept the surrender of or otherwise enforce a lien over a share held in uncertificated form, the Company may, subject to the Statutes and these Articles and the facilities and requirements of the relevant system: |
6.10.1 | require the Holder of that Uncertificated Share by notice to change that share into certificated form within the period specified in the notice and to hold that share in certificated form so long as required by the Company; |
6.10.2 | require the Holder of that Uncertificated Share by notice to give any instructions necessary to transfer title to that share by means of the relevant system within the period specified in the notice; |
6.10.3 | require the Holder of that Uncertificated Share by notice to appoint any person to take any step including, without limitation, the giving of any instructions by means of the relevant system necessary to transfer that share within the period specified in the notice; |
6.10.4 | take any action that the Board considers appropriate to achieve the sale, transfer, disposal of, forfeiture, re-allotment or surrender of that share or otherwise to enforce a lien in respect of it; and |
6.10.5 | assume that the entries on any record of securities maintained by it in accordance with the Regulations and regularly reconciled with the relevant Operator register of securities are a complete and accurate reproduction of the particulars entered in the Operator register of securities. Accordingly the Company will not be liable in respect of any act or thing done or omitted to be done by or on behalf of it in reliance upon such assumption. Any provision of these Articles which requires or envisages that action will be taken in reliance on information contained in the Register will be construed to permit that action to be taken in reliance on information contained in any relevant record of securities (as so maintained and reconciled). |
7 |
7. | Lien |
7.1 | The Company has a first and paramount lien on every share, which is not a fully paid share, for all money, whether presently payable or not, called or payable at a fixed time in respect of such share. The Company’s lien, if any, on a share extends to all Dividends or other money payable on it or in respect of it. The Board may resolve that any share will be exempt from the provisions of this article 7.1 for some specified period. |
7.2 | For the purpose of enforcing such lien, the Company may sell, in such manner as the Board thinks fit, any share on which the Company has a lien, but no sale will be made unless some money in respect of which the lien exists are presently payable and 14 Clear Days have expired after a notice in writing, stating and demanding payment of the money presently payable and including notice of intention to sell in default, has been served on the Holder for the time being of the shares or the person entitled by reason of his death or bankruptcy to the shares. |
7.3 | The net proceeds of any such sale will be applied in or towards payment or satisfaction of the amount in respect of which the lien exists as is presently payable and any residue will, subject to a like lien in respect of sums not presently payable as existed upon the shares prior to the sale, be paid to the person entitled to the shares immediately prior to the sale. |
7.4 | For giving effect to any such sale, the Board may authorise some person to transfer the shares sold to their purchaser. |
7.5 | The purchaser will be registered as the Holder of the shares so transferred and he will not be bound to see to the application of the purchase money, nor will his title to the shares be affected by any irregularity or invalidity in the proceedings in reference to the sale. |
8. | Calls on shares |
8.1 | The Board may, subject to the provisions of these Articles and to any conditions of allotment, from time to time make calls upon the Members in respect of any money unpaid on their shares, whether on account of the nominal value of the shares or by way of premium. Each Member will, subject to being given at least 14 Clear Days’ notice specifying the time or times and place of payment, pay to the Company at the time or times and place so specified the amount called on his shares. |
8.2 | A call may be payable by instalments and may be postponed or wholly revoked or in part revoked, as the Board may determine. |
8.3 | A call will be deemed to have been made at the time when the resolution of the Board authorising the call was passed. |
8.4 | The joint Holders of a share are jointly and severally liable to pay all calls in respect of it and any one of such persons may give effective receipts for any return of capital payable in respect of such shares. |
8.5 | If by the terms of any admission document, prospectus, listing particulars or any other document relating to an issue of shares in the Company or by the conditions of allotment, any amount is payable in respect of any shares by instalments, every such instalment will be payable as if it were a call duly made by the Board of which due notice had been given. |
8 |
8.6 | If a sum called in respect of a share is not paid before or on the day appointed for its payment, the person from whom the sum is due must pay interest on the sum at such rate as may be fixed by the terms of allotment of the share or, if no rate is fixed, at the appropriate rate, as defined by section 592 CA 2006, from the day appointed for its payment to the time of actual payment. The Board is at liberty to waive payment of such interest wholly or in part. |
8.7 | Any sum which by or pursuant to the terms of issue of a share becomes payable upon allotment or at any fixed date, whether on account of the amount of the share or by way of premium, will for all the purposes of these Articles be deemed to be a call duly made and payable on the date on which, by or pursuant to the terms of issue, it becomes payable. In case of non payment, all the relevant provisions of these Articles as to payment of interest, forfeiture or otherwise apply as if such sum had become payable by virtue of a call duly made and notified. |
8.8 | The Board may make arrangements on the issue of shares for a difference between the Holders in the amount of calls to be paid and in the times of payment. |
8.9 | The Board may receive from any Member willing to advance it all or any part of the money unpaid upon the shares held by him, beyond the sums actually called up on them, as a payment in advance of calls, and such payment in advance of calls will extinguish, so far as they extend, the liability upon the shares in respect of which it is advanced. The Company may pay interest upon the money so received, or so much of it as from time to time exceeds the amount of the calls then made upon the shares in respect of which it has been received, at such rate as the Members paying such sum and the Board agree. Any such payment in advance will not entitle the Holder of the shares in question to participate in any Dividend in respect of the amount advanced. |
9. | Forfeiture of shares |
9.1 | If a Member fails to pay any call or instalment of a call before or on the date appointed for its payment the Board may, at any time after that date, serve a notice on him requiring payment of so much of the call or instalment as is unpaid, together with any interest which may have accrued on it and all expenses incurred by the Company by reason of such non payment. |
9.2 | The notice will name a further date, not earlier than 14 Clear Days from the date of its service, on or before which, and the place where, the payment required by the notice is to be made, and will state that, in the event of non payment on or before the date, and at the place appointed, the shares on which the call was made will be liable to be forfeited. |
9.3 | If the requirements of any such notice are not complied with, any share in respect of which it has been given may at any time before payment of all calls, interest and expenses due in respect of it has been made, be forfeited by a resolution of the Board. Such forfeiture will include all Dividends which have been declared on the forfeited shares and not actually paid before the forfeiture. |
9.4 | When any share has been forfeited, notice of the forfeiture will be served upon the person who was before forfeiture the Holder of it, but no forfeiture will be in any manner invalidated by any omission to give such notice. Subject to the provisions of the Statutes, any share so forfeited will become the property of the Company, no voting rights may be exercised in respect of it and the Board may within three years of such forfeiture sell, re-allot, or otherwise dispose of it in such manner as they think fit, either to the person who was before the forfeiture its Holder, or to any other person, and either with or without any past or accruing Dividends, and in the case of re-allotment, with or without any money paid on it by the former Holder being credited as Paid Up on it. Any share not so disposed of within a period of three years from the date of its forfeiture will be cancelled in accordance with the provisions of the Statutes. |
9 |
9.5 | The Board may at any time, before any share so forfeited has been cancelled or sold, re-allotted or otherwise disposed of, annul the forfeiture upon such conditions as they think fit. |
9.6 | A person whose shares have been forfeited ceases to be a Member in respect of the forfeited shares and must, if the shares are Certificated Shares, surrender to the Company the certificate for them. That person remains liable to pay to the Company all money which at the date of forfeiture was payable by him to the Company in respect of the shares and interest on them in accordance with article 8.6, and the Board may enforce payment without any allowance for the value of the shares at the time of forfeiture. |
9.7 | A statutory declaration by a Director or the Secretary that a share has been duly forfeited on a date stated in the declaration is conclusive evidence of the facts stated in it as against all persons claiming to be entitled to the share. Such declaration and the receipt by the Company of the consideration, if any, given for the share on its sale, re-allotment or disposal, together with the certificate, if any, for the share delivered to a purchaser or allottee of it, subject to the execution of a transfer if so required, constitutes a good title to the share. Where a forfeited share held in uncertificated form is to be transferred to any person, the Board may exercise any of the Company’s powers under article 6.10 to effect the transfer of the share to that person. The Company may receive any consideration for the share on its disposal. The person to whom the share is sold, re-allotted or disposed of will be registered as its Holder and will not be bound to see to the application of any consideration, nor will his title to the share be affected by any irregularity or invalidity in the proceedings in reference to the forfeiture, sale, re-allotment or disposal of the share. |
9.8 | The Board may accept the surrender of any share liable to be forfeited under these Articles and in any such case any reference in these Articles to forfeiture includes surrender. |
10. | Transfer of shares |
10.1 | Subject to articles 6.7 to 6.9, any Member may transfer any of his Certificated Shares by instrument of transfer in any usual form or in such other form as the Board approves. The instrument must be Executed by or on behalf of the transferor and (except in the case of a share which is fully Paid Up) by or on behalf of the transferee but need not be under seal. The transferor is deemed to remain the Holder of the share until the name of the transferee is entered in the Register in respect of it. Transfers of shares in uncertificated form will be effected by means of the relevant system in accordance with the Statutes and these Articles. |
10.2 | Subject to article 6, the Board may refuse to register a transfer of a Certificated Share unless the instrument of transfer: |
10.2.1 | is in respect of only one class of shares; |
10.2.2 | is in favour of not more than four joint transferees; |
10.2.3 | is duly stamped (if required); and |
10 |
10.2.4 | is lodged at the Office or such other place as the Board may decide accompanied by the certificate for the shares to which it relates (except in the case of a transfer by a recognised person to whom no certificate was issued) and such other evidence (if any) as the Board may reasonably require to prove the title of the transferor and the due execution by him of the transfer or, if the transfer is Executed by some other person on his behalf, the authority of that person to do so. |
10.3 | The Board may in its absolute discretion and without giving any reasons, refuse to register any transfer of a Certificated Share which is not fully Paid Up, but this discretion may not be exercised in such a way as to prevent dealings in the shares from taking place on an open and proper basis. |
10.4 | The Board may, in circumstances permitted by the London Stock Exchange, disapprove the transfer of a Certificated Share if the exercise of such power does not disturb the market in the shares. |
10.5 | The Board may refuse to register the transfer of an Uncertificated Share in any circumstances permitted by the London Stock Exchange, the Regulations and the rules and practices of the Operator of the relevant system if the exercise of such power does not disturb the market in the shares. |
10.6 | The Board shall not refuse to register any transfer or renunciation of partly paid shares which are admitted to, or for which Depository Shares are admitted to, Nasdaq on the grounds that they are partly paid shares in circumstances where such refusal would prevent dealings in such shares from taking place on an open and proper basis. |
10.7 | If the Board refuses to register a transfer of any share it must serve on the transferee a notice of such refusal within whichever of the following periods is the earlier: |
10.7.1 | the time required by the Listing Rules or the London Stock Exchange; and |
10.7.2 | two months after the date on which the transfer was lodged with the Company or the Operator instruction was received, as the case may be. |
10.8 | No fee will be charged for the registration of a transfer or other document relating to or affecting the title to any share or for making any entry in the Register affecting the title to any share. |
10.9 | Subject to article 46, all instruments of transfer which are registered may be retained by the Company but any instrument of transfer which the Board refuses to register will (except in the case of suspected fraud) be returned to the person depositing it when notice of the refusal is given. |
11. | Transmission of shares |
11.1 | If a Member dies, the survivors or survivor (where the deceased was a joint Holder) and the executors or administrators of the deceased (where he was a sole or only surviving Holder) are the only persons recognised by the Company as having any title to his interest in the shares. Nothing in this article will release the estate of a deceased joint Holder from any liability in respect of any share jointly held by him. |
11.2 | Except as provided in these Articles, any person becoming entitled to a share in consequence of the death or bankruptcy of a Member may, upon producing such evidence as to his title as may be required by the Board, elect either to be registered himself as the Holder of the share or to have some person nominated by him registered as its Holder. |
11 |
11.3 | If the person becoming entitled by transmission to a Certificated Share elects to be registered himself, he must deliver or send to the Company a notice in writing signed by him stating that he so elects. If he elects to have another person registered, and the share is a Certificated Share, he must signify his election by signing a transfer of the share in favour of that person. If the person elects to be registered or have another person registered, and the share is an Uncertificated Share, he must take any action as the Board may require including, without limitation, the execution of any document and the giving of any instruction by means of a relevant system to enable himself or that other person to be registered as the Holder of the share. All the limitations, restrictions and provisions of these Articles relating to the right to transfer and the registration of transfers of shares apply to any such notice or transfer as if the death or bankruptcy of the Member had not occurred and the notice or transfer were a transfer signed by such Member. |
11.4 | A person becoming entitled to a share in consequence of the death or bankruptcy of a Member will, upon supply to the Company of such evidence as the Board may reasonably require as to his title to the share, be entitled to receive and may give a discharge for all benefits arising or accruing on or in respect of the share, but he will not be entitled in respect of that share to receive notices of or to attend or vote at meetings of the Company, or, except as previously stated, to any of the rights or privileges of a Member until he has become a Member in respect of the share. The Board may at any time serve notice requiring any such person who is the Holder of a fully Paid Up share to elect either to be registered himself or to transfer the share and, if within 60 days the notice is not complied with, such person will be deemed to have elected to be registered as a Member in respect of the share and may be registered accordingly. |
12. | Disclosure of interests in shares |
12.1 | If a Member, or any other person appearing to be interested in shares held by that Member, has been issued with a notice under section 793 of CA 2006 (Section 793 Notice) and has failed in relation to any shares (Default Shares, which expression includes any shares issued after the date of such notice in right of those shares) to give the Company the information required by the Section 793 Notice within the prescribed period from the service of the notice, the following sanctions shall apply unless the Board determines otherwise: |
12.1.1 | the Member shall not be entitled in respect of the Default Shares to be present or to vote (either in person or by representative or proxy) at any general meeting or at any separate meeting of the holders of any class of shares or to exercise any other right conferred by membership in relation to any such meeting; and |
12.1.2 | where the Default Shares represent at least 0.25% in nominal value of the issued shares of their class (calculated exclusive of any shares held as treasury shares): |
12.1.2.1 | any dividend or other money payable for such shares shall be withheld by the Company, which shall not have any obligation to pay interest on it, and the Member shall not be entitled to elect, to receive shares instead of that dividend; and |
12 |
12.1.2.2 | no transfer, other than an excepted transfer, of any shares held by the Member shall be registered unless the Member himself or herself is not in default of supplying the required information and the Member proves to the satisfaction of the Board that no person in default of supplying such information is interested in any of the shares that are the subject of the transfer. |
12.1.3 | for the purposes of ensuring article 12.1.2.2 can apply to all shares held by the Member, the Company may in accordance with the uncertificated securities rules, issue a written notification to the Operator requiring conversion into certificated form of any share held by the Member in uncertificated form. |
12.2 | Where the sanctions under article 12.1 apply in relation to any shares, they shall cease to have effect (and any dividends withheld under article 12.1.2 shall become payable): |
12.2.1 | if the shares are transferred by means of an excepted transfer but only in respect of the shares transferred; or |
12.2.2 | at the end of the period of seven days (or such shorter period as the Board may determine) following receipt by the Company of the information required by the Section 793 Notice and the Board being fully satisfied that such information is full and complete. |
12.3 | Where, on the basis of information obtained from a Member in respect of any share held by him or her, the Company issues a Section 793 Notice to any other person, it shall at the same time send a copy of the notice to the Member, but the accidental omission to do so, or the non-receipt by the Member of the copy, shall not invalidate or otherwise affect the application of article 12.1. |
12.4 | For the purpose of this Articles: |
12.4.1 | a person, other than the Member holding a share, shall be treated as appearing to be interested in that share if the Member has informed the Company that the person is, or may be, so interested, or if the Company (after taking account of any information obtained from the Member or, pursuant to a Section 793 Notice, from anyone else) knows or has reasonable cause to believe that the person is, or may be, so interested; |
12.4.2 | interested shall be construed as it is for the purpose of section 793 of CA 2006; |
12.4.3 | reference to a person having failed to give the Company the information required by a notice, or being in default as regards supplying such information, includes reference: |
12.4.3.1 | to his, her or it having failed or refused to give all of any part of it; and |
12.4.3.2 | to his, her or it having given information which he or she knows to be false in a material particular or having recklessly given information which is false in a material particular; |
12.4.4 | prescribed period means fourteen days; |
13 |
12.4.5 | excepted transfer means, in relation to any shares held by a Member: |
12.4.5.1 | a transfer by way of or pursuant to acceptance of a takeover offer for the Company (within the meaning of section 974 of CA 2006); or |
12.4.5.2 | a transfer in consequence of a sale made through Nasdaq or any other recognised investment exchange (as defined in section 285 of the FSMA) or any other stock exchange on which the Company’s shares or Depositary Shares are normally traded; or |
12.4.5.3 | a transfer which is shown to the satisfaction of the Board to be made in consequence of a sale of the whole of the beneficial interest in the shares to a person who is unconnected with the Member and with any other person appearing to be interested in the shares. |
13. | Approved depositaries |
Maintenance of register by Approved Depositary
13.1 | An Approved Depositary shall maintain a register or system(s) (the “Proxy Register”) in which shall be recorded the aggregate number of ordinary shares which for the time being are registered in the name of the Approved Depositary or its nominee (the “Depositary Shares”) as well as the name and address of each person who is for the time being appointed as an Appointed Proxy pursuant to Article 13.2 below and, against his name and address, the number of Depositary Shares in respect of which that Appointed Proxy’s appointment for the time being subsists (his “Appointed Number”). The Proxy Register shall be open to inspection by any person authorised by the Company during usual business hours and the Approved Depositary shall furnish to the Company or its agents upon demand all such information as to the contents of the Proxy Register, or any part of it, as may be requested. |
Appointment of Approved Proxies
13.2 | Without prejudice to the right of an Approved Depositary or its nominee to exercise any rights conferred in these Articles, an Approved Depositary or its nominee may appoint as its proxy or proxies such person or persons as it thinks fit (each such person being an “Appointed Proxy”) and may determine the method by which and the terms upon which, such appointments are made, save that each such appointment shall specify the Appointed Number in respect of which that appointment is made and the aggregate Appointed Numbers of all the Appointed Proxies subsisting at any one time shall not exceed the aggregate number of Depositary Shares. |
Rights of Appointed Proxies
13.3 | Subject to the CA 2006 and any other provisions of law and subject to the provisions of this Article 13.3, and so long as the Depositary Shares shall be of a sufficient number so as to include his Appointed Number, an Appointed Proxy: |
13.3.1 | shall upon production to the Company at a general meeting of written evidence of his appointment (which shall be in such form as the Company and the Approved Depositary shall determine from time to time) be entitled to the same rights, and subject to the same restrictions, in relation to his Appointed Number as though the ordinary shares represented by the Appointed Number were registered in the name of the Approved Depositary (or its nominee) and the Appointed Proxy was a person validly appointed as proxy by the Approved Depositary (or its nominee); and |
14 |
13.3.2 | shall himself be entitled, by an Instrument of proxy duly signed by him and deposited with the Company in accordance with Article 59, to appoint another person as his proxy in relation to his Appointed Number so that the provisions of these paragraphs shall apply (mutatis mutandis) in relation to such an appointment as though the ordinary shares represented by the Appointed Number were registered in the name of the Appointed Proxy and the appointment by the Appointed Proxy was made. |
Notices to Appointed Proxies
13.4 | The Company may send an Appointed Proxy at his address as is shown in the Proxy Register all notices and other Documents which are sent to the Holders of ordinary shares. |
Payment of dividends to Appointed Proxies
13.5 | The Company may pay to an Appointed Proxy at his address as shown in the Proxy Register all dividends payable on the ordinary shares in respect of which he has been appointed as Appointed Proxy, and payment of any such dividend shall be a good discharge to the Company of its obligation to make payment to the Approved Depositary or its nominee in respect of the ordinary shares concerned. |
Determination of entitlement of Appointed Proxies
13.6 | For the purposes of determining which persons are entitled as Appointed Proxies: |
13.6.1 | to exercise the rights conferred by Article 13.3; |
13.6.2 | to receive notices and other Documents sent pursuant to Article 13.4; and |
13.6.3 | to be paid dividends pursuant to Article 13.5. |
and each Appointed Proxy’s Appointed Number, the Approved Depositary may determine that the Appointed Proxies who are so entitled shall be the persons entered in the Proxy Register at the close of business on a date (an “Appointed Proxy Record Date”) determined by the Approved Depositary in consultation with the Company.
13.7 | When an Appointed Proxy Record Date is determined for a particular purpose: |
13.7.1 | the number of Depositary Shares in respect of which a person entered in the Proxy Register as an Appointed Proxy is to be treated as having been appointed for that purpose shall be the number appearing against his name in the Proxy Register as at the close of business on the Appointed Proxy Record Date; and |
13.7.2 | changes to entities in the Proxy Register after the close of business on the Appointed Proxy Record Date shall be disregarded in determining the entitlement of any person for the purpose concerned. |
No interest in Shares
13.8 | Except as required by law, no Appointed Proxy shall be recognised by the Company as holding any interest in Shares upon any trust and subject to the recognition of the rights conferred in relation to general meetings by appointments made by Appointed Proxies pursuant to Article 13.3.2 the Company shall be entitled to treat any person entered in the Proxy Register as an Appointed Proxy as the only person (other than the Approved Depositary) who has any interest in the ordinary shares in respect of which the Appointed Proxy has been appointed. |
15 |
Questions as to validity to vote Depositary Shares
13.9 | If any question shall arise as to whether any particular person or persons has or have been validly appointed to vote (or exercise any other right) in respect of any Depositary Shares (whether by reason of the aggregate number of Shares in respect of which appointments are recorded in the Proxy Register exceeding the aggregate number of Depositary Shares or for any other reason) such question shall if arising at or in relation to a general meeting be determined by the Chairman of the Meeting (and if arising in any other circumstances shall be determined by the Directors) whose determination (which may include declining to recognise a particular appointment or appointments as valid) shall if made in good faith be conclusive and binding on all persons interested. |
14. | New shares |
All new shares are subject to the provisions of these Articles with reference to payment of calls, lien, forfeiture, transfer, transmission and otherwise. Unless otherwise provided by these Articles or by the conditions of issue, the new shares will upon issue be ordinary shares.
15. | Alteration of capital |
15.1 | The Company may by ordinary resolution: |
15.1.1 | consolidate and divide all or any of its share capital into shares of larger nominal value than its existing shares; and |
15.1.2 | subdivide its shares, or any of them, into shares of smaller nominal value, subject nevertheless to the Statutes, and so that the resolution by which any share is subdivided may determine that, as between the Holders of the shares resulting from such subdivision, one or more of the shares may have any such preferred or other special rights over or may have such deferred rights or be subject to any such restrictions as compared with the others as the Company has power to attach to new shares. |
15.2 | All shares created in accordance with article 15.1.1 or 15.1.2 will be subject to all the provisions of these Articles. |
15.3 | The Company may from time to time by special resolution reduce its share capital, capital redemption reserve fund, any share premium account or any other non distributable reserves in any manner authorised by the Statutes and diminish the amount of its share capital by the amount of the shares so cancelled. |
15.4 | Whenever as a result of any consolidation of shares any Members would become entitled to fractions of a share, the Board may for the purpose of eliminating such fractions sell the shares representing the fractions for the best price reasonably obtainable and distribute the proceeds of sale in due proportion among the Members who would have been entitled to the fractions of shares. |
15.5 | For the purpose of any such sale, the Board may authorise some person to transfer the shares representing the fractions to their purchaser, whose name will be entered in the Register as the Holder of the shares, and who will not be bound to see to the application of the purchase money, and the title to the shares of such purchaser will not be affected by any irregularity or invalidity in the proceedings in reference to the sale. |
16 |
16. | Convening and format of general meetings |
16.1 | Subject to the provisions of CA 2006, the annual general meeting will be held at such time and place or places as the Board may determine. |
16.2 | In the case of any general meeting and without prejudice to article 16.3 and article 16.4, the Directors may make arrangements for simultaneous attendance at and participation in the general meeting in more than one physical place anywhere in the world by persons entitled to attend the meeting. The Members present in person or by proxy at a satellite place shall be counted in the quorum for, and be entitled to vote at, the general meeting in question. The general meeting shall be duly constituted and its proceedings valid if the chair of the general meeting is satisfied that adequate facilities are available throughout the meeting to ensure that Members attending at the principal place and any satellite place(s) (each as defined below) are able to: |
16.2.1 | participate in the business for which the meeting has been convened; |
16.2.2 | hear all persons who speak (whether by the use of microphones, loudspeakers, audio-visual communications equipment or otherwise) in the principal meeting place and any satellite meeting place; and |
16.2.3 | be heard by all other persons so present in the same way. |
The general meeting shall be deemed to take place at the place where the chair of the general meeting presides (the “principal place”, with any other location where that meeting takes place being referred in these articles as a “satellite place”). The powers of the chair shall apply equally to each satellite place, including his or her power to adjourn the meeting as referred to in article 19.
16.3 | Without prejudice to article 16.2 and article 16.4, the Directors may determine in relation to any general meeting (including any general meeting that is being held at more than one physical place) to enable persons entitled to attend and participate to do so by simultaneous attendance and participation by means of electronic facility or facilities determined by the Directors (any such general meeting being a “hybrid general meeting”). The Members or their proxies present personally or by means of an electronic facility or facilities shall be counted in the quorum for, and entitled to participate in, the general meeting in question. |
The general meeting shall be duly constituted and its proceedings valid if the chair of the general meeting is satisfied that adequate facilities are available throughout the general meeting to ensure that Members attending the general meeting by all means (including by means of an electronic facility or facilities) are able to:
16.3.1 | participate in the business for which the general meeting has been convened; |
16.3.2 | hear all persons who speak at the general meeting; and |
16.3.3 | be heard by all other persons attending and participating in the general meeting. |
16.4 | Without prejudice to article 16.2 and article 16.3, the Directors may determine in relation to any general meeting to enable persons entitled to attend and participate to do so by means of electronic facility or facilities determined by the Directors with no Member necessarily in physical attendance (any such general meeting being an “electronic general meeting”). The Members or their proxies present by means of an electronic facility or facilities shall be counted in the quorum for, and entitled to participate in, the general meeting in question. The general meeting shall be duly constituted and its proceedings valid if the chair of the general meeting is satisfied that adequate facilities are available throughout the general meeting to ensure that Members attending the general meeting who are not present together at the same place may, by means of an electronic facility or facilities, attend, speak and vote at it. |
17 |
16.5 | If a general meeting is held as a hybrid general meeting or an electronic general meeting, the Directors (and, at a general meeting, the chair) may (subject to the requirements of CA 2006) make any arrangement and impose any requirement or restriction in connection with participation by such electronic facility or facilities, including any arrangement, requirement or restriction that is: |
16.5.1 | necessary to ensure the identification of those taking part and the security of the electronic facility or facilities; and |
16.5.2 | proportionate to the achievement of those objectives. |
In this respect, the Board may authorise any voting application, system or facility for hybrid general meetings or electronic general meetings as it sees fit.
16.6 | If, at any hybrid general meeting or electronic general meeting, any document is required to be on display or to be available for inspection at the meeting (whether prior to or for the duration of the meeting or both), the Company shall ensure that it is available in electronic form to persons entitled to inspect it for at least the required period of time, and this will be deemed to satisfy any such requirement. |
16.7 | Nothing in these articles: |
16.7.1 | shall preclude the holding and conducting of a general meeting in such a way that persons who are not present together at the same place may by electronic means attend and speak and vote at it; or |
16.7.2 | prevents a general meeting being held both physically and electronically. |
17. | Procedure where meetings held at more than one place |
17.1 | The provisions of this article shall apply if any general meeting is held at or adjourned to more than one place. |
17.2 | The notice of such a Meeting or adjourned meeting shall specify the place at which the Chairman of the Meeting shall preside (for the purposes of this article 17 the “Specified Place”) and the Directors shall make arrangements for simultaneous attendance and participation at the Specified Place and at other places by Members, provided that persons attending at any particular place shall be able to see and hear and be seen and heard by means of audio visual links by persons attending the Specified Place and at the other places at which the meeting is held. |
17.3 | The Directors may from time to time make such arrangements for the purpose of controlling the level of attendance at any such place (whether involving the issue of tickets or the imposition of some geographical or regional means of selection or otherwise) as they shall in their absolute discretion consider appropriate, and may from time to time vary any such arrangements or make new arrangements in place of them, provided that a Member who is not entitled to attend, in person or by proxy, at any particular place shall be entitled so to attend at one of the other places, and the entitlement of any Member so to attend the meeting or adjourned meeting at such place shall be subject to any such arrangements as may from time to time be in force and by the notice of meeting or adjourned meeting stated to apply to the meeting. |
18 |
17.4 | For the purposes of all other provisions of these Articles, any such meeting shall be treated as being held at the Specified Place. |
17.5 | If a meeting is adjourned to more than one place, not less than seven days’ notice of the adjourned meeting shall be given despite any other provision of these Articles. |
18. | Notice of general meetings |
18.1 | Subject to the provisions of section 307 CA 2006, an annual general meeting must be called by at least 21 Clear Days’ notice and all other general meetings must be called by at least 14 Clear Days’ notice. |
18.2 | Every notice must specify the Principal Place, the day and the time of meeting and, in the case of an annual general meeting, must specify the meeting as such. |
18.3 | Notices must be served in the manner stated in these Articles on all the Members, other than those who under the provisions of these Articles or under the rights attached to the shares held by them are not entitled to receive the notice, to each of the Directors and to the Auditors. |
18.4 | Notwithstanding that it is called by shorter notice than that specified in article 18.1, a meeting of the Company is deemed to have been duly called if it is so agreed: |
18.4.1 | in the case of a meeting called as an annual general meeting, by all the Members entitled to attend and vote at it; or |
18.4.2 | in the case of any other meeting, by a majority in number of the Members having a right to attend and vote at the meeting, being a majority together holding not less than 95% in nominal value of the shares giving that right (excluding any shares held as treasury shares). |
18.5 | If the Board, in its absolute discretion, considers that it is impractical or unreasonable for any reason to hold a general meeting on the date or at the time or place specified in the notice calling the general meeting, it may postpone the general meeting to another date, time and/or place. In that event notice of the date, time and place of the postponed meeting will, if practicable, be placed in at least two national newspapers in the United Kingdom. Notice of the business to be transacted at such postponed meeting will not be required. |
18.6 | The accidental omission to give notice of a meeting or resolution or to send any notification when required by the Statutes or these Articles relating to the publication of a notice of meeting on a website or (in cases where proxies are sent out with the notice) the accidental omission to send a proxy to, or the non receipt of any such notice, resolution, notification or proxy by, any person entitled to receive it will not invalidate the proceedings at that meeting. |
18.7 | In every notice calling a meeting of the Company or any class of the Members of the Company, there will appear with reasonable prominence a statement that a Member entitled to attend and vote is entitled to appoint one or more proxies to exercise all the Member’s rights and to attend, speak and vote instead of him, and that a proxy need not also be a Member. |
18.8 | Where special notice of a resolution is required by any provision contained in CA 2006, the resolution is not effective unless notice of the intention to move it has been given to the Company not fewer than 28 days, or such shorter period as CA 2006 permits, before the meeting at which it is moved, and the Company must give to its Members, notice of any such resolution as required by and in accordance with the provisions of CA 2006. |
19 |
18.9 | It is the duty of the Company, subject to the provisions of CA 2006, on the requisition in writing of such number of Members as is specified in CA 2006 and, unless the Company otherwise resolves, at the expense of the requisitionists: |
18.9.1 | to give to Members entitled to receive notice of the next annual general meeting notice of any resolution which may properly be moved and is intended to be moved at that meeting; and |
18.9.2 | to circulate to Members entitled to have notice of any general meeting sent to them, a statement of not more than 1,000 words with respect to the matter referred to in any proposed resolution or the business to be dealt with at that meeting. |
19. | Proceedings at general meetings |
19.1 | The Board may direct that Members or proxies wishing to attend any general meeting must submit to such searches or other security arrangements or restrictions as the Board considers appropriate in the circumstances and may, in its absolute discretion, refuse entry to, or eject from, such general meeting any Member or proxy who fails to submit to such searches or otherwise to comply with such security arrangements or restrictions. |
19.2 | No business may be transacted at any general meeting unless a quorum is present. Except as otherwise provided in these Articles, two persons entitled to vote at the meeting each being a Member or a proxy for a Member or a representative of a corporation which is a Member, duly appointed as such in accordance with the Statutes, are a quorum. In calculating whether a quorum is present for the purposes of this article 19.2, if two or more persons are appointed as proxies for the same Member or two or more persons are appointed as corporate representatives of the same corporate Member only one of those proxies and only one of those corporate representatives will be counted. |
19.3 | If within half an hour from the time appointed for the meeting a quorum is not present, the meeting, if convened on the requisition of, or by, Members, will be dissolved. In any other case, it will stand adjourned to the same day in the next week at the same time and place, or to such other day and at such other time and place as the Board may determine. |
19.4 | If, at such adjourned meeting, a quorum is not present within 15 minutes from the time appointed for holding the meeting, the Member or Members present in person or by proxy and entitled to vote will have power to decide upon all matters which could properly have been disposed of at the meeting as originally convened. |
19.5 | The chairman, if any, of the Board, or in his absence some other Director nominated by the chairman in writing, will preside as chairman at every general meeting of the Company, but if at any meeting neither the chairman nor such other Director is present within 15 minutes after the time appointed for holding the meeting, or if neither of them is willing to act as chairman, the Directors present may choose some Director present to be chairman, or if no Director is present, or if all the Directors present decline to take the chair, the Members present may choose some Member present to be chairman. |
19.6 | The chairman may, with the consent of any meeting at which a quorum is present, and must if so directed by the meeting, adjourn the meeting from time to time and from place to place, but no business may be transacted at any adjourned meeting except business which might lawfully have been transacted at the meeting as originally convened. |
20 |
19.7 | When a meeting is adjourned for 30 days or more or for an indefinite period, the Company must give at least seven Clear Days’ notice, specifying the place, the day and the time of the adjourned meeting and that the Member or Members present will form a quorum, but it will not be necessary to specify in such notice the nature of the business to be transacted at the adjourned meeting. Except as stated, it will not be necessary to give any notice of an adjournment. |
19.8 | At any general meeting, a resolution put to the vote of the meeting must be decided exclusively on a poll. |
19.9 | The instrument appointing a proxy to vote at a meeting is deemed also to confer authority to vote on a poll. |
19.10 | If any votes are counted which ought not to have been counted or might have been rejected, or if any votes are not counted which ought to have been counted, the error will not vitiate the result of the voting unless it is pointed out at the same meeting, or at any adjournment of it, and it is in the opinion of the chairman of the meeting of sufficient magnitude to vitiate the result of the voting. |
19.11 | In the case of a resolution duly proposed as a special resolution no amendment, other than an amendment to correct a patent error, may be considered or voted upon. In the case of a resolution duly proposed as an ordinary resolution, no amendment, other than an amendment to correct a patent error, may be considered or voted upon unless, either at least 48 hours prior to the time appointed for holding the meeting or adjourned meeting at which such ordinary resolution is to be proposed (regarding which, no account will be taken of any part of a day that is not a working day within the meaning of section 1173 CA 2006) notice in writing of the terms of the amendment and intention to move it is lodged at the Office, or the chairman, in his absolute discretion, decides that it may be considered or voted upon. If an amendment is proposed to any resolution under consideration but is ruled out of order by the chairman of the meeting the proceedings on the substantive resolution will not be invalidated by any error in such ruling. |
19.12 | Subject to the provisions of article 19.13, a poll will be taken in such manner as the chairman may direct, including the use of ballot or voting papers or tickets, and the result of a poll will be deemed to be the resolution of the meeting. The chairman may appoint scrutinisers, who need not be Members, and may fix some place and time for the purpose of declaring the result of the poll. |
19.13 | A poll on the election of a chairman or on a question of adjournment must be taken immediately. A poll on any other question must be taken immediately or at such time and place as the chairman directs, not being more than 30 days from the date of the meeting or the adjourned meeting. No notice need be given of a poll not taken immediately if the time and place at which it is to be taken are announced at the meeting. In any other case, at least seven days’ notice must be given specifying the time and place at which the poll is to be taken. |
19.14 | In the case of an equality of votes, the chairman of the meeting is entitled to a further or casting vote. |
20. | Votes of Members |
20.1 | Subject to any special rights or restrictions as to voting attached to any share by or in accordance with these articles, on a poll every Member present in person or by proxy and entitled to vote has one vote for every share of which he is the Holder. |
21 |
20.2 | In the case of joint Holders of a share, the person whose name appears first in the Register is entitled, to the exclusion of the other joint Holders, to vote, whether in person or by proxy, in respect of the share. |
20.3 | A Member who is a patient within the meaning of the Mental Health Act 1983 may vote by his receiver, curator bonis, or other person appointed by such court (who may on a poll vote by proxy) provided that such evidence as the Board may require of the authority of the person claiming to vote has been deposited at the Office not fewer than 48 hours before the time for holding the meeting or adjourned meeting at which such person claims to vote. |
20.4 | No Member is entitled to be present or to be counted in the quorum or vote, either in person or by proxy, at any general meeting or at any separate meeting of the Holders of a class of shares or on a poll or to exercise other rights conferred by Membership in relation to the meeting or poll, unless all calls or other monies due and payable in respect of the Member’s share or shares have been paid. This restriction ceases on payment of the amount outstanding and all costs, charges and expenses incurred by the Company by reason of non payment. |
20.5 | No objection may be raised to the qualification of any voter except at the meeting or adjourned meeting at which the vote objected to is given or cast, and every vote not disallowed at such meeting will be valid for all purposes. Any such objection made in due time will be referred to the chairman of the meeting, whose decision is final, binding and conclusive. |
20.6 | On a poll, votes may be given either in person or by proxy and a Member entitled to more than one vote need not, if he votes, use all his votes or cast all the votes he uses in the same way. |
20.7 | Any person, whether a Member or not, may be appointed to act as a proxy. A Member may appoint more than one proxy to attend the same meeting so long as each proxy is appointed to exercise the rights attached to a different share or shares held by that Member. Deposit of an instrument of proxy does not preclude a Member from attending and voting in person at the meeting or any adjournment of it. |
20.8 | The appointment of a proxy must be in writing and in any usual form, or such other form as may be approved by the Board, and must be signed by the appointor or by his agent duly authorised in writing or if the appointor is a corporation, must be either under its common seal or signed by an officer or agent so authorised. If the appointment is in Electronic Form, it must be Executed on behalf of the appointor. The Board may, but will not be bound to, require evidence of authority of such officer or agent. An instrument of proxy need not be witnessed. |
20.9 | The appointment of a proxy and (if required by the Board) any power of attorney or other authority under which it is Executed, or a certified copy of such authority, must be delivered to the Office, or such other place in the United Kingdom specified for that purpose in the notice calling the meeting, or in any such proxy (or, where the appointment of the proxy was contained in an Electronic Communication, at the Electronic Address of the Company), not fewer than 48 hours before the time appointed for holding the meeting or adjourned meeting at which the person named in the instrument proposes to vote. In default, the proxy will not be valid. The appointment of a proxy to vote at any meeting and deposited as set out in this article will authorise the proxy so appointed to vote on any poll taken or demanded at such meeting or at any adjournment of such meeting. |
22 |
20.10 | In relation to any shares which are held in uncertificated form, the Board may from time to time permit appointments of a proxy to be made by means of an Electronic Communication in the form of an uncertificated proxy instruction (that is, a properly authenticated dematerialised instruction, or other instruction or notification, which is sent by means of the relevant system concerned and received by such participant in that system acting on behalf of the Company as the Board may prescribe, in such form and subject to such terms and conditions as may from time to time be prescribed by the Board and subject always to the facilities and requirements of the relevant system concerned). The Board may in a similar manner permit supplements to, or amendments or revocations of, any such uncertificated proxy instruction to be made by like means. The Board may in addition prescribe the method of determining the time at which any such properly authenticated dematerialised instruction or other instruction or notification is to be treated as received by the Company or such participant. The Board may treat any such uncertificated proxy instruction which purports to be or is expressed to be sent on behalf of a Holder of a share as sufficient evidence of the authority of the person sending that instruction to send it on behalf of that Holder. |
20.11 | No appointment of a proxy will be valid after the expiry of 12 months from the date of its execution, or its receipt by the participant in the relevant system concerned acting on behalf of the Company, except at an adjourned meeting or on a poll demanded at a meeting or an adjourned meeting in cases where the meeting was originally held within 12 months from such date. |
20.12 | A vote given in accordance with the terms of a proxy or by the duly authorised representative of a corporate Member or a poll demanded by proxy or by the duly authorised representative of a corporate Member will be valid, notwithstanding, in the case of a proxy, the previous death or insanity of the principal, or the revocation of the instrument of proxy or of the authority under which the instrument of proxy was Executed, provided that no notice in writing (including by Electronic Communication) of such death, insanity or revocation has been received by the Company at the Office at least three hours before the commencement of the meeting or adjourned meeting at which the proxy is used. |
20.13 | For the purposes of articles 20.9 to 20.12 Electronic Address includes in the case of any uncertificated proxy instructions an identification number of a participant in the relevant system concerned. |
20.14 | The Board may at the expense of the Company send, by post or otherwise, to the Members proxies, with or without provision for their return prepaid, for use at any general meeting or at any separate meeting of the Holders of any class of shares of the Company either in blank or nominating in the alternative any one or more of the Directors or any other persons. If, for the purpose of any meeting, invitations to appoint as proxy a person, or one of a number of persons, specified in the invitations are issued at the Company’s expense, they will be issued to all, and not to some only, of the Members entitled to be sent a notice of the meeting and to vote at it by proxy. |
20.15 | In calculating any periods mentioned in this article 20 no account will be taken of any part of a day that is not a working day (within the meaning of section 1173 CA 2006. |
20.16 | Without prejudice to the provisions of this article 20 and subject always to articles 5.10 and 19.2 as regards quorum, the Directors may, for the purposes of any general meeting of the Company or a separate meeting of the Holders of any class of shares, permit eligible Members to cast their votes in respect of any business to be disposed of by means of a designated website or other approved Electronic Communication. |
23 |
21. | Corporations acting by representatives |
Any corporation which is a Member of the Company may by resolution of its directors or other governing body authorise any person or persons as it thinks fit to act as its representative or representatives at any meeting of the Company or of any class of Members of the Company. The person or persons so authorised will be entitled to exercise the same powers on behalf of the corporation which he or they represent as the corporation could exercise if it were an individual Member of the Company and the corporation will, for the purposes of these Articles, be deemed to be present in person at any such meeting if any person so authorised is present at it.
22. | Directors |
22.1 | Unless and until otherwise determined by the Company by ordinary resolution, the number of Directors is not subject to a maximum but must not be fewer than two. |
22.2 | A Director is not required to hold any share qualification but is nevertheless entitled to attend and speak at any general meeting or at any separate meeting of the Holders of any class of shares of the Company. |
23. | Alternate Directors |
23.1 | Any Director, other than an alternate Director, may at any time appoint any other Director, or any person approved by resolution of the Board, to be an alternate Director of the Company, and may at any time remove any alternate Director so appointed by him from office and, subject to such approval by the Board, appoint another person in his place. An alternate Director so appointed is not required to hold any share qualification. |
23.2 | Subject to his giving to the Company an address within the United Kingdom at which notices may be served upon him, an alternate Director is entitled to receive notices of all meetings of the Board and to attend and vote as a Director at any such meeting at which the Director appointing him is not personally present, and generally to perform all the functions of his appointor as a Director in the absence of such appointor. |
23.3 | An alternate Director will cease to be an alternate Director on the happening of any event which, if he were a Director, would cause him to vacate such office or if his appointor ceases for any reason to be a Director. If, however, any Director retires whether by rotation or otherwise but is reappointed by the meeting at which such retirement took effect, any appointment made by him pursuant to article 23.1 which was in force immediately prior to his retirement will continue to operate after his re-appointment as if he had not so retired. |
23.4 | All appointments and removals of alternate Directors must be effected by notice in writing signed by the Director making or revoking such appointment sent to or left at the Office. |
23.5 | Except as otherwise provided in these Articles, an alternate Director is deemed for all purposes to be an officer of the Company and is alone responsible to the Company for his own acts and defaults, and he is not deemed to be the agent of or for the Director appointing him. An alternate Director is not entitled to receive any remuneration from the Company for his services as such but his remuneration is payable out of the remuneration payable to the Director appointing him, and will consist of such part, if any, of the latter’s remuneration as is agreed between them. An alternate Director is entitled to be indemnified by the Company to the same extent as if he were a Director. |
24 |
24. | Powers and duties of Directors |
24.1 | The business of the Company is managed by the Board who may exercise all such powers of the Company as are not by the Statutes or by these Articles required to be exercised by the Company in general meeting, subject nevertheless to the provisions of these Articles and of the Statutes, and to such directions, whether or not inconsistent with these Articles, as may be prescribed by the Company by special resolution. No such direction and no alteration of these Articles will invalidate any prior act of the Board which would have been valid if such direction or alteration had not been given or made. The general powers given by this article 24.1 are not limited or restricted by any special authority or power given to the Board by any other article. |
24.2 | The Board may from time to time provide for the management and transaction of the affairs of the Company in any specified locality, including abroad, in such manner as they think fit, and the provisions contained in articles 25.2 to 25.4 are without prejudice to the general powers conferred by this article 24.2. |
24.3 | The Board may exercise the powers conferred upon the Company by section 129 CA 2006 with regard to the keeping of an overseas branch register and the Board may, subject to the provisions of the Statutes, make and vary such regulations as they may think fit respecting the keeping of any such register. |
24.4 | The Board may establish and maintain, or procure the establishment and maintenance of, any pension, annuity or superannuation funds, whether contributory or otherwise, for the benefit of, and give or procure the giving of donations, gratuities, pensions, allowances and emoluments to, any person who is or was at any time a Director of or in the employment or service of the Company, or of any company which is a subsidiary of the Company or is allied to or associated with the Company or any such subsidiary or of any of the predecessors in business of the Company or any such other company, or who may be or have been a Director or officer of the Company, or of any such other company, and to the spouse, civil partner, child, and dependants of any such person. |
24.5 | Subject to particulars with respect to the proposed payment being disclosed to the Members of the Company and to the proposal being approved by the Company by ordinary resolution, if the Statutes so require, any Director who holds or has held any executive position or agreement for services is entitled to participate in and retain for his own benefit any such donation, gratuity, pension, allowance or emolument. |
24.6 | The Board may also establish, subsidise and subscribe to any institutions, associations, societies, clubs or funds calculated to be for the benefit of, or to advance the interests and well being of, the Company or of any person or any other company mentioned in article 24.4, and make payments for or towards the insurance of any such person and subscribe or guarantee money for charitable or benevolent objects, or for any exhibition or for any political, public, general or useful object, and do any of such matters, either alone or in conjunction with any company mentioned in article 24.4. |
24.7 | The Board may exercise the voting power conferred by the shares in any other company held or owned by the Company or exercisable by members of the Board as directors of such other company in such manner in all respects as they think fit, including its exercise in favour of any resolution appointing themselves or any of them directors or other officers or employees of such company or voting or providing for the payment of remuneration to such officers or employees. |
25 |
24.8 | All cheques, promissory notes, drafts, bills of exchange and other negotiable or transferable instruments and all receipts for money paid to the Company, must be signed, drawn, accepted, endorsed or otherwise Executed, as the case may be, in such manner as the Board may from time to time determine by resolution. |
25. | Delegation of Directors’ powers and duties |
25.1 | The Board may delegate any of their powers, duties, discretion and authorities to committees consisting of such members or member of their body as they think fit. Any committee so formed must in the exercise of the powers, duties, discretions and authorities so delegated, conform to any regulations that may be imposed on it by the Board. |
25.2 | The Board may establish any councils, committees, local boards or agencies for managing any of the affairs of the Company, either in the United Kingdom or elsewhere, and may appoint any persons to be members of such local boards, or managers or agents, and may fix their remuneration, and may delegate to any council, committee, local board, manager or agent any of the powers, authorities and discretions vested in the Board, with power to subdelegate, and may authorise the members of any local board, or any of them, to fill any vacancies in it, and to act notwithstanding vacancies. Any such appointment or delegation may be made upon such terms and subject to such conditions as the Board think fit, and the Board may remove any person so appointed, and may annul or vary any such delegation, but no person dealing in good faith and without notice of any such annulment or variation will be affected by it. |
25.3 | The Board may from time to time, and at any time, appoint, whether by power of attorney or otherwise, any corporation, firm or person, or any fluctuating body of persons, whether nominated directly or indirectly by the Board, to be the agent of the Company for such purposes and with such powers, authorities and discretions, not exceeding those vested in or exercisable by the Board under these Articles, and for such period and subject to such conditions as they may think fit. Any such appointment may contain such provisions for the protection and convenience of persons dealing with any such agent as the Board may think fit, and may also authorise any such agent to subdelegate all or any of the powers, authorities and discretions vested in him. |
25.4 | The meetings and proceedings of any such committee consisting of two or more members are governed by the provisions of these Articles regulating the meetings and proceedings of the Board so far as they are applicable and are not superseded by any regulations made by the Board under article 25.1. No resolution of a committee is effective unless a majority of its members present are Directors. |
26. | Borrowing powers |
26.1 | The Board may exercise all the powers of the Company to borrow money and to mortgage or charge its undertaking, property and uncalled capital, or any part of it, and subject to the provisions of the Statutes, to issue debentures and other securities whether outright or as collateral security for any debt, liability or obligation of the Company or of any third party. |
26.2 | The Board may secure or provide for the payment of any money to be borrowed or raised by a mortgage of or charge upon all or any part of the undertaking or property of the Company, both present and future, and upon any capital remaining unpaid upon the shares of the Company whether called up or not, or by any other security. The Board may confer upon any mortgagees or persons in whom any debenture or security is vested such rights and powers as they think necessary or expedient. They may vest any property of the Company in trustees for the purpose of securing any money so borrowed or raised and confer upon the trustees, or any receiver to be appointed by them, or by any debenture Holder, such rights and powers as the Board may think necessary or expedient in relation to the undertaking or property of the Company or its management or realisation, or the making, receiving, or enforcing of calls upon the Members in respect of unpaid capital, and otherwise. The Board may make and issue debentures to trustees for the purpose of further security and the Company may remunerate any such trustees. |
26 |
26.3 | The Board may give security for the payment of any money payable by the Company in same manner as for the payment of money borrowed or raised. |
26.4 | The Board must keep a register of charges in accordance with the Statutes and the fee to be paid by any person, other than a creditor or Member of the Company for each inspection of the register of charges to be kept under the Statutes is £0.05 (five pence). |
27. | Appointment and retirement of Directors |
27.1 | Each Director must retire from office at the third annual general meeting after the annual general meeting or general meeting (as the case may be) at which he was appointed or last re appointed. |
27.2 | Any Director who has held office with the Company, other than employment or executive office, and who, at the date of the annual general meeting, has held such office for nine years or more, will be subject to re appointment at each annual general meeting. |
27.3 | A Director who retires at an annual general meeting, whether by rotation or otherwise, may, if willing to act, be re-appointed. If he is not re appointed or deemed to have been re-appointed under article 27.4, he will retain office until the meeting appoints someone in his place or, if it does not do so, until the end of the meeting. |
27.4 | The Company, at the annual general meeting at which a Director retires in the manner set out in article 27.1 or article 27.2 may fill the vacated office and, in default, the retiring Director, if willing to act, is deemed to have been re-appointed, unless at such meeting it is expressly resolved not to fill the vacancy, or a resolution for the re-appointment of such Director is put to the meeting and lost. |
27.5 | No person other than a retiring Director (by rotation or otherwise) may be appointed or re appointed as a Director at any general meeting unless: |
27.5.1 | he is recommended by the Board for appointment; or |
27.5.2 | not fewer than seven nor more than 42 Clear Days before the day appointed for the meeting, there is given to the Company notice in writing by a Member duly qualified to be present and to vote at the meeting for which such notice is given of his intention to propose such person for appointment stating the required particulars for the purposes of the Company’s register of Directors and, also, notice in writing signed by the person to be proposed of his willingness to be appointed. |
27.6 | At a general meeting, a motion for the appointment of two or more persons as Directors by a single resolution will be void, unless a resolution that it is so made has been first agreed to by the meeting without any vote being given against it and, for the purpose of this article 27.6, a motion for approving a person’s appointment or for nominating a person for appointment is treated as a motion for his appointment. |
27 |
27.7 | The Company may from time to time by ordinary resolution increase or reduce the number of Directors and may also determine in what rotation such increased or reduced number is to go out of office. Without prejudice to the provisions of article 27.8, the Company may by ordinary resolution appoint any person to be a Director, either to fill a casual vacancy or as an additional Director. |
27.8 | The Board and the Company in general meeting each have power at any time, and from time to time, to appoint any person to be a Director, either to fill a casual vacancy or as an additional Director, but so that the total number of Directors does not at any time exceed the maximum number, if any, fixed by or in accordance with these Articles. Subject to the provisions of the Statutes and of these Articles, any Director so appointed by the Directors holds office only until the conclusion of the next following annual general meeting and is eligible for reappointment at that meeting. Any Director who retires under this article is not taken into account in determining the Directors who are to retire by rotation at such meeting. |
27.9 | Any contract of employment entered into by a Director with the Company may not include a term that it is to continue or may be continued, otherwise than at the instance of the Company, for a period exceeding two years during which the employment either cannot be terminated by the Company by notice or can be so terminated only in specified circumstances, unless such term is first approved by ordinary resolution of the Company. |
27.10 | There is no restriction as to the age of Directors except as required by the Statutes. |
28. | Disqualification and removal of Directors |
28.1 | The office of a Director must be vacated in any of the following events: |
28.1.1 | if, not being a Director who has agreed to serve as a Director for a fixed term, he resigns his office by notice in writing signed by him and authorised in such manner as the other Directors may require, sent to or left at the Office; |
28.1.2 | if he becomes bankrupt or makes any arrangement or composition with his creditors generally or applies to the court for an interim order under section 253 Insolvency Act 1986 in connection with a voluntary arrangement under that Act; |
28.1.3 | if a registered medical practitioner who has examined him gives a written opinion to the Company stating that he has become physically or mentally incapable of acting as a director and may remain so for more than three months and the Directors resolve that his office be vacated; |
28.1.4 | if he is absent from meetings of the Directors for six successive months without leave, and his alternate Director, if any, has not during such period attended in his place, and the Directors resolve that his office be vacated; |
28.1.5 | if he ceases to be a Director by virtue of any provision of the Statutes or pursuant to these Articles; or |
28.1.6 | if he becomes prohibited by law from being a Director. |
28.2 | The Company may in accordance with, and subject to the provisions of the Statutes, by ordinary resolution of which special notice has been given, remove a Director before the expiry of his period of office and may appoint another person in his place. Such removal is without prejudice to any claim such Director may have for breach of any contract of service between him and the Company. The person so appointed is subject to retirement at the same time as if he had become a Director on the day on which the Director in whose place he is appointed was last appointed or reappointed a Director. |
28 |
29. | Executive and other Directors |
29.1 | Subject to the provisions of the Statutes, the Board may from time to time and at any time appoint one or more of their body to hold any executive office in relation to the management of the business of the Company on such terms, for such period and with or without such title(s) as they may decide. The Board may, from time to time, subject to the provisions of any service contract between the appointee(s) and the Company, remove or dismiss him or them from such office and appoint another or others in his or their place or places. |
29.2 | A Director who holds any such executive office is, while he continues to hold that office, subject to retirement by rotation in accordance with the provisions of article 27, and he is taken into account in determining the retirement by rotation of Directors. He is also, subject to the provisions of article 28.1 and of any service contract between him and the Company, subject to the same provisions as to removal and as to vacation of office as the other Directors of the Company. If he ceases to hold the office of Director for any cause, his appointment as the Holder of an executive office will also terminate. |
29.3 | The remuneration of any Director holding executive office may consist of salary, commission, profit participation, share options, pension or insurance benefit or any combination of them, or otherwise as determined by the Board. |
29.4 | The Board may entrust to and confer upon any Director appointed to any such executive office any of the powers exercisable by them, other than the power to make calls or forfeit shares, upon such terms and conditions and with such restrictions as the Board think fit, and either collaterally with or to the exclusion of their own powers, and may from time to time revoke, withdraw, alter or vary all or any of such powers. |
29.5 | Subject to the provisions of the Statutes, the Board may from time to time, and at any time, pursuant to this article appoint any person to any post with such descriptive title including that of Director, whether as executive, group, divisional, departmental, deputy, assistant, local, advisory director or otherwise, as they may determine. They may define, limit, vary and restrict the powers, authorities and discretions of any person so appointed and may fix and determine his remuneration and duties, and subject to any contract between him and the Company, may remove from such post any person so appointed. A person so appointed is not a Director for any of the purposes of these Articles or of the Statutes, and accordingly is not a member of the Board or of any committee of the Board, nor is he entitled to be present at any meeting of the Board or of any such committee, except at the request of the Board or of such committee. If present at such request, he is not entitled to vote at such meeting. |
30. | Remuneration of Directors |
30.1 | The Directors are entitled to fees (in addition to salaries) at such rate or rates as may from time to time be determined by the Board, but the aggregate fees of the Directors will not exceed £500,000 (one hundred and fifty thousand pounds) per annum, or such additional sum as may from time to time be determined by the Company by ordinary resolution. In the case of an executive Director, such fees are payable to him in addition to his remuneration as an executive Director. |
29 |
30.2 | The Company may, by ordinary resolution, also vote extra fees to the Directors which will, unless otherwise determined by the resolution by which it is voted, be divided among the Directors as they may agree, or failing agreement, equally. The Directors’ fees are deemed to accrue from day to day. |
30.3 | Any Director who serves on any committee, or who devotes special attention to the business of the Company, or who otherwise performs services which in the opinion of the Board are outside the scope of the ordinary duties of a Director, may be paid such extra remuneration by way of salary, participation in profits or otherwise as the Board may determine. |
31. | Directors’ expenses |
The Directors are also entitled to be paid all travelling, hotel and other expenses properly incurred by them in connection with the business of the Company or in attending and returning from meetings of the Board or of committees of the Board or general meetings.
32. | Directors’ interests |
32.1 | A Director, including an alternate Director, may hold any other office or place of profit under the Company, other than the office of auditor, in conjunction with his office of Director and may act in a professional capacity to the Company, on such terms as to tenure of office, remuneration and otherwise as the Board may determine. |
32.2 | Subject to the Statutes and to the provisions of these Articles, no Director or intending Director, including an alternate Director, is disqualified by his office from contracting with the Company either with regard to his tenure or any other office or place of profit, or as seller, purchaser or otherwise. No such contract, or any contract or arrangement entered into by or on behalf of the Company in which any Director is in any way, whether directly or indirectly, interested, is liable to be avoided, nor is any Director so contracting or being so interested obliged to account to the Company for any profit realised by any such contract or arrangement by reason of the Director holding that office or of his fiduciary relationship with the Company. |
32.3 | Any Director, including an alternate Director, may continue to be or become a director or other officer, employee or member of or otherwise interested in any other company promoted by the Company or in which the Company may be interested, as a seller, member or otherwise, or which is a holding company of the Company or a subsidiary of any such holding company. No such Director is accountable for any remuneration or other benefits received by him as a director or other officer or member of, or from his interest in, any such other company. The Board may exercise the voting power conferred by the shares in any other company held or owned by the Company, or exercisable by the directors of such other company, in such manner in all respects as they think fit, subject to the restrictions contained in article 32.8 and article 31. |
32.4 | A Director, including an alternate Director, who is in any way, whether directly or indirectly, interested in a contract, transaction or arrangement or proposed contract, transaction or arrangement, with the Company must declare the nature of his interest at a meeting of the Board. In the case of a proposed contract, transaction or arrangement, the declaration must be made at the meeting of the Board at which the question of entering into the contract, transaction or arrangement is first taken into consideration or, if the Director was not at the date of that meeting interested in the proposed contract, transaction or arrangement, at the next meeting of the Board held after he became so interested. In a case where the Director becomes interested in a contract, transaction or arrangement after it is made, the declaration must be made at the first meeting of the Board held after the Director becomes so interested. In a case where the Director is interested in a contract, transaction or arrangement which has been made before he was appointed a Director, the declaration must be made at the first meeting of the Board held after he is so appointed. |
30 |
32.5 | For the purposes of article 32.4, a general notice given to the Board by any Director to the effect that he is a member of any specified company or firm and is to be regarded as interested in any contract which may, after the date of the notice, be made with such company or firm is deemed a sufficient declaration of interest in relation to any contract so made if such Director gives the notice at a meeting of the Board or takes reasonable steps to secure that it is brought up and read at the next meeting of the Board after it is given. |
32.6 | Except as provided in these Articles, a Director may not vote at a meeting of the Board or of a committee of the Board on any resolution concerning a matter: |
32.6.1 | in which he has (either alone or together with any person connected with him, as provided in section 252 CA 2006) a material interest, other than an interest in shares or debentures or other securities of or in the Company; and |
32.6.2 | (subject to article 33) which conflicts or may conflict with the interests of the Company. |
32.7 | A Director is not counted in the quorum at a meeting in relation to any resolution on which he is debarred from voting. |
32.8 | Notwithstanding the provisions of articles 32.6 and 32.7 and 33, a Director is entitled to vote and be counted in the quorum in respect of any resolution concerning any of the following matters: |
32.8.1 | the giving of any security, guarantee or indemnity to him in respect of money lent or obligations incurred by him or by any other person at the request of or for the benefit of the Company or any of its subsidiaries; |
32.8.2 | the giving of any security, guarantee or indemnity to a third party in respect of a debt or obligation of the Company or any of its subsidiaries for which he himself has assumed responsibility in whole or in part under a guarantee or indemnity or by the giving of security; |
32.8.3 | any proposal concerning an offer of shares or debentures or other securities of or by the Company or any of its subsidiaries for subscription or purchase in which offer he is or is to be interested as a participant as the Holder of such shares, debentures or other securities or in its underwriting or sub-underwriting; |
32.8.4 | any contract, arrangement, transaction or other proposal concerning any other company in which he holds an interest not representing 1% or more of any class of the equity share capital (calculated exclusive of any shares of that class held as treasury shares) of such company, or of any third company through which his interest is derived, or of the voting rights available to members of the relevant company, any such interest being deemed for the purpose of this article 32.8.4 to be a material interest in all circumstances; |
32.8.5 | any contract, arrangement, transaction or other proposal concerning the adoption, modification or operation of a superannuation fund or retirement, death or disability benefits scheme under which he may benefit and which has been approved by or is subject to and conditional upon approval by HM Revenue & Customs; |
31 |
32.8.6 | any contract, arrangement, transaction or proposal concerning the adoption, modification or operation of any scheme for enabling employees including full time executive Directors of the Company and/or any subsidiary to acquire shares of the Company or any arrangement for the benefit of employees of the Company or any of its subsidiaries, which does not award him any privilege or benefit not awarded to the employees to whom such scheme relates; or |
32.8.7 | any contract, arrangement, transaction or proposal concerning insurance which the Company proposes to maintain or purchase for the benefit of Directors or for the benefit of persons including Directors. |
32.9 | A Director may not vote or be counted in the quorum on any resolution concerning his own appointment as the Holder of any office or place of profit with the Company or any company in which the Company is interested, including fixing or varying the terms of his appointment or its termination. |
32.10 | Where proposals are under consideration concerning the appointment, including fixing or varying the terms of appointment, of two or more Directors to offices or employments with the Company or any company in which the Company is interested, such proposals may be divided and considered in relation to each Director separately. In such cases, each of the Directors concerned, if not debarred from voting under article 32.6 or 32.9, is entitled to vote and be counted in the quorum in respect of each resolution except that concerning his own appointment. |
32.11 | If any question arises at any meeting as to the materiality of a Director’s interest or as to the entitlement of any Director to vote and such question is not resolved by his voluntarily agreeing to abstain from voting, such question must be referred to the chairman of the meeting and his ruling in relation to any other Director will be final and conclusive, except in a case where the nature or extent of the interests of the Director concerned have not been fairly disclosed. If the question concerns the chairman, it must be referred to such other Director present at the meeting, other than the chairman, as the Directors present appoint. |
32.12 | Subject to the Statutes, the Company may by ordinary resolution suspend or relax the provisions of articles 32.4 to 32.11 to any extent or ratify any transaction not duly authorised by reason of a contravention of these Articles. |
33. | Conflicts of interest requiring Board authorisation |
33.1 | The Board may, if the quorum and voting requirements set out in this article 33 are satisfied, authorise any matter that would otherwise involve a Director (Relevant Director) breaching his duty under chapters 2 and 3 of part 10CA 2006 to avoid conflicts of interest. |
33.2 | Any Director (including the Relevant Director) may propose that the Relevant Director be authorised in relation to any matter which is the subject of such a conflict. The proposal and any authority given by the Board will be determined in the same way as any other matter proposed to and resolved by the Board under these Articles, except that the Relevant Director and any other Director with a similar interest: |
33.2.1 | will not count towards the quorum at the meeting at which the conflict is considered; |
32 |
33.2.2 | may, if the Board so decides, be excluded from any Board meeting while the conflict is under consideration; and |
33.2.3 | may not vote on any resolution authorising the conflict, but except that, if he or they in fact vote, the resolution will be valid if it would have been passed even if the vote or votes had not been counted. |
33.3 | Where the Board gives authority in relation to such a conflict: |
33.3.1 | the Board may (whether at the time of giving the authority or at any time or times subsequently) impose such terms upon the Relevant Director and any other Director with a similar interest as it deems appropriate, including, without limitation, the exclusion of the Relevant Director and any other Director with a similar interest from the receipt of information, or participation in discussion (whether at meetings of the Board or otherwise) relating to the conflict; |
33.3.2 | the Relevant Director and any other Director with a similar interest will be obliged to comply with any terms imposed by the Board from time to time in relation to the conflict; |
33.3.3 | the authority may also provide that where the Relevant Director, and any other Director with a similar interest, obtains information that is confidential to a third party, the Relevant Director or such other Director, as the case may be, will not be obliged to disclose that information to the Company, or to use the information in relation to the Company’s affairs, where to do so would amount to a breach of that confidence; |
33.3.4 | the terms of the authority must be recorded in writing; and |
33.3.5 | the authority may be withdrawn by the Board at any time. |
34. | Proceedings of Directors |
34.1 | The Board may meet together for the despatch of business, adjourn and otherwise regulate their meetings as they think fit. Questions arising at any meeting are determined by a majority of votes. In case of an equality of votes, the chairman has a second or casting vote. A Director who is also an alternate Director is entitled, in the absence of the Director whom he is representing, to a separate vote on behalf of such Director in addition to his own vote. A Director may, and the Secretary on the requisition of a Director must, at any time call a meeting of the Board. It is not necessary to give notice of a Board meeting to any Director for the time being absent from the United Kingdom, except where an address for such notice has been given pursuant to article 34.2. |
34.2 | Notice of meetings of the Board is deemed to be duly given to a Director if it is given to him personally or by word of mouth or sent in writing or other means to him at his last known address or any other address (including an Electronic Address) given by him from time to time the Company for this purpose. A Director absent or intending to be absent from the United Kingdom may request the Board that notices of Board meetings will during his absence be sent in writing to him at his last known address or any other address (including an Electronic Address) given by him to the Company for this purpose, whether or not out of the United Kingdom. |
34.3 | The quorum necessary for the transaction of the business of the Board may be fixed by the Board, and unless so fixed at any other number, is two. If a Board meeting is attended by a Director who is acting as an alternate for one or more other Directors, the Director or Directors for whom he is the alternate will be counted in the quorum despite their absence, and if on this basis there is a quorum the meeting may be held despite the fact that only one Director is physically present. A meeting of Directors for the time being at which a quorum is present is competent to exercise all powers and discretions for the time being exercisable by the Board. |
33 |
34.4 | All or any of the Directors, including alternates, or members of any committee of the Board may participate in a meeting of the Board or that committee by means of a conference telephone or any communication equipment which allows all persons participating in the meeting to hear each other. A person so participating is deemed to be present in person at the meeting and may vote or be counted in a quorum. Accordingly, a meeting of the Board or a committee of the Board may be held where each of those present or deemed to be present is in communication with the others only by telephone or other communication equipment. A meeting where those present or deemed to be present are in different locations is deemed to take place where the largest group of those participating is assembled, or, if there is no such group, where the chairman of the meeting then is. |
34.5 | The continuing Directors may act notwithstanding any vacancy in their body. If the number of the Directors is less than the prescribed minimum, the remaining Director or Directors must immediately appoint an additional Director or additional Directors to make up such minimum or convene a general meeting of the Company for the purpose of making such appointment. If there is no Director or Directors able or willing to act, any two Members may summon a general meeting for the purpose of appointing Directors. Any additional Director so appointed holds office, subject to the provisions of the Statutes and these Articles, only until the end of the annual general meeting of the Company next following such appointment, unless he is re-elected during such meeting. He is eligible for re-election at such meeting and does not retire by rotation at such meeting nor is taken into account in determining the rotation or retirement of Directors at such meeting. |
34.6 | The Board may from time to time elect from their number, and remove, a chairman and one or more deputy chairmen or vice chairmen and determine the period for which any such person is to hold office. The chairman, or in his absence, the deputy chairman or vice chairman (to be chosen, if in each case there are more than one, by agreement amongst them or, failing agreement, by lot) or in the absence of any of them, some other Director nominated by a majority of the other Directors in writing, presides at all meetings of the Board. If no such chairman, deputy chairman or vice chairman is elected, or if at any meeting the chairman or the deputy chairman or the vice chairman or such other Director is not present within five minutes after the time appointed for holding it, or if none of them is willing to act as chairman, the Directors present may choose one of their number to be chairman of the meeting. |
34.7 | A resolution in writing, agreed to by all the Directors for the time being entitled to receive notice of a meeting of the Board (if that number is sufficient to constitute a quorum) or of a committee of the Board, is as effective as a resolution passed at a Board meeting or of a committee of the Board, duly convened and held. For this purpose a Director signifies his consent to a proposed resolution in writing when the Company receives from him or his alternate a document or an Electronic Communication at such address (including an Electronic Address) as may be specified by the Company indicating his agreement to the resolution, authenticated in the manner required by section 1146 CA 2006. |
34.8 | A meeting of the Directors for the time being at which a quorum is present is competent to exercise all powers and discretions for the time being exercisable by the Board. |
34 |
34.9 | All acts done bona fide by any meeting of Directors, or of a committee of the Board, or by any person acting as Director, are as valid as if every such person had been duly appointed, was qualified, had continued to be a Director and had been entitled to vote, notwithstanding that it is afterwards discovered that there was some defect in the appointment of any such Director or person acting as a Director, or that they or any of them were disqualified, or had vacated office, or were not entitled to vote. |
35. | Secretary |
35.1 | Subject to the Statutes, the Secretary of the Company is appointed by the Board on such terms and for such periods as they may think fit, and the Board may so appoint one or more assistant or deputy Secretary. Any Secretary or assistant or deputy Secretary so appointed may at any time be removed from office by the Board, without prejudice to any claim for damages for breach of any contract of service between him and the Company. |
35.2 | Anything by the Statutes required or authorised to be done by the Secretary may, if the office is vacant or there is for any other reason no Secretary capable of acting, be done by any assistant or deputy Secretary or, if there is no assistant or deputy Secretary capable of acting, by any officer of the Company authorised generally or specifically in that behalf by the Board. Any provision of the Statutes or of these Articles requiring or authorising a thing to be done by a Director and Secretary is not satisfied by its being done by the same person acting both as Director and as, or in the place of, the Secretary. |
36. | Minutes |
36.1 | The Board must ensure that minutes are made of: |
36.1.1 | all appointments of officers and committees made by the Board; |
36.1.2 | the names of the Directors present at each meeting of Board and of any committee of the Board and all business transacted at such meetings; and |
36.1.3 | all orders, resolutions and proceedings at all meetings of the Company, of the Holders of any class of shares in the Company and of the Board and of committees of the Board. |
36.2 | Any such minute, if purporting to be signed by the chairman of the meeting at which the proceedings were held, or by the chairman of the next succeeding meeting, is prima facie evidence of the matters stated in such minutes without any further proof. |
37. | Seal and authentication of documents |
37.1 | The Board may provide a common seal for the Company and have power from time to time to destroy it and to substitute a new seal for it. |
37.2 | A document expressed to be Executed by the Company signed as provided by section 44(2) CA 2006 has effect as if Executed under seal. |
37.3 | The Board may exercise the powers conferred on the Company by section 50 CA 2006 with regard to having an official seal solely for sealing documents creating or evidencing securities of the Company. Any such documents to which such official seal is affixed need not be signed by any person. |
37.4 | The Board must provide for the safe custody of the seal and the seal may never be used except by the authority of a resolution of the Board or of a committee of the Board authorised for that purpose by the Board. The Board may from time to time make such regulations as it thinks fit, subject to the provisions of these Articles in relation to share and debenture certificates, determining the persons and the number of such persons who may sign every instrument to which the seal is affixed and, until otherwise so determined, every such instrument must be signed by one Director and must be countersigned by a second Director or by the Secretary. |
35 |
37.5 | The Company may have official seals under the provisions of section 49 CA 2006 for use abroad. Wherever reference is made in these Articles to the seal, the reference, when and so far as may be applicable, is deemed to include any such official seal. |
37.6 | Any Director or the Secretary or any person appointed by the Board for the purpose has power to authenticate any documents affecting the constitution of the Company and any resolutions passed by the Company or the Board or any committee of the Board, and any books, records, documents and accounts relating to the business of the Company, and to certify copies of them or extracts from them as true copies or extracts. A document purporting to be a copy of a resolution, or a copy of or an extract from the minutes of a meeting of the Company or of the Board or any committee of the Board, which is certified as stated, is conclusive evidence in favour of all persons dealing with the Company upon the faith of any such copy that such resolution has been duly passed or, as the case may be, that such copy or extract is a true and accurate record of proceedings at a duly constituted meeting. |
38. | Dividends |
38.1 | Subject to article 38.2, the profits of the Company available for distribution and resolved to be distributed are applied in the payment of Dividends to the Members in accordance with their respective rights and priorities. The Company in general meeting may declare Dividends accordingly. |
38.2 | The Board may, at its discretion, make provisions to enable any member as the Board shall determine to receive duly declared dividends in a currency or currencies other than sterling. For the purposes of the calculation of the amount receivable in respect of any dividend, the rate of exchange to be used to determine the foreign currency equivalent of any sum payable as a dividend shall be such rate or rates and the payment shall be on such terms and conditions as the Board may in its absolute discretion determine. |
38.3 | No Dividend or interim Dividend is payable otherwise than in accordance with the provisions of the Statutes and no Dividend may exceed the amount recommended by the Board. |
38.4 | Subject to the rights of persons, if any, entitled to shares with preferential or other special rights as to Dividends, all Dividends must be declared and paid according to the amounts Paid Up on the shares in respect of which the Dividend is paid. No amount Paid Up on a share in advance of the date on which a call is payable may be treated as Paid Up for this purposes. All Dividends will be apportioned and paid pro rata according to the amounts Paid Up on the shares during any portion or portions of the period in respect of which the Dividend is paid, except that if any share is issued on terms providing that it carries any particular rights as to Dividend, such share will rank for Dividend accordingly. |
36 |
38.5 | Subject to the provisions of the Statutes and of these Articles, the Board may, if they think fit, from time to time pay to the Members such interim Dividends as appear to the Board to be justified by the distributable profits of the Company. If at any time the share capital of the Company is divided into different classes, the Board may pay such interim Dividends in respect of those shares in the capital of the Company which confer on their Holders deferred or non preferred rights, as well as in respect of those shares which confer on their Holders preferential rights with regard to Dividend. No Dividend, whether interim, final or otherwise, may be paid on shares carrying deferred or non preferred rights if, at the time of payment, any preferential Dividend is in arrears. The Board may also pay half yearly, or at other suitable intervals to be settled by them, any Dividend which may be payable at a fixed rate if they are of the opinion that the distributable profits justify the payment and if and to the extent that such payment is permitted by the Statutes. So long as the Board act in good faith, they will not incur any responsibility to the Holders of shares conferring a preference for any damage that they may suffer by reason of the payment of an interim Dividend on any shares having deferred or non preferred rights. |
38.6 | Subject to the provisions of the Statutes or as otherwise required by law, where any asset, business or property is bought by the Company as from a past date, whether such date is before or after the incorporation of the Company, the profits or losses attributable to it as from such date may at the discretion of the Board in whole or in part be carried to revenue account and treated for all purposes as profits or losses of the Company. Except as stated, if any shares or securities are purchased cum Dividend or interest, such Dividend or interest may at the discretion of the Board be treated as revenue and it will not be obligatory to capitalise it or any part of it. |
38.7 | The Board may deduct from any Dividend or other money payable to any Member on or in respect of a share all sums of money, if any, presently payable by him to the Company on account of calls or otherwise in relation to the shares of the Company. The Company may cease to send any cheque or warrant through the post for any Dividend payable on any shares in the Company which is normally paid in that manner on those shares if, in respect of at least two consecutive Dividends payable on those shares, the cheques or warrants have been returned undelivered or remain not cashed or, if following one such occasion, reasonable enquiries have failed to establish any new address of the registered Holder. Subject to the provisions of these Articles, the Company must recommence sending cheques or warrants in respect of Dividends payable on those shares if the Holder or person entitled by transmission claims the arrears of Dividend and does not instruct the Company to pay future Dividends in some other way. |
38.8 | The Board may retain the Dividends payable upon shares in respect of which any person is, under the provisions as to the transmission of shares contained in these Articles, entitled to become a Member, or which any person is under those provisions entitled to transfer, until such person becomes a Member in respect of such shares or transfers them. |
38.9 | All Dividends, interest or other sums payable and unclaimed for one year, after having been declared, may be invested or otherwise made use of by the Board for the benefit of the Company until claimed and the Company is not constituted a trustee in respect of them. No Dividend will bear interest as against the Company. |
38.10 | Any Dividend which has remained unclaimed for a period of 12 years from the date on which it becomes due for payment will, if the Board so resolve, be forfeited and cease to remain owing by the Company and will from then on belong to the Company absolutely. |
37 |
38.11 | Any Dividend or other money payable on or in respect of a share may be paid by cheque, warrant, bank transfer or money order, or by any other method including, without limitation, by electronic means, as the Directors may consider appropriate. Any such payment may be sent through the post or other delivery service (or by any means offered by the Company as the Member or person entitled to it may agree in writing) to the registered address of the Member or person entitled to it and, in the case of joint Holders, to any one of such joint Holders or, to such person and such address as the Holder or joint Holders may in writing direct. Every such payment will be made payable to the order of the person to whom it is sent or to such other person as the Holder or joint Holders may in writing direct and such payment will be a good discharge to the Company. Every such payment will be sent at the risk of the person entitled to the money. |
38.12 | If several persons are registered as joint Holders of any share any one of them may give effectual receipts for any Dividend or other money payable on or in respect of the share. |
38.13 | The Board may, if authorised by an ordinary resolution of the Company, offer any Holders of ordinary shares the right to elect to receive ordinary shares, credited as fully Paid Up, instead of cash in respect of the whole, or some part, to be determined by the Board, of any Dividend specified by the ordinary resolution. The following provisions will apply: |
38.13.1 | an ordinary resolution may specify a particular Dividend or may specify all or any Dividends declared within a specified period but such period may not end later than the beginning of the annual general meeting next following the date of the meeting at which the ordinary resolution is passed; |
38.13.2 | the entitlement of each Holder of ordinary shares to new ordinary shares is such that the relevant value of the entitlement is as nearly as possible equal to, but not greater than, the cash amount, disregarding any tax credit of the Dividend that such Holder elects to forgo; |
38.13.3 | on or as soon as practicable after announcing that they are to declare or recommend any Dividend, the Board, if they intend to offer an election in respect of that Dividend, must also announce that intention, and, after determining the basis of allotment, if the Board decide to proceed with the offer, must notify the Holders of ordinary shares in writing of the right of election and specify the procedure to be followed and the place at which, and the latest time by which elections must be lodged in order to be effective; |
38.13.4 | the Board may not proceed with any election unless the Company has sufficient reserves or funds that may be capitalised to give effect to it after the basis of allotment is determined; |
38.13.5 | the Board may exclude from any offer any Holders of ordinary shares where the Board believes that the making of the offer to them would or might involve the contravention of the laws of any territory or that for any other reason the offer should not be made to them; |
38.13.6 | the Dividends, or that part of the Dividend in respect of which a right of election has been offered, will not be payable on ordinary shares other than for which an election has been made (elected ordinary shares) and, instead, additional ordinary shares will be allotted to the Holders of the elected ordinary shares on the basis of the allotment calculated as stated. For such purpose, the Board will capitalise, out of any amount for the time being standing to the credit of any reserve or fund, including the profit and loss account, whether or not it is available for distribution as the Board may determine, a sum equal to the aggregate nominal amount of the additional ordinary shares to be allotted on that basis and apply it in paying up in full the appropriate number of ordinary shares for allotment and distribution to the Holders of the elected ordinary shares on that basis; and |
38 |
38.13.7 | the additional ordinary shares when allotted will rank equally in all respects with the fully Paid Up shares then in issue except that they will not be entitled to participate in the relevant Dividend. |
38.13.8 | For the purposes of this article 38.13, the “relevant value” of an ordinary share shall be equal to: either (i) the average middle market quotation for the ordinary shares as derived from the Daily Official List of London Stock Exchange, or (ii) in the case of Depositary Shares, the average middle-market quotation of Depositary Shares traded on Nasdaq (adjusted as the Directors shall determine to reflect the number of ordinary shares represented by each Depositary Share), in either case, on such five consecutive dealing days as the Directors shall determine, provided the first of such days shall be on or after the day on which such ordinary shares are first quoted “ex” the relevant dividend, or shall be calculated in such other manner as the Directors may determine and is set out in the announcement of the availability of the election in respect of the relevant dividend. A certificate or report by the auditors of the Company as to the amount of the relevant value in respect of any dividend shall be conclusive evidence of that amount and in giving such a certificate or report, the auditors of the Company may rely on advice or information from brokers or other sources of information as they think fit. |
38.14 | A general meeting declaring a Dividend may, upon the recommendation of the Board, direct payment of such Dividend wholly or in part by the distribution of specific assets, and in particular of Paid Up shares or debentures of the Company or any other company, and the Board must give effect to such resolution. Where any difficulty arises in regard to the distribution, they may settle it as they think expedient and, in particular but without limitation, may issue fractional certificates and may fix the value for distribution of such specific assets or any part of them, and may determine that cash payments will be made to any Members upon the basis of the value so fixed, in order to adjust the rights of Members. They may vest any specific assets in trustees upon trust for the persons entitled to the Dividend as may seem expedient to the Board, and generally may make such arrangements for the allotment, acceptance and sale of such specific assets or fractional certificates, or any part of them, and otherwise as they think fit. |
39. | Reserves |
39.1 | Subject to the provisions of the Statutes, the Board may before recommending any Dividend, whether preferential or otherwise, carry to reserve out of the profits of the Company, including any premiums received upon the issue of debentures or other securities of the Company, such sums as they think proper as a reserve or reserves. |
39.2 | All sums standing to reserve may be applied from time to time at the discretion of the Board for meeting depreciation or contingencies or for special Dividends or bonuses or for equalising Dividends or for repairing, improving or maintaining any of the property of the Company or for such other purposes as the Board may decide are conducive to the objects of the Company or any of them. Pending their application such sums may either be employed in the business of the Company or be invested in such investments as the Board think fit. |
39 |
39.3 | The Board may divide the reserve into such special funds as they think fit, and may consolidate into one fund any special funds or any parts of any special funds into which the reserve has been divided, as they think fit. Any sum which the Board may carry to reserve out of the unrealised profits of the Company will not be mixed with any reserve to which profits available for distribution have been carried. The Board may also without placing them to reserve carry forward any profits which they may think it not prudent to divide. |
40. | Capitalisation of profits |
40.1 | Subject as set out in articles 40.2, and 40.3 the Board may with the authority of an ordinary resolution of the Company: |
40.1.1 | resolve to capitalise any undivided profits of the Company, whether or not they are available for distribution and including profits standing to any reserve, or, any sum standing to the credit of the Company’s share premium account or capital redemption reserve funds; |
40.1.2 | appropriate the profits or sum resolved to be capitalised to the Members in proportion to the nominal amount of ordinary shares, whether or not fully Paid Up, held by them respectively, and apply such profits or sum on their behalf, either in or towards paying up the amounts, if any, for the time being unpaid on any shares held by such Members respectively, or in paying up in full shares or debentures of the Company of a nominal amount equal to such profits or sum, and allot and distribute such shares or debentures credited as fully Paid Up, to and amongst such Members, or as they may direct, in due proportion, or partly in one way and partly in the other; |
40.1.3 | resolve that any shares allotted under this article to any Member in respect of a holding by him of any partly Paid Up ordinary shares will, so long as such ordinary shares remain partly Paid Up, rank for Dividends only to the extent that such partly Paid Up ordinary shares rank for Dividend; |
40.1.4 | make such provisions by the issue of fractional certificates or by payment in cash or otherwise as the Board think fit for the case of shares or debentures becoming distributable under this article in fractions; |
40.1.5 | authorise any person to enter on behalf of all the Members concerned into an agreement with the Company providing for the allotment to them respectively, credited as fully Paid Up, of any shares or debentures to which they may be entitled upon such capitalisation and any agreement made under such authority being effective and binding on all such Members; and |
40.1.6 | generally do all acts and things required to give effect to such resolution. |
40.2 | The share premium account and the capital redemption reserve fund and any such profits which are not available for distribution may, for the purposes of article 40.1, only be applied in the paying up of shares to be allotted to Members credited as fully Paid Up. |
40.3 | In the case where any sum is applied in paying amounts for the time being unpaid on any shares of the Company or in paying up in full debentures of the Company, the amount of the net assets of the Company at that time must be not less than the aggregate of the called up share capital of the Company and its undistributable reserves and must not be reduced below that aggregate by the payment of those amounts as shown in the latest audited accounts of the Company, or such other accounts as may be relevant. |
40 |
41. | Accounts |
41.1 | The Board must ensure that proper accounting records are kept in accordance with the Statutes. |
41.2 | The accounting records must be kept at the Office or, subject to the provisions of the Statutes, at such other place as the Board think fit, and must always be open to inspection by the officers of the Company. No Member, other than a Director, has any right of inspecting any account or book or document of the Company, except as conferred by the Statutes or authorised by the Board or by the Company in general meetings. |
41.3 | The Board must from time to time, in accordance with the provisions of the Statutes, ensure that there are prepared and laid before the Company in general meeting such profit and loss accounts balance sheets, group accounts, if any, and reports as are specified in the Statutes. |
41.4 | Subject to the Statutes, a copy of every Directors’ report and Auditors’ report accompanied by the Company’s annual accounts and every other document required by law to be attached to them or a summary financial statement derived from the Company’s annual accounts, prepared in accordance with the Statutes, must, not fewer than 21 Clear Days before the date of the meeting at which copies of those documents are to be laid, be sent to every Member (whether or not entitled to receive notices of general meetings) and to every Holder of debentures of the Company (whether nor not entitled to receive notices of general meetings) and to the Auditors and to every other person who is entitled to receive notices of general meetings from the Company. This article 41.4 does not require such documents to be sent to any Member or Holder of debentures of whose address the Company is not aware nor to more than one of the joint Holders of any shares or debentures. |
41.5 | The accidental omission to send any document required to be sent to any person under article 41.4 or the non receipt of any document by any person entitled to receive it does not invalidate any such document or the proceedings at the general meeting. |
41.6 | Whenever any of the Company’s shares or debentures have been admitted to listing by the UK Listing Authority, the required number of such documents must, at the same time, be forwarded to the appropriate officer of the UK Listing Authority. |
42. | Record dates |
Notwithstanding any other provision of these Articles but without prejudice to the rights attached to any shares and subject to the Statutes, the Company or the Board may fix any date as the record date for any Dividend, distribution, interest, allotment, issue, notice, information, document or circular and such record date may be on or at any time before any date on which such Dividend, distribution, interest, allotment or issue is paid or made and on or at any time before or after any date on which such Dividend, distribution, interest, allotment, issue, notice, information, document or circular is declared, made, paid, given or served.
43. | Audit |
43.1 | Auditors must be appointed and their duties, powers, rights and remuneration regulated in accordance with the Statutes. |
41 |
43.2 | Once at least in every year the accounts of the Company must be examined and the correctness of the balance sheet, profit and loss account and group accounts, if any, ascertained by the Auditors. |
44. | Notices |
44.1 | A notice or other document or information to be sent to or by any person under these Articles (other than a notice calling a meeting of the Board or of a committee of the Board) must be in writing or sent using Electronic Communication to an Electronic Address notified for that purpose to the person sending the notice or other document or information. |
44.2 | A notice or other document or information may be delivered or sent to a Member or another person by the Company personally or by post. Any letter or other document, if not delivered personally, must be sent by first class post and addressed to such Member or other person at the postal address in the Register (or at another address within the United Kingdom notified for the purpose) or left at that address in any envelope addressed to that Member or other person. Electronic Communications may be used for sending a notice or other document or information to a Member or other person where that Member or other person has agreed, or is deemed to have agreed, to the use of Electronic Communication and has specified an Electronic Address for this purpose. A notice or other document or information may be sent to a Member or other person by the Company by placing it on a website and sending the Member or other person concerned notification of the availability of the notice, document or information on the website, where the Member or other person has agreed, or is deemed, as provided by the Statutes, to have agreed to having such notices, documents or information sent to him in that manner. |
44.3 | Without prejudice to article 44.2, the Company may send or supply a notice or any other document or information that is required or authorised to be sent or supplied to a Member or any other person by the Company by any provision of the Statutes, or pursuant to these Articles or to any other rule or regulation to which the Company may be subject, in Electronic Form or by making it available on a website, and the provisions of schedule 5 to CA 2006 will apply whether or not any such notice, document or information is required or authorised by the Statutes to be sent or supplied. |
44.4 | Any notice or other document or information to be sent to a Member or other person may be sent by reference to the Register or the Company’s other records as they stand at any time within the period of 15 days before the notice or other document or information is sent and no change in the Register or the Company’s other records after that time will invalidate the sending of the notice or other document or information. |
44.5 | In the case of joint Holders of a share, a notice or other document or information will be sent to whichever of them is named first in the Register and a notice or other document or information sent in this way is sufficiently sent to all the joint Holders. |
44.6 | If any Member or other person (or, in the case of joint Holders, the person first named in the Register) has a registered address which is not within the United Kingdom but, not fewer than 14 Clear Days before the notice or other document or information is sent, has given to the Company an address within the United Kingdom at which notices or other documents or information may be sent to him or an Electronic Address to which notices or other documents or information may be sent using Electronic Communications, that Member is entitled to have notices or other such documents or information sent to him at that address or Electronic Address; otherwise no such Member or other person is entitled to receive any notice or document or information from the Company. |
42 |
44.7 | If, on three consecutive occasions, a notice or other document or information sent to a Member or other person is returned undelivered, such Member or other person will not thereafter be entitled to receive notices or other documents or information from the Company until he has communicated with the Company and supplied in writing to it a new address within the United Kingdom for the service of notices or other documents or information or has informed the Company, in such manner as may be specified by the Company, of an Electronic Address for the service of notices or other documents or information by Electronic Communication. For these purposes, a notice or other document or information sent by post will be treated as returned undelivered if it is sent back to the Company or its agents and a notice or other document or information sent by Electronic Communication will be treated as returned undelivered if the Company or its agents receive notification that it was not delivered to the address to which it was sent. |
44.8 | Any notice or other document or information sent addressed to a Member or another person at his registered address (or another address within the United Kingdom or an Electronic Address notified for the purpose) is deemed to be served, if personally delivered, at the time of delivery or, if sent by first class post, on the next Business Day after the letter is posted or, in the case of a notice or other document or information contained in an Electronic Communication, on the same day it is sent. A notice or other document or information left at such an address within the United Kingdom is deemed to be served on the day it is left. In proving service it is sufficient to establish that the letter was properly addressed and, if sent by post, prepaid or stamped and posted. Proof that a notice or other document or information contained in an Electronic Communication was sent in accordance with guidance issued by the Institute of Chartered Secretaries and Administrators will be conclusive evidence that the notice or other document or information was served. |
44.9 | Any Member present, either personally or by proxy, at any general meeting of the Company or of the Holders of any class of shares in the Company will for all purposes be deemed to have been given due notice of such meeting and, where requisite, of the purposes for which such meeting was called. |
44.10 | A person who becomes entitled by transmission, transfer or otherwise to a share is bound by a notice in respect of that share (other than a notice served by the Company under a Section 793 Notice (“Notice by company requiring information about interests in its shares”)) which, before his name is entered in the Register, has been properly sent to a person from whom he derives his title. |
44.11 | Where a person is entitled by transmission to a share, the Company may send a notice or other document or information to that person as if he were the Holder of a share by addressing it to him or to the representative of the deceased or trustee of the bankrupt Member at an address in the United Kingdom or Electronic Address supplied for that purpose by the person claiming or be entitled by transmission. Until an address has been supplied, a notice or other document or information may be sent in any manner in which it might have been sent if the death or bankruptcy or other event had not occurred. The giving of notice in accordance with this article 44.11 is sufficient notice to all other persons interested in the share. |
43 |
44.12 | If, by reason of the suspension or curtailment of postal or Electronic Communication services in the United Kingdom, the Company is unable effectively to convene a general meeting by notice sent through the post or by Electronic Communication, or to send any other document or information by post or by Electronic Communication, the Board may, if it thinks fit and as an alternative to any other method of service permitted by these Articles, send notice of the meeting or the other document or information to Members affected by the suspension or curtailment by a notice advertised in at least one United Kingdom national newspaper. Such notice or other document or information will be deemed to have been duly received by affected Members who are entitled to receive it at noon on the day when the advertisement appears. In any such case the Company must send confirmatory copies of the notice or other document or information by post or by Electronic Communication, as appropriate, to such affected Members if at least five days prior to the meeting, or any other appropriate date in connection with the document or information, the posting of notices or other documents or information or the sending of them by Electronic Communications again becomes practicable. |
45. | Untraced Members |
45.1 | The Company is entitled to sell at the best price reasonably obtainable any share of a Member or any share to which a person is entitled by transmission if: |
45.1.1 | during a period of 12 years the Company has paid at least three Dividends, whether interim or final in respect of the share in question and all cheques and warrants in respect of any such Dividend sent in the manner authorised by these Articles by the Company have been returned undelivered or remained uncashed and no communication has been received by the Company from the Member or the person entitled by transmission; |
45.1.2 | the Company has, at the expiry of the period of 12 years, by advertisement in both a United Kingdom national daily newspaper and in a newspaper circulating in the area which includes the address held by the Company for sending notices relating to the share in question or the last known address of the Member or other person entitled by transmission, giving notice of its intention to sell the share; |
45.1.3 | the Company has not, during the further period of three months after the date of the advertisement and prior to the exercise of the power of sale, received any communication from the Member or person entitled by transmission; and |
45.1.4 | the Company has first given notice, and other information as may be required, in writing to the UK Listing Authority of its intention to sell such shares or stock. |
45.2 | To give effect to any such sale, the Board may, in relation to Certificated Shares, appoint any person to execute as transferor an instrument of transfer of such share and such instrument of transfer will be as effective as if it had been Executed by the registered Holder of or person entitled by the transmission to such share. In relation to Uncertificated Shares the Board may, in accordance with the Statutes, issue a written notification to the Operator of the relevant system requiring conversion of the shares into certificated form and exercise any of the Company’s powers under article 6.10.3 to effect the transfer of the shares to, or in accordance with the directions of, the purchaser and the exercise of such powers will be as effective as if exercised by the registered Holder of, or person entitled by transmission to, such shares. In relation to both certificated and Uncertificated Shares the transferee is not bound to see to the application of the purchase money and the title of the transferee is not affected by any irregularity or invalidity in the proceedings relating to the sale. |
44 |
45.3 | The Company must account to the Member or other person entitled to such share for the net proceeds of such sale by crediting all money in respect of those proceeds to a separate account, which are a permanent debt of the Company, and the Company will be deemed to be a debtor and not a trustee in respect of it for such Member or other person. Money carried to such separate account may either be employed in the business of the Company or invested in such investments, other than shares of the Company or its holding company if any, as the Board may from time to time think fit. |
46. | Destruction of documents |
46.1 | The Company may destroy: |
46.1.1 | any share certificate which has been cancelled at any time after the expiry of one year from the date of such cancellation; |
46.1.2 | any Dividend mandate or any variation or cancellation of it or any notification of change of name or address (including an Electronic Address) at any time after the expiry of two years from the date such mandate, variation, cancellation or notification was recorded by the Company; |
46.1.3 | any instrument of transfer of shares which has been registered or Operator instructions for the transfer of shares at any time after the expiry of six years from the date of registration; |
46.1.4 | any other document on the basis of which any entry in the Register is made at any time after the expiry of six years from the date an entry in the Register was first made in respect of it; |
46.1.5 | any proxy appointment that has been used for the purpose of a poll at any time after the expiration of one year from the date of use; and |
46.1.6 | any proxy appointment that has not been used for the purpose of a poll at any time after one month from the end of the meeting to which the proxy appointment relates and at which no poll was demanded. |
46.2 | It will be conclusively presumed in favour of the Company that every share certificate so destroyed was a valid certificate duly and properly cancelled, that every instrument of transfer so destroyed was a valid and effective instrument duly and properly registered and that every other document destroyed under article 46.1 was a valid and effective document, in accordance with its recorded particulars in the books or records of the Company. |
46.3 | The provisions of article 46.2 apply only to the destruction of a document in good faith and without express notice to the Company that the preservation of such document was relevant to a claim. |
46.4 | Nothing contained in article 46.1 is construed as imposing upon the Company any liability in respect of the destruction of any such document earlier than as set out in article 46.1 or in any case where the conditions of article 46.3 are not fulfilled. |
46.5 | References in this article 46 to the destruction of any document include references to its disposal in any manner. |
45 |
47. | Winding-up |
47.1 | If the Company is wound up, whether the liquidation is voluntary, under supervision or by the court, the liquidator may, with the authority of a special resolution, divide among the Members (excluding any holding shares or treasury shares) in specie the whole or part of the assets of the Company, whether or not the assets consist of property of one kind or of different kinds. For those purposes the liquidator may set such value as he deems fair upon any one or more class or classes of property and may determine how such division will be effected as between the Members or different classes of Members. If any such division is carried out otherwise than in accordance with the existing rights of the Members, every Member will have the same right of dissent and other ancillary rights as if such resolution were a special resolution passed in accordance with section 110 Insolvency Act 1986. The liquidator may, with the same authority, vest any part of the assets in trustees upon such trusts for the benefit of Members as the liquidator, with the same authority, thinks fit and the liquidation of the Company may be closed and the Company dissolved. No Member will be compelled to accept any shares in respect of which there is a liability. |
47.2 | The Board must exercise the power conferred upon them by section 247 CA 2006 only with the prior sanction of a special resolution. If at any time the capital of the Company is divided into different classes of shares, the exercise of such power is deemed to be a variation of the rights attached to each class of shares and, accordingly, requires the prior consent in writing of the Holders of three fourths in nominal value of the issued shares of each class (excluding treasury shares) or the prior sanction of a special resolution passed at a separate meeting of the Holders of the shares of each class (excluding any shares of a class held as treasury shares) convened and held in accordance with the provisions of article 5.10. |
48. | Indemnity |
Subject to the provisions of the Statutes, every Director or other officer (except the Auditors) of the Company will be indemnified out of the assets of the Company, against all costs, charges, expenses, losses and liabilities which he may sustain or incur in connection with the execution of his duties and powers or otherwise in relation to them. Without prejudice to the generality of the previous sentence, any such person will be indemnified out of the assets of the Company against any liability incurred by him in defending any proceedings, whether civil or criminal, in relation anything done or omitted or alleged to have been done or omitted by him as an officer of the Company and in which judgment is given in his favour (or the proceedings are otherwise disposed of without any finding or admission of any material breach of duty by him) or in which he is acquitted or in connection with any application in which relief is granted to him by the court from liability for negligence, default, breach of duty or breach of trust in relation to the affairs of the Company. Subject to the Statutes, the Company may purchase and maintain for any Director, Secretary or other officer of the Company insurance against any liability which by virtue of any rule of law would otherwise attach to him in respect of any negligence, default, breach of duty or breach of trust of which he may be guilty in relation to the Company.
49. | Indemnity against claims in respect of shares |
49.1 | The provisions of article 49.2 will apply whenever any law for the time being of any country, state or place imposes or purports to impose any immediate or future or possible liability on the Company to make any payment, or empowers any government or taxing authority or government official to require the Company to make any payment, in respect of any shares held either jointly or solely by a Member or in respect of any Dividends or other money due or payable or accruing due or which may become due or payable to such Members by the Company or in respect of any such shares or for or on account or in respect of any Member in consequence of: |
46 |
49.1.1 | the death or bankruptcy of such Member; |
49.1.2 | the non payment of any Income Tax or other tax by such Member; or |
49.1.3 | the non payment of any Inheritance Tax or any estate, probate, succession, death, stamp or other duty by the executors or administrators or other legal personal representatives of such Member or by or out of his estate. |
49.2 | In the circumstances described in article 49.1 the Company: |
49.2.1 | will be fully indemnified by such Member or his executors or administrators or his other legal personal representatives from all liability arising by virtue of such law; and |
49.2.2 | may recover as a debt due from such Member or his executors or administrators or his other legal personal representatives wherever constituted or residing, any money paid by the Company under or in consequence of any such law, together with interest on it at the rate of 15% per annum from the date of payment to the date of repayment. |
49.3 | Nothing contained in articles 49.1 and 49.2 prejudices or affects any right or remedy which any law may confer or purport to confer on the Company and, as between the Company and every such Member as is referred to in article 49.1, his executors, administrators or other legal personal representatives, and estate wherever constituted or situated, any right or remedy which such law confers or purports to confer on the Company will be enforceable by the Company. |
50. | Exclusive jurisdiction |
50.1 | Save in respect of any cause of action arising under the Securities Act or the Exchange Act, unless the majority of the Board consents to the selection of an alternative forum, the courts of England and Wales shall be the exclusive forum for the resolution of: |
50.1.1 | any derivative action or proceeding brought on behalf of the Company; |
50.1.2 | any action or proceeding asserting a claim of breach of fiduciary duty owed by any director, officer or other employee to the Company; |
50.1.3 | any action or proceeding asserting a claim arising out of any provision of CA 2006 or these Articles; or |
50.1.4 | any action or proceeding asserting a claim or otherwise related to the affairs of the Company. |
50.2 | Unless the majority of the Board consents to the selection of an alternative forum in the United States, the United States District Court for the Southern District of New York shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act or the Exchange Act. |
50.3 | Any person or entity purchasing or otherwise acquiring any interest in the Company’s shares shall be deemed to have notice of and to have consented to the provisions of this article 50. |
47 |
Exhibit 4.1
TABLE OF CONTENTS
Page | ||
PARTIES | 3 | |
RECITALS | 3 | |
Section 1. | Certain Definitions | 3 |
(a) | ADR Register | 3 |
(b) | ADRs; Direct Registration ADRs | 3 |
(c) | ADS | 3 |
(d) | Beneficial Owner | 3 |
(e) | Custodian | 3 |
(f) | Deliver, execute, issue et al. | 4 |
(g) | Delivery Order | 4 |
(h) | Deposited Securities | 4 |
(i) | Direct Registration System | 4 |
(j) | Holder | 4 |
(k) | Securities Act of 1933 | 4 |
(l) | Securities Exchange Act of 1934 | 4 |
(m) | Shares | 5 |
(n) | Transfer Office | 5 |
(o) | Withdrawal Order | 5 |
Section 2. | Form of ADRs | 5 |
Section 3. | Deposit of Shares | 5 |
Section 4. | Issue of ADRs | 7 |
Section 5. | Distributions on Deposited Securities | 7 |
Section 6. | Withdrawal of Deposited Securities | 7 |
Section 7. | Substitution of ADRs | 7 |
Section 8. | Cancellation and Destruction of ADRs; Maintenance of Records | 8 |
Section 9. | The Custodian | 8 |
Section 10. | Lists of Holders | 8 |
Section 11. | Depositary's Agents | 8 |
Section 12. | Resignation and Removal of the Depositary; Appointment of Successor Depositary | 9 |
Section 13. | Reports | 10 |
Section 14. | Additional Shares | 10 |
Section 15. | Indemnification | 10 |
Section 16. | Notices | 11 |
Section 17. | Counterparts | 12 |
Section 18. | No Third Party Beneficiaries; Holders and Beneficial Owners as Parties; Binding Effect | 12 |
Section 19. | Severability | 13 |
Section 20. | Governing Law; Consent to Jurisdiction | 13 |
Section 21. | Agent for Service | 14 |
Section 22. | Waiver of Immunities | 15 |
Section 23. | Waiver of Jury Trial | 15 |
TESTIMONIUM | ||
SIGNATURES |
- i -
EXHIBIT A
Page | |||
FORM OF FACE OF ADR | A-1 | ||
Introductory Paragraph | A-1 | ||
(1) | Issuance of ADSs | A-2 | |
(2) | Withdrawal of Deposited Securities | A-3 | |
(3) | Transfers, Split-Ups and Combinations of ADRs | A-3 | |
(4) | Certain Limitations to Registration, Transfer etc. | A-4 | |
(5) | Liability for Taxes, Duties and Other Charges | A-5 | |
(6) | Disclosure of Interests | A-6 | |
(7) | Charges of Depositary | A-7 | |
(8) | Available Information | A-11 | |
(9) | Execution | A-11 | |
Signature of Depositary | A-11 | ||
Address of Depositary's Office | A-11 | ||
FORM OF REVERSE OF ADR | A-11 | ||
(10) | Distributions on Deposited Securities | A-12 | |
(11) | Record Dates | A-13 | |
(12) | Voting of Deposited Securities | A-14 | |
(13) | Changes Affecting Deposited Securities | A-15 | |
(14) | Exoneration | A-16 | |
(15) | Resignation and Removal of Depositary; the Custodian | A-19 | |
(16) | Amendment | A-20 | |
(17) | Termination | A-20 | |
(18) | Appointment; Acknowledgements and Agreements | A-21 | |
(19) | Waiver | A-22 | |
(20) | Elective Distributions in Cash or Shares | A-22 |
- ii -
DEPOSIT AGREEMENT dated as of ____________________ __, 2021 (the "Deposit Agreement") among ARGO BLOCKCHAIN PLC and its successors (the "Company"), JPMORGAN CHASE BANK, N.A., as depositary hereunder (the "Depositary"), and all Holders and Beneficial Owners from time to time of American Depositary Receipts issued hereunder ("ADRs") evidencing American Depositary Shares ("ADSs") representing deposited Shares (defined below). The Company hereby appoints the Depositary as depositary for the Deposited Securities and hereby authorizes and directs the Depositary to act in accordance with the terms set forth in this Deposit Agreement. All capitalized terms used herein have the meanings ascribed to them in Section 1 or elsewhere in this Deposit Agreement. The parties hereto agree as follows:
1. Certain Definitions.
(a) "ADR Register" is defined in paragraph (3) of the form of ADR (Transfers, Split-Ups and Combinations of ADRs).
(b) "ADRs" mean the American Depositary Receipts executed and delivered hereunder. ADRs may be either in physical certificated form or Direct Registration ADRs (as hereinafter defined). ADRs in physical certificated form, and the terms and conditions governing the Direct Registration ADRs, shall be substantially in the form of Exhibit A annexed hereto (the "form of ADR"). The term "Direct Registration ADR" means an ADR, the ownership of which is recorded on the Direct Registration System. References to "ADRs" shall include certificated ADRs and Direct Registration ADRs, unless the context otherwise requires. The form of ADR is hereby incorporated herein and made a part hereof; the provisions of the form of ADR shall be binding upon the parties hereto.
(c) Subject to paragraph (13) of the form of ADR, (Changes Affecting Deposited Securities) each "ADS" evidenced by an ADR represents the right to receive, and to exercise the beneficial ownership interests in, the number of Shares specified in the form of ADR attached hereto as Exhibit A (as amended from time to time) that are on deposit with the Depositary and/or the Custodian and a pro rata share in any other Deposited Securities, subject, in each case, to the terms of this Deposit Agreement and the ADSs. The ADS(s)-to-Share(s) ratio is subject to amendment as provided in the form of ADR (which may give rise to fees contemplated in paragraph (7) thereof) (Charges of Depositary).
(d) "Articles of Association" means the articles of association of the Company, as amended and in effect from time to time.
(e) "Beneficial Owner" means as to any ADS, any person or entity having a beneficial ownership interest in such ADS. A Beneficial Owner need not be the Holder of the ADR evidencing such ADS. If a Beneficial Owner of ADSs is not a Holder, it must rely on the Holder of the ADR(s) evidencing such ADSs in order to assert any rights or receive any benefits under this Deposit Agreement. The arrangements between a Beneficial Owner of ADSs and the Holder of the corresponding ADRs may affect the Beneficial Owner’s ability to exercise any rights it may have.
3 |
(f) "Custodian" means the agent or agents of the Depositary (singly or collectively, as the context requires) and any additional or substitute Custodian appointed pursuant to Section 9.
(g) The terms "deliver", "execute", "issue", "register", "surrender", "transfer" or "cancel", when used with respect to Direct Registration ADRs, shall refer to an entry or entries or an electronic transfer or transfers in the Direct Registration System, and, when used with respect to ADRs in physical certificated form, shall refer to the physical delivery, execution, issuance, registration, surrender, transfer or cancellation of certificates representing the ADRs.
(h) "Delivery Order" is defined in Section 3.
(i) "Deposited Securities" as of any time means all Shares at such time deposited under this Deposit Agreement and any and all other Shares, securities, property and cash at such time held by the Depositary or the Custodian in respect or in lieu of such deposited Shares and other Shares, securities, property and cash. Deposited Securities are not intended to, and shall not, constitute proprietary assets of the Depositary, the Custodian or their nominees. Beneficial ownership in Deposited Securities is intended to be, and shall at all times during the term of the Deposit Agreement continue to be, vested in the Beneficial Owners of the ADSs representing such Deposited Securities.
(j) "Direct Registration System" means the system for the uncertificated registration of ownership of securities established by The Depository Trust Company ("DTC") and utilized by the Depositary pursuant to which the Depositary may record the ownership of ADRs without the issuance of a certificate, which ownership shall be evidenced by periodic statements issued by the Depositary to the Holders entitled thereto. For purposes hereof, the Direct Registration System shall include access to the Profile Modification System maintained by DTC which provides for automated transfer of ownership between DTC and the Depositary.
(k) "Holder" means the person or persons in whose name an ADR is registered on the ADR Register. For all purposes under the Deposit Agreement and the ADRs, a Holder shall be deemed to have all requisite authority to act on behalf of any and all Beneficial Owners of the ADSs evidenced by the ADR(s) registered in such Holder's name.
(l) "Securities Act of 1933" means the United States Securities Act of 1933, as from time to time amended.
4 |
(m) "Securities Exchange Act of 1934" means the United States Securities Exchange Act of 1934, as from time to time amended.
(n) "Shares" mean the ordinary shares of the Company, and shall include the rights to receive Shares specified in paragraph (1) of the form of ADR (Issuance of ADSs).
(o) "Transfer Office" is defined in paragraph (3) of the form of ADR (Transfers, Split-Ups and Combinations of ADRs).
(p) "Withdrawal Order" is defined in Section 6.
2. Form of ADRs.
(a) Direct Registration ADRs. Notwithstanding anything in this Deposit Agreement or in the form of ADR to the contrary, ADSs shall be evidenced by Direct Registration ADRs, unless certificated ADRs are specifically requested by the Holder.
(b) Certificated ADRs. ADRs in certificated form shall be printed or otherwise reproduced at the discretion of the Depositary in accordance with its customary practices in its American depositary receipt business, or at the request of the Company typewritten and photocopied on plain or safety paper, and shall be substantially in the form set forth in the form of ADR, with such changes as may be required by the Depositary or the Company to comply with their obligations hereunder, any applicable law, regulation or usage or to indicate any special limitations or restrictions to which any particular ADRs are subject. ADRs may be issued in denominations of any number of ADSs. ADRs in certificated form shall be executed by the Depositary by the manual or facsimile signature of a duly authorized officer of the Depositary. ADRs in certificated form bearing the facsimile signature of anyone who was at the time of execution a duly authorized officer of the Depositary shall bind the Depositary, notwithstanding that such officer has ceased to hold such office prior to the delivery of such ADRs.
(c) Binding Effect. Holders of ADRs, and the Beneficial Owners of the ADSs evidenced by such ADRs, shall each be bound by the terms and conditions of this Deposit Agreement and of the form of ADR, regardless of whether such ADRs are Direct Registration ADRs or certificated ADRs.
3. Deposit of Shares.
(a) Requirements. In connection with the deposit of Shares hereunder, the Depositary or the Custodian may require the following in a form satisfactory to it:
(i) a written order directing the Depositary to issue to, or upon the written order of, the person or persons designated in such order a Direct Registration ADR or ADRs evidencing the number of ADSs representing such deposited Shares (a "Delivery Order");
5 |
(ii) proper endorsements or duly executed instruments of transfer in respect of such deposited Shares;
(iii) instruments assigning to the Depositary, the Custodian or a nominee of either any distribution on or in respect of such deposited Shares or indemnity therefor; and
(iv) proxies entitling the Custodian to vote such deposited Shares.
(b) Registration of Deposited Securities. As soon as practicable after the Custodian receives Deposited Securities pursuant to any such deposit or pursuant to paragraph (10) (Distributions on Deposited Securities) or (13) (Changes Affecting Deposited Securities) of the form of ADR, the Custodian shall present such Deposited Securities for registration of transfer into the name of the Depositary, the Custodian or a nominee of either, in each case for the benefit of Holders, to the extent such registration is practicable, at the cost and expense of the person making such deposit (or for whose benefit such deposit is made) and shall obtain evidence satisfactory to it of such registration. Deposited Securities shall be held by the Custodian for the account and to the order of the Depositary for the benefit of Holders of ADRs (to the extent not prohibited by law) at such place or places and in such manner as the Depositary shall determine. Notwithstanding anything else contained herein, in the form of ADR and/or any outstanding ADSs, the Depositary, the Custodian and their respective nominees are intended to be, and shall at all times during the term of the Deposit Agreement be, the record holder(s) only of the Deposited Securities represented by the ADSs for the benefit of the Holders. The Depositary, on its own behalf and on behalf of the Custodian and their respective nominees, disclaims any beneficial ownership interest in the Deposited Securities held on behalf of the Holders.
(c) Delivery of Deposited Securities. Deposited Securities may be delivered by the Custodian to any person only under the circumstances expressly contemplated in this Deposit Agreement. To the extent that the provisions of or governing the Shares make delivery of certificates therefor impracticable, Shares may be deposited hereunder by such delivery thereof as the Depositary or the Custodian may reasonably accept, including, without limitation, by causing them to be credited to an account maintained by the Custodian for such purpose with the Company or an accredited intermediary, such as a bank, acting as a registrar for the Shares, together with delivery of the documents, payments and Delivery Order referred to herein to the Custodian or the Depositary.
6 |
4. Issue of ADRs. After any such deposit of Shares, the Custodian shall notify the Depositary of such deposit and of the information contained in any related Delivery Order by letter, first class airmail postage prepaid, or, at the request, risk and expense of the person making the deposit, by SWIFT, cable, telex or facsimile transmission. After receiving such notice from the Custodian, the Depositary, subject to this Deposit Agreement, shall properly issue at the Transfer Office, to or upon the order of any person named in such notice, an ADR or ADRs registered as requested and evidencing the aggregate ADSs to which such person is entitled.
5. Distributions on Deposited Securities. To the extent that the Depositary determines in its discretion that any distribution pursuant to paragraph (10) of the form of ADR (Distributions on Deposited Securities) is not practicable with respect to any Holder, the Depositary may (after consultation with the Company, if practicable, in the case where the Depository believes such distribution is not practicable with respect to all Holders) make such distribution as it so deems practicable, including the distribution of foreign currency, securities or property (or appropriate documents evidencing the right to receive foreign currency, securities or property) or the retention thereof as Deposited Securities with respect to such Holder's ADRs (without liability for interest thereon or the investment thereof).
6. Withdrawal of Deposited Securities. In connection with any surrender of an ADR for withdrawal of the Deposited Securities represented by the ADSs evidenced thereby, the Depositary may require proper endorsement in blank of such ADR (or duly executed instruments of transfer thereof in blank) and the Holder's written order directing the Depositary to cause the Deposited Securities represented by the ADSs evidenced by such ADR to be withdrawn and delivered to, or upon the written order of, any person designated in such order (a "Withdrawal Order"). Directions from the Depositary to the Custodian to deliver Deposited Securities shall be given by letter, first class airmail postage prepaid, or, at the request, risk and expense of the Holder, by SWIFT, cable, telex or facsimile transmission. Delivery of Deposited Securities may be made by the delivery of certificates (which, if required by law shall be properly endorsed or accompanied by properly executed instruments of transfer or, if such certificates may be registered, registered in the name of such Holder or as ordered by such Holder in any Withdrawal Order) or by such other means as the Depositary may deem practicable, including, without limitation, by transfer of record ownership thereof to an account designated in the Withdrawal Order maintained either by the Company or an accredited intermediary, such as a bank, acting as a registrar for the Deposited Securities.
7. Substitution of ADRs. The Depositary shall execute and deliver a new Direct Registration ADR in exchange and substitution for any mutilated certificated ADR upon cancellation thereof or in lieu of and in substitution for such destroyed, lost or stolen certificated ADR, unless the Depositary has notice that such ADR has been acquired by a bona fide purchaser, upon the Holder thereof filing with the Depositary a request for such execution and delivery and a sufficient indemnity bond and satisfying any other reasonable requirements imposed by the Depositary.
7 |
8. Cancellation and Destruction of ADRs; Maintenance of Records. All ADRs surrendered to the Depositary shall be cancelled by the Depositary. The Depositary is authorized to destroy ADRs in certificated form so cancelled in accordance with its customary practices. The Depositary, however, shall maintain or cause its agents to maintain records of all ADRs surrendered and Deposited Securities withdrawn under Section 6 hereof and paragraph (2) of the form of ADR, substitute ADRs delivered under Section 7 hereof, and canceled or destroyed ADRs under this Section 8, in keeping with the procedures ordinarily followed by stock transfer agents located in the United States or as required by the laws or regulations governing the Depositary.
9. The Custodian.
(a) Rights of the Depositary. Any Custodian in acting hereunder shall be subject to the directions of the Depositary and shall be responsible solely to it. The Depositary reserves the right to add, replace or remove a Custodian. The Depositary will give prompt notice of any such action, which will be advance notice if practicable. The Depositary may discharge any Custodian at any time upon notice to the Custodian being discharged.
(b) Rights of the Custodian. Any Custodian may resign from its duties hereunder by providing at least 30 days' prior written notice to the Depositary. Any Custodian ceasing to act hereunder as Custodian shall deliver, upon the instruction of the Depositary, all Deposited Securities held by it to a Custodian continuing to act. Notwithstanding anything to the contrary contained in this Deposit Agreement (including the ADRs) and, subject to the further limitations set forth in subparagraph (p) of paragraph (14) of the form of ADR (Exoneration), the Depositary shall not be responsible for, and shall incur no liability in connection with or arising from, any act or omission to act on the part of the Custodian except to the extent that any Holder has incurred liability directly as a result of the Custodian having (i) committed fraud or willful misconduct in the provision of custodial services to the Depositary or (ii) failed to use reasonable care in the provision of custodial services to the Depositary as determined in accordance with the standards prevailing in the jurisdiction in which the Custodian is located.
10. Lists of Holders. The Company shall have the right to inspect transfer records of the Depositary and its agents and the ADR Register, take copies thereof and require the Depositary and its agents to supply copies of such portions of such records as the Company may request. The Depositary or its agent shall furnish to the Company promptly upon the written request of the Company, a list of the names, addresses and holdings of ADSs by all Holders as of a date within seven days of the Depositary's receipt of such request.
11. Depositary's Agents. The Depositary may perform its obligations under this Deposit Agreement through any agent appointed by it, provided that the Depositary shall notify the Company of such appointment and shall remain responsible for the performance of such obligations as if no agent were appointed, subject to paragraph (14) of the form of ADR (Exoneration).
8 |
12. Resignation and Removal of the Depositary; Appointment of Successor Depositary.
(a) Resignation of the Depositary. The Depositary may at any time resign as Depositary hereunder by written notice of its election to do so delivered to the Company, such resignation to take effect upon the appointment of a successor depositary and its acceptance of such appointment as hereinafter provided.
(b) Removal of the Depositary. The Depositary may at any time be removed by the Company by providing no less than 60 days' prior written notice of such removal to the Depositary, such removal to take effect the later of (i) the 60th day after such notice of removal is first provided and (ii) the appointment of a successor depositary and its acceptance of such appointment as hereinafter provided. Notwithstanding the foregoing, if upon the resignation or removal of the Depositary a successor depositary is not appointed within the applicable 60-day period as specified in paragraph (17) of the form of ADR (Termination), then the Depositary may elect to terminate this Deposit Agreement and the ADR and the provisions of said paragraph (17) shall thereafter govern the Depositary's obligations hereunder.
(c) Appointment of Successor Depositary. In case at any time the Depositary acting hereunder shall resign or be removed, the Company shall use its commercially reasonable efforts to appoint a successor depositary, which shall be a bank or trust company having an office in the Borough of Manhattan, The City of New York. Every successor depositary shall execute and deliver to its predecessor and to the Company an instrument in writing accepting its appointment hereunder, and thereupon such successor depositary, without any further act or deed, shall become fully vested with all the rights, powers, duties and obligations of its predecessor. The predecessor depositary, only upon payment of all sums due to it and on the written request of the Company, shall (i) execute and deliver an instrument transferring to such successor all rights and powers of such predecessor hereunder (other than its rights to indemnification and fees owing, each of which shall survive any such removal and/or resignation), (ii) duly assign, transfer and deliver all right, title and interest to the Deposited Securities to such successor, and (iii) deliver to such successor a list of the Holders of all outstanding ADRs. Any such successor depositary shall promptly mail notice of its appointment to such Holders. Any bank or trust company into or with which the Depositary may be merged or consolidated, or to which the Depositary shall transfer substantially all its American depositary receipt business, shall be the successor of the Depositary without the execution or filing of any document or any further act.
9 |
13. Reports. On or before the first date on which the Company makes any communication available to holders of Deposited Securities or any securities regulatory authority or stock exchange, by publication or otherwise, the Company shall transmit to the Depositary a copy thereof in English or with an English translation or summary. The Company has delivered to the Depositary, the Custodian and any Transfer Office, a copy of all provisions of or governing the Shares and any other Deposited Securities issued by the Company or any affiliate of the Company and, promptly upon any change thereto, the Company shall deliver to the Depositary, the Custodian and any Transfer Office, a copy (in English or with an English translation) of such provisions as so changed. The Depositary and its agents may rely upon the Company's delivery of all such communications, information and provisions for all purposes of this Deposit Agreement and the Depositary shall have no liability for the accuracy or completeness of any thereof.
14. Additional Shares. The Company agrees with the Depositary that neither the Company nor any company controlling, controlled by or under common control with the Company shall (a) issue (i) additional Shares, (ii) rights to subscribe for Shares, (iii) securities convertible into or exchangeable for Shares or (iv) rights to subscribe for any such securities or (b) deposit any Shares under this Deposit Agreement, except, in each case, under circumstances complying in all respects with the Securities Act of 1933. At the reasonable request of the Depositary where it deems necessary, the Company will furnish the Depositary with legal opinions, in forms and from counsels reasonably acceptable to the Depositary, dealing with such issues requested by the Depositary. The Depositary will not knowingly accept for deposit hereunder any Shares required to be registered under the Securities Act of 1933 unless a registration statement is in effect and will use reasonable efforts to comply with written instructions of the Company not to accept for deposit hereunder any Shares identified in such instructions at such times and under such circumstances as may reasonably be specified in such instructions in order to facilitate the Company's compliance with the requirements of the securities laws, rules and regulations in the United States.
15. Indemnification.
(a) Indemnification by the Company. The Company shall indemnify, defend and save harmless each of the Depositary, the Custodian and their respective directors, officers, employees, agents and affiliates against any loss, liability or expense (including reasonable fees and expenses of counsel) which may arise out of acts performed or omitted, in connection with the provisions of this Deposit Agreement and of the ADRs, as the same may be amended, modified or supplemented from time to time in accordance herewith (i) by either the Depositary or a Custodian or their respective directors, officers, employees, agents and affiliates, except for any liability or expense directly arising out of the negligence, or willful misconduct of the Depositary or its directors, officers or affiliates acting in their capacities as such hereunder, or (ii) by the Company or any of its directors, officers, employees, agents and affiliates.
10 |
The indemnities set forth in the preceding paragraph shall also apply to any liability or expense which may arise out of any misstatement or alleged misstatement or omission or alleged omission in any registration statement, proxy statement, prospectus (or placement memorandum), or preliminary prospectus (or preliminary placement memorandum) relating to the offer, issuance, withdrawal or sale of ADSs or the deposit of Shares in connection therewith, except to the extent any such liability or expense arises out of (i) information relating to the Depositary or its agents (other than the Company), as applicable, furnished in writing by the Depositary expressly for use in any of the foregoing documents and not changed or altered by the Company or (ii) if such information is provided, the failure to state a material fact necessary to make the information provided not misleading.
(b) Indemnification by the Depositary. Subject to the limitations provided for in Section 15(c) below, the Depositary shall indemnify, defend and save harmless the Company against any direct loss, liability or expense (including reasonable fees and expenses of counsel resulting therefrom) incurred by the Company in respect of this Deposit Agreement to the extent such loss, liability or expense is due to the negligence or willful misconduct of the Depositary.
(c) Damages or Lost Profits. Notwithstanding any other provision of this Deposit Agreement or the ADRs to the contrary, neither the Depositary nor any of its agents shall be liable for any indirect, special, punitive or consequential damages (including, without limitation, legal fees and expenses) or lost profits, in each case of any form incurred by any person or entity, whether or not foreseeable and regardless of the type of action in which such a claim may be brought.
(d) Survival. The obligations set forth in this Section 15 shall survive the termination of this Deposit Agreement and the succession or substitution of any indemnified person.
16. Notices.
(a) Notice to Holders. Notice to any Holder shall be deemed given when first mailed, first class postage prepaid, to the address of such Holder on the ADR Register or received by such Holder. Failure to notify a Holder or any defect in the notification to a Holder shall not affect the sufficiency of notification to other Holders or to the Beneficial Owners of ADSs held by such other Holders. The Depositary's only notification obligations under this Deposit Agreement and the ADRs shall be to Holders. Notice to a Holder shall be deemed, for all purposes of the Deposit Agreement and the ADRs, to constitute notice to any and all Beneficial Owners of the ADSs evidenced by such Holder’s ADRs.
11 |
(b) Notice to the Depositary or the Company. Notice to the Depositary or the Company shall be deemed given when first received by it at the address or facsimile transmission number set forth in (i) or (ii), respectively, or by electronic transmission to the e-mail address set forth below or otherwise provided by the Depositary or the Company to the other in writing, or at such other address or facsimile transmission number as either may specify to the other by written notice:
(i) | JPMorgan Chase Bank, N.A. |
383 Madison Avenue, Floor 11
New York, New York, 10179
Attention: Depositary Receipts Group
Fax: (302) 220-4591
E-mail Address: DR_Global_CSM@jpmorgan.com
(ii) | Argo Blockchain Plc |
50 Jermyn Street
Room 4, 1st floor
SW1Y 6LX
Attention: Alex Appleton
E-mail Address: alex@argoblockchain.com
Delivery of a notice by means of electronic messaging shall be deemed to be effective at the time of the initiation of the transmission by the sender (as shown on the sender’s records) to the email address set forth above, notwithstanding that the intended recipient retrieves the message at a later date, fails to retrieve such message, or fails to receive such notice on account of its failure to maintain the designated e-mail address, its failure to designate a substitute e-mail address or for any other reason.
17. Counterparts. This Deposit Agreement may be executed in any number of counterparts, each of which shall be deemed an original and all of which shall constitute one instrument. Delivery of an executed signature page of this Deposit Agreement by facsimile or other electronic transmission (including “.pdf”, “.tif” or similar format) shall be effective as delivery of a manually executed counterpart hereof.
18. No Third-Party Beneficiaries; Holders and Beneficial Owners as Parties; Binding Effect. This Deposit Agreement is for the exclusive benefit of the Company, the Depositary, the Holders, and their respective successors hereunder, and, except to the extent specifically set forth in Section 15 of this Deposit Agreement, shall not give any legal or equitable right, remedy or claim whatsoever to any other person. The Holders and Beneficial Owners from time to time shall be parties to this Deposit Agreement and shall be bound by all of the provisions hereof. A Beneficial Owner shall only be able to exercise any right or receive any benefit hereunder solely through the Holder of the ADR(s) evidencing the ADSs owned by such Beneficial Owner.
12 |
19. Severability. If any provision of this Deposit Agreement or the ADRs is invalid, illegal or unenforceable in any respect, the remaining provisions contained herein and therein shall in no way be affected thereby.
20. Governing Law; Consent to Jurisdiction.
(a) The Deposit Agreement, the ADSs and the ADRs shall be governed by and construed in accordance with the internal laws of the State of New York without giving effect to the application of the conflict of law principles thereof.
(b) By the Company or the Depository. The Company irrevocably agrees that any legal suit, action or proceeding against the Company brought by the Depositary, arising out of or based upon this Deposit Agreement, the ADSs or the ADRs or the transactions contemplated hereby or thereby, may be instituted in any state or federal court in New York, New York, and irrevocably waives any objection which it may now or hereafter have to the laying of venue of any such proceeding, and irrevocably submits to the non-exclusive jurisdiction of such courts in any such suit, action or proceeding. The Company also irrevocably agrees that any legal suit, action or proceeding against the Depositary brought by the Company, arising out of or based upon this Deposit Agreement or the transactions contemplated hereby, may only be instituted in a state or federal court in New York, New York.
(c) By Holders and Beneficial Owners. By holding or owning an ADR or ADS or an interest therein, Holders and Beneficial Owners each irrevocably agree that any legal suit, action or proceeding against or involving Holders or Beneficial Owners brought by the Company or the Depositary, arising out of or based upon this Deposit Agreement, the ADSs, the ADRs or the transactions contemplated herein, therein, hereby or thereby, may be instituted in a state or federal court in New York, New York, and by holding an ADS or an interest therein each irrevocably waives any objection which it may now or hereafter have to the laying of venue of any such proceeding, and irrevocably submits to the exclusive jurisdiction of such courts in any such suit, action or proceeding. By holding or owning an ADR or ADS or an interest therein, Holders and Beneficial Owners each also irrevocably agree that any legal suit, action or proceeding against or involving the Depositary and/or the Company brought by Holders or Beneficial Owners, arising out of or based upon this Deposit Agreement, the ADSs, the ADRs or the transactions contemplated herein, therein, hereby or thereby, including, without limitation, claims under the Securities Act of 1933, may be instituted only in the United States District Court for the Southern District of New York (or in the state courts of New York County in New York if either (i) the United States District Court for the Southern District of New York lacks subject matter jurisdiction over a particular dispute or (ii) the designation of the United States District Court for the Southern District of New York as the exclusive forum for any particular dispute is, or becomes, invalid, illegal or unenforceable).
(d) Notwithstanding the foregoing, any action against the Company based on this Deposit Agreement, the ADSs or the ADRs or the transactions contemplated hereby or thereby, may be instituted by the Depositary in any competent court in England and/or the United States.
13 |
21. Agent for Service.
(a) Appointment. The Company has appointed Puglisi & Associates, 850 Library Avenue, Suite 204, Newark, DE 19711, 302-738-6680, as its authorized agent (the "Authorized Agent") upon which process may be served in any such action arising out of or based on this Deposit Agreement or the transactions contemplated hereby which may be instituted in any state or federal court in New York, New York by the Depositary or any Holder, and waives any other requirements of or objections to personal jurisdiction with respect thereto. Subject to the Company’s rights to replace the Authorized Agent with another entity in the manner required were the Authorized Agent to have resigned, such appointment shall be irrevocable.
(b) Agent for Service of Process. The Company represents and warrants that the Authorized Agent has agreed to act as said agent for service of process, and the Company agrees to take any and all action, including the filing of any and all documents and instruments, that may be necessary to continue such appointment in full force and effect as aforesaid. The Company further hereby irrevocably consents and agrees to the service of any and all legal process, summons, notices and documents in any suit, action or proceeding against the Company, by service by mail of a copy thereof upon the Authorized Agent (whether or not the appointment of such Authorized Agent shall for any reason prove to be ineffective or such Authorized Agent shall fail to accept or acknowledge such service), with a copy mailed to the Company by registered or certified air mail, postage prepaid, to its address provided in Section 16(b) hereof. The Company agrees that the failure of the Authorized Agent to give any notice of such service to it shall not impair or affect in any way the validity of such service or any judgment rendered in any suit, action or proceeding based thereon. If, for any reason, the Authorized Agent named above or its successor shall no longer serve as agent of the Company to receive service of process in New York, the Company shall promptly appoint a successor that is a legal entity with offices in New York, New York, so as to serve and will promptly advise the Depositary thereof.
(c) Waiver of Personal Service of Process. In the event the Company fails to continue such designation and appointment in full force and effect, the Company hereby waives personal service of process upon it and consents that any such service of process may be made by certified or registered mail, return receipt requested, directed to the Company at its address last specified for notices hereunder, and service so made shall be deemed completed five (5) days after the same shall have been so mailed.
14 |
22. Waiver of Immunities. To the extent that the Company or any of its properties, assets or revenues may have or may hereafter be entitled to, or have attributed to it, any right of immunity, on the grounds of sovereignty or otherwise, from any legal action, suit or proceeding, from the giving of any relief in any respect thereof, from setoff or counterclaim, from the jurisdiction of any court, from service of process, from attachment upon or prior to judgment, from attachment in aid of execution or judgment, or from execution of judgment, or other legal process or proceeding for the giving of any relief or for the enforcement of any judgment, in any jurisdiction in which proceedings may at any time be commenced, with respect to its obligations, liabilities or other matters under or arising out of or in connection with the Shares or Deposited Securities, the ADSs, the ADRs or this Deposit Agreement, the Company, to the fullest extent permitted by law, hereby irrevocably and unconditionally waives, and agrees not to plead or claim, any such immunity and consents to such relief and enforcement.
23. Waiver of Jury Trial. EACH PARTY TO THIS DEPOSIT AGREEMENT (INCLUDING, FOR AVOIDANCE OF DOUBT, EACH HOLDER AND BENEFICIAL OWNER OF, AND/OR HOLDER OF INTERESTS IN, ADSS OR ADRS) HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY SUIT, ACTION OR PROCEEDING AGAINST THE DEPOSITARY AND/OR THE COMPANY DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THE SHARES OR OTHER DEPOSITED SECURITIES, THE ADSs OR THE ADRs, THE DEPOSIT AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREIN OR THEREIN, OR THE BREACH HEREOF OR THEREOF (WHETHER BASED ON CONTRACT, TORT, COMMON LAW OR ANY OTHER THEORY) INCLUDING, WITHOUT LIMITATION, ANY SUIT, ACTION OR PROCEEDING UNDER THE UNITED STATES FEDERAL SECURITIES LAWS. No provision of this Deposit Agreement or any ADR is intended to constitute a waiver or limitation of any rights which Holders or Beneficial Owners may have under the Securities Act of 1933 or the Securities Exchange Act of 1934, to the extent applicable.
[Signature Page Follows.]
15 |
IN WITNESS WHEREOF, ARGO BLOCKCHAIN PLC and JPMORGAN CHASE BANK, N.A. have duly executed this Deposit Agreement as of the day and year first above set forth and all Holders and Beneficial Owners shall become parties hereto upon acceptance by them of ADSs issued in accordance with the terms hereof, or upon acquisition of any beneficial interest therein.
ARGO BLOCKCHAIN PLC | ||
By: | ||
Name: | ||
Title | ||
JPMORGAN CHASE BANK, N.A. | ||
By: | ||
Name: | ||
Title: |
[Signature Page to Deposit Agreement.]
EXHIBIT A
ANNEXED TO AND INCORPORATED IN
DEPOSIT AGREEMENT
[FORM OF FACE OF ADR]
________ | No. of ADSs: _________ |
Number | |
Each ADS represents | |
TEN (10)] Shares | |
CUSIP: |
AMERICAN DEPOSITARY RECEIPT
evidencing
AMERICAN DEPOSITARY SHARES
representing
ORDINARY SHARES
of
ARGO BLOCKCHAIN PLC
(Incorporated under the laws of England and Wales)
JPMORGAN CHASE BANK, N.A., a national banking association organized under the laws of the United States of America, as depositary hereunder (the "Depositary"), hereby certifies that ____________________________________ is the registered owner (a "Holder") of ______________ American Depositary Shares ("ADSs"), each (subject to paragraph (13) (Changes Affecting Deposited Securities)) representing ten (10) ordinary shares (including the rights to receive Shares described in paragraph (1) (Issuance of ADSs), "Shares" and, together with any other securities, cash or property from time to time held by the Depositary in respect or in lieu of deposited Shares, the "Deposited Securities"), of ARGO BLOCKCHAIN PLC, a corporation organized under the laws of England and Wales (the "Company"), deposited under the Deposit Agreement dated as of ____________________ __, 2021 (as amended from time to time, the "Deposit Agreement") among the Company, the Depositary and all Holders and Beneficial Owners from time to time of American Depositary Receipts issued thereunder ("ADRs"), each of whom by accepting an ADR becomes a party thereto. The Deposit Agreement and this ADR (which includes the provisions set forth on the reverse hereof) shall be governed by and construed in accordance with the internal laws of the State of New York without giving effect to the application of the conflict of law principles thereof. All capitalized terms used herein, and not defined herein, shall have the meanings ascribed to such terms in the Deposit Agreement.
A-1 |
(1) Issuance of ADSs.
(a) Issuance. This ADR is one of the ADRs issued under the Deposit Agreement. Subject to the other provisions hereof, the Depositary may so issue ADRs for delivery at the Transfer Office (as hereinafter defined) only against deposit of: (i) Shares in a form satisfactory to the Custodian; or (ii) rights to receive Shares from the Company or any registrar, transfer agent, clearing agent or other entity recording Share ownership or transactions.
(b) Lending. In its capacity as Depositary, the Depositary shall not lend Shares or ADSs.
(c) Representations and Warranties of Depositors. Every person depositing Shares under the Deposit Agreement represents and warrants that:
(i) | such Shares and the certificates therefor are duly authorized, validly issued and outstanding, fully paid, nonassessable and legally obtained by such person, |
(ii) | all pre-emptive and comparable rights, if any, with respect to such Shares have been validly waived or exercised, |
(iii) | the person making such deposit is duly authorized so to do, |
(iv) | the Shares presented for deposit are free and clear of any lien, encumbrance, security interest, charge, mortgage or adverse claim and |
(v) | such Shares (A) are not "restricted securities" as such term is defined in Rule 144 under the Securities Act of 1933 ("Restricted Securities") unless at the time of deposit the requirements of paragraphs (c), (e), (f) and (h) of Rule 144 shall not apply and such Shares may be freely transferred and may otherwise be offered and sold freely in the United States or (B) have been registered under the Securities Act of 1933. To the extent the person depositing Shares is an "affiliate" of the Company as such term is defined in Rule 144, the person also represents and warrants that upon the sale of the ADSs, all of the provisions of Rule 144 which enable the Shares to be freely sold (in the form of ADSs) will be fully complied with and, as a result thereof, all of the ADSs issued in respect of such Shares will not be on the sale thereof, Restricted Securities. |
A-2 |
Such representations and warranties shall survive the deposit and withdrawal of Shares and the issuance and cancellation of ADSs in respect thereof and the transfer of such ADSs.
(d) The Depositary may refuse to accept for such deposit any Shares identified by the Company in order to facilitate compliance with the requirements of the Securities Act of 1933 or the Rules made thereunder.
(2) Withdrawal of Deposited Securities. Subject to paragraphs (4) (Certain Limitations to Registration, Transfer etc.) and (5) (Liability for Taxes, Duties and Other Charges), upon surrender of (a) a certificated ADR in a form satisfactory to the Depositary at the Transfer Office or (b) proper instructions and documentation in the case of a Direct Registration ADR, the Holder hereof is entitled to delivery at, or to the extent in dematerialized form from, the Custodian's office of the Deposited Securities at the time represented by the ADSs evidenced by this ADR. At the request, risk and expense of the Holder hereof, the Depositary may deliver such Deposited Securities at such other place as may have been requested by the Holder. Notwithstanding any other provision of the Deposit Agreement or this ADR, the withdrawal of Deposited Securities may be restricted only for the reasons set forth in General Instruction I.A.(1) of Form F-6 (as such instructions may be amended from time to time) under the Securities Act of 1933.
(3) Transfers, Split-Ups and Combinations of ADRs. The Depositary or its agent will keep, at a designated transfer office (the "Transfer Office"), (i) a register (the "ADR Register") for the registration, registration of transfer, combination and split-up of ADRs, and, in the case of Direct Registration ADRs, shall include the Direct Registration System, which at all reasonable times will be open for inspection by Holders and the Company for the purpose of communicating with Holders in the interest of the business of the Company or a matter relating to the Deposit Agreement and (ii) facilities for the delivery and receipt of ADRs. The term ADR Register includes the Direct Registration System. Title to this ADR (and to the Deposited Securities represented by the ADSs evidenced hereby), when properly endorsed (in the case of ADRs in certificated form) or upon delivery to the Depositary of proper instruments of transfer, is transferable by delivery with the same effect as in the case of negotiable instruments under the laws of the State of New York; provided that the Depositary, notwithstanding any notice to the contrary, may treat the person in whose name this ADR is registered on the ADR Register as the absolute owner hereof for all purposes and neither the Depositary nor the Company will have any obligation or be subject to any liability under the Deposit Agreement or any ADR to any Beneficial Owner, unless such Beneficial Owner is the Holder hereof. Subject to paragraphs (4) and (5), this ADR is transferable on the ADR Register and may be split into other ADRs or combined with other ADRs into one ADR, evidencing the aggregate number of ADSs surrendered for split-up or combination, by the Holder hereof or by duly authorized attorney upon surrender of this ADR at the Transfer Office properly endorsed (in the case of ADRs in certificated form) or upon delivery to the Depositary of proper instruments of transfer and duly stamped as may be required by applicable law; provided that the Depositary may close the ADR Register (and/or any portion thereof) at any time or from time to time when deemed expedient by it. Additionally, at the reasonable request of the Company, the Depository may close the issuance book portion of the ADR Register in order to enable the Company to comply with applicable law. At the request of a Holder, the Depositary shall, for the purpose of substituting a certificated ADR with a Direct Registration ADR, or vice versa, execute and deliver a certificated ADR or a Direct Registration ADR, as the case may be, for any authorized number of ADSs requested, evidencing the same aggregate number of ADSs as those evidenced by the certificated ADR or Direct Registration ADR, as the case may be, substituted.
A-3 |
(4) Certain Limitations to Registration, Transfer etc. Prior to the issue, registration, registration of transfer, split-up or combination of any ADR, the delivery of any distribution in respect thereof, or, subject to the last sentence of paragraph (2) (Withdrawal of Deposited Securities), the withdrawal of any Deposited Securities, and from time to time in the case of clause (b)(ii) of this paragraph (4), the Company, the Depositary or the Custodian may require:
(a) payment with respect thereto of (i) any stock transfer or other tax or other governmental charge, (ii) any stock transfer or registration fees in effect for the registration of transfers of Shares or other Deposited Securities upon any applicable register and (iii) any applicable charges as provided in paragraph (7) (Charges of Depositary) of this ADR;
(b) the production of proof satisfactory to it of (i) the identity of any signatory and genuineness of any signature and (ii) such other information, including without limitation, information as to citizenship, residence, exchange control approval, beneficial ownership of any securities, compliance with applicable law, regulations, provisions of or governing Deposited Securities and terms of the Deposit Agreement and this ADR, as it may deem necessary or proper; and
(c) compliance with such regulations as the Depositary may establish consistent with the Deposit Agreement.
The issuance of ADRs, the acceptance of deposits of Shares, the registration, registration of transfer, split-up or combination of ADRs or, subject to the last sentence of paragraph (2) (Withdrawal of Deposited Securities), the withdrawal of Deposited Securities may be suspended, generally or in particular instances, when the ADR Register or any register for Deposited Securities is closed or when any such action is deemed advisable by the Depositary.
A-4 |
(5) Liability for Taxes, Duties and Other Charges. If any tax or other similar governmental charges (including any related penalties and/or interest) shall become payable by or on behalf of the Custodian or the Depositary with respect to this ADR, any Deposited Securities represented by the ADSs evidenced hereby or any distribution thereon, such tax or other governmental charge shall be paid by the Holder hereof to the Depositary and by holding or having held this ADR or any ADSs evidenced hereby, the Holder and all Beneficial Owners hereof and thereof, and all prior Holders and Beneficial Owners hereof and thereof, jointly and severally, agree to indemnify, defend and save harmless each of the Depositary and its agents in respect of such tax or other governmental charge. Each Holder of this ADR and Beneficial Owner of the ADSs evidenced hereby, and each prior Holder and Beneficial Owner hereof and thereof (collectively, the "Tax Indemnitors"), by holding or having held an ADR or an interest in ADSs, acknowledges and agrees that the Depositary shall have the right to seek payment of amounts owing with respect to this ADR under this paragraph (5) from any one or more Tax Indemnitor(s) as determined by the Depositary in its sole discretion, without any obligation to seek payment from any other Tax Indemnitor(s).The Depositary may refuse to effect any registration, registration of transfer, split-up or combination hereof or, subject to the last sentence of paragraph (2) (Withdrawal of Deposited Securities), any withdrawal of such Deposited Securities until such payment is made. The Depositary may also deduct from any distributions on or in respect of Deposited Securities, or may sell by public or private sale for the account of the Holder hereof any part or all of such Deposited Securities, and may apply such deduction or the proceeds of any such sale in payment of such tax or other governmental charge, the Holder hereof remaining liable for any deficiency, and shall reduce the number of ADSs evidenced hereby to reflect any such sales of Shares. In connection with any distribution to Holders, the Company will remit to the appropriate governmental authority or agency all amounts (if any) required to be withheld and owing to such authority or agency by the Company; and the Depositary and the Custodian will remit to the appropriate governmental authority or agency all amounts (if any) required to be withheld and owing to such authority or agency by the Depositary or the Custodian. To the extent legally permissible and in the Depositary’s possession, the Depositary will forward to the Company such information from its transfer records as the Company may reasonably request to enable the Company or its agent to file any necessary reports with governmental authorities or agencies. If the Depositary determines that any distribution in property other than cash (including Shares or rights) on Deposited Securities is subject to any tax that the Depositary or the Custodian is obligated to withhold, the Depositary may dispose of all or a portion of such property in such amounts and in such manner as the Depositary deems necessary and practicable to pay such taxes, by public or private sale, and the Depositary shall distribute the net proceeds of any such sale or the balance of any such property after deduction of such taxes to the Holders entitled thereto. Each Holder and Beneficial Owner agrees to indemnify the Depositary, the Company, the Custodian and any of their respective officers, directors, employees, agents and affiliates against, and hold each of them harmless from, any claims by any governmental authority with respect to taxes, additions to tax, penalties or interest arising out of any refund of taxes, reduced rate of withholding at source or other tax benefit obtained which obligations shall survive any transfer or surrender of ADSs or the termination of the Deposit Agreement.
A-5 |
(6) Disclosure of Interests.
(a) General. To the extent that the provisions of or governing any Deposited Securities may require disclosure of or impose limits on beneficial or other ownership of, or interests in, Deposited Securities, other Shares and other securities and may provide for blocking transfer, voting or other rights to enforce such disclosure or limits, Holders and Beneficial Owners agree to comply with all such disclosure requirements and ownership limitations and to comply with any reasonable Company instructions in respect thereof. The Company reserves the right to instruct Holders (and through any such Holder, the Beneficial Owners of ADSs evidenced by the ADRs registered in such Holder's name) to deliver their ADSs for cancellation and withdrawal of the Deposited Securities so as to permit the Company to deal directly with the Holder and/or Beneficial Owner thereof as a holder of Shares and Holders and Beneficial Owners agree to comply with such instructions. The Depositary agrees to cooperate with the Company in its efforts to inform Holders of the Company's exercise of its rights under this paragraph and agrees to consult with, and provide reasonable assistance without risk, liability or expense on the part of the Depositary, to the Company on the manner or manners in which it may enforce such rights with respect to any Holder.
(b) Jurisdiction Specific.
Notwithstanding any provision of the Deposit Agreement or of the ADRs and without limiting the foregoing, by being a Holder or Beneficial Owner, each such Holder and Beneficial Owner agrees to provide such information as the Company may request in a disclosure notice (a "Disclosure Notice") given pursuant to the United Kingdom Companies Act 2006 (as amended from time to time and including any statutory modification or re-enactment thereof, the "Companies Act") or the Articles of Association of the Company. By accepting or holding, or owning an interest in, an ADR, each Holder and Beneficial Owner acknowledges that it understands that failure to comply with a Disclosure Notice may result in the imposition of sanctions against the Holder or Beneficial Owner in respect of which the non-complying person is or was, or appears to be or has been, interested as provided in the Companies Act and the Articles of Association which currently may include, subject to the granting of an appropriate order by the court, the withdrawal of the voting rights of such Holder or Beneficial Owner and the imposition of restrictions on the rights to receive dividends on and to transfer the Shares indirectly held or owned by such Holder and/or Beneficial Owner through the ADSs representing such Shares (including the ADRs evidencing such ADSs). In addition, by accepting or holding, or owning an interest in, an ADR, each Holder and Beneficial Owner agrees to comply with the provisions of the Disclosure Guidance and Transparency Rules published by the United Kingdom Financial Conduct Authority (as amended from time to time, the "DTRs") with regard to the notification to the Company of interests (including indirect interests by holding or owning an interest in ADRs) in Shares and certain financial instruments, which currently provide, inter alia, that a Holder and Beneficial Owner must notify the Company of the percentage of its voting rights he held or deemed to be held through its direct or indirect holding of certain financial instruments (or a combination of such holdings), including indirectly by holding or owing an interest in ADRs) if the percentage of those voting rights (i) reaches, exceeds or falls below 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10% and each 1% threshold thereafter up to 100% as a result of an acquisition or disposal (including indirectly by holding or owning an interest in ADRs) of Shares or certain financial instruments, or (ii) reaches, exceeds or falls below such applicable thresholds as a result of events changing the breakdown of voting rights and on the basis of information disclosed by the Company in accordance with the DTRs. The notification must be effected as soon as possible, but not later than two trading days after the Holder or Beneficial Owner, as the case may be, (a) learns of the direct or indirect acquisition or disposal or of the direct or indirect possibility of exercising voting rights, or on which, having regard to the circumstances, should have learned of it, regardless of the date on which the direct or indirect acquisition, disposal or possibility of exercising voting rights takes effect, or (b) is informed of the event mentioned in (ii) above.
A-6 |
Any summary of the laws and regulations of the United Kingdom and of the terms of the Company's constitutional and/or governing documents has been provided by the Company solely for the convenience of Holders, Beneficial Owners and the Depositary. While such summaries are believed by the Company to be accurate as of the date of the Deposit Agreement, (i) they are summaries and as such may not include all aspects of the materials summarized applicable to a Holder or Beneficial Owner, and (ii) these laws and regulations and the Company's constitutional and/or governing documents may change after the date of the Deposit Agreement. Neither the Depositary nor the Company has any obligation to update any such summaries.
(7) Charges of Depositary.
(a) Rights of the Depositary. The Depositary may charge, and collect from, (i) each person to whom ADSs are issued, including, without limitation, issuances against deposits of Shares, issuances in respect of Share Distributions, Rights and Other Distributions (as such terms are defined in paragraph (10) (Distributions on Deposited Securities)), issuances pursuant to a stock dividend or stock split declared by the Company, or issuances pursuant to a merger, exchange of securities or any other transaction or event affecting the ADSs or the Deposited Securities, and (ii) each person surrendering ADSs for withdrawal of Deposited Securities or whose ADSs are cancelled or reduced for any other reason U.S.$5.00 for each 100 ADSs (or portion thereof) issued, delivered, reduced, cancelled or surrendered, or upon which a Share Distribution or elective distribution is made or offered (as the case may be). The Depositary may sell (by public or private sale) sufficient securities and property received in respect of Share Distributions, Rights and Other Distributions prior to such deposit to pay such charge.
A-7 |
(b) Additional charges by the Depositary. The following additional charges shall also be incurred by the Holders, the Beneficial Owners, by any party depositing or withdrawing Shares or by any party surrendering ADSs and/or to whom ADSs are issued (including, without limitation, issuances pursuant to a stock dividend or stock split declared by the Company or an exchange of stock regarding the ADSs or the Deposited Securities or a distribution of ADSs pursuant to paragraph (10) (Distributions on Deposited Securities), whichever is applicable:
(i) | a fee of U.S.$0.05 or less per ADS held for any Cash distribution made, or for any elective cash/stock dividend offered, pursuant to the Deposit Agreement, |
(ii) | a fee for the distribution or sale of securities pursuant to paragraph (10) hereof, such fee being in an amount equal to the fee for the execution and delivery of ADSs referred to above which would have been charged as a result of the deposit of such securities (for purposes of this paragraph (7) treating all such securities as if they were Shares) but which securities or the net cash proceeds from the sale thereof are instead distributed by the Depositary to Holders entitled thereto, |
(iii) | an aggregate fee of U.S.$0.05 or less per ADS per calendar year (or portion thereof) for services performed by the Depositary in administering the ADRs (which fee may be charged on a periodic basis during each calendar year and shall be assessed against Holders as of the record date or record dates set by the Depositary during each calendar year and shall be payable at the sole discretion of the Depositary by billing such Holders or by deducting such charge from one or more cash dividends or other cash distributions), and |
(iv) | a fee for the reimbursement of such fees, charges and expenses as are incurred by the Depositary and/or any of its agents (including, without limitation, the Custodian and expenses incurred on behalf of Holders in connection with compliance with foreign exchange control regulations or any law or regulation relating to foreign investment) in connection with the servicing of the Shares or other Deposited Securities, the sale of securities (including, without limitation, Deposited Securities), the delivery of Deposited Securities or otherwise in connection with the Depositary's or its Custodian's compliance with applicable law, rule or regulation (which fees and charges shall be assessed on a proportionate basis against Holders as of the record date or dates set by the Depositary and shall be payable at the sole discretion of the Depositary by billing such Holders or by deducting such charge from one or more cash dividends or other cash distributions). |
A-8 |
(c) Other Obligations and Charges. The Company will pay all other charges and expenses of the Depositary and any agent of the Depositary (except the Custodian) pursuant to agreements from time to time between the Company and the Depositary, except:
(i) | stock transfer or other taxes and other governmental charges (which are payable by Holders or persons depositing Shares); |
(ii) | SWIFT, cable, telex and facsimile transmission and delivery charges incurred at the request of persons depositing, or Holders delivering Shares, ADRs or Deposited Securities (which are payable by such persons or Holders); and |
(iii) | transfer or registration fees for the registration or transfer of Deposited Securities on any applicable register in connection with the deposit or withdrawal of Deposited Securities (which are payable by persons depositing Shares or Holders withdrawing Deposited Securities). |
(d) Foreign Exchange Related Matters. To facilitate the administration of various depositary receipt transactions, including disbursement of dividends or other cash distributions and other corporate actions, the Depositary may engage the foreign exchange desk within JPMorgan Chase Bank, N.A. (the “Bank”) and/or its affiliates in order to enter into spot foreign exchange transactions to convert foreign currency into U.S. dollars (“FX Transactions”). For certain currencies, FX Transactions are entered into with the Bank or an affiliate, as the case may be, acting in a principal capacity. For other currencies, FX Transactions are routed directly to and managed by an unaffiliated local custodian (or other third party local liquidity provider), and neither the Bank nor any of its affiliates is a party to such FX Transactions.
A-9 |
The foreign exchange rate applied to an FX Transaction will be either (a) a published benchmark rate, or (b) a rate determined by a third party local liquidity provider, in each case plus or minus a spread, as applicable. The Depositary will disclose which foreign exchange rate and spread, if any, apply to such currency on the “Disclosure” page (or successor page) of www.adr.com (as updated by the Depositary from time to time, “ADR.com”). Such applicable foreign exchange rate and spread may (and neither the Depositary, the Bank nor any of their affiliates is under any obligation to ensure that such rate does not) differ from rates and spreads at which comparable transactions are entered into with other customers or the range of foreign exchange rates and spreads at which the Bank or any of its affiliates enters into foreign exchange transactions in the relevant currency pair on the date of the FX Transaction. Additionally, the timing of execution of an FX Transaction varies according to local market dynamics, which may include regulatory requirements, market hours and liquidity in the foreign exchange market or other factors. Furthermore, the Bank and its affiliates may manage the associated risks of their position in the market in a manner they deem appropriate without regard to the impact of such activities on the Company, the Depositary, Holders or Beneficial Owners. The spread applied does not reflect any gains or losses that may be earned or incurred by the Bank and its affiliates as a result of risk management or other hedging related activity.
Notwithstanding the foregoing, to the extent the Company provides U.S. dollars to the Depositary, neither the Bank nor any of its affiliates will execute an FX Transaction as set forth herein. In such case, the Depositary will distribute the U.S. dollars received from the Company.
Further details relating to the applicable foreign exchange rate, the applicable spread and the execution of FX Transactions will be provided by the Depositary on ADR.com. The Company, Holders and Beneficial Owners each acknowledge and agree that the terms applicable to FX Transactions disclosed from time to time on ADR.com will apply to any FX Transaction executed pursuant to the Deposit Agreement.
(e) Disclosure of Potential Depositary Payments. The Depositary anticipates reimbursing the Company for certain expenses incurred by the Company that are related to the establishment and maintenance of the ADR program upon such terms and conditions as the Company and the Depositary may agree from time to time. The Depositary may make available to the Company a set amount or a portion of the Depositary fees charged in respect of the ADR program or otherwise upon such terms and conditions as the Company and the Depositary may agree from time to time.
(f) The right of the Depositary to receive payment of fees, charges and expenses as provided above shall survive the termination of the Deposit Agreement. As to any Depositary, upon the resignation or removal of such Depositary, such right shall extend for those fees, charges and expenses incurred prior to the effectiveness of such resignation or removal.
A-10 |
(8) Available Information. The Deposit Agreement, the provisions of or governing Deposited Securities and any written communications from the Company, which are both received by the Custodian or its nominee as a holder of Deposited Securities and made generally available to the holders of Deposited Securities, are available for inspection by Holders at the offices of the Depositary and the Custodian, at the Transfer Office, on the U.S. Securities and Exchange Commission’s website, or upon request from the Depositary (which request may be refused by the Depositary at its discretion). The Depositary will distribute copies of such communications (or English translations or summaries thereof) to Holders when furnished by the Company. The Company is subject to the periodic reporting requirements of the Securities Exchange Act of 1934 and accordingly files certain reports with the United States Securities and Exchange Commission (the "Commission"). Such reports and other information may be inspected and copied through the Commission’s EDGAR system or at public reference facilities maintained by the Commission located at the date hereof at 100 F Street, NE, Washington, DC 20549.
(9) Execution. This ADR shall not be valid for any purpose unless executed by the Depositary by the manual or facsimile signature of a duly authorized officer of the Depositary.
Dated:
JPMORGAN CHASE BANK, N.A., as Depositary |
By |
Authorized Officer |
The Depositary's office is located at 383 Madison Avenue, Floor 11, New York, New York 10179.
A-11 |
[FORM OF REVERSE OF ADR]
(10) Distributions on Deposited Securities. Subject to paragraphs (4) (Certain Limitations to Registration, Transfer etc.) and (5) (Liability for Taxes, Duties and other Charges), to the extent practicable, the Depositary will distribute as soon as reasonably practicable to each Holder entitled thereto on the record date set by the Depositary therefor at such Holder's address shown on the ADR Register, in proportion to the number of Deposited Securities (on which the following distributions on Deposited Securities are received by the Custodian) represented by ADSs evidenced by such Holder's ADRs:
(a) Cash. Any U.S. dollars available to the Depositary resulting from a cash dividend or other cash distribution or the net proceeds of sales of any other distribution or portion thereof authorized in this paragraph (10) ("Cash"), on an averaged or other practicable basis, subject to (i) appropriate adjustments for taxes withheld, (ii) such distribution being impermissible or impracticable with respect to certain Holders, and (iii) deduction of the Depositary's and/or its agents' fees and expenses in (1) converting any foreign currency to U.S. dollars by sale or in such other manner as the Depositary may determine to the extent that it determines that such conversion may be made on a reasonable basis, (2) transferring foreign currency or U.S. dollars to the United States by such means as the Depositary may determine to the extent that it determines that such transfer may be made on a reasonable basis, (3) obtaining any approval or license of any governmental authority required for such conversion or transfer, which is obtainable at a reasonable cost and within a reasonable time and (4) making any sale by public or private means in any commercially reasonable manner.
(b) Shares. (i) Additional ADRs evidencing whole ADSs representing any Shares available to the Depositary resulting from a dividend or free distribution on Deposited Securities consisting of Shares (a "Share Distribution") and (ii) U.S. dollars available to it resulting from the net proceeds of sales of Shares received in a Share Distribution, which Shares would give rise to fractional ADSs if additional ADRs were issued therefor, as in the case of Cash.
(c) Rights. (i) Warrants or other instruments in the discretion of the Depositary representing rights to acquire additional ADRs in respect of any rights to subscribe for additional Shares or rights of any nature available to the Depositary as a result of a distribution on Deposited Securities ("Rights"), to the extent that the Company timely furnishes to the Depositary evidence satisfactory to the Depositary that the Depositary may lawfully distribute the same (the Company has no obligation to so furnish such evidence), or (ii) to the extent the Company does not so furnish such evidence and sales of Rights are practicable, any U.S. dollars available to the Depositary from the net proceeds of sales of Rights as in the case of Cash, or (iii) to the extent the Company does not so furnish such evidence and such sales cannot practicably be accomplished by reason of the nontransferability of the Rights, limited markets therefor, their short duration or otherwise, nothing (and any Rights may lapse).
A-12 |
(d) Other Distributions. (i) Securities or property available to the Depositary resulting from any distribution on Deposited Securities other than Cash, Share Distributions and Rights ("Other Distributions"), by any means that the Depositary may deem equitable and practicable, or (ii) to the extent the Depositary deems distribution of such securities or property not to be equitable and practicable, any U.S. dollars available to the Depositary from the net proceeds of sales of Other Distributions as in the case of Cash.
The Depositary reserves the right to utilize a division, branch or affiliate of JPMorgan Chase Bank, N.A. to direct, manage and/or execute any public and/or private sale of securities hereunder. Such division, branch and/or affiliate may charge the Depositary a fee in connection with such sales, which fee is considered an expense of the Depositary contemplated above and/or under paragraph (7) (Charges of Depositary). Any U.S. dollars available will be distributed by checks drawn on a bank in the United States for whole dollars and cents. Fractional cents will be withheld without liability and dealt with by the Depositary in accordance with its then current practices. All purchases and sales of securities will be handled by the Depositary in accordance with its then current policies, which are currently set forth on ADR.com, the location and contents of which the Depositary shall be solely responsible for.
(11) Record Dates. The Depositary may, after consultation with the Company if practicable, fix a record date (which, to the extent applicable, shall be as near as practicable to any corresponding record date set by the Company) for the determination of the Holders who shall be responsible for the fee assessed by the Depositary for administration of the ADR program and for any expenses provided for in paragraph (7) hereof as well as for the determination of the Holders who shall be entitled to receive any distribution on or in respect of Deposited Securities, to give instructions for the exercise of any voting rights, to receive any notice or to act in respect of other matters and only such Holders shall be so entitled or obligated.
A-13 |
(12) Voting of Deposited Securities.
(a) Notice of any Meeting or Solicitation. As soon as practicable after receipt of notice of any meeting at which the holders of Shares are entitled to vote, or of solicitation of consents or proxies from holders of Shares or other Deposited Securities, the Depositary shall fix the ADS record date in accordance with paragraph (11) above provided that if the Depositary receives a written request from the Company in a timely manner and at least 30 days prior to the date of such vote or meeting, the Depositary shall, at the Company's expense, distribute to Holders a notice (the “Voting Notice”) stating (i) final information particular to such vote and meeting and any solicitation materials, (ii) that each Holder on the record date set by the Depositary will, subject to any applicable provisions of the laws of England and Wales, the provisions of the Deposit Agreement, the Articles of Association and the provisions of, or governing, the Deposited Securities, be entitled to instruct the Depositary as to the exercise of the voting rights, if any, pertaining to the Deposited Securities represented by the ADSs evidenced by such Holder's ADRs and (iii) the manner in which such instructions may be given, including instructions to give a discretionary proxy to a person designated by the Company. Each Holder shall be solely responsible for the forwarding of Voting Notices to the Beneficial Owners of ADSs registered in such Holder's name. There is no guarantee that Holders and Beneficial Owners generally or any Holder or Beneficial Owner in particular will receive the notice described above with sufficient time to enable such Holder or Beneficial Owner to return any voting instructions to the Depositary in a timely manner.
(b) Voting of Deposited Securities. Following actual receipt by the ADR department responsible for proxies and voting of Holders’ instructions (including, without limitation, instructions of any entity or entities acting on behalf of the nominee for DTC), the Depositary shall, in the manner and on or before the time established by the Depositary for such purpose, endeavor to vote or cause to be voted the Deposited Securities represented by the ADSs evidenced by such Holders’ ADRs in accordance with such instructions insofar as practicable and permitted under the provisions of or governing Deposited Securities. The Depositary will not itself exercise any voting discretion in respect of any Deposited Securities.
(c) Alternative Methods of Distributing Materials. Notwithstanding anything contained in the Deposit Agreement or any ADR, the Depositary may, to the extent not prohibited by any law, rule, or regulation or by the rules and/or requirements of the stock exchange on which the ADSs are listed, in lieu of distribution of the materials provided to the Depositary in connection with any meeting of or solicitation of consents or proxies from holders of Deposited Securities, distribute to the Holders a notice that provides Holders with or otherwise publicizes to Holders instructions on how to retrieve such materials or receive such materials upon request (i.e., by reference to a website containing the materials for retrieval or a contact for requesting copies of the materials). Holders are strongly encouraged to forward their voting instructions as soon as possible. Voting instructions will not be deemed received until such time as the ADR department responsible for proxies and voting has received such instructions, notwithstanding that such instructions may have been physically received by JPMorgan Chase Bank, N.A., as Depositary, prior to such time.
A-14 |
(13) Changes Affecting Deposited Securities.
(a) Subject to paragraphs (4) (Certain Limitations to Registration, Transfer etc.) and (5) (Liability for Taxes, Duties and Other Charges), the Depositary may, in its discretion, and shall if reasonably requested by the Company, amend this ADR or distribute additional or amended ADRs (with or without calling this ADR for exchange) or cash, securities or property on the record date set by the Depositary therefor to reflect any change in par value, split-up, consolidation, cancellation or other reclassification of Deposited Securities, any Share Distribution or Other Distribution not distributed to Holders or any cash, securities or property available to the Depositary in respect of Deposited Securities from (and the Depositary is hereby authorized to surrender any Deposited Securities to any person and, irrespective of whether such Deposited Securities are surrendered or otherwise cancelled by operation of law, rule, regulation or otherwise, to sell by public or private sale any property received in connection with) any recapitalization, reorganization, merger, consolidation, liquidation, receivership, bankruptcy or sale of all or substantially all the assets of the Company.
(b) To the extent the Depositary does not so amend this ADR or make a distribution to Holders to reflect any of the foregoing, or the net proceeds thereof, whatever cash, securities or property results from any of the foregoing shall constitute Deposited Securities and each ADS evidenced by this ADR shall automatically represent its pro rata interest in the Deposited Securities as then constituted.
(c) Promptly upon the occurrence of any of the aforementioned changes affecting Deposited Securities, the Company shall notify the Depositary in writing of such occurrence and as soon as practicable after receipt of such notice from the Company, may instruct the Depositary to give notice thereof, at the Company's expense, to Holders in accordance with the provisions hereof. Upon receipt of such instruction, the Depositary shall give notice to the Holders in accordance with the terms thereof, as soon as reasonably practicable.
A-15 |
(14) Exoneration.
(a) The Depositary, the Company, and each of their respective directors, officers, employees, agents and affiliates and each of them shall: (i) incur no liability to Holders or Beneficial Owners (A) if any present or future law, rule, regulation, fiat, order or decree of the United States, England and Wales, the European Union, or any other country or jurisdiction, or of any governmental or regulatory authority or any securities exchange or market or automated quotation system, the provisions of or governing any Deposited Securities, any present or future provision of the Company's charter, any act of God, war, terrorism, nationalization, epidemic, pandemic, expropriation, currency restrictions, work stoppage, strike, civil unrest, revolutions, rebellions, explosions, computer failure or circumstance beyond its direct and immediate control shall prevent or delay, or shall cause any of them to be subject to any civil or criminal penalty in connection with, any act which the Deposit Agreement or this ADR provides shall be done or performed by it or them (including, without limitation, voting pursuant to paragraph (12) hereof), or (B) by reason of any non-performance or delay, caused as aforesaid, in the performance of any act or things which by the terms of the Deposit Agreement it is provided shall or may be done or performed or any exercise or failure to exercise any discretion given it in the Deposit Agreement or this ADR (including, without limitation, any failure to determine that any distribution or action may be lawful or reasonably practicable); (ii) incur or assume no liability to Holders or Beneficial Owners except to perform its obligations to the extent they are specifically set forth in this ADR and the Deposit Agreement without gross negligence or willful misconduct and the Depositary shall not be a fiduciary or have any fiduciary duty to Holders or Beneficial Owners; (iii) in the case of the Depositary and its agents, be under no obligation to appear in, prosecute or defend any action, suit or other proceeding in respect of any Deposited Securities, ADSs or this ADR; (iv) in the case of the Company and its agents hereunder be under no obligation to appear in, prosecute or defend any action, suit or other proceeding in respect of any Deposited Securities, ADSs or this ADR, which in its opinion may involve it in expense or liability, unless indemnity satisfactory to it against all expense (including fees and disbursements of counsel) and liability be furnished as often as may be required; and (v) not be liable to Holders or Beneficial Owners for any action or inaction by it in reliance upon the advice of or information from legal counsel, accountants, any person presenting Shares for deposit, any Holder, any other person believed by it to be competent to give such advice or information, or in the case of the Depositary, the Company. The Depositary shall not be liable for the acts or omissions made by, or the insolvency of, any securities depository, clearing agency or settlement system.
(b) The Depositary. The Depositary shall not be responsible for, and shall incur no liability in connection with or arising from, the insolvency of any Custodian that is not a branch or affiliate of JPMorgan Chase Bank, N.A. The Depositary shall not have any liability for the price received in connection with any sale of securities, the timing thereof or any delay in action or omission to act nor shall it be responsible for any error or delay in action, omission to act, default or negligence on the part of the party so retained in connection with any such sale or proposed sale. Notwithstanding anything to the contrary contained in the Deposit Agreement (including the ADRs), subject to the further limitations set forth in subparagraph (p) of this paragraph (14), the Depositary shall not be responsible for, and shall incur no liability in connection with or arising from, any act or omission to act on the part of the Custodian except to the extent that any Holder has incurred liability directly as a result of the Custodian having (i) committed fraud or willful misconduct in the provision of custodial services to the Depositary or (ii) failed to use reasonable care in the provision of custodial services to the Depositary as determined in accordance with the standards prevailing in the jurisdiction in which the Custodian is located.
(c) The Depositary, its agents and the Company may rely and shall be protected in acting upon any written notice, request, direction, instruction or document believed by them to be genuine and to have been signed, presented or given by the proper party or parties.
A-16 |
(d) The Depositary shall be under no obligation to inform Holders or Beneficial Owners about the requirements of the laws, rules or regulations or any changes therein or thereto of any country or jurisdiction or of any governmental or regulatory authority or any securities exchange or market or automated quotation system.
(e) The Depositary and its agents will not be responsible for any failure to carry out any instructions to vote any of the Deposited Securities, for the manner in which any such vote is cast or for the effect of any such vote.
(f) The Depositary may rely upon instructions from the Company or its counsel in respect of any approval or license required for any currency conversion, transfer or distribution.
(g) The Depositary and its agents may own and deal in any class of securities of the Company and its affiliates and in ADRs.
(h) Notwithstanding anything to the contrary set forth in the Deposit Agreement or an ADR, the Depositary and its agents may fully respond to any and all demands or requests for information maintained by or on its behalf in connection with the Deposit Agreement, any Holder or Holders, any ADR or ADRs or otherwise related hereto or thereto to the extent such information is requested or required by or pursuant to any lawful authority, including without limitation laws, rules, regulations, administrative or judicial process, banking, securities or other regulators.
(i) None of the Depositary, the Custodian or the Company shall be liable for the failure by any Holder or Beneficial Owner to obtain the benefits of credits or refunds of non-U.S. tax paid against such Holder's or Beneficial Owner's income tax liability.
(j) The Depositary is under no obligation to provide the Holders or Beneficial Owners, or any of them, with any information about the tax status of the Company. The Depositary and the Company shall not incur any liability for any tax or tax consequences that may be incurred by Holders and Beneficial Owners on account of their ownership or disposition of the ADRs or ADSs.
(k) The Depositary shall not incur any liability for the content of any information submitted to it by or on behalf of the Company for distribution to the Holders or for any inaccuracy of any translation thereof, for any investment risk associated with acquiring an interest in the Deposited Securities, for the validity or worth of the Deposited Securities, for the credit-worthiness of any third party, for allowing any rights to lapse upon the terms of the Deposit Agreement or for the failure or timeliness of any notice from the Company.
A-17 |
(l) Notwithstanding anything herein or in the Deposit Agreement to the contrary, the Depositary and the Custodian(s) may use third party delivery services and providers of information regarding matters such as pricing, proxy voting, corporate actions, class action litigation and other services in connection herewith and the Deposit Agreement, and use local agents to provide services such as attendance at meetings of issuers of securities. Although the Depositary and the Custodian will use reasonable care (and cause their agents to use reasonable care) in the selection and retention of such third party providers and local agents, they will not be responsible for any errors or omissions made by them in providing the relevant information or services.
(m) The Depositary shall not be liable for any acts or omissions made by a successor depositary whether in connection with a previous act or omission of the Depositary or in connection with any matter arising wholly after the removal or resignation of the Depositary.
(n) By holding or owning an ADR or ADS or an interest therein, Holders and Beneficial Owners each irrevocably agree that any legal suit, action or proceeding against or involving Holders or Beneficial Owners brought by the Company or the Depositary, arising out of or based upon the Deposit Agreement, the ADSs, the ADRs or the transactions contemplated therein, herein, thereby or hereby, may be instituted in a state or federal court in New York, New York, and by holding or owning an ADR or ADS or an interest therein each irrevocably waives any objection which it may now or hereafter have to the laying of venue of any such proceeding, and irrevocably submits to the non-exclusive jurisdiction of such courts in any such suit, action or proceeding. By holding or owning an ADR or ADS or an interest therein, Holders and Beneficial Owners each also irrevocably agree that any legal suit, action or proceeding against or involving the Depositary brought by Holders or Beneficial Owners, arising out of or based upon the Deposit Agreement, the ADSs, the ADRs or the transactions contemplated therein, herein, thereby or hereby, including, without limitation, claims under the Securities Act of 1933, may only be instituted in the United States District Court for the Southern District of New York (or in the state courts of New York County in New York if either (i) the United States District Court for the Southern District of New York lacks subject matter jurisdiction over a particular dispute or (ii) the designation of the United States District Court for the Southern District of New York as the exclusive forum for any particular dispute is, or becomes, invalid, illegal or unenforceable).
(o) The Company has agreed to indemnify the Depositary and its agents under certain circumstances and the Depositary has agreed to indemnify the Company under certain circumstances.
A-18 |
(p) Neither the Depositary, the Company nor any of their respective agents shall be liable to Holders or Beneficial Owners for any indirect, special, punitive or consequential damages (including, without limitation, legal fees and expenses) or lost profits, in each case of any form incurred by any person or entity (including, without limitation, Holders and Beneficial Owners), whether or not foreseeable and regardless of the type of action in which such a claim may be brought.
(q) No provision of the Deposit Agreement or this ADR is intended to constitute a waiver or limitation of any rights which Holders or Beneficial Owners may have under the Securities Act of 1933 or the Securities Exchange Act of 1934, to the extent applicable.
(15) Resignation and Removal of Depositary; the Custodian.
(a) Resignation. The Depositary may resign as Depositary by written notice of its election so to do delivered to the Company, such resignation to take effect upon the appointment of a successor depositary and its acceptance of such appointment as provided in the Deposit Agreement.
(b) Removal. The Depositary may at any time be removed by the Company by no less than 60 days' prior written notice of such removal, to become effective upon the later of (i) the 60th day after delivery of the notice to the Depositary and (ii) the appointment of a successor depositary and its acceptance of such appointment as provided in the Deposit Agreement.
(c) The Custodian. The Depositary may appoint substitute or additional Custodians and the term "Custodian" refers to each Custodian or all Custodians as the context requires.
A-19 |
(16) Amendment. Subject to the last sentence of paragraph (2) (Withdrawal of Deposited Securities), the ADRs and the Deposit Agreement may be amended by the Company and the Depositary, provided that any amendment that imposes or increases any fees or charges on a per ADS basis (other than stock transfer or other taxes and other governmental charges, transfer or registration fees, SWIFT, cable, telex or facsimile transmission costs, delivery costs or other such expenses), or that shall otherwise prejudice any substantial existing right of Holders or Beneficial Owners, shall become effective 30 days after notice of such amendment shall have been given to the Holders. Every Holder and Beneficial Owner at the time any amendment to the Deposit Agreement so becomes effective shall be deemed, by continuing to hold such ADR, to consent and agree to such amendment and to be bound by the Deposit Agreement as amended thereby. In no event shall any amendment impair the right of the Holder of any ADR to surrender such ADR and receive the Deposited Securities represented thereby, except in order to comply with mandatory provisions of applicable law. Any amendments or supplements which (i) are reasonably necessary (as agreed by the Company and the Depositary) in order for (a) the ADSs to be registered on Form F-6 under the Securities Act of 1933 or (b) the ADSs or Shares to be traded solely in electronic book-entry form and (ii) do not in either such case impose or increase any fees or charges to be borne by Holders, shall be deemed not to prejudice any substantial rights of Holders or Beneficial Owners. Notwithstanding the foregoing, if any governmental body or regulatory body should adopt new laws, rules or regulations which would require amendment or supplement of the Deposit Agreement or the form of ADR to ensure compliance therewith, the Company and the Depositary may amend or supplement the Deposit Agreement and the ADR at any time in accordance with such changed laws, rules or regulations. Such amendment or supplement to the Deposit Agreement in such circumstances may become effective before a notice of such amendment or supplement is given to Holders or within any other period of time as required for compliance. Notice of any amendment to the Deposit Agreement or form of ADRs shall not need to describe in detail the specific amendments effectuated thereby, and failure to describe the specific amendments in any such notice shall not render such notice invalid, provided, however, that, in each such case, the notice given to the Holders identifies a means for Holders and Beneficial Owners to retrieve or receive the text of such amendment (i.e., upon retrieval from the Commission's, the Depositary's or the Company's website or upon request from the Depositary).
(17) Termination. The Depositary may, and shall at the written direction of the Company, terminate the Deposit Agreement and this ADR by mailing notice of such termination to the Holders at least 30 days prior to the date fixed in such notice for such termination; provided, however, if the Depositary shall have (i) resigned as Depositary hereunder, notice of such termination by the Depositary shall not be provided to Holders unless a successor depositary shall not be operating hereunder within 60 days of the date of such resignation, or (ii) been removed as Depositary hereunder, notice of such termination by the Depositary shall not be provided to Holders unless a successor depositary shall not be operating hereunder on the 60th day after the Company's notice of removal was first provided to the Depositary. Notwithstanding anything to the contrary herein, the Depositary may terminate the Deposit Agreement without notice to the Company, but subject to giving 30 days’ notice to the Holders, under the following circumstances: (i) in the event of the Company’s bankruptcy or insolvency, (ii) if the Shares cease to be listed on an internationally recognized stock exchange, (iii) if the Company effects (or will effect) a redemption of all or substantially all of the Deposited Securities, or a cash or share distribution representing a return of all or substantially all of the value of the Deposited Securities, or (iv) there occurs a merger, consolidation, sale of all or substantially all assets or other transaction as a result of which securities or other property are delivered in exchange for or in lieu of Deposited Securities.
A-20 |
After the date so fixed for termination, the Depositary and its agents will perform no further acts under the Deposit Agreement and this ADR, except to receive and hold (or sell) distributions on Deposited Securities and deliver Deposited Securities being withdrawn. As soon as practicable after the date so fixed for termination, the Depositary shall use its reasonable efforts to sell the Deposited Securities and shall thereafter (as long as it may lawfully do so) hold in an account (which may be a segregated or unsegregated account) the net proceeds of such sales, together with any other cash then held by it under the Deposit Agreement, without liability for interest, in trust for the pro rata benefit of the Holders of ADRs not theretofore surrendered. After making such sale, the Depositary shall be discharged from all obligations in respect of the Deposit Agreement and this ADR, except to account for such net proceeds and other cash. After the date so fixed for termination, the Company shall be discharged from all obligations under the Deposit Agreement except for its obligations to the Depositary and its agents.
(18) Appointment; Acknowledgements and Agreements. Each Holder and each Beneficial Owner, upon acceptance of any ADSs or ADRs (or any interest in any of them) issued in accordance with the terms and conditions of the Deposit Agreement shall be deemed for all purposes to (a) be a party to and bound by the terms of the Deposit Agreement and the applicable ADR(s), (b) appoint the Depositary its attorney-in-fact, with full power to delegate, to act on its behalf and to take any and all actions contemplated in the Deposit Agreement and the applicable ADR(s), to adopt any and all procedures necessary to comply with applicable law and to take such action as the Depositary in its sole discretion may deem necessary or appropriate to carry out the purposes of the Deposit Agreement and the applicable ADR(s), the taking of such actions to be the conclusive determinant of the necessity and appropriateness thereof, and (c) acknowledge and agree that (i) nothing in the Deposit Agreement or any ADR shall give rise to a partnership or joint venture among the parties thereto nor establish a fiduciary or similar relationship among such parties, (ii) the Depositary, its divisions, branches and affiliates, and their respective agents, may from time to time be in the possession of non-public information about the Company, Holders, Beneficial Owners and/or their respective affiliates, (iii) the Depositary and its divisions, branches and affiliates may at any time have multiple banking relationships with the Company, Holders, Beneficial Owners and/or the affiliates of any of them, (iv) the Depositary and its divisions, branches and affiliates may, from time to time, be engaged in transactions in which parties adverse to the Company or the Holders or Beneficial Owners may have interests, (v) nothing contained in the Deposit Agreement or any ADR(s) shall (A) preclude the Depositary or any of its divisions, branches or affiliates from engaging in such transactions or establishing or maintaining such relationships, or (B) obligate the Depositary or any of its divisions, branches or affiliates to disclose such transactions or relationships or to account for any profit made or payment received in such transactions or relationships, (vi) the Depositary shall not be deemed to have knowledge of any information held by any branch, division or affiliate of the Depositary and (vii) notice to a Holder shall be deemed, for all purposes of the Deposit Agreement and this ADR, to constitute notice to any and all Beneficial Owners of the ADSs evidenced by such Holder’s ADRs. For all purposes under the Deposit Agreement and this ADR, the Holder hereof shall be deemed to have all requisite authority to act on behalf of any and all Beneficial Owners of the ADSs evidenced by this ADR.
A-21 |
(19) Waiver. EACH PARTY TO THE DEPOSIT AGREEMENT (INCLUDING, FOR AVOIDANCE OF DOUBT, EACH HOLDER AND BENEFICIAL OWNER OF, AND/OR HOLDER OF INTERESTS IN, ADSS OR ADRS) HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY SUIT, ACTION OR PROCEEDING AGAINST THE DEPOSITARY AND/OR THE COMPANY DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THE SHARES OR OTHER DEPOSITED SECURITIES, THE ADSs OR THE ADRs, THE DEPOSIT AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREIN OR THEREIN, OR THE BREACH HEREOF OR THEREOF (WHETHER BASED ON CONTRACT, TORT, COMMON LAW OR ANY OTHER THEORY) INCLUDING, WITHOUT LIMITATION, ANY SUIT, ACTION OR PROCEEDING UNDER THE UNITED STATES FEDERAL SECURITIES LAWS. No provision of the Deposit Agreement or any ADR is intended to constitute a waiver or limitation of any rights which Holders or Beneficial Owners may have under the Securities Act of 1933 or the Securities Exchange Act of 1934, to the extent applicable.
(20) Elective Distributions in Cash or Shares. Whenever the Company intends to distribute a dividend payable at the election of the holders of Shares in cash or in additional Shares, the Company shall give notice thereof to the Depositary at least 30 days prior to the proposed distribution stating whether or not it wishes such elective distribution to be made available to Holders. Upon receipt of notice indicating that the Company wishes such elective distribution to be made available to Holders, the Depositary shall consult with the Company to determine, and the Company shall assist the Depositary in its determination, whether it is lawful and reasonably practicable to make such elective distribution available to the Holders. The Depositary shall make such elective distribution available to Holders only if (i) the Company shall have timely requested that the elective distribution is available to Holders, (ii) the Depositary shall have determined that such distribution is reasonably practicable and (iii) the Depositary shall have received satisfactory documentation within the terms of Section 14 of the Deposit Agreement including, without limitation, any legal opinions of counsel in any applicable jurisdiction that the Depositary in its reasonable discretion may request, at the expense of the Company. If the above conditions are not satisfied, the Depositary shall, to the extent permitted by law, distribute to the Holders, on the basis of the same determination as is made in the local market in respect of the Shares for which no election is made, either (x) cash or (y) additional ADSs representing such additional Shares. If the above conditions are satisfied, the Depositary shall establish a record date and establish procedures to enable Holders to elect the receipt of the proposed dividend in cash or in additional ADSs. The Company shall assist the Depositary in establishing such procedures to the extent necessary. Nothing herein shall obligate the Depositary to make available to Holders a method to receive the elective dividend in Shares (rather than ADSs). There can be no assurance that Holders or Beneficial Owners generally, or any Holder and/or Beneficial Owner in particular, will be given the opportunity to receive elective distributions on the same terms and conditions as the holders of Shares.
A-22 |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Registration Statement on Form F-1 of Argo Blockchain plc of our report dated May 20, 2021 relating to the financial statements of Argo Blockchain plc, which appears in this Registration Statement. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
London, England
/s/ PKF Littlejohn LLP
September 14, 2021
II-1